improv
clinic
outcom
staphylococcu
aureu
septicaemia
earli
select
appropri
antibiot
treatment
crucial
molecular
diagnost
repres
attract
approach
rapid
identif
aureu
determin
methicillin
resist
direct
comparison
molecular
assay
meca
real
time
pcr
standard
laboratori
procedur
evalu
bd
geneohm
tm
staphsr
assay
use
detect
aureu
methicillinresist
aureu
mrsa
staphylococci
spike
blood
cultur
bottl
case
detect
aureu
mssa
mrsa
bd
geneohm
tm
staphsr
assay
sensit
specif
confid
interv
ci
respect
mrsa
test
ci
sensit
ci
specif
overal
discrep
result
aros
assay
due
presenc
methicillinsuscept
revert
mrsa
strain
mrsa
strain
undetect
bd
geneohm
tm
staphsr
assay
compar
realtimepcr
base
molecular
approach
convent
standard
laboratori
method
bd
geneohm
tm
staphsr
turn
appropri
diagnost
tool
rapid
hour
preliminari
identif
aureu
mrsa
blood
cultur
bacteri
contamin
current
major
infecti
hazard
platelet
transfus
detect
bacteri
contamin
platelet
concentr
pc
implement
sever
blood
servic
routin
qualiti
control
test
date
transfusiontransmit
bacteri
sepsi
complet
prevent
present
studi
novel
flow
cytometrybas
method
develop
rapid
pointofissu
screen
pc
bacteri
contamin
bactiflow
flow
cytomet
use
detect
count
bacteria
base
esteras
activ
viabl
cell
protocol
bacteri
screen
pc
establish
enzymat
digest
centrifiltr
elimin
viabl
platelet
select
label
bacteria
fluoresc
esteras
substrat
result
bactiflow
countsml
show
excel
correl
plate
count
result
cfuml
lower
detect
limit
assay
determin
cfuml
wherea
timeto
result
less
hour
investig
new
applic
comparison
incub
bactalert
cultur
system
rapid
nucleic
acidbas
immunoassay
detect
method
rtpcr
pan
genera
detect
technolog
studi
demonstr
bactiflow
assay
suitabl
rapid
bacteri
screen
pc
fulfil
requir
pointofissuetest
pc
accept
timetoresult
specif
sensit
cost
evalu
bd
geneohm
tm
staphsr
assay
detect
methicillinresist
methicillinsuscept
staphylococcu
aureu
isol
spike
posit
blood
cultur
bottl
groebner
dion
plant
v
kempf
institut
medizinisch
mikrobiologi
und
hygien
germani
bd
diagnost
geneohm
canada
improv
clinic
outcom
staphylococcu
aureu
septicaemia
earli
select
appropri
antibiot
treatment
crucial
molecular
diagnost
repres
attract
approach
rapid
identif
aureu
determin
methicillin
resist
direct
comparison
molecular
assay
meca
real
time
pcr
standard
laboratori
procedur
evalu
bd
geneohm
tm
staphsr
assay
use
detect
aureu
methicillinresist
aureu
mrsa
staphylococci
spike
blood
cultur
bottl
case
detect
aureu
mssa
mrsa
bd
geneohm
tm
staphsr
assay
sensit
specif
confid
interv
ci
respect
mrsa
test
ci
sensit
ci
specif
overal
discrep
result
aros
assay
due
presenc
methicillinsuscept
revert
mrsa
strain
mrsa
strain
undetect
bd
geneohm
tm
staphsr
assay
compar
realtimepcr
base
molecular
approach
convent
standard
laboratori
method
bd
geneohm
tm
staphsr
turn
appropri
diagnost
tool
rapid
hour
preliminari
identif
aureu
mrsa
blood
cultur
vollmer
k
kleesiek
j
dreier
institut
laboratoriumsund
transfusionsmedizin
herzund
diabeteszentrum
nrw
der
bochum
bad
oeynhausen
germani
bacteri
contamin
current
major
infecti
hazard
platelet
transfus
detect
bacteri
contamin
platelet
concentr
pc
implement
sever
blood
servic
routin
qualiti
control
test
date
transfusiontransmit
bacteri
sepsi
complet
prevent
present
studi
novel
flow
cytometrybas
method
develop
rapid
pointofissu
screen
pc
bacteri
contamin
bactiflow
flow
cytomet
use
detect
count
bacteria
base
esteras
activ
viabl
cell
protocol
bacteri
screen
pc
establish
enzymat
digest
centrifiltr
elimin
viabl
platelet
select
label
bacteria
fluoresc
esteras
substrat
result
bactiflow
countsml
show
excel
correl
plate
count
result
cfuml
lower
detect
limit
assay
determin
cfuml
wherea
timeto
result
less
hour
investig
new
applic
comparison
incub
bactalert
cultur
system
rapid
nucleic
acidbas
immunoassay
detect
method
rtpcr
pan
genera
detect
technolog
studi
demonstr
bactiflow
assay
suitabl
rapid
bacteri
screen
pc
fulfil
requir
pointofissuetest
pc
accept
timetoresult
specif
sensit
cost
introduct
test
avid
toxoplasmaspecif
immunoglobulin
g
avid
test
prove
especi
use
serolog
screen
pregnanc
rule
recent
infect
mani
case
persist
posit
igm
compar
new
avid
test
kit
architect
abbott
laboratori
abbott
park
illinoi
usa
architect
vida
avid
test
marci
letoil
franc
vida
materi
method
analys
biolab
gmbh
motherchildhealthservic
styrian
statutori
health
insur
compani
provid
screen
test
toxoplasmosi
pregnanc
major
pregnant
women
austrian
state
upper
austria
styria
sera
upper
austria
sera
styria
test
avid
architect
vida
test
one
specimen
upper
austria
yield
indetermin
result
vida
therefor
exclud
betaretroviru
smrv
squirrel
monkey
retroviru
first
isol
lung
cell
cultur
squirrel
monkey
viru
could
propag
seri
differ
mammalian
cell
line
origin
although
smrv
describ
nonpathogen
human
anim
report
presenc
varieti
cell
line
led
suggest
zkb
zentral
kommiss
biologisch
sicherheit
laboratori
germani
use
cell
line
genet
engin
test
occur
smrv
investig
human
anim
cell
line
dsmz
cell
bank
six
cell
line
found
posit
smrv
thu
result
show
low
abund
smrv
certifi
cell
line
low
infect
rate
indic
smrv
transmit
cross
contamin
compar
distribut
mycoplasma
cell
line
cross
contamin
latter
major
problem
reproduc
research
result
cell
line
control
continu
contamin
agent
mention
common
difficult
detect
littl
harm
host
cultiv
obligat
intracellular
bacteria
like
chlamydiacea
rickettsiacea
lead
similar
problem
cure
extrem
difficult
differ
contamin
agent
well
control
measur
present
import
discuss
perform
commerci
mrsa
natassay
clinic
routin
n
ostendorf
zentrallabor
st
katharinenhospit
frechen
frechen
germani
object
april
introduc
commerci
avail
mrsa
nucleic
acid
amplif
techniqu
nat
assay
xpert
mrsa
stat
screen
patient
certain
condit
ass
qualiti
sampl
reliabl
new
procedur
cultur
done
swab
result
two
year
compar
method
screen
mrsa
nat
done
consult
microbiologist
initi
phase
standard
microbiolog
swab
ami
medium
use
month
swab
chang
dri
cotton
swab
sampl
streak
columbia
agar
plate
sheep
blood
perform
nat
cultur
inspect
aureuscoloni
hour
suspect
cultur
identifi
procedur
done
one
swab
intent
although
contact
blood
agar
could
possibl
interfer
result
nat
result
test
evalu
test
invalid
result
judg
expert
system
natanalys
use
swab
ami
medium
sampl
produc
invalid
result
chang
dri
cotton
swab
sampl
invalid
specimen
found
mrsa
posit
found
posit
cultur
remain
neg
patient
differ
result
test
mrsaposit
posit
nattest
plausibl
patient
complet
screen
initi
posit
result
specimen
neg
cultur
patient
lost
followup
natneg
sampl
sampl
invalid
result
neg
cultur
conclus
genexpert
mrsa
system
show
good
correl
result
mrsascreen
cultur
nevertheless
number
invalid
test
procedur
rel
high
sampl
process
scheme
blood
stream
infect
microorgan
lifethreaten
condit
accompani
high
mortal
rate
especi
critic
ill
neutropen
patient
blood
cultur
advic
identif
pathogen
prior
initi
antibiot
treatment
major
drawback
diagnost
tool
high
rate
fals
neg
result
due
inappropri
growth
condit
growth
inhibit
due
antibiot
treatment
long
timetoresult
detect
identif
molecular
method
includ
pcr
discuss
promis
tool
rapid
detect
pathogen
case
report
patient
report
sever
repetit
blood
cultur
drawn
initi
antibiot
therapi
parallel
univers
rdna
realtim
pcr
appli
use
new
test
sepsitesttm
molzym
bremen
adequ
antibiot
treatment
confirm
later
microbiolog
test
observ
associ
decreas
bacteri
dna
load
blood
sampl
time
conclus
case
suggest
sepsitesttm
abl
correctli
diagnos
bacteri
blood
stream
infect
moreov
effect
adequ
antibiot
treatment
monitor
decreas
rel
bacteri
dna
load
success
blood
sampl
fenner
h
petersen
n
wies
f
hein
n
siemsen
l
frommelt
dept
microbiolog
inst
clinic
patholog
microbiol
dr
fenner
colleagu
hamburg
germani
dept
molecular
diagnost
inst
clinic
patholog
microbiol
dr
fenner
colleagu
hamburg
germani
fen
lab
gmbh
envir
medicin
hamburg
germani
surgeri
hamburg
germani
microbiolog
institut
clinic
microbiolog
hamburg
germani
background
cultur
ist
gold
standard
time
consum
method
detect
bacteria
small
coloni
variant
synovi
fluid
compar
new
commerci
avail
real
time
pcr
assay
septifast
roch
switzerland
normal
use
blood
cultur
detect
bacteria
use
synovi
fluid
sf
aim
studi
earlier
sensit
detect
small
amount
gram
posit
gram
neg
bacteria
reduc
time
detect
differenti
contamin
infect
materi
detect
method
appli
method
sf
obtain
septifast
perform
accord
standard
oper
procedur
cultur
done
ml
sf
aerob
anaerob
growth
media
preliminari
test
detect
limit
septifast
test
staphylococcu
aureu
ecoli
klebsiella
spp
enterococci
spike
cultur
neg
sampl
sf
result
detect
limit
septifast
lower
cfu
per
ml
sf
sf
sampl
collect
patient
neg
septifast
cultur
three
isol
gram
neg
bacteria
staphylococcu
aureu
detect
cultur
septifast
two
seven
isol
detect
cultur
could
recogn
septifast
techniqu
lack
septifast
databas
one
cultur
posit
result
might
contamin
staphylococcu
spp
one
cultur
posit
result
staphylococcu
epidermidi
detect
septifast
conclus
synovi
fluid
main
focu
septifast
test
howev
fast
sensit
detect
gram
neg
strain
staphylococcu
aureu
possibl
within
less
hour
therefor
method
valuabl
add
cultur
case
joint
infect
need
urg
decis
therapi
matrixassist
laser
desorpt
ioniz
timeofflight
malditof
mass
spectrometri
modern
techniqu
identifi
speci
microorgan
advantag
method
fast
reliabl
speci
identif
simpl
workflow
low
consum
cost
previous
method
success
appli
scientif
research
analys
examin
malditof
suitabl
tool
identif
broad
rang
pathogen
bacteria
yeast
clinic
practic
six
month
period
clinic
isol
routin
diagnost
investig
parallel
malditof
anaylsi
microflexbiotyp
bruker
dalton
bremen
germani
convent
standard
method
biochem
reaction
eg
api
system
oxidas
catalas
etc
select
media
gram
stain
microscopi
etc
case
contrast
result
malditof
standard
analysi
method
addit
identif
techniqu
phoenix
system
rdna
sequenc
perform
final
differenti
isol
total
bacteria
yeast
speci
identifi
almost
malditof
identif
result
correspond
standard
method
moreov
malditof
identif
result
confirm
phoenix
andor
pcr
analys
malditof
standard
method
yield
incongru
result
therefor
suggest
examin
isol
identifi
correctli
malditof
mass
spectrometri
summari
malditof
base
identif
provid
faster
long
run
inexpens
bacteri
speci
identif
convent
method
high
accuraci
expans
malditof
databas
even
enhanc
qualiti
malditof
identif
result
wolter
christner
aepfelbach
h
rohd
institut
medizinisch
mikrobiologi
virologi
und
hygien
hamburgeppendorf
hamburg
germani
methicillinresist
staphylococcu
aureu
mrsa
major
caus
nosocomi
infect
earli
detect
potenti
nosocomi
outbreak
initi
hospit
infect
control
measur
import
step
limit
mrsa
dissemin
reach
goal
time
determin
epidemiolog
related
clinic
mrsa
isol
essenti
genet
type
method
like
pulsedfield
gel
electrophoresi
pfge
spatyp
multilocu
sequenc
type
mlst
high
discriminatori
power
howev
method
time
consum
cost
intens
preclud
short
term
type
broad
routin
applic
aim
studi
evalu
gener
potenti
whole
cell
matrixassist
laser
desorpt
ionizationtimeofflight
mass
spectrometri
malditofm
base
finger
print
clonal
discrimin
clinic
mrsa
isol
total
isol
belong
spa
type
five
major
clonal
lineag
analyz
malditofm
protein
mass
signatur
base
dendrogram
creat
use
biotyp
softwar
distanc
level
five
major
maldi
tof
cluster
distinguish
show
complet
concord
clonal
related
deduc
spatyp
assess
stabil
malditofm
spectra
marker
strain
identif
sequenti
isol
collect
three
persist
colon
patient
month
analyz
spatyp
pfge
malditofm
type
result
genet
method
demonstr
close
related
sequenti
isol
patient
accordingli
malditofm
show
cluster
consecut
isol
patient
result
suggest
malditofm
potenti
becom
valuabl
tool
inexpens
rapid
type
mrsa
hospit
infect
control
videoscan
platform
multiplex
pcr
detect
e
coli
gene
j
weinreich
j
nitschk
c
p
schierack
center
cardiovascular
research
ccr
germani
senftenberg
germani
fachbereich
bio
chemieund
verfahrenstechnik
hochschul
lausitz
fh
senftenberg
germani
within
framework
innoprofil
project
new
technolog
molecular
diagnost
realtimepcrarray
fund
bundesministerium
bildung
und
forschung
bmbf
germani
develop
microparticlebas
dna
detect
technolog
rapid
simultan
detect
pcr
product
differ
microparticl
popul
defin
vari
ratio
two
fluorophor
includ
pcr
mastermix
microparticl
popul
present
uniqu
gene
specif
captur
probe
surfac
pcr
amplicon
label
report
dye
directli
dna
amplif
pcr
product
hybrid
complementari
captur
probe
respect
microparticl
hybrid
thu
pcr
success
automat
analys
videoscan
platform
sampl
analys
parallel
convent
plate
format
present
data
amplif
gene
chua
yiaa
use
classifi
e
coli
phylogenet
ecor
group
clermont
et
al
employ
four
differ
microparticl
popul
carri
correspond
captur
probe
neg
control
unrel
sequenc
respect
comparison
standard
etbragaros
gel
base
analysi
show
detect
hybrid
pcr
product
use
videoscan
platform
likewis
specif
sensit
conclus
videoscan
platform
proven
reliabl
dna
detect
tool
combin
pcr
subsequ
hybrid
microparticl
higher
diagnost
sensit
achiev
format
automat
analysi
multiplex
pcr
assay
save
labour
time
result
higher
sampl
throughput
contrast
convent
multiplex
pcr
examin
use
agaros
gel
semiquantit
dnastrip
technolog
evalu
treatment
periodont
accur
identif
microorgan
one
cornerston
form
fundament
clinic
microbiolog
investig
infecti
diseas
speed
accuraci
classic
biochem
test
microbi
identif
limit
mani
case
satisfactori
thu
novel
technolog
microorgan
speci
identif
introduc
clinic
routin
present
comparison
malditof
mass
spectrometri
fingerprint
speci
identif
current
practic
russian
clinic
laboratori
microbi
speci
identif
clinic
specimen
done
parallel
tradit
microbiolog
method
malditof
ms
fingerprint
coloni
transfer
water
precipit
ethanol
centrifug
pellet
suspend
pure
acetonitril
formic
acid
analyz
microflex
tm
bruker
daltonik
germani
gener
coloni
analyz
per
cultur
plate
speci
identif
done
use
maldi
biotyp
softwar
bruker
daltonik
germani
addit
rrna
gene
sequenc
discord
result
perform
microb
wound
urin
genit
tract
pharynx
patient
studi
total
coloni
plate
primari
select
plate
plate
suscept
test
identifi
use
maldi
biotyp
techniqu
coloni
speci
identif
standard
laboratori
method
maldi
biotypertm
concord
case
discord
mass
spectrometri
microbiolog
id
found
maldi
identif
result
could
confirm
rrna
sequenc
one
microorgan
malditof
ms
analysi
gave
identif
result
therefor
malditof
ms
profil
use
maldi
biotyp
found
excel
method
microbi
speci
identif
clinic
set
meisel
p
j
popp
institut
physikalisch
chemi
friedrich
jena
jena
germani
optic
detect
method
becom
relev
field
hygien
monitor
detect
singl
bacteria
cell
microraman
spectroscopi
spatial
resolut
approx
provid
fast
sensit
analysi
method
principl
identif
due
spectroscop
fingerprint
molecular
composit
bacterium
compar
establish
microbiolog
molecularbas
approach
one
percept
reduct
sampl
prepar
analysi
time
offer
direct
examin
bacteri
cell
extract
natur
habitat
without
precultiv
hygien
relev
microorgan
pseudomona
major
caus
nosocomi
infect
microbi
spoilag
food
hazard
spa
drink
water
opportunist
organ
widespread
soil
water
area
environ
furthermor
presenc
often
indic
presenc
waterborn
microb
fast
reliabl
screen
tool
pseudomona
necessari
limit
impact
contamin
context
singl
bacteria
cell
differ
pseudomona
speci
investig
speci
identif
preform
raman
spectroscop
databas
usag
chemometr
method
acknowledg
grate
acknowledg
financi
support
deutsch
forschungsgemeinschaft
po
p
et
al
appli
environment
microbiolog
evalu
novel
fulli
autom
clostridium
difficil
pcr
method
deliv
answer
within
one
hour
directli
clinic
sampl
rapid
molecuar
sceen
method
avail
culturebas
screen
commonli
use
method
studi
conduct
evalu
clinic
use
differ
mrsascreen
protocol
use
current
diagnost
method
total
consecut
specimen
patient
suspect
mrsa
colon
infect
routin
screen
two
laboratori
includ
gold
standard
defin
combin
cultur
select
chromogen
media
scm
nonselect
media
nsm
enrich
broth
eb
hour
adit
subcultur
scm
eb
hour
comparison
made
screen
scmnsm
screen
use
one
select
chromogen
medium
hour
screen
scmnsm
without
eb
result
total
mrsa
detect
among
detect
subcultur
eb
scm
hour
incub
sensit
specif
ppv
npv
comparison
gold
standard
follow
respect
conclus
despit
similar
npv
valu
sensit
cultur
base
screen
mrsa
significantli
lower
eb
subcultur
incub
time
less
hour
use
use
protocol
deviat
gold
standard
routin
microlab
mrsa
posit
patient
would
detect
studi
studi
use
commerci
biologsystem
hayward
usa
analys
strain
belong
differ
speci
subspeci
genu
francisella
determin
oxid
contain
carbonsubstr
use
method
biochem
differenti
francisella
speci
subspeci
speci
subspeci
affili
test
strain
confirm
rdnaand
rdna
sequenc
analysi
substrat
belong
system
nine
oxid
francisellastrain
test
oxid
none
strain
test
oxid
differenti
francisella
tularensi
f
philomiragia
well
f
tul
subspeci
tularensi
subsp
holarctica
subsp
mediasiatica
subsp
novicida
could
distinguish
respect
pattern
reaction
extend
carbon
sourc
util
method
analys
differ
metabol
reaction
may
use
futur
method
biochem
identif
differenti
strain
belong
genu
francisella
within
hour
method
may
use
analysi
character
new
francisella
speci
subspeci
last
year
raman
spectroscopi
emerg
power
tool
analysi
singl
cell
even
tissu
invivo
spectroscopi
inform
cell
compon
live
cell
analys
without
destroy
aid
microraman
spectroscopi
possibl
resolv
textur
submicron
rang
record
raman
spectra
within
spatial
resolut
focu
work
lie
identif
microorgan
without
need
cultiv
step
microraman
spectroscopi
reveal
spatial
resolut
approx
quit
size
rang
bacteria
combin
microraman
spectroscopi
differ
chemometr
approach
allow
identif
bacteria
even
strain
level
howev
real
sampl
local
step
necessari
prior
identif
local
microorgan
complex
sampl
matrix
like
eg
air
food
sampl
often
complic
sinc
mani
particl
exhibit
similar
size
shape
compar
microorgan
therefor
local
routin
establish
allow
differenti
biotic
abiot
particl
one
possibl
approach
use
fluoresc
stain
sinc
fluoresc
sever
order
magnitud
stronger
raman
spectroscopi
right
combin
fluoresc
imag
raman
spectroscop
necessari
identifi
microorgan
singl
cell
level
gramposit
anaerob
cocci
gpac
part
commens
microbiotia
human
account
onethird
anaerob
isol
recoverd
clinic
materi
late
taxonomi
gpac
chang
dramat
former
genu
peptostreptococcu
divid
six
phylogenet
group
genera
propos
parvimona
finegoldia
peptoniphilu
anaerococcu
peptostreptococcu
gallicola
phenotyp
identif
gpac
alway
straightforward
speci
easili
differenti
variou
molecular
method
identifi
gpac
becom
avail
togeth
approach
base
malditof
mass
spectrometri
present
studi
gpac
strain
analys
malditof
ms
appli
simpl
standard
prepar
protocol
strain
prove
access
mass
spectral
analysi
without
constraint
even
storag
agar
plate
aerob
condit
hour
result
mass
spectra
evalu
taxonom
resolut
sarami
spectral
archiv
microbi
identif
system
mass
spectral
pattern
highli
reproduc
specif
dendrogram
base
similar
mass
spectral
pattern
similar
topolog
rdna
gene
sequenc
tree
gpac
speci
thu
easili
distinguish
mass
spectrometri
one
speci
complex
peptoniphilu
ivorii
sl
sever
distinct
type
could
discern
question
coher
speci
test
identif
perform
mass
spectral
data
sequenc
clinic
isol
fed
sarami
databas
appli
analysi
blind
sampl
identifi
correctli
remain
could
identifi
unambigu
molecular
method
high
success
rate
underlin
high
potenti
maldisarami
rapid
identif
anaerob
within
minut
laboratori
analys
infect
diagnost
gener
consum
potenti
caus
direct
harm
r
siekmeier
wetzel
abteilung
medizinprodukt
bundesinstitut
arzneimittel
und
medizinprodukt
bfarm
bonn
germani
european
direct
invitro
diagnost
medic
devic
ivd
regul
market
post
market
surveil
ivd
european
econom
area
manufactur
inform
respons
compet
author
ca
incid
field
correct
action
relat
ivd
germani
feder
institut
drug
medic
devic
bfarm
respons
ca
ivd
ivd
analys
specifi
annex
ii
direct
respons
paulehrlichinstitut
pei
end
bfarm
receiv
total
report
regard
ivd
relat
laboratori
analys
infect
diagnost
gener
consum
analys
respect
type
risk
caus
report
product
failur
analys
group
case
characteris
direct
harm
laboratori
personnel
case
indirect
harm
patient
detail
risk
direct
harm
caus
analys
electr
shock
burn
infect
mechan
hurt
wherea
patient
risk
due
erron
delay
result
consum
case
relat
risk
direct
harm
infect
risk
indirect
harm
erron
delay
result
respect
expect
product
relat
analys
reveal
infect
risk
especi
analys
consum
diagnost
base
cultur
molecular
biolog
method
e
method
base
analysi
fresh
sampl
interestingli
case
direct
harm
analys
consum
caus
user
error
howev
even
though
relev
risk
direct
harm
report
sever
outcom
result
suggest
ivd
infect
diagnost
bear
risk
patient
misdiagnosi
also
bear
relev
risk
direct
harm
user
lab
personnel
consid
accordingli
user
manufactur
erhard
f
seyfarth
welker
uc
hipler
clinic
applic
anagnostec
gmbh
potsdam
germani
klinik
dermatologi
und
dermatologisch
allergologi
jena
jena
germani
pathogen
yeast
speci
dermatolog
clinic
sampl
belong
genera
candida
pichia
issatchenkia
rhodotorula
trichosporon
howev
occurr
yeast
speci
dermatolog
sampl
consid
rapid
identif
method
requir
reliabl
identif
uncommon
pathogen
adequ
treatment
analys
yeast
specimen
dermatolog
sampl
malditof
ms
technolog
microbiolog
identif
current
replac
classic
methodolog
medic
mycolog
yeast
cell
prepar
mass
spectrometri
directli
agar
plate
appli
standard
protocol
analys
automat
mass
spectra
sampl
match
databas
sarami
spectral
archiv
microbi
identif
system
contain
mass
spectral
data
high
number
refer
strain
among
blind
isol
could
identifi
common
yeast
speci
consist
result
id
c
analys
isol
mass
spectral
pattern
show
similar
frequent
encount
candida
speci
eg
c
albican
c
glabrata
remain
isol
sever
show
similar
candida
sp
mass
spectral
pattern
could
subsequ
identifi
unambigu
speci
genera
pichia
issatchenkia
rhodotorula
trichosporon
remain
six
isol
mass
spectral
data
correspond
refer
strain
avail
time
first
analys
collect
consecut
malditof
mssarami
success
appli
rapid
reliabl
identif
major
yeast
isol
system
prove
highli
adapt
recognit
identif
rare
fungal
pathogen
direct
databas
extens
comparison
two
differ
fulli
autom
bacteri
identif
system
microscan
rdna
sequenc
malditof
c
lens
fenner
h
fenner
bakteriologi
labor
dr
fenner
und
kollegen
hamburg
germani
applic
malditof
receiv
interest
microbiolog
laboratori
diagnost
comparison
classic
autom
identif
system
rapid
bacteri
identif
outstand
howev
reliabl
identif
need
verifi
clinic
cultur
sampl
isol
test
parallel
use
either
one
two
autom
system
biomerieux
microscan
siemen
healthcar
diagnost
rdna
sequenc
malditof
bruker
dalton
use
smear
method
sampl
applic
malditof
target
extract
protocol
perform
two
spot
sampl
appli
malditof
target
one
cover
formic
acid
ad
matrix
isol
gram
gram
test
use
malditof
isol
gram
gram
use
malditof
rdna
isol
gram
gram
use
malditof
microscan
ident
identif
found
compar
malditof
compar
malditof
rdna
compar
malditof
microscan
almost
ambigu
result
report
use
rdna
sequenc
due
streptococcu
sp
malditof
system
result
rdna
show
result
malditof
unidentifi
bacteria
includ
malditof
databas
identif
result
malditof
superior
gram
gramaerob
bacteria
compar
micoscan
applic
formic
acid
yield
better
identif
score
gram
bacteria
malditof
use
rapid
method
identifi
bacteria
speci
routin
microbiolog
laboratori
diagnost
extend
identif
spectra
autom
system
gener
result
malditof
review
especi
identif
result
uncommon
bacteria
bacteria
usual
difficult
identifi
autom
microbiolog
diagnost
use
malditof
microscan
walkaway
system
malditof
ms
base
differenti
bacteria
yeast
clinic
sampl
altern
biochem
test
system
schubert
b
c
wagner
hogardt
max
von
pettenkoferinstitut
hygien
und
medizinisch
mikrobiologi
germani
object
studi
compar
novel
matrix
assist
laser
desorptionionis
time
flight
malditof
base
method
bacteri
differenti
common
biochem
test
system
studi
criteria
includ
perform
time
accuraci
easi
use
method
answer
shall
given
whether
novel
system
futur
altern
biochem
test
system
method
yeast
bacteri
isol
obtain
form
clinic
sampl
investig
parallel
malditof
system
microflexbiotyp
bruker
dalton
bremen
germani
use
biochem
test
system
api
phoenix
becton
dickinson
case
incongru
result
system
sequenc
gene
perform
final
molecular
differenti
isol
result
bacteri
isol
compris
isol
differ
member
enterobacteriacea
nonfer
gram
neg
rod
gramneg
bacteria
staphylococci
streptococci
gramposit
rod
eg
corynebacteria
time
differenti
less
min
isol
ident
result
obtain
system
maldi
inferior
superior
biochem
test
conclus
malditof
enabl
bacteri
fungal
differenti
yet
provid
substanti
data
antibiot
resist
isol
bacteria
cultur
plate
requir
suitabl
detect
bacteria
directli
clinic
sampl
howev
malditof
base
method
bacteri
differenti
provid
reliabl
result
within
minut
easi
perform
enabl
genotyp
certain
extend
enlarg
maldidatabas
improv
method
even
though
initi
acquisit
malditof
apparatu
expens
essenti
cost
consum
make
system
especi
interest
larg
scale
diagnost
laboratori
identif
anaerob
requir
often
labori
expens
method
malditofm
offer
possibl
rapid
costeffect
identif
microorgan
includ
anaerob
speci
malditofm
identif
base
comparison
spectrum
mass
signal
isol
varieti
spectra
store
databas
db
describ
amplif
sarami
databas
sdb
anagnostec
clinic
relev
anaerob
speci
spectra
obtain
malditofm
shimadzu
one
key
featur
sdb
differenti
spectra
sp
superspectra
ssp
ssp
contain
characterist
mass
signal
certain
speci
alig
ssp
allow
faster
precis
identif
compar
align
singl
spectra
sdb
compris
spectra
ssp
less
regard
anaerob
speci
order
establish
malditofm
standard
identif
method
anaerob
influenc
cultur
media
exposit
oxygen
cultur
matrix
embed
sampl
exclud
test
set
refer
strain
comparison
standard
identif
method
clinic
isol
mainli
belong
bacteroid
speci
finegoldia
magna
could
easili
accur
identifi
malditof
sdb
contrast
identif
porphyromona
prevotella
fusobacterium
speci
sdb
contain
suffici
data
therefor
spectra
differ
speci
genera
obtain
analys
creat
ssp
essenti
spectra
strain
belong
certain
speci
cluster
insid
speci
show
clear
differ
spectra
speci
eg
fusobacterium
varium
contrast
mani
prevotella
speci
show
larger
heterogen
isol
show
mark
differ
strain
within
speci
requir
reidentif
concern
ongo
taxonom
develop
implement
malditof
analysi
standard
identif
method
clinic
microbiolog
laboratori
marschal
p
braitmaier
u
schumach
ib
autenrieth
institut
medizinisch
mikrobiologi
und
hygien
germani
matrix
assist
laser
desorptionionis
malditof
increasingli
use
identif
bacteri
isol
describ
implement
methodolog
shimadzuanagnostec
workflow
laboratori
begin
malditofm
analys
mta
perform
columbiablood
agar
plate
influenc
differ
cultur
media
mta
result
exclud
follow
analys
perform
parallel
standard
identif
procedur
media
case
discrep
result
obtain
standard
method
mta
addit
identif
assay
gene
sequenc
analysi
perform
evalu
parallel
test
isol
includ
refer
strain
incorrect
mta
result
obtain
isol
could
clearli
identifi
either
mta
refer
method
mainli
due
lack
technic
skill
test
mta
result
obtain
identif
rate
eg
enterococcu
faecium
rais
begin
later
consequ
mta
accept
standard
identif
method
least
differ
strain
certain
speci
correctli
identifi
four
month
applic
identif
clinic
isol
strain
base
mta
order
assess
reproduc
mta
test
perform
duplic
begin
implement
discrep
result
found
declin
rapidli
qualiti
control
measur
system
spot
escherichia
coli
appli
begin
end
sampl
target
given
adequ
technic
train
mta
accur
rapid
costeffect
identif
system
suitabl
clinic
relev
aerob
speci
contrast
identif
system
sarami
databas
anagnostec
allow
amend
addit
speci
regard
individu
requir
identif
microorgan
clinic
sampl
malditof
mass
spectrometri
current
implement
diagnost
laboratori
rapid
costeffect
method
march
medizinisch
laboratorien
receiv
offici
accredit
identif
microorgan
malditof
ms
sarami
spectral
archiv
microbi
identif
system
deutsch
akkreditierungsstel
chemi
dach
prerequisit
perform
sarami
test
rigor
analys
set
refer
strain
clinic
isol
could
shown
physicochem
factor
eg
cell
number
matrix
amount
biotic
factor
eg
incub
time
temperatur
growth
media
limit
effect
perform
import
result
fals
identif
result
mixtur
two
speci
analys
one
analys
fals
identif
obtain
ident
experi
perform
independ
two
laboratori
nearli
result
confirm
high
reproduc
system
next
step
enterobacteriacea
isol
routin
sampl
identifi
biochem
method
sarami
summari
sarami
system
higher
dropout
rate
low
rate
fals
result
compar
biochem
identif
system
latter
show
incorrect
identif
strain
first
analysi
mean
second
analysi
error
rate
could
reduc
contrast
error
rate
malditof
ms
due
identif
singl
citrobact
younga
strain
c
freundii
sarami
identif
group
clinic
relev
bacteria
also
valid
accredit
microorgan
routin
identif
perform
mostli
malditof
ms
e
seibold
maier
kostrzewa
wd
splettstoess
abteilung
immunologi
und
epidemiologi
institut
mikrobiologi
der
bundeswehr
germani
microbiolog
applic
bremen
germani
aim
bacteri
speci
francisella
tularensi
caus
tularemia
regard
potenti
agent
bioterror
phenotyp
discrimin
close
relat
differ
virul
francisella
tularensi
subspeci
tradit
phenotyp
method
difficult
timeconsum
overcom
challeng
test
abil
mass
assist
laser
desorptionion
time
flight
mass
spectrometri
malditof
ms
identifi
discrimin
differ
strain
genu
francisella
speci
subspeci
level
method
refer
spectra
repres
strain
clinic
relev
francisella
speci
subspeci
establish
evalu
capabl
correctli
identifi
blindcod
francisella
strain
within
databas
includ
francisella
refer
spectra
well
spectra
mainli
clinic
relev
microorgan
refer
method
identif
f
tularensi
subspeci
rdna
sequenc
use
result
blindcod
strain
correctli
identifi
accord
design
speci
subspeci
show
cross
identif
microorgan
within
databas
evid
discrimin
speci
subspeci
level
observ
cluster
analysi
principl
compon
analysi
identif
francisella
strain
highli
reproduc
differ
condit
conclus
proper
identif
f
tularensi
subspeci
clinic
specimen
environment
sampl
major
concern
context
bioterror
establish
reliabl
prognost
measur
patient
studi
proof
abil
malditof
ms
reliabl
identifi
distinguish
f
tularensi
subspeci
without
challeng
relat
phenotyp
method
malditof
ms
provid
subspeci
identif
within
minut
obtain
isol
holzmann
w
schneiderbrachert
hj
lind
u
reischl
institut
medizinisch
mikrobiologi
und
hygien
regensburg
regensburg
germani
pneumocysti
jirovecii
emerg
pathogen
caus
sever
respiratori
infect
immunocompromis
patient
standard
method
laboratori
diagnosi
pneumocysti
infect
base
microscop
detect
pneumocysti
organ
respiratori
specimen
howev
method
establish
evalu
primarili
hiv
posit
patient
suspect
pneumocysti
infect
therefor
limit
data
avail
accuraci
microscopi
detect
pneumocysti
immunocompromis
patient
without
hiv
patient
usual
present
much
lower
amount
pneumocysti
organ
respiratori
specimen
evalu
impact
quantit
real
time
pcr
provid
higher
sensit
specif
addit
microscopi
compar
result
immunofluoresc
microscopi
p
jirovecii
quantit
realtim
pcr
target
msggene
p
jirovecii
patient
microscopi
neg
pcr
posit
microscopi
pcr
posit
addit
case
neg
pcr
posit
microscopi
observ
quantiti
genomeequival
per
ml
rang
sampl
analys
determin
applic
cutoff
valu
asymptomat
carriag
analys
respiratori
sampl
nonimmunocompromis
patient
presenc
p
jirovecii
pcr
control
howev
sampl
prove
neg
p
jirovecii
opinion
quantit
realtim
pcr
superior
convent
microscopi
diagnosi
pcp
immunocompromis
patient
studi
nearli
pcrposit
patient
would
fals
classifi
pcp
neg
standard
microscopi
addit
found
asymptomat
carriag
pneumocysti
nonimmunocompromis
control
group
contrast
previou
report
rdna
realtim
pcr
heart
valv
decis
tool
diagnosi
infect
endocard
vollmer
c
piper
horstkott
k
kleesiek
j
dreier
institut
bad
oeynhausen
germani
kardiologisch
klinik
bad
oeynhausen
germani
crucial
factor
diagnosi
effect
therapi
infecti
endocard
ie
identif
etiolog
agent
current
microbiolog
moleculargenet
method
limit
due
fals
neg
result
present
studi
new
moleculargenet
diagnost
strategi
improv
detect
pathogen
heart
valv
patient
ie
evalu
heart
valv
hv
surgic
remov
patient
proven
ie
suspici
intraop
morpholog
find
comorbid
associ
increas
infecti
risk
examin
rdna
pcr
convent
pcr
hv
cultur
retain
sampl
hv
analyz
realtim
pcr
target
bacteri
rdna
fungal
rdna
mycoplasm
tuf
gene
patient
classifi
four
categori
activ
ie
ie
ambigu
infect
statu
heal
ie
valv
diseas
ie
pcr
cultur
method
retrospect
analyz
accord
predict
valu
rdna
pcr
reveal
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
compar
cultiv
respect
use
realtim
pcr
increas
diagnost
sensit
npv
bacteri
load
creactiv
protein
crp
white
blood
cell
wbc
decreas
antibiot
treatment
bacteri
load
show
correl
crp
wbc
crp
wbc
significantli
correl
conclus
rdna
realtim
pcr
surgic
remov
hv
improv
diagnosi
ie
patient
cultur
neg
ie
pcr
assay
explant
heart
valv
high
prognost
impact
new
commerci
pcr
test
sepsitesttm
molzym
bremen
valid
bacteraemia
prospect
multicentr
studi
includ
blood
sampl
patient
system
inflammatori
respons
syndrom
sepsi
neutropen
fever
test
complet
system
includ
dna
prepar
ml
whole
blood
sampl
univers
rdna
pcr
assay
bacteria
posit
sampl
identifi
sequenc
analysi
amplicon
result
obtain
compar
blood
cultur
bc
result
compar
bc
diagnost
sensit
specif
pcrsequenc
respect
posit
rate
pcrsequenc
higher
bc
pcrsequencingposit
bcneg
patient
receiv
antibiot
pcr
result
judg
possibl
true
bacteraemia
conclus
pcr
test
promis
tool
rapid
diagnosi
bacteraemia
blood
sampl
hour
earlier
pathogenadapt
antibiot
therapi
critic
ill
patient
perform
western
blot
analysi
diagnosi
followup
import
schistosomainfect
reiterowona
nachtsheim
hoerauf
institut
medizinisch
mikrobiologi
immunologi
und
parasitologi
immip
bonn
bonn
germani
introduct
non
endem
countri
steadi
rise
case
import
schistosomiasi
observ
infect
usual
diagnos
basi
clinic
data
laboratori
assay
screen
stool
urin
microscopi
egg
sensit
enough
detect
infect
serolog
accept
appropri
diagnost
method
among
variou
antibodi
techniqu
develop
exist
sensit
enough
diagnosi
acut
chronic
schistosomiasi
case
low
worm
burden
ifat
detect
antibodi
gutassoci
antigen
gaa
adult
mansoni
worm
meet
requir
commerci
aim
studi
aim
evalu
antibodi
dynam
patient
acut
chronic
infect
specif
treatment
ifat
gaa
adult
mansoni
worm
use
refer
test
commerci
avail
western
blot
assay
ldbio
western
blot
wb
describ
test
good
sensit
excel
specif
detect
confirm
schistosomiasi
sulahian
et
al
patient
n
travel
immigr
preselect
accord
follow
aspect
schistosomainfect
proven
seroconvers
ifat
n
microscopi
egg
treatment
praziquantel
least
bw
singl
dose
follow
period
year
three
patient
show
symptom
typic
katayama
fever
first
present
altogeth
serum
sampl
test
ifat
wb
result
none
sera
patient
earli
acut
infect
ifatfluoresc
pattern
restrict
gutassoci
antigen
met
criteria
posit
wb
result
specif
band
serum
sampl
chronic
infect
egg
excret
immigr
show
ifatfluoresc
pattern
equal
distribut
worm
tissu
produc
posit
wb
profil
neg
nonspecif
wb
profil
convert
posit
treatment
conclus
ldbio
wb
assay
suitabl
test
system
diagnosi
primari
acut
chronic
schistosomiasi
travel
origin
non
endem
countri
diagnost
valu
differ
assay
differ
popul
group
discuss
rya
hassan
u
bilitewski
bisa
helmholtz
centr
infect
research
braunschweig
germani
simplist
approach
diagnosi
microorgan
direct
method
requir
addit
reagent
special
sampl
prepar
procedur
thu
appli
linear
sweep
voltammetri
lsv
anod
potenti
rang
suspens
opportunist
fungal
pathogen
candida
albican
nonpathogen
yeast
saccharomyc
cerevisia
obtain
oxid
peak
mv
peak
potenti
independ
respect
yeast
strain
shift
peak
scan
rate
indic
irrevers
electrochem
reaction
peak
current
increas
linearli
yeast
cell
number
rang
x
cell
ml
elucid
electron
transfer
step
underli
electrochem
signal
investig
influenc
electron
transport
chain
inhibitor
rotenon
antimycin
potassium
cyanid
signal
cyanid
decreas
signal
point
cytochrom
c
oxidas
cox
relev
protein
complex
thu
appli
singl
gene
delet
mutant
nuclear
cox
subunit
cerevisia
delet
subunit
elimin
signal
almost
total
subunit
influenc
access
heme
electron
transfer
heme
suggest
electrochem
signal
due
electron
shuttl
mechan
heme
heme
electron
transfer
step
cytochrom
c
oxidas
cox
outer
part
cell
wall
allow
interact
electrod
therefor
method
recommend
diagnost
method
mitochondri
diseas
andor
mitochondri
defect
eukaryot
microorgan
develop
pcrelisa
method
diagnosi
seven
common
dermatophyt
f
pankewitz
graeser
institut
microbiolog
hygien
univers
medicin
berlin
berlin
germani
last
year
increas
number
studi
publish
deal
develop
molecular
method
detect
dermatophyt
clinic
specimen
main
advantag
compar
gold
standard
microscopi
cultur
accur
speci
diagnosi
save
time
describ
pcrelisa
method
diagnosi
seven
dermatophyt
speci
probe
use
assay
design
specif
sensit
test
use
dna
extract
cultur
region
ribosom
dna
amplifi
first
round
pcr
polymorph
use
separ
close
relat
speci
second
amplif
step
implement
increas
sensit
previou
result
demonstr
sensit
pcr
elisa
drop
long
fragment
use
therefor
region
amplifi
separ
panfung
primer
produc
approx
bp
fragment
eight
specif
probe
develop
detect
trichophyton
rubrum
interdigital
tonsuran
verrucosum
microsporum
cani
epidermophyton
floccosum
trichophyton
speci
arthroderma
benhamia
elisa
assay
also
abl
differenti
zoophil
anthropophil
interdigital
strain
sensit
probe
evalu
dilut
standard
dna
cani
tonsuran
imposs
develop
specif
probe
singl
nucleotid
polymorph
enough
differenti
zoophil
anthropophil
interdigital
strain
sensit
test
assay
result
detect
limit
eight
probe
conclus
first
pcr
assay
abl
differenti
among
close
relat
speci
differenti
hous
pcr
protozoan
coccidi
parasit
genu
cryptosporidium
caus
cryptosporidiosi
intestin
diseas
human
anim
world
wide
preval
ethiopia
report
rang
children
younger
five
year
adult
aid
patient
howev
studi
molecularli
character
cryptosporidium
isol
ethiopia
studi
faecal
sampl
patient
diarrhoea
screen
cryptosporidium
oocyst
sampl
collect
differ
region
ethiopia
sampl
posit
cryptosporidium
modifi
ziehlneelson
stain
dna
extract
posit
sampl
pcr
amplif
cowp
ssurrna
gene
fragment
perform
total
sampl
posit
three
type
method
use
ase
irflp
ssurrna
rsa
irflp
cowp
andor
sequenc
product
major
isol
identifi
c
parvum
one
c
homini
one
mix
infect
sequenc
gene
fragment
isol
result
three
differ
subgenotyp
c
parvum
belong
zoonot
allel
famili
iia
one
subgenotyp
c
homini
ib
first
studi
molecular
character
cryptosporidium
isol
associ
human
cryptosporidiosi
ethiopia
identifi
c
parvum
major
caus
human
cryptosporidiosi
ethiopia
suggest
zoonot
sourc
transmiss
diseas
rather
anthroponot
transmiss
c
homini
report
develop
countri
schistosoma
mansoni
signal
transduct
process
develop
reproduct
organ
beckmann
quack
c
burmeist
c
buro
long
c
dissou
cg
greveld
institut
parasitolog
justusliebigunivers
giessen
germani
inserm
institut
pasteur
lill
cedex
franc
parasit
helminth
schistosoma
mansoni
caus
schistosomiasi
infecti
diseas
worldwid
signific
schistosom
repres
trematod
dioeciou
exhibit
nearli
uniqu
biolog
phenomenon
pairingdepend
induct
mainten
sexual
matur
femal
constant
pairingcontact
male
induc
prolifer
differenti
cell
reproduct
organ
femal
prerequisit
egg
product
lead
pathogenesi
parasit
last
year
clone
gene
encod
signal
transduct
protein
elucid
function
use
combin
standard
novel
techniqu
includ
local
studi
treatment
adult
schistosom
cultur
vitro
chemic
inhibitor
rnai
posttranscript
silenc
gene
function
confoc
laser
scan
microscopi
studi
morpholog
consequ
experiment
approach
applic
method
led
identif
syk
kinas
key
molecul
gonad
develop
postul
first
model
commun
signal
pathway
includ
receptor
tyrosin
kinas
integrinand
g
proteincoupl
receptor
activ
ovari
femal
regul
mitogen
activ
differenti
pathway
also
activ
test
male
probabl
fulfil
similar
role
ovari
find
provid
first
evid
involv
syk
kinas
gonad
develop
eukaryot
addit
elucid
signal
process
control
reproduct
schistosom
open
novel
perspect
fight
parasit
identif
novel
antifung
compound
use
ht
activityselect
assay
fungal
infect
repres
today
seriou
notyetsolv
health
problem
industri
countri
hiv
infect
lifeprolong
technolog
invas
treatment
transplant
therapi
anticanc
drug
provid
opportun
fungi
colon
caus
seriou
infect
human
treatment
especi
system
infect
larg
reli
chemotherapi
limit
high
cost
potent
antifung
consequ
infect
fungal
pathogen
repres
signific
health
problem
econom
burden
societi
identifi
novel
compound
antifung
activ
develop
assay
allow
identifi
toler
potent
antimicrobi
agent
compound
librari
also
cover
potenti
vitro
target
pathogen
host
simultan
assay
mimic
smallest
unit
natur
infect
incub
host
cell
presenc
compound
pathogen
eg
candida
albican
predomin
caus
fungal
infect
host
cell
surviv
determin
ass
effici
select
respect
compound
addit
minim
inhibitori
concentr
pathogen
test
system
simultan
provid
toler
activ
compound
host
cell
express
select
index
use
assay
system
compound
deriv
preselect
basic
chemic
structur
screen
one
hit
identifi
compound
librari
investig
detail
chemic
modif
lead
structur
target
identif
use
transcript
profil
c
albican
use
tissu
model
deriv
primari
cell
second
test
system
aim
block
fungal
infect
addit
effect
compound
identifi
current
test
fungal
speci
includ
aspergillu
spp
candida
spp
sura
gene
requir
mannosyl
inositolphosphorylceramid
dispens
growth
sporul
aspergillu
fumigatu
kotz
j
wagen
j
engel
f
routier
f
ebel
munich
germani
zentrum
biochemi
abt
chemi
medizinisch
hochschul
hannov
hannov
germani
candida
albican
mannosyl
inositolphosphorylceramid
protein
essenti
step
format
complex
sphingolipid
phosphomannan
major
pamp
pathogen
associ
molecular
pattern
fungal
pathogen
jouault
et
al
j
infect
di
genom
aspergillu
fumigatu
harbour
one
gene
encod
protein
homolog
ortholog
protein
saccharomyc
cerevisia
delet
gene
complement
result
mutant
expect
isol
hyphal
glycolipid
reveal
block
first
step
mannosylinositolphosphorylceramid
synthesi
result
absenc
complex
glycolipid
howev
delet
mutant
appar
growth
sporul
defect
differ
media
differ
temperatur
contrast
candida
yeast
mutant
fumigatu
insensit
moder
concentr
ca
mm
exhibit
appar
growth
defect
tenfold
higher
ca
concentr
could
compens
osmot
stabil
addit
copper
shown
prevent
growth
inhibit
ca
cerevisia
mutant
observ
similar
effect
mutant
found
fumigatu
gener
sensit
copper
cerevisia
final
sinc
phospholipomannan
shown
major
pamp
c
albican
analyz
import
sura
interact
fumigatu
innat
immun
system
infect
primari
murin
macrophag
mutant
parent
complement
strain
analysi
cytokin
respons
reveal
signific
differ
demonstr
contrast
c
albican
mannosylinositolphosphorylceramidederiv
glycolipid
fumigatu
recogn
murin
pattern
recognit
receptor
surfac
phosphoglycer
mutas
candida
albican
interact
vitronectin
bind
endotheli
epitheli
human
cell
cm
lopez
pf
zipfel
depart
infect
biolog
leibniz
institut
natur
product
research
infect
biolog
han
institut
friedrich
schiller
univers
jena
germani
candida
albican
opportunist
fungu
caus
diseas
particularli
immunocompromis
patient
interact
c
albican
human
host
primarili
mediat
compon
found
ist
cell
surfac
previous
report
laboratori
glycolyt
enzym
phosphoglycer
mutas
surfac
protein
express
yeast
hyphal
form
c
albican
surfac
bind
factor
h
factor
hlike
protein
plasminogen
help
fungu
evad
innat
immun
system
degrad
extracellular
matrix
studi
aim
identifi
role
surfac
interact
c
albican
human
host
recombin
shown
bind
vitronectin
vn
glycoprotein
constitu
human
serum
compon
extracellular
matrix
use
enzymelink
immunosorb
assay
elisa
vn
bound
immobil
recombin
concentrationdepend
manner
bind
inhibit
heparin
suggest
vn
bind
ist
heparinbind
site
role
surfac
bind
vn
human
serum
confirm
block
assay
wholecel
elisa
flow
cytometri
western
blot
heatinactiv
human
serum
preincub
increas
amount
decreas
amount
acquir
vn
detect
surfac
c
albican
also
true
cell
surfac
block
polyclon
antibodi
protein
addit
recombin
bound
endotheli
epitheli
human
cell
concentrationdepend
bind
cell
shown
flow
cytometri
result
impli
multipl
role
surfac
c
albican
use
fungu
bind
solubl
host
protein
directli
bind
interact
human
cell
mccormick
f
ebel
maxvonpettenkoferinstitut
munich
germani
sever
speci
fungu
aspergillu
known
secret
small
ribonucleolyt
protein
capabl
cross
lipid
membran
absenc
known
receptor
cytosol
fungal
ribotoxin
inhibit
protein
biosynthesi
cleav
singl
phosphodiest
bond
eukaryot
rrna
highli
conserv
sequenc
sarcinricin
loop
though
ribotoxin
secret
aspergillu
giganteu
wellcharacter
vitro
shown
toxic
varieti
mammalian
cell
line
littl
known
toxic
mitogillin
homolog
major
allergen
secret
opportunist
pathogen
aspergillu
fumigatu
often
call
protein
also
known
trigger
matur
immatur
dendrit
cell
mitogillin
without
ctermin
ha
tag
clone
yeast
express
vector
stream
secret
signal
sequenc
control
alcohol
oxidas
promot
regul
induc
methanol
transform
pichia
pastori
mitogillin
secret
medium
concentr
use
purifi
protein
intend
studi
enzymat
activ
toxic
sever
mammalian
cell
line
well
primari
human
macrophag
h
peltrochellacsahuanga
koltzscher
af
schmalreck
hj
tietz
g
haas
medic
microbiolog
aachen
germani
carpegen
gmbh
muenster
muenster
germani
mb
muenchen
muenchen
germani
date
lack
reliabl
simpl
method
identif
main
reason
difficulti
encount
set
compar
preval
studi
four
germ
tube
form
yeast
gfi
ie
c
africana
c
albican
c
dubliniensi
c
stellatoidea
current
consid
sucroseneg
biovar
c
albican
yeast
phenotyp
genet
highli
similar
phenotyp
method
fail
fulfil
expect
requir
discrimin
power
definit
identif
four
yeast
even
molecular
genet
base
diagnost
tool
may
imped
sinc
sequenc
respect
gene
region
differ
one
two
base
pair
base
intern
transcrib
spacer
sequenc
oligonucleotid
array
develop
differenti
gfi
use
especi
design
set
oligonucleotid
probe
commerci
avail
chip
base
hybrid
assay
gfi
strain
predominantli
obtain
cultur
collect
test
identifi
c
albican
n
c
dubliniensi
n
c
africana
n
c
stellatoidea
n
obtain
speci
assign
confirm
sequenc
analys
nuclear
region
reveal
speciesspecif
barcod
align
posit
four
yeast
ie
tact
c
africana
cacc
c
albican
gccc
c
dubliniensi
tacc
c
stellatoidea
base
chip
hybrid
result
speci
confirm
sequenc
analysi
c
albican
strain
obtain
cultur
collect
reclassifi
c
stellatoidea
slow
grow
difficulttoidentifi
strain
c
africana
clearli
separ
gfi
dna
chip
conclus
microarray
analysi
prove
promis
technolog
identif
phenotyp
similar
yeast
thu
enabl
high
throughput
analysi
therebi
facilit
compar
preval
studi
success
candida
albican
human
pathogen
explain
ist
abil
adapt
wide
spectrum
environment
condit
within
ist
host
c
albican
strain
homozyg
mate
type
locu
revers
switch
normal
yeast
form
white
elong
cell
form
opaqu
mate
compet
form
fungu
cell
type
differ
abil
colon
infect
variou
tissu
therefor
switch
may
allow
c
albican
better
adapt
differ
host
nich
whiteopaqu
switch
occur
spontan
low
frequenc
control
sever
posit
neg
act
transcript
factor
form
transcript
feedback
loop
ensur
semist
mainten
two
phase
howev
whiteopaqu
switch
also
induc
environment
signal
indic
upstream
regul
may
control
activ
transcript
factor
respons
signal
order
systemat
search
regul
express
put
protein
kinas
phosphatas
regul
kinas
kinas
regul
phosphatas
phosphatas
regul
identifi
c
albican
genom
well
predict
hyperact
dominantneg
allel
gene
tetracyclineinduc
promot
whiteopaqu
switchingcompet
mtlalpha
strain
screen
librari
strain
identifi
four
protein
kinas
whose
forc
express
effici
stimul
white
cell
switch
opaqu
phase
result
function
analysi
kinas
relationship
known
regul
whiteopaqu
switch
import
transduct
environment
signal
influenc
switch
present
work
support
eranet
pathogenom
identif
dermatophyt
mold
speci
malditof
mass
spectrometri
reich
stark
g
huesgen
p
bosshard
routin
procedur
dermatophyt
mold
identif
reli
examin
strain
characterist
microscop
morpholog
convent
method
use
identifi
dermatophyt
mold
often
timeconsum
may
inconclus
atyp
microscop
coloni
morpholog
present
studi
evalu
promis
altern
base
analysi
clinic
fungal
isol
malditof
mass
spectrometri
total
isol
belong
speci
dermatophyt
mold
analyz
isol
obtain
refer
sampl
ringversuchsproben
instand
ev
n
well
reliabl
identifi
clinic
isol
varieti
specimen
includ
skin
nail
scrape
hair
fragment
clinic
isol
obtain
univers
hospit
zurich
depart
dermatolog
n
synlab
laboratori
leinfelden
mani
fungi
attach
strong
agar
sampl
harvest
without
agar
contamin
possibl
therefor
isol
addit
inocul
liquid
cultur
media
almost
malditof
identif
result
match
convent
method
respect
ident
refer
sampl
four
mismatch
obtain
clinic
isol
trichophyton
mentagropyt
var
interdigital
identifi
incorrectli
trichophyton
tonsuran
n
howev
mismatch
aris
databas
discrep
could
elimin
develop
databasein
summari
malditof
analys
common
dermatophyt
mold
result
reliabl
speci
identif
furthermor
procedur
allow
rapid
identif
result
isol
could
identifi
alreadi
growth
time
day
inocul
liquid
cultur
media
rosenow
b
riemenschneid
u
reichard
medizinisch
mikrobiologi
germani
aspergillu
fumigatu
one
preval
airborn
fungal
pathogen
immunocompromis
patient
caus
usual
fatal
invas
diseas
could
shown
anim
model
protect
immun
respons
establish
surviv
invas
aspergillosi
indic
fumigatu
express
antigen
infect
may
induc
protect
immun
reaction
base
sera
rabbit
subleth
model
invas
aspergillosi
fumigatuscdnaexpressionlibrari
screen
reactiv
antigenclon
altogeth
differ
cdna
identifi
deniku
et
al
infect
immun
proof
concept
among
also
singl
antigen
far
known
induct
protect
immun
respons
shown
anim
vaccin
trial
base
isol
cdna
express
plasmid
construct
correspond
protein
produc
recombin
manner
e
coli
among
theos
protein
eg
aminopeptidas
heat
shock
protein
cell
wall
associ
protein
protein
involv
proteinbind
gener
cell
surfac
antigen
differ
conserv
hypothet
protein
without
known
function
secondari
fumigatu
knockoutmut
gene
interest
creat
recent
discov
adama
b
chosen
targetgen
well
adam
disintegrin
metalloproteas
relat
homologu
mammalian
adam
import
function
eg
sheddas
involv
detoxifi
reactiv
oxygen
speci
like
mutant
crucial
role
infect
process
grown
sever
condit
like
phvalu
temperatur
oxid
stress
obtain
antigen
togeth
knockoutmut
test
mousemodel
arthroderma
benhamia
use
dual
strategi
evad
host
complement
attack
schindler
brakhag
pf
zipfel
leibniz
institut
natur
product
research
infect
biolog
infect
biolog
friedrich
schiller
univers
jena
germani
leibniz
institut
natur
product
research
infect
biolog
molecular
appli
microbiolog
friedrich
schiller
univers
jena
germani
dermatophyt
caus
human
cutan
mycosi
repres
preval
worldwid
health
problem
immun
evas
dermatophyt
import
virul
pathogen
therefor
interest
understand
immun
escap
strategi
pathogen
arthroderma
benhamia
investig
model
organ
skin
infect
complement
system
form
first
line
immun
defens
invad
microorgan
human
skin
human
complement
regul
factor
h
mediat
degrad
complement
major
opsonisin
phagocytosi
demonstr
factor
h
local
express
human
keratinocyt
shown
western
blot
analysi
cultur
supernat
furthermor
factor
h
bind
surfac
benhamia
shown
direct
bind
assay
immunostain
elisa
pathogen
bound
factor
h
inhibit
deposit
fungal
surfac
thu
dermatophyt
avoid
opson
host
complement
subsequ
phagocytosi
addit
benhamia
use
second
independ
strategi
block
human
complement
fungu
secret
proteas
degrad
complement
compon
reveal
cleavag
assay
haemolyt
test
impli
benhamia
protect
complement
attack
interf
complement
activ
kinet
studi
degrad
show
essenti
benhamia
survivi
bind
host
complement
regul
factor
h
first
minut
infect
mediat
inactiv
later
time
point
secret
fungal
proteas
take
role
degrad
result
suggest
benhamia
use
two
subsequ
independ
immun
escap
strategi
overexpress
gene
encod
multidrug
efflux
pump
major
facilit
superfamili
major
caus
resist
wide
use
antimycot
agent
fluconazol
toxic
compound
candida
albican
zinc
cluster
transcript
factor
control
express
respons
induc
chemic
gainoffunct
mutat
respons
constitut
upregul
clinic
vitro
gener
fluconazoleresist
c
albican
strain
test
far
order
gain
insight
regul
activ
intend
identifi
function
domain
transcript
factor
delimit
minim
size
essenti
activ
allel
serial
ctermin
delet
express
c
albican
mutant
contain
report
gene
fusion
capabl
induc
promot
analys
fac
analysi
addit
intern
fragment
fuse
tetracyclin
repressor
test
abil
induc
transcript
tetrdepend
promot
investig
ntermin
locat
dnabind
domain
suffici
specif
activ
promot
confer
drug
resist
fuse
fragment
transcript
activ
domain
final
interdepend
bzip
transcript
factor
also
induc
express
studi
express
hyperact
allel
background
vice
versa
hyperact
allel
background
result
analys
contribut
detail
understand
function
import
regul
drug
resist
c
albican
singh
w
abu
rayyan
h
michelsnies
k
institut
medizinisch
mikrobiologi
und
hygien
germani
tetracyclin
tet
use
long
time
import
tool
visualis
imag
cancer
cell
bone
section
advanc
molecular
biolog
provid
tet
control
transcript
activ
system
method
induc
gene
express
transcript
revers
turn
presenc
tet
one
deriv
like
doxycyclin
recent
tet
introduc
induc
promot
candida
albican
control
express
construct
tetinduc
gfp
gene
express
c
albican
screen
cell
presenc
absenc
tet
surprisingli
found
even
wild
type
strain
treat
tet
show
fluoresc
fitc
channel
systemat
investig
transform
vector
contain
cagfp
control
tetinduc
promot
c
albican
screen
gfp
express
presenc
absenc
tet
observ
addit
tet
excit
blue
light
nm
effect
c
albican
suggest
low
degre
gfp
express
howev
cell
well
wild
type
c
albican
cell
without
gfp
show
ampl
green
fluoresc
presenc
tet
detect
fitc
channel
brief
exposur
uv
light
nm
suggest
uvdepend
activ
tet
fluoresc
phenomenon
observ
cervisea
e
coli
uvlight
supposedli
modifi
calcium
ionbound
tet
molecul
structur
caus
addit
absorb
nm
summari
show
exposur
uv
light
nm
gener
artefact
fluoresc
imag
nm
tetinduc
transcript
activ
system
use
gfp
express
compars
highperform
liquid
chromatographi
bioassay
voriconazol
drug
monitor
plasma
j
steinmann
j
j
buer
pm
rath
insitut
medic
microbiolog
univers
hospit
essen
essen
germani
backround
voriconzaol
vrc
broadspectrum
triazol
antigfung
agent
recommend
firstlin
therapi
patient
invas
aspergillosi
therapeut
option
treat
candidiasi
recent
studi
shown
vrc
drug
monitor
plasma
improv
efficaci
safeti
patient
outcom
purpos
studi
compar
highperform
liquid
chromatographi
hplc
bioassay
determin
vrc
level
plasma
method
standard
sampl
pool
plasma
contain
differ
vrc
level
prepar
standard
control
sampl
method
biolog
activ
vrc
measur
plate
diffus
assay
use
vrchypersuscept
candida
kefyr
strain
mic
mgl
csli
mcf
inocula
comparison
bioassay
hplc
system
agil
seri
uv
detect
use
solvent
extract
hexandichlormethan
follow
revers
phase
hplc
column
isocrat
mobil
phase
acetonitrilbufferwat
use
result
accuraci
low
medium
high
vrc
concentr
bioassay
vs
hplc
hplc
lower
higher
detect
limit
bioassay
vs
vs
correl
coeffici
bioassay
hplc
method
use
regress
analysi
show
hplc
bioassay
r
n
patient
result
rang
bioassay
hplc
conclus
method
clinic
use
monitor
vrc
plasma
level
hplc
improv
accuraci
detect
limit
vrc
plasma
level
compar
bioassay
bioanalyt
method
also
valuabl
tool
therapeut
drug
monitor
especi
laboratori
without
access
hplc
takac
cgk
institut
med
mikrobiologi
germani
toxoplasma
gondii
one
widespread
intracellular
parasit
human
lead
lifethreaten
toxoplasmosi
immunodefici
individu
parasit
transmit
ingest
tissu
cyst
contain
raw
undercook
meat
chronic
infect
livestock
howev
littl
known
factor
sustain
chronic
infect
muscular
tissu
livestock
recent
shown
spontan
stage
convers
replic
tachyzoit
gondii
potenti
persist
bradyzoit
occur
murin
primari
skelet
muscl
cell
psmc
studi
evalu
effect
alon
combin
tnf
intracellular
develop
gondii
skelet
muscl
cell
use
parasit
express
show
consider
reduc
replic
gondii
perman
murin
muscl
cell
psmc
wherea
effect
clearli
lower
murin
fibroblast
costimul
tnf
reduc
toxoplasma
replic
slightli
wherea
synerg
evid
toxoplasmainfect
psmc
reduc
replic
toxoplasma
skelet
muscl
cell
treat
confirm
western
blot
analys
lysat
cell
immunofluoresc
microscopi
reveal
strongli
decreas
infect
rate
psmc
treat
compar
untreat
control
number
parasit
per
parasitophor
vacuol
pv
also
lower
skelet
muscl
cell
untreat
control
remark
show
stimul
diminish
stage
convers
rate
tachyzoit
bradyzoit
cell
lower
extent
psmc
togeth
result
suggest
consider
reduc
develop
gondii
skelet
muscl
cell
facilit
stage
convers
bradyzoit
candida
albican
ubiquit
saprophyt
mucou
membran
predominantli
colonis
gastrointestin
tract
complement
import
part
innat
immun
infect
facilit
among
effect
chemotaxi
opsonis
sometim
follow
lysi
intrud
cascad
system
tightli
control
sever
fluid
phase
cellular
regul
factor
h
fh
solubl
plasma
protein
main
fluid
phase
regul
complement
altern
pathway
wherea
protein
import
classic
complement
pathway
regul
protein
acquir
onto
surfac
number
human
pathogen
convey
resist
complement
thu
contribut
pathogen
potenti
identifi
high
affin
glucos
transport
c
albican
fh
bind
molecul
probe
express
librari
homozyg
c
albican
delet
mutant
demonstr
ist
function
fhbind
protein
mutant
show
markedli
decreas
bind
fh
even
lead
increas
complement
activ
enhanc
termin
complement
complex
deposit
incub
human
serum
compar
wild
type
parent
strain
abil
mutant
form
hypha
impair
comparison
wild
type
studi
show
multifunct
complement
evas
molecul
major
fhand
even
molecul
cell
surfac
addit
c
albican
gene
play
role
modul
virul
factor
hypha
format
gener
approach
identifi
transcript
regul
morphogenet
variabl
candida
albican
weyler
j
institut
molekular
infektionsbiologi
germani
human
fungal
pathogen
candida
albican
display
remark
morphogenet
variabl
addit
grow
bud
yeast
c
albican
also
grow
filament
hypha
pseudohypha
form
chlamydospor
depend
environment
condit
strain
homozyg
mate
type
locu
mtl
also
switch
normal
yeast
form
white
elong
cell
type
opaqu
mate
compet
form
fungu
transcript
factor
play
import
role
regul
development
process
express
regul
often
modul
morphogenesi
therefor
morphogenesi
stimul
normal
noninduc
condit
forc
express
activ
identifi
novel
regul
filament
growth
chlamydospor
format
whiteopaqu
switch
clone
gene
encod
confirm
put
c
albican
transcript
factor
wwwcandidagenomeorg
includ
known
hyperact
allel
gene
place
control
tetracyclineinduc
promot
park
yn
et
al
ec
induc
gene
express
cassett
introduc
genom
c
albican
model
strain
whiteopaqu
switchingcompet
mtlalpha
strain
librari
current
screen
grow
strain
presenc
doxycyclin
induc
gene
express
differ
condit
identifi
novel
regul
morphogenesi
screen
deriv
librari
indic
sever
transcript
factor
known
role
whiteopaqu
switch
induc
mass
convers
white
opaqu
state
find
suggest
implic
regulatori
circuit
govern
master
regul
result
screen
function
analysi
identifi
regul
present
ghosh
dutta
ray
raha
crystallographi
molecular
biolog
divis
saha
institut
nuclear
physic
kolkata
india
entamoeba
histolytica
microaerophil
parasit
protozoan
normal
resid
within
hypox
environ
human
gut
expos
number
differ
stress
present
studi
investig
surviv
death
strategi
pathogen
stress
condit
explor
molecular
mechan
stress
respons
pathogen
respons
oxid
stress
induc
parasit
found
execut
apoptosi
like
cell
death
featur
mammalian
apoptosi
like
cell
shrinkag
plasma
membran
bleb
nuclear
dna
fragment
well
conserv
howev
parasit
respond
differenti
respons
heat
shock
found
surviv
stress
even
long
exposur
investig
reveal
molecular
mechan
yield
critic
role
singl
typic
mapk
famili
protein
e
histolytica
differenti
phosphoryl
henc
activ
protein
respons
stress
condit
well
correl
ultim
fate
organ
indic
possibl
role
ehmapk
mediat
cell
surviv
moreov
addit
mapk
parasit
genom
also
code
five
put
silent
inform
regul
gene
shown
associ
cellular
longev
number
differ
cell
type
especi
yeast
present
studi
rtpcr
analysi
put
gene
respons
oxid
stress
reveal
massiv
downregul
one
gene
indic
probabl
role
particular
homologu
cell
surviv
ist
downregul
essenti
prerequisit
induct
cell
death
taken
togeth
studi
attempt
light
compon
yet
unknown
molecular
pathway
associ
surviv
death
respons
e
histolytica
respons
particular
stress
turn
provid
suitabl
candid
target
control
amoebiasi
character
gene
encod
cell
surfac
protein
induc
hostpathogen
interact
zavrel
r
hernandez
k
sohn
n
hauser
rupp
institut
stuttgart
stuttgart
germani
institut
bioverfahrenstechnik
igb
fraunhof
stuttgart
germani
candida
albican
commens
fungu
live
skin
mucos
surfac
healthi
human
especi
immunocompromis
patient
turn
opportunist
pathogen
candida
colon
variou
host
nich
signific
differ
ph
nutrient
avail
includ
skin
gastrointestin
urogenit
tract
reveal
whether
c
albican
abl
specif
respond
differ
host
nich
use
transcript
profil
order
identifi
c
albican
gene
differenti
regul
adhes
plastic
vagin
intestin
tissu
model
studi
focus
gene
encod
cell
surfac
protein
cell
surfac
critic
hostpathogen
interact
site
direct
interact
human
host
mediat
environment
sens
adhes
also
interact
host
immun
system
sever
gene
identifi
specif
upregul
tissu
one
gene
encod
protein
predict
local
plasma
membran
carri
four
transmembran
domain
term
adhes
upregul
factor
interestingli
identifi
six
homologou
c
albican
genom
five
togeth
locat
chromosom
kb
geneclust
delet
studi
show
direct
involv
auf
gene
adhes
invas
process
indic
role
cell
fit
stationari
phase
growth
express
cerevisia
local
plasma
membran
protein
encod
gene
upregul
adhes
includ
two
predict
gpiprotein
function
studi
regard
adhes
invas
well
cell
wall
structur
stabil
perform
use
delet
overexpress
strain
studi
qualifi
structur
element
cell
wall
rather
adhesin
rapid
immun
respons
candida
infect
mediat
part
number
innat
recognit
molecul
known
pattern
recognit
receptor
prr
prr
recogn
conserv
motif
call
pathogenassoci
molecular
pattern
pamp
repres
broad
group
microbi
pathogen
compon
prr
signal
pathway
trigger
subsequ
inflammatori
respons
crucial
success
host
defenc
pathogen
fungal
cell
wall
major
structur
provid
potenti
fungal
pamp
known
stimul
innat
immun
respons
first
examin
effect
differ
cell
wall
extract
c
albican
found
increas
tlr
express
cytokin
secret
howev
could
observ
differ
extract
analysi
show
five
fraction
contain
glycosyl
cell
wall
protein
cwp
calbican
cwp
two
potenti
glycosyl
side
nglycosyl
known
recognis
mannos
receptor
mr
recognis
oglycosyl
use
block
antibodi
could
show
cwf
cytokin
induct
mr
independ
wherea
deglycosyl
cwp
abolish
cytokin
respons
surprisingli
observ
strong
growth
inhibit
cwfstimul
oral
epitheli
cell
detail
analysi
show
cell
cycl
inhibit
result
increas
activ
apoptosi
induct
analys
confoc
microscopi
flow
cytometri
prolifer
inhibit
apoptosi
induct
independ
mr
signal
depend
tlr
adapt
protein
sinc
growth
oral
keratinocyt
defici
mice
significantli
increas
compar
wildtyp
keratinocyt
conclus
could
show
glycosyl
cell
wall
protein
modul
first
innat
immun
respons
oral
epitheli
cell
induc
prolifer
inhibit
apoptosi
delet
candida
albican
histidin
kinas
improv
recognit
phagocyt
increas
exposur
cell
wall
immun
defens
fungi
phagocytot
immun
cell
mainli
activ
via
recognit
fungal
cell
wall
opportunist
candida
albican
cover
beneath
mannan
layer
pathogen
yeast
abl
escap
immun
attack
c
albican
histidin
kinas
report
involv
cell
wall
biosynthesi
virul
investig
whether
delet
respect
gene
influenc
activ
phagocyt
c
albican
fluorimetr
phagocytosi
assay
reveal
among
histidin
kinas
gene
play
promin
role
phagocyt
activ
uptak
null
mutant
strain
macrophag
neutrophil
significantli
increas
compar
parent
strain
furthermor
lack
relat
enhanc
acidif
phagosom
remark
level
phagocytosi
phagosom
matur
equal
nonpathogen
yeast
saccharomyc
cerevisia
improv
activ
phagocyt
could
correl
alter
access
immun
recognit
stain
fluoresceinconjug
antibodi
elucid
amount
access
mutant
significantli
increas
investig
show
inhibit
phagocytosi
reduc
uptak
ingest
parent
strain
hardli
affect
moreov
delet
result
enhanc
releas
macrophag
downstream
reaction
activ
receptor
conclus
c
albican
histidin
kinas
like
involv
mask
immun
recognit
homologu
fungal
histidin
kinas
mammal
consid
promis
target
new
antifung
agent
invas
aspergillosi
ia
one
major
life
threaten
fungal
infect
associ
hematolog
malign
solid
organ
transplant
dendrit
cell
import
compon
innat
immun
system
defenc
pathogen
fungi
acquir
antigen
peripheri
migrat
secondari
lymphoid
tissu
activ
cell
matur
secret
cytokin
chemokin
antigen
structur
aspergillu
fumigatu
influenc
human
innat
immun
system
uncharacter
studi
character
interact
fumigatu
antigen
monocytederiv
immatur
dendrit
cell
idc
antigen
recombinantli
express
pichia
pastori
system
quantifi
capac
induc
dc
cytokin
chemokin
gene
express
cytokin
chemokin
secret
local
antigen
dc
apoptosi
furthermor
investig
perform
mix
lymphocyt
reaction
mlr
dc
load
antigen
abl
induc
tcell
prolifer
show
high
abil
compar
stimul
dc
demonstr
increas
express
gene
encod
proinflammatori
cytokin
eg
chemokin
use
germl
delet
mutant
confront
assay
idc
decreas
gene
express
protein
secret
compar
stimul
wild
type
morpholog
detect
apoptosi
dc
induc
incub
compar
dc
without
stimuli
furthermor
mlr
reveal
dc
abl
present
autolog
tcell
conclus
induct
cytokin
releas
apoptosi
human
idc
may
constitut
novel
immunomodulatori
mechan
result
destruct
function
impair
idc
parallel
immun
evas
fumigatu
adopt
transfer
protect
immun
cryptosporidium
parvuminfect
interferongamma
mice
naiv
recipi
tessema
e
dauber
f
petri
institut
medic
microbiolog
hygien
univers
medic
center
mainz
mainz
germani
cryptosporidium
parvum
caus
chronic
lifethreaten
diarrhea
young
host
immunodefici
individu
aid
patient
howev
immunocompet
individu
diseas
selflimit
data
human
infect
anim
model
demonstr
major
role
cellular
immun
respons
cell
domin
player
addit
cell
cytokin
especi
interferongamma
requir
protect
investig
possibl
transfer
immun
c
parvuminfect
gko
defici
mice
naiv
mice
transfer
differ
lymphocyt
prepar
strain
defici
mice
suscept
infect
recov
within
two
week
intraepitheli
lymphocyt
iel
cell
spleen
mesenter
lymph
node
mln
prepar
donor
mice
peak
infect
recoveri
three
day
transfer
recipi
infect
c
parvum
transfer
iel
cell
isol
resolut
infect
day
strain
donor
mice
reduc
parasit
load
gko
recipi
mice
significantli
protect
rate
gko
mice
reach
spleen
mln
cell
iel
respect
mice
protect
rate
respect
protect
lymphocyt
isol
mice
peak
infect
day
significantli
higher
gko
mice
isol
day
emphas
role
hostparasit
interact
howev
resolut
infect
mechan
evolv
render
iel
cell
potent
protect
mice
sever
infect
transfer
plu
cell
lead
increas
protect
rate
indic
cell
essenti
protect
infect
infect
toxoplasma
gondii
diminish
constitut
hla
gene
express
humanderiv
macrophag
p
stall
cgk
institut
medic
microbiolog
georgaugustunivers
germani
intracellular
parasit
toxoplasma
gondii
highli
preval
mammal
import
opportunist
pathogen
human
acut
infect
gondii
dissemin
within
host
via
infect
variou
cell
type
includ
profession
antigenpres
cell
papc
inhibit
mhc
class
class
ii
express
follow
infect
murin
papc
gondii
establish
consid
import
evas
strategi
dampen
antiparasit
immun
respons
formal
prove
gondii
also
diminish
hla
express
humanderiv
macrophag
express
hlaa
b
c
hladr
dp
dq
molecul
human
monocyt
isol
peripher
blood
mononuclear
cell
pbmc
promin
inhibit
follow
vitroinfect
gondii
although
lower
extent
constitut
hla
express
also
inhibit
parasit
infect
remark
constitut
well
hlaa
b
c
hladr
dp
dq
express
appear
higher
monocyt
deriv
blood
donor
chronic
toxoplasma
infect
seroneg
control
contrast
parasiteinduc
inhibit
hla
express
similarli
observ
monocyt
deriv
toxoplasmaposit
neg
blood
donor
interfer
gondii
constitut
andor
hlaa
b
c
hladr
dp
dq
express
confirm
use
humanderiv
monocyt
cell
parasitemedi
blockad
hlaexpress
abrog
increas
cytokin
concentr
hlaa
mrna
dosedepend
diminish
follow
toxoplasma
infect
similarli
transcript
level
transcript
factor
ciita
also
reduc
gondii
result
indic
parasitemedi
inhibit
hla
express
humanderiv
macrophag
partial
mediat
via
parasit
interfer
earli
step
gene
express
although
candida
glabrata
becom
second
import
pathogen
candida
speci
virul
mechan
identifi
far
get
comprehens
idea
virul
mechan
c
glabrata
use
widerang
gene
delet
studi
order
elucid
gene
involv
pathogen
studi
undertaken
within
eranet
consortium
funpath
gene
code
predict
protein
cell
wall
known
signal
pathway
membranebound
receptor
transport
transcript
factor
identifi
compar
genom
analysi
subsequ
delet
delet
mutant
present
librari
screen
biolog
assay
eg
strain
alter
cell
wall
stabil
stress
toler
adhes
sever
strain
found
surviv
assay
plate
sensit
congo
red
osmot
stress
increas
temperatur
gene
delet
mutant
presum
involv
cell
wall
integr
mapkpathway
abil
adher
surfac
test
seri
test
increas
complex
approxim
host
environ
far
gene
identifi
import
adher
simpl
assay
system
associ
cell
wall
involv
cytokinesi
verifi
screen
result
investig
adhes
invas
behaviour
promis
mutant
strain
human
epitheli
model
addit
primari
screen
plan
analys
adhes
abil
mutant
strain
epitheli
model
compar
approach
pool
mutant
delet
strain
tag
specif
barcod
sequenc
detect
via
inhous
barcod
microarray
experi
vivo
model
carri
project
partner
funpath
use
genom
wide
transcript
profil
possibl
instanc
character
strain
reduc
adhes
invas
behaviour
result
gener
allow
conclus
basic
pathogen
mechan
possibl
target
therapi
fungal
infect
function
domain
transcript
factor
candida
albican
w
abu
rayyan
singh
h
michelsnies
k
institut
medizinisch
mikrobiologi
und
hygien
germani
candida
albican
infect
rang
mucos
lesion
lifethreaten
invas
candidiasi
hyphal
growth
transcript
regul
adapt
host
environ
key
issu
pathogenesi
c
albican
member
tea
transcript
factor
famili
previous
shown
involv
signal
event
lead
hyphal
format
gene
regul
delet
mutant
longer
form
hypha
vitro
avirul
vivo
earlier
studi
show
tea
transcript
factor
recogn
bind
tea
consensu
sequenc
tc
nand
cterminu
major
role
pseudohyph
develop
mate
cerevisia
suggest
presenc
cooper
act
protein
domain
investig
whether
c
albican
similar
protein
domain
might
differenti
requir
dna
bind
cooper
interact
dna
protein
respect
transform
sever
construct
modifi
open
read
frame
wildtyp
contain
ctermin
delet
mutant
strain
minim
influenc
environment
factor
integr
modifi
orf
control
c
albicansadapt
revers
tetdepend
transactiv
rtta
use
tetinduc
hyphal
format
readout
transform
orf
construct
ctermin
delet
induc
hyphal
growth
mutant
ntermin
delet
disrupt
transcript
activ
growth
rate
transform
ntermin
delet
reduc
fewer
hyphal
element
display
shorter
degre
polar
growth
conclus
show
ntermin
domain
essenti
hyphal
develop
cooper
interact
cterminu
might
play
limit
role
c
albican
type
ii
nadh
dehydrogenas
drug
target
toxoplasma
gondii
ss
lin
u
w
bohn
institut
medizinisch
mikrobiologi
germani
select
inhibit
respiratori
chain
apicomplexan
parasit
well
establish
strategi
drug
treatment
mode
action
complex
iii
inhibitor
atovaquon
signific
differ
organ
respiratori
chain
plasmodium
falciparum
toxoplasma
gondii
compar
human
mitochondria
absenc
canconi
complex
instead
parasit
express
type
ii
nadh
dehydrogenas
contrast
complex
singl
subunit
nonproton
pump
enzym
recent
identifi
quinolon
hdq
high
affin
inhibitor
gondii
hdq
deriv
potent
inhibitor
gondii
replic
nanomolar
rang
probabl
interfer
ubiquinol
bind
site
physiolog
consequ
hdq
treatment
intracellular
parasit
fast
depolar
mitochondri
membran
potenti
shown
live
cell
imag
use
cation
fluoresc
probe
strong
reduct
intracellular
atp
level
ongo
studi
includ
determin
orient
two
gondii
isoform
toward
inner
mitochondri
membran
intern
extern
enzym
use
split
gfp
approach
function
studi
condit
knockout
mutant
agarw
c
doerig
g
pradel
research
center
infecti
diseas
univers
wuerzburg
wuerzburg
germani
global
health
institut
station
lausann
switzerland
protein
kinas
pk
play
crucial
role
eukaryot
cellular
process
plasmodium
falciparum
kinom
compris
repres
eukaryot
pk
group
includ
cmgc
cdk
mapk
cdklike
group
encompass
pk
regul
prolifer
differenti
process
date
littl
inform
avail
regard
famili
cmgc
group
cdklike
kinas
cyclin
depend
kinas
like
kinas
clk
eukaryot
clk
major
regul
mrna
splice
phosphoryl
serineargininerich
sr
protein
function
splice
pathway
thu
clk
particip
control
gene
express
may
particularli
import
plasmodium
view
establish
import
posttranscript
regul
gene
express
malaria
parasit
studi
aim
characteris
four
pfclk
lammer
kinas
biochem
function
level
main
focu
lammer
kinas
show
four
clk
gene
transcrib
throughout
asexu
blood
stage
gametocyt
lammer
kinas
possess
two
nuclear
local
signal
upstream
ctermin
catalyt
domain
order
experiment
verifi
stagespecif
express
pattern
protein
level
polyclon
mous
antibodi
gener
indirect
immunofluoresc
western
blot
data
indic
local
kinas
parasit
nucleu
coloc
parasit
nucleu
confirm
via
immunoelectron
microscopi
revers
genet
gene
tag
studi
via
singlecrossov
homolog
recombin
reflect
essenti
kinas
complet
asexu
parasit
cycl
kinas
activ
assay
nativ
lammer
kinas
immunoprecipit
parasit
extract
indic
phosphoryl
commonli
use
kinas
substrat
histon
mbp
casein
investig
kinas
interact
partner
via
coimmunoprecipit
present
progress
smdia
rhodiasrc
signal
complex
member
crucial
differenti
process
gonad
schistosoma
mansoni
schistosomiasi
parasit
diseas
worldwid
signific
affect
human
anim
schistosom
egg
respons
pathogenesi
understand
process
control
gonad
develop
might
open
new
perspect
intervent
srclike
tyrosinekinas
schistosoma
mansoni
express
gonad
ist
pharmacolog
inhibit
reduc
mitogen
activ
egg
product
pair
femal
vitro
sinc
src
kinas
import
signal
transduct
protein
interest
unravel
signal
cascad
involv
understand
ist
cellular
role
gonad
yeast
twohybrid
cdna
librari
adult
mansoni
screen
employ
bait
construct
encod
domain
uniqu
site
among
bind
partner
found
diaphan
homolog
smdia
character
smdia
singlecopi
gene
transcrib
throughout
develop
bia
toward
male
transcript
deduc
amino
acid
sequenc
reveal
diaphanouscharacterist
function
domain
bind
studi
truncat
smdia
clone
identifi
interact
site
demonstr
maxim
bind
effici
depend
ntermin
part
formin
homolog
domain
interdomain
region
smdia
locat
upstream
combin
uniqu
site
domain
respect
smdia
also
directli
interact
gtpase
mansoni
situ
hybrid
experi
demonstr
smdia
coloc
gonad
gender
first
rnai
studi
final
show
remark
phenotyp
indic
dysfunct
oocyt
matur
data
provid
first
evid
exist
two
cooper
pathway
involv
rho
src
bridg
smdia
probabl
organ
cytoskelet
event
reproduct
organ
parasit
beyond
gonad
eukaryot
regul
aspergillu
fumigatu
extracellular
proteolyt
activ
dispens
virul
bergmann
hartmann
krappmann
zentrum
infektionsforschung
germani
virul
fungal
pathogen
aspergillu
fumigatu
part
base
saprophyt
lifestyl
mould
evolv
crucial
function
saprophyt
resid
secret
proteas
allow
assimil
proteinac
substrat
impact
extracellular
proteolyt
activ
pathogenesi
aspergillosi
howev
remain
controversi
order
address
issu
characteris
conserv
regulatori
factor
prtt
act
express
secret
proteas
pursu
express
prtt
appear
regul
posttranscript
exist
mrna
leader
sequenc
impli
translat
control
via
kinas
signal
phenotyp
classif
delet
mutant
reveal
express
sever
major
extracellular
proteas
prttdepend
result
inabl
utilis
protein
nutrit
sourc
certain
gene
encod
secret
proteas
regul
prtt
strikingli
delet
strain
attenu
virul
test
leukopen
mous
model
make
strong
case
reconsid
impact
secret
proteas
pulmonari
aspergillosi
incorpor
novel
adhesinlik
protein
cell
wall
human
pathogen
candida
glabrata
ms
weig
medizinisch
mikrobiologi
germani
establish
human
infect
fungal
cell
wall
proteom
govern
crucial
pathogenhost
interact
make
use
microscop
imag
biochem
analysi
immunoanalysi
bioinformat
tandem
mass
spectrometri
explor
speci
specif
characterist
cell
wall
c
glabrata
interestingli
c
glabrata
incorpor
approx
protein
cell
wall
compar
baker
yeast
comprehens
silico
inspect
genom
c
glabrata
reveal
pathogen
organ
contain
except
larg
number
gpidepend
cell
wall
protein
could
serv
adhesin
phylogenet
cell
wall
adhesin
form
seven
cluster
one
known
epafamili
lectin
analys
differ
strain
growth
condit
show
differ
set
adhesin
coval
incorpor
carbohydr
backbon
cell
wall
process
determin
cell
surfac
characterist
hydrophob
adhes
capac
appar
larg
repertori
adhesin
dynam
cell
wall
incorpor
subset
significantli
contribut
adapt
c
glabrata
differ
host
tissu
virul
simul
membran
interact
antibiot
peptid
target
cell
wall
biosynthesi
isotherm
titrat
calorimetri
biosensor
measur
alkaddah
wiedemann
k
studi
analys
mode
action
glycopeptid
vancomycin
lantibiot
gallidermin
special
emphasi
target
molecul
lipid
ii
event
membran
surfac
membran
bilay
use
differ
model
membran
system
simul
peptidemembran
interact
although
peptid
inhibit
cell
wall
biosynthesi
target
molecul
interact
cytoplasm
membran
differ
significantli
determin
bind
affin
peptid
model
membran
made
dopc
dopc
supplement
purifi
lipid
ii
use
two
differ
masssensit
biosensor
quartz
crystal
microbalanceqcm
surfac
acoust
wavesaw
bind
affin
vancomycin
increas
significantli
presenc
lipid
ii
vs
good
agreement
specif
complex
lipid
ii
vancomycin
membran
surfac
case
gallidermin
antimicrobi
activ
result
combin
cell
wall
inhibit
peptid
insert
membran
bilay
concordantli
compar
vancomycin
bind
affin
gallidermin
pure
dopc
membran
significantli
stronger
enhanc
presenc
lipid
ii
isotherm
titrat
calorimetri
itc
confirm
strong
insert
gallidermin
dopc
membran
support
merocyanin
fluoresc
assay
conclus
combin
biosensor
techniqu
itc
enabl
us
gain
deeper
insight
membraneassoci
process
lipid
iitarget
antimicrobi
peptid
bonelli
rr
schneider
sahl
hg
wiedemann
insight
vivo
activ
lantibiot
gallidermin
epidermin
modeofact
studi
antimicrob
agent
chemoth
lantibiot
small
microbi
peptid
antibiot
produc
varieti
gramposit
bacteria
antibiot
differ
bacteriocin
presenc
nonproteinogen
thioether
amino
acid
lanthionin
methyllanthionin
lantibiot
gene
encod
ribosom
synthes
prepeptid
contain
leader
cleavag
site
separ
ctermin
propeptid
ntermin
leader
matur
inact
prepeptid
undergo
extens
posttransl
modif
includ
introduct
uniqu
amino
acid
well
proteolyt
remov
leaderth
structur
gene
lana
well
gene
involv
lantibiot
biosynthesi
modif
lanm
lanp
regul
lanr
lank
export
lant
p
immun
lanefg
organ
biosynthet
gene
cluster
b
licheniformi
harbour
put
lantibiot
gene
cluster
encod
new
twopeptid
lantibiot
name
lichenicidin
mcclerren
et
al
gene
cluster
compris
two
structur
gene
two
modif
enzym
addit
orf
show
sequenc
similar
protein
involv
lantibiot
product
abl
detect
antimicrobi
activ
cultur
supernant
well
isopropanol
cell
wash
extract
b
licheniformi
agar
well
diffus
assay
antimicrobi
substanc
exhibit
activ
gramposit
bacteria
inact
gramneg
c
albican
two
b
licheniformi
mutant
strain
harbour
insert
modif
enzym
character
decreas
loss
activ
isopropanol
extract
result
indic
activ
isopropanol
extract
repres
lichenicidin
substract
malditof
analysi
predict
mass
da
activ
peptid
mass
da
activ
peptid
model
glycolyt
pathway
streptococcu
pyogen
streptococcu
pyogen
group
streptococci
ga
import
human
pathogen
caus
wide
varieti
diseas
rang
mild
superfici
infect
skin
throat
life
threaten
system
invas
diseas
sequela
ga
equip
mani
virul
factor
allow
bacteria
infect
persist
within
host
cell
infect
ga
expos
differ
host
environ
chang
nutrit
condit
potenti
affect
central
metabol
bacteria
order
understand
central
metabol
pyogen
better
order
abl
compar
lactic
acid
bacteria
set
detail
quantit
model
glycolysi
organ
model
base
literatur
data
found
sabio
rk
databas
experiment
data
experiment
data
measur
glucos
limit
continu
cultur
well
glucos
puls
experi
moreov
individu
glycolyt
enzym
pyogen
clone
kinet
paramet
km
valu
alloster
regul
measur
vitro
turn
alloster
regul
glycolysi
differ
pyogen
comparison
lactic
acid
bacteria
lactococcu
lacti
enterococcu
faecali
especi
role
inorgan
phosphat
alloster
regul
lactatedehydrogenas
activ
contrari
situat
l
lacti
summari
kinet
model
pyogen
human
pathogen
allow
us
defin
similar
differ
pathogen
nonpathogen
lactic
acid
bacteria
may
uncov
exist
link
central
metabol
virul
leadabsorb
bacterium
immobil
sawdust
biosorb
remov
lead
wastewat
tabatabaei
j
fooladi
g
ebrahimipour
microbiolog
alzahra
univers
tehran
iran
biolog
scienc
shahid
beheshti
univers
tehran
iran
industri
oper
variou
industri
result
creat
wast
contamin
environ
directli
indirectli
form
toxic
pollut
materi
increas
level
pollut
variou
ecosystem
remov
heavi
metal
ion
wastewat
receiv
great
attent
recent
decad
year
global
awar
underli
detriment
heavi
metal
environ
one
pollut
element
lead
contamin
environ
result
variou
industri
activ
caus
sever
poison
human
be
live
creatur
applic
tradit
treatment
techniqu
need
enorm
cost
continu
input
chemic
witch
becom
uneconom
caus
environ
damag
tendenc
use
biolog
method
purifi
lead
wast
pollut
sinc
econom
chemic
method
research
leadabsorb
strain
delftia
sp
isol
wastewat
immobil
onto
sawdust
investig
potenti
biosorb
remov
lead
aqueou
solut
metal
remov
capac
sawdust
immobil
biomass
test
continu
flow
fixedb
column
found
highli
effect
remov
lead
wastewat
immobil
enhanc
biosorpt
lead
compar
free
biomass
aim
studi
develop
new
cheap
technolog
remov
lead
pollut
wastewat
genu
dermabact
homini
speci
first
describ
jone
collin
belong
larg
group
human
colon
develop
opportunist
virul
termin
ill
patient
reduc
defens
capac
homini
isol
human
skin
variou
biolog
sourc
cerebr
abscess
blood
gramposit
coccobacilli
catalaseposit
grow
small
greyishwhit
coloni
confus
coagulaseneg
staphylococci
present
studi
clinic
isol
skin
blood
atccstrain
homini
investig
isol
identifi
api
coryn
system
germani
typic
gaschromatograph
profil
wholecel
fatti
acid
methyl
ester
fame
fameprofil
isol
homini
constantli
show
group
signific
peak
identifi
previous
unknown
compound
identifi
ga
chromatographymass
spectrometri
gcm
follow
cleavag
doubl
bond
ozonolysi
gcm
carri
hewlettpackard
msd
instrument
interfac
directli
hewlettpackard
ga
chromatograph
structur
analysi
reveal
compound
repres
alken
isoand
anteisostructur
correspond
fatti
acid
precursor
doubl
bond
locat
alken
excel
taxonom
marker
biolog
function
mechan
format
rare
bacteri
alken
micrococcu
stenotrophomona
arthrobact
yet
elucid
fria
et
al
appl
environ
microbiol
contrast
role
similar
alken
pheromon
insect
well
document
thu
might
specul
ecolog
function
alken
produc
bacteria
l
hoffmann
c
seyboldt
lebensmitteluntersuchungdiagnostik
fzmb
gmbh
bad
langensalza
germani
diagnostik
tllv
bad
langensalza
germani
institut
bakteriel
infektionen
und
zoonosen
fli
jena
germani
botul
cow
rel
rare
high
mortal
rate
may
caus
consider
financi
loss
caus
often
ingest
feed
contamin
botulinum
toxin
especi
silag
haylag
produc
anaerob
condit
may
favor
environ
toxin
produc
clostridium
botulinum
also
like
contamin
feed
cadav
outbreak
botul
import
recogn
first
symptom
anim
avoid
ingest
possibl
contamin
feed
prevent
anim
affect
diseas
depend
amount
ingest
toxin
cours
diseas
may
peracut
prolong
sever
day
even
week
therapi
affect
anim
limit
avail
antitoxin
type
botulinum
toxin
treatment
antitoxin
expens
therapi
often
unsuccess
special
attent
must
pay
prevent
especi
process
produc
silag
haylag
also
control
qualiti
feed
soon
daili
visual
control
whole
part
cadav
ahead
feed
anim
import
case
report
describ
cours
botul
type
c
cohort
dairi
cow
partial
advanc
pregnanc
adult
calf
die
euthan
within
period
hour
day
clinic
symptom
typic
stumbl
paralysi
hind
extrem
subsequ
down
temporari
aggress
fever
limit
appetit
anim
die
respiratori
paralysi
excrement
intestin
liver
feed
botulinum
type
c
detect
caus
diseas
probabl
cadav
rabbit
mummifi
cat
found
feed
also
posit
botulinum
type
c
toxin
systemat
review
econom
impact
sequenti
therapi
ivpo
ciprofloxacin
sever
infect
qualiti
econom
evalu
rather
heterogen
limit
howev
evid
cost
contain
sequenti
therapi
cip
shown
decis
conclus
quantit
aspect
provid
present
intracellular
bacteria
need
maintain
osmot
stabil
mean
cell
wall
peptidoglycan
reliabl
detect
oblig
intracellular
genu
chlamydia
far
nevertheless
chlamydia
suscept
antibiot
target
cell
wall
biosynthesi
paradox
known
chlamydi
anomali
genomewid
search
within
chlamydia
result
identif
nearli
complet
pathway
peptidoglycan
biosynthesi
start
investig
fundament
membran
associ
step
peptidoglycan
biosynthesi
lead
format
lipidbound
precursor
lipid
lipid
ii
therefor
integr
membran
protein
mray
membran
associ
protein
murg
c
pneumonia
overproduc
escherichia
coli
purifi
previous
demonstr
vitro
activ
mray
murg
present
data
kinet
structur
featur
substrat
specif
coupl
assay
find
strengthen
hypothesi
lipid
ii
synthes
function
peptidoglycan
biosynthesi
pathway
present
chlamydia
addit
result
suggest
pathway
may
exploit
antibiot
therapi
chlamydi
infect
r
schiller
reidl
khan
u
dobrindt
institut
molecular
infect
biolog
univers
germani
long
time
protein
glycosyl
consid
restrict
eukaryot
advanc
analyt
method
genom
sequenc
evid
nand
oglycosyl
bacteri
protein
constantli
increas
szymanski
wren
wide
accept
least
eubacteria
express
glycoprotein
detail
inform
glycosyl
structurefunct
relationship
avail
eubacteri
protein
protein
glycosyl
bacteria
shown
contribut
differ
aspect
hostpathogen
interact
eg
adhes
protect
proteolyt
cleavag
antigen
variat
protect
immun
escherichia
coli
sever
autotransport
protein
ie
aidai
tiba
antigen
display
oglycosyl
surfac
protein
sherlock
et
al
repres
abund
phasevari
outer
membran
protein
e
coli
belong
aida
autotransport
famili
henderson
et
al
describ
confer
aggreg
fluf
cell
promot
biofilm
format
uptak
surviv
macrophag
well
longterm
persist
uropathogen
e
coli
upec
murin
urinari
tract
aidai
tiba
requir
oglycosyl
function
correspond
heptosyl
transferas
identifi
howev
enzym
respons
oglycosyl
still
unknown
henc
character
protein
glycosyl
uropathogen
e
coli
strain
order
elucid
glycoprotein
biosynthet
pathway
particular
focu
studi
includ
compar
genom
analysi
function
character
put
glycosyl
transferaseencod
open
read
frame
e
coli
strain
plectasin
fungal
defensin
antibiot
peptid
target
bacteri
cell
wall
precursor
lipid
ii
antimicrobi
peptid
serv
vital
role
firstlin
host
defenc
found
throughout
anim
plant
kingdom
although
evolutionari
ancient
amp
still
repres
effect
weapon
gramposit
gramneg
bacteria
fungi
envelop
virus
kill
rapidli
among
antimicrobi
peptid
defensin
repres
import
peptid
famili
fungal
defensin
plectasin
amino
acid
peptid
produc
saprophyt
ascomycet
pseudoplectania
nigrella
plectasin
share
primari
structur
featur
defensin
spider
scorpion
dragonfli
mussel
fold
cysteinestabil
alphabetastructur
unlik
convent
antibiot
act
via
defin
target
molecul
antimicrobi
defenc
peptid
assum
act
unspecif
permeabilis
cell
membran
contrast
wide
held
view
report
first
time
bacteri
cell
wall
precursor
lipid
ii
molecular
target
defensin
use
seri
cellular
approach
vitro
cell
wall
biosynthesi
assay
narrow
target
pathway
specif
mechan
action
zasloff
natur
human
highli
charg
cation
host
defenc
peptid
produc
epitheli
cell
neutrophil
retain
antimicrobi
activ
broad
rang
pathogen
includ
multiresist
staphylococcu
aureu
even
high
salt
condit
unlik
convent
antibiot
act
via
defin
target
molecul
antimicrobi
host
defenc
peptid
assum
act
unspecif
permeabilis
cell
membran
transcript
respons
pattern
reveal
induc
staphylococc
cell
wall
stress
stimulon
sass
et
al
suggest
particularli
staphylococci
cell
wall
biosynthesi
inhibit
analysi
intracellular
pool
nucleotideactiv
precursor
reveal
accumul
ultim
precursor
udpmurnacpentapeptid
cell
indic
cell
wall
biosynthesi
inhibit
put
mechan
action
moreov
accumul
experi
demonstr
cell
complet
deenergis
still
abl
maintain
small
cytoplasm
compound
vitro
test
individu
mray
murgand
femxcatalys
cell
wall
biosynthesi
reaction
indic
signific
inhibit
contrast
crosslink
reaction
aureu
substanti
inhibit
preliminari
data
suggest
may
stoichiometr
bind
lipid
ii
current
analys
bind
condit
paramet
detail
evalu
vitro
antibacteri
activ
gallium
curcumin
gallium
diacetylcurcumin
tajbakhsh
curcumin
main
yellow
bioactiv
compon
turmer
powder
deriv
rhizom
medicin
plant
curcuma
longa
shown
curcumin
sever
biolog
effect
antibacteri
activ
develop
new
compound
order
improv
antibacteri
effect
report
aim
studi
evalu
antibacteri
effect
gallium
curcumin
ga
cur
gallium
diacetylcurcumin
ga
dac
compar
curcumin
agent
test
staphylococcu
aureu
atcc
staphylococcu
epidermidi
atcc
psudomona
aeruginosa
atcc
escherichia
coli
atcc
broth
dilut
method
appli
determin
minimum
inhibitori
concentr
mic
ga
cur
ga
dac
exhibit
antibacteri
activ
aureu
epidermidi
wherea
show
effect
p
aeruginosa
e
coli
similar
curcumin
mic
ga
cur
ga
dac
epidermidi
equal
mic
curcumin
bacterium
mic
ga
dac
aureu
howev
mic
ga
cur
aureu
lower
mic
curcumin
bacteri
strain
therefor
ga
cur
found
antibacteri
activ
aureu
curcumin
could
good
candid
vivo
studi
opportunist
pathogen
p
aeruginosa
contamin
drink
water
system
pose
threat
human
health
basi
present
studi
observ
exposur
p
aeruginosa
coppercontain
drink
water
domest
plumb
system
result
loss
cultur
copper
ion
suppos
involv
effect
sinc
inactiv
bacteria
occur
drink
water
without
detect
copper
level
ii
addit
copper
chelat
diethyldithiocarbam
ddtc
coppercontain
water
prevent
loss
cultur
laboratori
experi
perform
studi
effect
copper
viabil
p
aeruginosa
expos
bacteria
cellsml
cupric
sulfat
deioniz
water
h
microscop
fluoresc
stain
techniqu
cultur
determin
coloni
count
use
assess
proport
viabl
cell
upon
exposur
copper
cultur
decreas
log
unit
total
cell
number
dapistain
cell
repres
intact
dnacontain
bacteria
membran
integr
cell
determin
livedead
baclight
kit
remain
unchang
number
respir
cell
determin
reduct
tetrazolium
chlorid
decreas
approxim
log
unit
still
log
unit
higher
compar
coloni
count
chelat
ddtc
ad
copperstress
bacteria
complet
restor
cultur
observ
sever
day
result
indic
copperexpos
p
aeruginosa
enter
viabl
noncultur
vbnc
state
resuscit
bacteria
cultur
state
possibl
copper
stress
abolish
cell
vbnc
state
hygien
relev
sinc
recogn
convent
cultur
method
result
underestim
number
viabl
potenti
infecti
bacteria
evalu
antivir
activ
pure
non
pure
curcumin
vero
cell
line
mani
studi
done
biolog
action
curcumin
princip
element
turmer
powder
evalu
new
compound
curcumin
antivir
effect
interest
research
vitro
studi
attempt
evalu
antivir
activ
pure
non
pure
curcumin
ko
strain
herp
simplex
viru
type
good
repres
envelop
human
virusesin
studi
use
dmso
good
solvent
curcumin
hand
regard
cytotox
dmso
face
limit
measur
antivir
activ
use
vero
cell
line
proper
cell
line
replic
found
use
microgram
microgram
non
pure
curcumin
pure
curcumin
cpe
inhibit
meanwhil
compound
sisnt
show
antivir
activ
microgram
use
could
conclud
curcumin
may
new
deriv
could
good
sourc
new
antivir
compound
investig
c
becker
kp
becker
peterpetersen
gymnasium
mannheim
germani
sinc
earli
hiv
spread
across
world
subsaharan
africa
affect
region
due
number
reason
specif
area
lack
inform
poor
access
medic
care
one
hand
number
behaviour
factor
hand
eg
frequent
chang
sexual
partner
unprotect
sex
prostitut
concomit
std
despit
mani
effort
undertaken
govern
well
ngo
littl
success
could
achiev
fight
spread
hiv
order
analys
reason
possibl
give
hint
overcom
unsatisfi
situat
mathemat
model
develop
abl
simul
spread
infect
take
account
variou
influenc
paramet
like
preval
time
zero
avail
therapi
protect
includ
still
hypothet
vaccin
sexual
behaviour
differ
group
person
etc
simul
cover
region
subregion
may
differ
characterist
popul
one
million
individu
live
popul
monitor
daili
period
one
hundr
year
paramet
like
hiv
incid
hiv
preval
age
distribut
calcul
differ
group
person
import
result
simul
perform
consequ
therapi
infect
individu
well
protect
individu
risk
perform
least
order
lower
incid
preval
infect
measur
kept
effect
decad
neglect
measur
establish
result
failur
chang
sexual
behaviour
effect
seem
applic
consid
avail
medic
care
inform
one
hand
million
infect
peopl
subsaharan
africa
probabl
vaccin
may
way
solv
problem
evalu
glutamatedehydrogenas
gdh
antigeneia
realtim
pcrtest
detect
c
difficil
stool
specimen
present
evalu
glutam
dehydrogenas
gdh
antigentest
detect
clostridium
difficil
realtim
pcrtest
detect
toxinproduc
c
difficil
stool
specimen
c
difficil
examin
specimen
test
c
diff
techlab
detect
gdhantigen
stool
specimen
posit
gdh
antigentest
analyz
eia
detect
toxin
b
meridian
cultur
cycloserincefoxitinfructos
ccfa
agar
perform
stool
specimen
posit
gdhantigeneia
result
neg
toxin
beia
result
cultur
c
difficil
isol
test
toxin
beia
addit
gdhneg
gdhposit
toxin
beia
neg
stool
specimen
collect
analysi
xpert
c
difficilepcrassay
cepheid
cultur
ccfaagar
stool
specimen
neg
gdhtest
posit
show
indetermin
result
gdhtest
posit
specimen
reveal
posit
result
toxineia
neg
toxineia
neg
specimen
show
growth
c
difficiletoxin
posit
isol
c
difficiletoxin
neg
isol
specimen
show
growth
c
difficil
concern
pcrtest
gdhneg
specimen
posit
xpertassay
specimen
posit
gdhtest
neg
direct
toxin
beia
show
toxin
posit
result
xpert
c
difficileassay
result
confirm
cultur
describ
procedur
detect
c
difficil
show
good
perform
routin
laboratori
xpert
c
difficil
realtim
pcrassay
show
high
sensit
reduc
time
result
barth
j
abdulmawjood
r
bauerfeind
institut
hygien
und
infektionskrankheiten
der
tier
giessen
giessen
germani
institut
nahrungsmittelkund
giessen
giessen
germani
epec
repres
diarrhoeagen
pathogen
human
anim
character
abil
caus
attach
effac
ae
lesion
intestin
cell
studi
prompt
uncov
occurr
genet
variabl
epec
strain
diarrheic
pig
therefor
e
coli
isol
pig
farm
germani
screen
intimin
gene
eae
pcr
eaeposit
isol
assess
eaetyp
virul
fit
associ
gene
least
one
repres
isol
detect
eaetyp
analyz
adhes
properti
induct
ae
lesion
porcin
human
epitheli
cell
vitro
one
hundr
seventeen
isol
pig
farm
detect
eaeposit
isol
encod
intimin
type
type
occur
less
frequent
addit
eae
isol
possess
variou
virul
fit
associ
gene
describ
previous
porcin
human
e
coli
isol
isol
paa
ehxa
asta
espi
bfpa
overal
found
differ
gene
pattern
repres
isol
repres
one
eaetyp
caus
ae
lesion
epitheli
cell
vitro
howev
ae
pattern
isol
vari
depend
cell
use
induc
ae
lesion
neither
cell
adhes
phenotyp
independ
presenc
adhes
gene
bfpa
paa
result
indic
phenotyp
genet
differ
epec
strain
common
diarrheic
pig
germani
differ
vitrobind
pattern
may
reflect
intimin
type
determin
capabl
epec
strain
colon
intestin
epithelium
particular
mammalian
host
speci
clostridium
difficil
pcr
ribotyp
associ
lethal
c
difficil
infect
hessen
arvand
hauri
nh
zaiss
g
bettgewel
zentrum
gesundheitsschutz
dillenburg
robert
koch
institut
wernigerod
germani
januari
april
case
sever
clostridium
difficil
infect
report
differ
district
hospit
state
hessen
germani
fortyon
c
difficil
isol
subject
microbiolog
analysi
pcr
ribotyp
pcr
ribotyp
rt
preval
strain
account
type
isol
follow
rt
eight
isol
rt
two
case
rt
one
isol
total
patient
clinic
outcom
known
die
within
day
admiss
c
difficil
report
underli
caus
contribut
death
patient
indic
case
fatal
rate
patient
lethal
c
difficil
infect
year
old
median
age
year
ribotyp
result
avail
seven
isol
associ
lethal
outcom
reveal
rt
three
case
rt
two
case
data
suggest
firstli
rt
strain
emerg
preval
hessen
secondli
along
possibl
virul
c
difficil
rt
toxigen
c
difficil
strain
like
rt
also
associ
lethal
c
difficil
infect
region
result
emphas
need
studi
molecular
epidemiolog
c
difficil
slpa
sequenc
type
characteris
clostridium
difficil
isol
ribotyp
alreadi
endem
western
part
germani
k
speck
herrmann
l
von
institut
medic
microbiolog
univers
saarland
homburg
germani
clostridium
difficil
associ
diarrhoea
cdad
becom
increas
challeng
hospit
acquir
infect
new
highli
virul
strain
ribotyp
respons
sever
epidem
outbreak
mutat
toxin
repressor
gene
tcdc
caus
increas
toxin
product
strain
also
character
increas
antibiot
resist
c
difficil
type
gener
perform
special
laboratori
howev
easi
applic
type
method
urgent
need
trial
prospect
studi
stool
sampl
patient
suspect
cdad
analyz
toxin
ab
elisa
standard
anaerob
cultur
ccf
agar
c
difficil
clinic
isol
character
sequenc
type
surfac
layer
protein
slpast
tcdc
antibiot
resist
test
moxifloxacin
clarithromycin
one
year
isol
collect
slpast
prove
highli
reproduc
easi
applic
method
c
difficil
type
preval
ribotyp
could
identifi
databank
search
wherea
slpa
sequenc
data
rare
sporad
isol
still
miss
cohort
patient
saarland
hospit
isol
identifi
outbreak
strain
confirm
detect
tcdc
delet
antibiot
resist
moxifloxacin
clarithromycin
case
sporad
strain
strain
show
similar
strain
caus
porcin
cdad
demonstr
characterist
tcdc
gene
delet
endem
strain
resist
moxifloxacin
clarithromycin
tcdc
sequenc
analysi
reveal
wildtyp
sequenc
establish
slpa
sequenc
type
fast
reliabl
type
c
difficil
clinic
isol
sever
case
cdad
found
infect
also
infect
ribotyp
lassach
savic
bogiatzi
institut
hospit
hygien
microbiolog
kage
austria
gramneg
spiral
shape
bacterium
helicobact
pylori
colon
human
gastric
mucosa
associ
differ
digest
diseas
gastriti
peptic
ulcer
mucosaassoci
lymphoid
tissu
lymphoma
gastric
cancer
treatment
choic
call
tripl
therapi
includ
proton
pump
inhibitor
two
antibiot
main
reason
failur
h
pylori
therapi
resist
one
antibiot
use
firstlin
therapi
treat
h
pylori
clarithromycin
fluorochinolon
previou
consumpt
macrolid
repres
potenti
risk
factor
develop
clarithromycin
resist
golden
standard
get
inform
possibl
resist
antibiot
cultur
follow
antibiogram
requir
gastric
endoscopi
although
cultur
repres
specif
method
detect
h
pylori
sometim
seem
problem
grow
bacterium
pcr
suitabl
detect
organ
slowgrow
present
low
number
fact
pcr
provid
result
high
sensit
specif
rapid
could
attract
altern
sinc
stool
obtain
total
noninvas
method
materi
could
easili
use
pcr
henc
reduc
need
gastric
endoscopi
aim
present
studi
compar
result
cultur
pcr
biopsi
develop
h
pylori
dnaextract
protocol
abl
detect
h
pylori
resist
clarithromycin
fluorochinolon
stool
sampl
therefor
obtain
biopsi
pcr
cultur
case
pcr
posit
cultur
sampl
posit
follow
antibiogram
possibl
case
complianc
result
pcr
antibiogram
good
stool
sampl
avail
pcr
sampl
analyz
show
good
complianc
result
biopsypcr
intestin
granuloma
format
egg
expuls
requir
host
bacteri
gut
flora
holzscheit
l
layland
c
prazer
da
costa
institut
medizinisch
mikrobiologi
immunologi
und
hygien
tu
germani
accord
recent
studi
schistosom
infect
forth
preval
helminth
infect
worldwid
fatal
aris
due
granulomat
immunemedi
respons
egg
becom
trap
host
liver
gut
schistosoma
mansoni
infect
immun
respons
characterist
switch
initi
immun
respons
strong
respons
eventu
control
strong
regulatori
mechan
previou
studi
demonstr
central
adaptor
molecul
innat
immun
respons
necessari
initi
antigenspecif
respons
interestingli
variou
schistosom
antigen
fail
stimul
dendrit
cell
releas
proinflammatori
cytokin
indic
addit
stimuli
requir
initi
antigenspecif
respons
schistosom
egg
penetr
lumen
gut
hypothezis
process
epitheli
barrier
disrupt
allow
commens
bacteria
enter
lamina
propria
therefor
bacteri
pamp
could
local
act
necessari
adjuv
instig
respons
thu
investig
whether
schistosoma
parasit
manipul
host
bacteri
repertoir
analys
parasitolg
microbiolog
immunolog
respons
infect
mice
simultan
deplet
bacteria
use
broad
spectrum
antibiot
antimycot
bacteri
deplet
found
significantli
less
inflamm
intestin
wand
accompani
signific
decreas
egg
load
intestin
granuloma
frequenc
develop
interestingli
mesenter
lymphnod
cell
respons
dampen
infecteddeplet
mice
howev
liver
granuloma
develop
normal
indic
immun
respons
affect
bacteriaresid
area
studi
demonstr
first
time
commens
host
deriv
bacteria
necessari
perpetu
lifecycl
helminth
support
eggpenetr
lumen
via
immun
respons
sever
inflamm
trigger
phenotyp
chang
helicobact
pylori
passag
mongolian
gerbil
stomach
k
buch
wiedemann
e
loell
r
haa
g
rieder
max
von
pettenkoferinstitut
bacteriolog
lmumunich
munich
germani
sinc
h
pylori
one
bacteri
speci
highest
rate
genet
divers
variabl
mongolian
gerbil
infect
model
start
get
better
understand
mechan
gener
h
pylori
strain
express
cagpathogen
island
cagpai
well
isogen
passag
gerbil
stomach
longterm
infect
experi
week
two
coloni
antral
corpu
tissu
infect
gerbil
conserv
genet
character
gene
express
h
pylori
virul
factor
mean
immunoblot
h
pylori
reisol
n
analyz
cagpai
stabil
interleukin
il
induct
express
adhesin
baba
oipa
h
pylori
reisol
rate
rang
eight
week
infect
obtain
signific
increas
activ
chronic
gastriti
antrum
corpu
wild
typeinfect
gerbil
express
analysi
reveal
genet
stabil
cagpai
gene
cagi
wherea
effector
protein
caga
stabli
express
begin
time
cours
block
one
third
reisol
week
wtinfect
parallel
tyrosin
phosphoryl
caga
reduc
induct
abil
miss
reisol
start
week
reduc
week
wtinfect
contrast
express
baba
oipa
show
gradual
decreas
time
reduct
respect
passag
gerbil
stomach
express
pattern
virul
factor
wtbut
mutantinfect
anim
reduc
therefor
conclud
analyz
chang
due
earli
sever
inflamm
antrum
corpu
mucosa
lead
histopatholog
chang
time
whether
observ
chang
regulatori
manifest
genet
level
discuss
insight
type
vi
secret
system
helicobact
hepaticu
l
bartonickova
sterzenbach
b
brennek
f
kop
j
schulz
suerbaum
c
josenhan
institut
medic
microbiolog
hospit
hygien
hannov
medic
school
hannov
germani
type
vi
secret
system
recent
discov
complex
secret
machineri
gramneg
bacteria
identifi
almost
genom
pathogen
well
nonpathogen
bacteria
far
sever
speci
role
pathogen
host
interact
shown
experiment
one
bacteria
possess
also
repres
speci
enterohepat
helicobact
sp
helicobact
hepaticu
inhabit
murin
intestin
tract
whole
genom
sequenc
h
hepaticu
resolv
genom
island
contain
secret
system
gene
identifi
recent
recogn
pathogen
island
sinc
presenc
led
sever
coliti
mice
sever
gene
encod
highli
conserv
compon
function
system
singl
compon
reveal
molecular
level
yet
aim
current
investig
molecular
character
particular
regard
surfac
compon
possibl
secret
transloc
effector
initi
focus
two
outer
compon
vgrg
present
three
gene
copi
hcp
vgrg
hcp
protein
also
propos
secret
substrat
system
also
perform
express
studi
sever
compon
vitro
vivo
infect
mice
show
h
hepaticu
compon
express
vitro
vivo
vivo
differ
mous
organ
differ
time
point
p
compon
express
differ
vitro
distinct
express
pattern
vgrg
hcp
express
growthdepend
manner
releas
bacteria
differenti
specif
growth
condit
subcellular
local
possibl
function
vgrg
hcp
protein
context
infect
differ
mutant
discuss
interact
helicobact
pylori
type
iv
secret
system
human
effector
protein
transloc
c
ertl
lf
jimenezsoto
r
haa
maxvonpettenkof
institut
lmu
germani
helicobact
pylori
hp
gramneg
spiralshap
bacterium
colon
persist
human
stomach
thu
lead
gastric
diseas
like
gastriti
peptic
ulcer
gastric
cancer
today
infect
pathogen
affect
least
world
popul
transloc
cytotoxinassoci
antigen
caga
via
type
iv
secret
system
host
cell
major
risk
factor
gastric
diseas
immunodomin
protein
caga
encod
togeth
cag
pathogen
island
compris
gene
get
direct
contact
human
epitheli
cell
hp
abl
transloc
effector
protein
caga
via
host
cell
caga
subsequ
tyrosinephosphoryl
interact
sever
eukaryot
signal
pathway
phosphorylationdepend
independ
way
hallmark
caga
potenti
induc
secret
also
effect
cytoskeleton
tight
junction
sever
transduct
pathway
cell
caga
consid
bacteri
oncoprotein
recent
abl
show
sever
compon
piluslik
cagi
cagi
well
transloc
effector
protein
caga
interact
host
cell
integrin
famili
heterodimer
cell
surfac
adhes
molecul
mediat
cellcel
cellextracellular
matrix
cellpathogen
interact
attempt
local
distinct
bind
region
caga
cagi
cagi
within
identifi
region
yeast
two
hybrid
assay
perform
gener
preliminari
data
biochem
confirm
data
go
accomplish
mammalian
two
hybrid
system
propos
new
model
interact
pathogen
hp
eukaryot
cell
mediat
specif
interact
host
cell
rohrer
w
fischer
r
haa
maxvonpettenkof
institut
lmu
germani
helicobact
pylori
colon
stomach
world
popul
make
one
success
human
pathogen
due
fact
genom
subject
rapid
mutat
frequent
recombin
event
h
pylori
one
divers
bacteri
speci
basic
mechan
underli
intraspeci
sequenc
variat
well
understood
known
natur
transform
compet
conjugationlik
mechan
contribut
horizont
gene
transfer
process
indic
conjug
plasmid
transfer
might
occur
h
pylori
came
sequenc
determin
cryptic
plasmid
mani
h
pylori
strain
contain
cryptic
plasmid
sequenc
plasmid
suggest
extens
gene
shuffl
evolut
spread
plasmid
contrast
natur
compet
bacteria
h
pylori
use
type
iv
secret
system
name
dna
uptak
besid
h
pylori
strain
possess
recent
lab
identifi
novel
name
project
interest
elucid
dna
transfer
h
pylori
bacteria
studi
underli
mechan
expect
identifi
machineri
mediat
dna
transfer
h
pylori
bacteria
achiev
sequenti
delet
gene
encod
h
pylori
strain
possibl
candid
dna
transfer
could
demonstr
transfer
chromosom
dna
first
time
transfer
indigen
plasmid
h
pylori
strain
could
show
play
role
plasmid
transfer
data
suggest
sever
divers
mechan
contribut
horizont
gene
transfer
h
pylori
complet
genom
sequenc
helicobact
pylori
strain
insight
gene
transfer
genom
evolut
avail
multipl
complet
genom
sequenc
individu
bacteri
speci
reveal
surpris
extent
intraspeci
genom
variabl
respect
core
genom
often
repres
small
fraction
entir
gene
repertoir
given
speci
human
gastric
pathogen
helicobact
pylori
known
speci
enorm
sequenc
divers
housekeep
gene
although
h
pylori
highli
adapt
speci
compar
reduc
genom
size
previou
data
suggest
consider
variabl
exist
gene
content
well
adapt
evolut
may
lead
strain
diverg
genom
comparison
sever
strain
therefor
requir
obtain
full
view
host
adapt
capabl
h
pylori
present
complet
genom
sequenc
duoden
ulcer
strain
chromosom
size
bp
presenc
addit
bp
plasmid
possess
comprehens
h
pylori
genom
far
comparison
complet
h
pylori
genom
sequenc
reveal
two
individu
h
pylori
strain
may
differ
gene
content
amount
gene
specif
genom
indic
h
pylori
possess
open
pangenom
strainspecif
gene
often
locat
potenti
genom
rearrang
site
cluster
three
distinct
genom
plastic
region
two
plastic
zone
integr
restrict
modif
gene
like
repres
genom
island
moreov
encod
complet
type
iv
secret
system
relat
clearli
distinct
microarray
analysi
use
determin
distribut
type
iv
secret
system
differ
h
pylori
strain
mutat
analysi
indic
involv
horizont
gene
transfer
togeth
comb
cag
system
h
pylori
contain
thu
four
distinct
type
iv
secret
system
wiedemann
e
r
haa
g
rieder
max
von
pettenkoferinstitut
bacteriolog
lmumunich
munich
germani
institut
patholog
lmumunich
munich
germani
h
pylori
persist
colon
stomach
human
popul
epidemiolog
studi
shown
h
pyloriassoci
corpu
domin
atroph
gastriti
risk
factor
develop
gastric
cancer
therefor
h
pylori
classifi
type
carcinogen
aim
base
investig
precancer
process
start
h
pyloriassoci
gastriti
follow
atrophi
metaplasia
dysplasia
final
lead
gastric
adenocarcinoma
use
mongolian
gerbil
model
method
anim
n
infect
h
pylori
wt
isogen
two
week
paraffin
section
antrum
corpu
mucosa
grade
histolog
chang
verifi
immunohistochemistri
physiolog
inflammatori
marker
measur
ria
qrtpcr
respect
result
comparison
wtinfect
corpu
mucosa
reveal
alreadi
sever
atroph
inflamm
eight
week
accompani
signific
upris
proinflammatori
cytokin
kc
physiolog
marker
ph
gastrin
histolog
chang
mucosa
toward
atrophi
metaplasia
dysplasia
occur
late
infect
interestingli
colon
densiti
wtinfect
gerbil
upris
corpu
continu
time
period
month
wtinfect
found
sever
histolog
chang
corpu
show
typic
precancer
marker
promin
gastriti
cystica
profunda
one
wtinfect
gerbil
develop
gastric
cancer
conclus
data
reveal
intact
cagpai
respons
earli
sever
inflamm
induc
later
physiolog
histopatholog
chang
step
cancer
pathway
atrophi
metaplasia
dysplasia
could
shown
even
develop
gastric
cancer
therefor
conclud
gerbil
model
one
best
model
mimick
human
situat
thorac
transplant
vascular
surgeri
hannov
medic
school
hannov
germani
object
surgic
site
infect
expens
complic
cardiac
surgeri
total
cost
coronari
arteri
bypass
graft
cabg
surgeri
follow
deep
sternal
wound
infect
dswi
estim
much
higher
normal
caus
expand
length
stay
reoper
special
treatment
vacuumassist
closur
therapi
antibiot
therapi
studi
compar
length
stay
total
cost
patient
undergo
cabg
develop
dswi
method
casecontrol
studi
perform
total
cost
analyz
compar
patient
undergo
cabg
without
dswi
inclus
criterion
case
develop
deep
sternal
wound
infect
accord
cdccriteria
hospit
stay
cabg
control
match
type
surgeri
drg
age
five
year
gender
durat
preoper
stay
two
day
time
develop
infect
taken
minimum
length
stay
control
control
show
sing
infect
hospit
stay
exclud
result
cabg
patient
dswi
januari
decemb
includ
studi
case
match
control
averag
cost
cabg
procedur
plu
treatment
dswi
euro
per
patient
almost
two
time
higher
mean
cost
cabg
alon
euro
p
averag
length
stay
lo
hospit
two
time
longer
day
vs
day
averag
lo
icu
also
longer
day
vs
day
signific
control
repres
basic
popul
conclus
dswi
devast
complic
surgeon
patient
also
import
econom
factor
hospit
averag
lost
singl
case
dswi
studi
period
measur
reduct
dswi
costeffect
therefor
bundl
infect
control
measur
essenti
evalu
weak
point
deal
mrsainfect
colon
patient
huber
u
geipel
herrmann
institut
medic
microbiolog
hygien
univers
saarland
hospit
homburg
germani
studi
discuss
extent
hygien
guidelin
treatment
nurs
patient
mrsa
realiz
period
meaning
screen
test
follow
therapi
decolon
erad
carri
adequ
moreov
intensifi
advic
support
given
institut
hospit
hygien
check
effect
accept
purpos
contin
visit
everi
newli
identifi
mrsapati
carri
check
list
reliabl
default
within
scope
activ
surveil
patientindividu
captur
mrsarelev
data
made
correspond
ward
got
written
inform
deviat
procedur
instruct
handl
mrsa
discov
end
observ
period
examin
achiev
medic
record
final
carri
order
get
full
survey
document
individu
mrsacas
visit
differ
ward
visit
mistak
could
found
realiz
hygien
guidelin
andor
therapi
correspond
mrsapati
percentag
visit
deficit
could
found
minimum
maximum
depend
ward
could
shown
unauthor
gradat
import
particular
hygien
measur
commit
sever
individu
involv
promis
control
mrsa
need
administr
scientif
guidanc
suffici
financi
personnel
resourc
period
visit
hygien
personnel
ward
mrsapati
support
complianc
lead
better
control
help
find
elimin
mistak
addit
measur
medic
staff
involv
care
patient
must
inform
train
adequ
deal
mrsa
h
frickmann
pp
gawlik
crusiu
podbielski
institut
microbiolog
virolog
hygien
univers
hospit
rostock
rostock
germani
medic
depart
air
base
kaufbeuren
medic
core
german
arm
forc
kaufbeuren
germani
puls
field
gel
electrophoresi
pfge
allow
comparison
clinic
methycillin
resist
staphylococcu
aureu
isol
strain
defin
epidem
clone
six
epidem
clone
regard
common
rostock
norddeutsch
hannoversch
berlin
barnim
rheinhessen
analysi
intend
monitor
distribut
differ
clone
univers
hospit
rostock
possibl
chang
cours
five
year
mrsa
isol
analys
use
restrict
enzym
smai
refer
strain
epidem
clone
mention
use
control
everi
singl
gel
allow
direct
comparison
analysi
perform
manual
help
softwar
gelcomparii
appli
math
analys
distinct
isol
year
clinic
isol
cluster
epidem
clone
follow
percent
absolut
count
bracket
norddeutsch
hannoversch
berlin
barnim
rheinhessen
one
isol
could
assign
six
clone
subsequ
identifi
belong
wiener
epidem
clone
nation
refer
centr
staphylococci
rki
wernigerod
epidem
clone
berlin
hannoversch
norddeutsch
remain
nearli
absent
hospit
clone
rheinhessen
predomin
isol
year
detect
rel
decreas
clone
mark
increas
clone
barnim
year
result
suggest
regularli
repeat
pfge
analysi
suitabl
method
detect
local
shift
distribut
epidem
clone
year
type
interv
two
year
appear
suffici
gener
survey
qualiti
nosocomi
outbreak
retriev
increas
last
year
weitzelkag
behnk
eckstein
stolzenhain
p
gastmeier
institut
hygien
und
umweltmedizin
charit
berlin
berlin
germani
background
publish
nosocomi
outbreak
could
provid
valuabl
knowledg
sourc
specif
outbreak
examin
varianc
qualiti
public
object
compar
characterist
variabl
outbreak
studi
year
time
differ
method
develop
maintain
softwar
applic
outbreak
articl
process
analysi
use
freeli
access
outbreak
databas
http
wwwoutbreakdatabasecom
determin
qualiti
outbreak
public
literatur
time
structur
questionnair
use
extract
specif
inform
follow
categori
use
refer
type
studi
applic
epidemiolog
fingerprint
method
type
microorgan
set
number
patient
personnel
involv
type
infect
sourc
infect
mode
transmiss
risk
factor
prevent
measur
perform
analysi
restrict
studi
type
appli
investig
outbreak
percentag
outbreak
without
sourc
identifi
actual
question
prevent
hospit
infect
develop
new
chemic
prepar
abl
kill
bacteri
spore
highli
resist
disinfect
antisept
oper
skin
area
nurs
surgeon
obstetrician
medic
person
hand
free
microbi
contamin
includ
agent
clostridi
infect
purpos
work
prove
sporocid
activ
new
polyhexamethilenguanidin
chlorid
deriv
teflex
teflex
new
water
solubl
skin
disinfect
prepar
phmghcl
deriv
regist
russian
feder
produc
compani
soft
protector
saint
petersbrug
sporocid
activ
bacteri
spore
bacillu
subtili
clostridium
perfringen
clostridium
difficil
investig
vitro
independ
microbiolog
expert
laboratori
suspens
method
establish
teflex
concentr
express
high
sporocid
action
bacillu
clostridium
speci
reduct
antimicrobi
sporocid
properti
allow
put
teflex
list
high
level
disinfect
use
skin
mucos
disinfect
method
detect
concentr
microbicid
activ
silver
contamin
water
system
c
unger
h
hund
rd
hund
c
institut
medizinisch
mirkobiologi
und
hygien
tudresden
dresden
germani
institut
textilund
bekleidungstechnik
tudresden
dresden
germani
silver
cation
show
antimicrobi
effect
microorgan
cytotox
human
cell
therefor
silver
compound
use
antimicrobi
agent
medicin
treatment
burn
coat
cathet
product
sport
cloth
sock
antimicrobi
effect
silver
coat
textil
test
differ
practic
applic
circul
water
equip
reduct
microorgan
detect
signific
effect
although
adequaci
concentr
silver
detect
aa
atom
absorpt
spectrometri
get
idea
mani
detect
silver
microbicid
activ
bound
organ
materi
complex
eg
silverthiosulf
silverrhodanid
specif
bioassay
develop
therefor
differ
bacteri
strain
test
differ
calcul
silverconcentr
aqua
dest
use
staphylococcu
aureu
pseudomona
aeruginosa
legionella
pneumophila
indic
strain
reduc
effect
allegor
graphic
regress
determin
follow
concentr
microbicid
activ
silver
water
sampl
calcul
result
show
might
discrep
concentr
silver
determin
aa
concentr
biocid
silver
determin
bioassay
establish
bioassay
well
adapt
procedur
assign
concentr
silver
differ
test
water
system
consid
differ
aspect
like
complex
fixat
silver
ion
organ
matrix
koshkolda
c
unger
c
institut
medizinisch
mikrobiologi
tu
dresden
dresden
germani
natur
microcosm
establish
laboratori
investig
interact
bacteria
protozoan
host
simul
natur
condit
microcosm
establish
base
microbi
commun
water
suppli
larg
build
contain
multipl
bacteri
speci
sphingomona
sp
chromobact
sp
flavimona
l
pneumophila
mtz
serogroup
hartmanella
sp
microcosm
stabl
sever
month
fresh
tap
water
ad
weekli
basi
l
pneumophila
express
protein
pad
l
pneumophila
amoeb
adhesin
involv
adherenceuptak
bacterium
amoeb
host
legionella
pneumophilaspecif
fit
factor
expos
surfac
bacteri
cell
length
amino
acid
investig
function
adhesin
detail
construct
knockout
mutant
natur
l
pneumophila
serogroup
strain
electropor
transform
mutat
confirm
western
blot
use
specif
monoclon
antibodi
pcranalysi
mutant
show
defect
adhes
acanthamoeba
castellanii
atcc
strain
reduc
uptak
within
hartmanella
vermiformi
strain
atcc
behaviour
wildtyp
mutant
strain
studi
natur
condit
within
microcosm
studi
way
suppos
padprotein
particular
l
pneumophila
serogroup
mtz
strain
involv
uptak
l
pneumophila
hartmanella
amoeba
intracellular
replic
uptak
within
acanthamoeba
castellanii
mrsaepimetri
process
model
mrsadynam
c
krickhahn
krickhahn
herrmann
u
geipel
methio
surveil
gmbh
homburg
germani
institut
medic
microbiolog
hygien
univers
saarland
hospit
homburg
germani
wellknown
problem
statist
mrsa
evalu
hospit
undifferenti
consider
new
mrsa
patient
known
mrsa
patient
resum
regardless
proport
new
mrsa
patient
caus
cumul
proport
nonerad
readmit
mrsa
patient
mrsa
patientpool
signific
often
decis
trend
annual
mrsa
burden
institut
avoid
blend
two
import
determin
epidemiolog
mrsa
proport
new
mrsaposit
patient
proport
known
mrsaposit
patient
must
describ
evalu
separ
purpos
develop
epimetr
model
allow
us
unlik
previou
mostli
static
close
period
evalu
statist
estim
emerg
mrsa
dynam
event
base
three
basic
vector
new
mrsa
patient
readmit
mrsa
patient
consist
compound
mrsa
patientpool
follow
dynam
arrang
group
follow
develop
histori
mrsa
situat
variabl
period
effect
surveil
simul
variou
scenario
chang
basic
vector
process
model
present
also
use
nosocomi
nonnosocomi
diseas
entiti
last
year
vancomycinresist
enterococci
vre
emerg
worldwid
import
hospitalacquir
pathogen
report
analysi
cluster
case
nosocomi
vre
german
univers
hospit
one
year
period
vre
isol
identifi
enterococcu
faecium
test
posit
vanbgenotyp
mean
age
patient
year
present
nosocomi
infect
vre
patient
die
case
vre
infect
directli
associ
patient
death
case
infect
vre
caus
death
contribut
patient
death
nosocomi
case
patient
hematolog
malign
suffer
solid
tumor
undergon
livertransplant
suffer
liveror
pancreasdiseas
remain
case
differ
underli
condit
found
addit
investig
vre
isol
collect
studi
period
reveal
belong
vanbgenotyp
contrast
describ
predomin
vanagenotyp
german
hospit
work
progress
identifi
clonal
relationship
vre
isol
use
mlst
order
provid
insight
whether
describ
cluster
due
unrecogn
outbreak
implement
vre
screen
procedur
stem
cell
transplant
unit
use
combin
cultureand
pcrbase
method
w
schneiderbrachert
u
reischl
hj
lind
holzmann
institut
medizinisch
mikrobiologi
und
hygien
regensburg
regensburg
germani
last
year
vancomycinresist
enterococci
vre
emerg
worldwid
import
hospitalacquir
pathogen
infect
caus
vre
account
increas
length
stay
hospit
overal
cost
mortal
control
spread
vre
implement
screen
program
risk
patient
essenti
start
screen
program
patient
bone
marrow
transplant
unit
univers
medic
center
regensburg
increas
sensit
specif
previou
report
screen
procedur
well
reduc
cost
work
time
establish
evalu
procedur
combin
initi
cultur
follow
pcr
studi
rectal
swab
taken
everi
patient
admiss
transfer
vre
select
enrich
broth
contain
vancomycin
incub
least
hour
growth
vre
suspect
realtim
lightcycl
pcr
perform
detect
presenc
vanaand
vanbgen
total
swab
process
color
chang
broth
indic
possibl
growth
enterococci
hr
howev
subsequ
pcr
analysi
confirm
presenc
vana
vanb
total
inocul
broth
show
bacteri
growth
even
hr
incub
combin
cultureand
pcrbase
method
use
tool
costeffect
rapid
detect
vre
screen
sampl
prove
valuabl
mean
control
spread
vre
hospit
switchabl
hygien
functionalis
textil
e
hein
b
dittrich
r
dwi
der
rwth
aachen
ev
aachen
germani
switchabl
control
releas
system
present
abl
inhibit
growth
gramposit
bacillu
subtili
textil
materi
nisin
antimicrobi
drug
encapsul
togeth
sodium
chlorid
silicon
microspher
get
contact
water
microspher
imbib
small
amount
water
encapsul
sodium
chlorid
dissolv
due
osmot
pressur
dissolut
water
imbib
microspher
result
silicon
microspher
swell
network
craze
occur
due
nisin
part
sodium
chlorid
releas
wet
encapsul
nisin
sodium
chlorid
conserv
microspher
long
time
nisinload
microspher
produc
use
solvent
evapor
process
particl
size
microspher
averag
releas
behaviour
sodium
chlorid
prove
use
ion
sensit
electrod
effect
releas
nisin
shown
monitor
growth
curv
bacillu
subtili
minimum
concentr
nisin
found
effect
inhibit
growth
bacillu
subtili
repeat
releas
nisin
microspher
also
confirm
shown
nisin
better
avail
acid
condit
thu
effect
mechan
swellingcontrol
releas
antimicrobi
effect
peptid
open
perspect
develop
new
finish
technic
textil
releas
peptid
take
place
condit
microbi
infest
given
microbi
growth
refil
drink
water
receptacl
depend
durat
use
stroh
b
jahn
hygien
und
umweltmedizin
hsk
dr
horst
schmidt
klinik
wiesbaden
wiesbaden
germani
drink
water
suppli
dispens
system
evolv
altern
bottl
water
minim
need
storag
hous
logist
bottl
water
patient
suppli
new
receptacl
everi
chang
bottl
use
dispens
system
patient
must
provid
receptacl
allow
dispens
water
avail
bed
side
obtain
criteria
replac
frequenc
receptacl
microbi
contamin
residu
volum
analyz
relat
durat
use
e
length
patient
hospit
stay
singl
use
pet
bottl
ml
volum
fill
dispens
system
suppli
patient
begin
hospit
stay
drink
glass
provid
ad
libitum
end
stay
bottl
collect
bottl
residu
volum
ml
includ
studi
control
freshli
dispens
aliquot
obtain
respect
dispens
system
microbiolog
analysi
perform
accord
standard
procedur
drink
water
qualiti
assess
addit
aliquot
plate
columbia
agar
analysi
contamin
bacteri
speci
overal
bottl
examin
compar
control
sampl
durat
use
correspond
length
stay
lo
rang
day
linear
regress
analysi
lo
coloni
count
incub
show
correl
r
cfu
r
cfu
similar
data
obtain
incub
respect
spectrum
microbi
contamin
predominantli
anthropogen
origin
staphylococci
account
contamin
result
indic
durat
use
influenc
microbi
contamin
refil
receptacl
receptacl
may
use
even
longer
hospit
stay
without
chang
andor
interim
reprocess
frequenc
methicillinresist
aureu
nasal
carri
among
teach
hospit
staff
jahe
javadpour
kazemi
n
moradi
natami
depart
microbiolog
hormozgan
univers
medic
scienc
bandar
abba
iran
staphylococcu
aureu
longley
recogn
import
pathogen
human
infect
special
hospit
patient
treatment
infect
due
methicillinresist
saureu
mrsa
often
multiresist
becom
problemat
screen
health
care
worker
allow
earli
detect
nasal
carrier
prevent
subsequ
transmiss
aim
studi
determin
frequenc
nasal
carrier
mrsa
among
shahid
mohammadi
hospit
staff
crosssect
studi
total
nasal
sampl
cultur
manitolsalt
agar
plate
incub
c
hour
identif
suspici
coloni
carri
coagulas
dnase
test
mrsa
strain
detect
oxacillin
disk
diffus
method
oxacillin
mic
consid
methicillin
resist
saureu
carriag
state
detect
member
mrsa
preval
saureu
mrsa
relat
age
sex
ward
occup
durat
work
hospit
cigarett
smoke
describ
ration
relat
job
carrier
state
mrsa
studi
direct
relat
observ
durat
presenc
hospit
nasal
carriag
mrsa
highest
rate
mrsa
carriag
seen
oper
room
staff
sinc
nasal
carriag
saureu
appear
play
key
role
epidemiolog
pathogenesi
staphylococc
infect
detect
erad
mrsa
carriag
recommend
background
numer
studi
demonstr
nosocomi
infect
methicillinresist
staphylococcu
aureu
mrsa
attend
increas
morbid
mortal
furthermor
present
high
financi
burden
hospit
commun
object
purpos
studi
investig
attribut
cost
nosocomi
mrsapneumonia
insid
german
drgsystem
method
conduct
casecontrol
studi
includ
patient
pt
nosocomi
pneumonia
caus
mrsa
meticillinsuscept
aureu
mssa
admit
januari
decemb
pneumonia
defin
use
cdc
criteria
nosocomi
case
mrsapneumonia
match
control
patient
mssapneumonia
ratio
use
follow
match
criteria
admiss
year
minimum
length
stay
correspond
time
risk
case
charlson
comorbidityindex
occurr
pneumonia
intens
care
unit
icu
result
analysi
includ
patient
case
control
median
overal
cost
patient
nosocomi
mrsapneumonia
signific
higher
control
patient
vs
furthermor
detect
signific
differ
median
financi
loss
case
control
vs
attribut
cost
mrsapneumonia
median
p
acquisit
mrsapneumonia
icu
p
ventil
p
liver
diseas
mrsapneumonia
predict
increas
cost
multivari
regress
analysi
conclus
studi
point
nosocomi
mrsapneumonia
associ
high
cost
healthcar
system
compar
mssapneumonia
appropri
infect
control
measur
costeffect
therefor
essenti
low
temperatur
inactiv
prion
surgic
steel
surfac
k
roth
zx
yan
l
stitz
ps
mauz
p
heeg
smp
gmbh
germani
molekularbiologi
smp
gmbh
germani
inst
immunologi
germani
klinik
germani
inst
medizinisch
mikrobiologi
u
hygien
germani
contrast
former
view
presenc
prpsc
restict
nerv
tissu
found
late
also
extraneur
tissu
thu
pose
consider
risk
iatrogen
transmiss
prionassoci
encephalopathi
mani
countri
offici
guidelin
recommend
alkalin
treatment
andor
steam
steril
prevent
cross
infect
via
contamin
invas
devic
report
anim
model
use
steel
wire
contamin
scrapi
strain
evalu
decontamin
process
prion
contamin
wire
subject
differ
clean
disinfect
steril
process
prior
implant
hamster
surviv
time
anim
use
paramet
infect
previou
studi
could
demonstr
alkalin
clean
effect
dri
steel
surfac
data
current
studi
indic
low
temperatur
hydrogen
peroxid
ga
plasma
steril
alon
combin
alkalin
deterg
highli
effect
prion
result
relev
process
thermolabil
critic
devic
electr
electron
optic
modul
delic
mechan
part
surgic
instrument
result
total
patient
patientday
includ
nosocomi
infect
record
lower
respiratori
tract
infect
five
common
pathogen
aureu
ni
p
aeruginosa
ni
klebsiella
spp
ni
e
coli
ni
enterobact
spp
ni
declin
order
primari
bloodstream
infect
diagnos
coagulaseneg
staphylococcu
ni
frequent
follow
aureu
ni
enterococcu
spp
ni
klebsiella
spp
ni
c
albican
ni
stratif
type
icu
differ
distribut
pathogen
could
shown
overal
aureu
isol
mrsa
rang
ratio
vre
suscept
enterococci
overal
proport
esbl
produc
bacteria
infect
caus
e
coli
infect
klebsiella
spp
conclus
kiss
data
present
overview
import
pathogen
associ
nosocomi
infect
show
current
trend
antimicrobi
resist
icu
germani
neonat
intens
care
unit
outbreak
extendedspectrum
escherichia
coli
control
treatment
probiot
j
herrmann
e
cloppenburg
c
roth
pfeifer
institut
krankenhaushygien
klinikum
oldenburg
oldenburg
germani
elisabeth
kinderkrankenhau
klinikum
oldenburg
oldenburg
germani
fg
nosokomial
infektionen
robert
koch
institut
wernigerod
germani
improv
surviv
lowbirthweight
infant
frequent
use
antibiot
drugresist
gramneg
bacteria
emerg
common
problem
neonat
intens
care
unit
extendedspectrum
esbl
enzym
produc
gramneg
bacteria
abil
inactiv
antibiot
contain
oxyimino
group
juli
decemb
colon
esbl
produc
escherichia
coli
observ
neonat
neonat
intens
care
unit
teach
hospit
oldenburg
germani
infect
control
measur
implement
fail
interrupt
outbreak
outbreak
investig
includ
case
identif
review
medic
record
environment
cultur
patient
surveil
cultur
personnel
stool
cultur
multiplex
pcr
blactxm
pulsedfield
gel
electrophoresi
pfge
genotyp
analysi
clinic
isol
isol
staff
indic
case
due
singl
clone
neonat
two
staff
member
colon
betalactamas
posit
escherichia
coli
strain
clonal
relat
pfgeanalysi
outbreak
control
immedi
start
per
os
treatment
neonat
probiot
contain
lactobacillu
acidophilu
bifidobacterium
infanti
role
crucial
conclus
analysi
alcohol
handrub
consumpt
german
paediatr
depart
n
f
schwab
c
geffer
c
reichardt
p
gastmeier
institut
hygien
und
umweltmedizin
berlin
germani
background
known
hand
disinfect
hd
often
suffici
realiz
wide
varianc
hand
hygien
complianc
compar
ward
alcohol
handrub
consumpt
ahc
wide
accept
surrog
paramet
hand
hygien
complianc
framework
german
campaign
aktion
sauber
compon
handkiss
establish
measur
ahc
particip
hospit
ward
creat
benchmark
data
object
investig
correl
ahc
intens
care
unit
icu
peripher
ward
belong
one
depart
focu
paediatr
ward
method
ahc
data
use
analysi
data
paediatr
icu
peripher
ward
record
separ
correl
ahc
group
investig
spearman
rank
correl
coeffici
result
total
depart
provid
data
paediatr
icu
mean
ahc
ml
per
patient
day
record
wide
rang
icu
interquantilerang
iqr
ml
per
patient
day
peripher
ward
median
ahc
per
patient
day
iqr
ml
per
patient
day
found
signific
correl
correl
ahc
intens
peripher
ward
within
paediatr
depart
shown
conclus
infect
control
climat
depart
probabl
role
model
head
depart
may
major
impact
ahc
hand
hygien
complianc
given
depart
observ
indic
activ
complianc
hand
hygien
mrsaposit
patient
scheithauer
h
haefner
schwanz
r
kopp
lemmen
krankenhaushygien
und
infektiologi
rwth
aachen
aachen
germani
klinik
oper
intensivmedizin
rwth
aachen
aachen
germani
introduct
hand
hygien
hh
consid
singl
effect
measur
prevent
control
healthcareassoci
infect
hcai
daili
number
indic
hh
hhi
perform
hh
activ
hha
patient
specif
isol
precaut
unknown
therefor
investig
hhi
hha
complianc
rate
cr
glove
usag
gu
mrsa
posit
patient
base
direct
observ
materi
method
observ
period
last
hour
done
evenli
throughout
day
surgic
intens
care
unit
icu
surgic
intermedi
care
unit
imcu
univers
hospit
aachen
analysi
perform
accord
indic
perform
usag
glove
document
result
hhipatientday
pd
hhapd
document
thu
result
cr
icu
imcu
respect
hhishift
occur
earli
shift
icu
imcu
follow
late
shift
significantli
less
hhi
occur
night
shift
despit
fact
cr
earli
shift
highest
icu
median
imcu
cr
highest
patient
contact
icu
imcu
signific
lower
asept
task
icu
imcu
figur
compar
indic
hha
patient
contact
asept
task
miss
glove
use
instead
icu
imcu
perform
nearli
document
hha
adequ
discuss
best
knowledg
present
first
data
hhi
hha
cr
mrsaposit
patient
includ
shiftand
indicationspecif
analysi
even
patient
special
isol
precaut
cr
turn
satisfactori
addit
effort
seem
necessari
improv
cr
especi
asept
task
indic
associ
import
impact
prevent
hcai
background
substanti
progress
radiolog
made
use
highpressur
injector
contrast
media
differ
radiolog
procedur
requir
differ
quantiti
contrast
media
system
may
use
contrast
media
fals
multipledos
vial
risk
microbi
contamin
investig
contrast
media
use
bacteri
contamin
occur
method
oneweek
period
infect
control
nurs
observ
document
handl
contrast
media
ct
nmr
angiolog
depart
tertiarycar
hospit
vial
line
use
day
collect
steril
test
perform
result
ct
nmr
angiolog
patient
pt
examin
use
contrast
media
vial
result
administr
pt
per
vial
use
contrast
media
vial
contamin
cfu
micrococci
spp
nacl
scandicain
vial
contamin
cfu
micrococci
spp
bacillu
spp
patient
line
contamin
cfu
micrococci
spp
bacillu
spp
coagulaseneg
staphylococci
observ
reveal
low
complianc
hand
disinfect
asept
task
prepar
injector
system
connect
disconnect
patient
one
injector
system
requir
contrast
media
load
use
open
system
conclus
radiolog
depart
mani
contrast
media
nacl
scandicain
use
fals
multipledos
vial
increas
risk
microbi
contamin
multipleus
might
hidden
use
injector
system
injector
requir
load
open
steril
vial
exist
procedur
applic
contrast
media
revisit
system
guarante
asept
applic
develop
implement
reduc
infect
risk
n
ac
breier
c
geffer
weitzelkag
p
gausmann
j
jaklin
p
gastmeier
institut
hygien
environment
medicin
berlin
berlin
germani
grb
ecclesia
gesellschaft
risikoberatung
versicherungsdienst
detmold
germani
object
patient
increasingli
demand
financi
compens
hospit
error
treatment
context
hospit
infect
error
treatment
still
rare
perform
studi
corpor
ecclesia
insur
evalu
claim
hygien
failur
hf
impact
error
treatment
view
panel
expert
pe
method
systemat
analys
notif
claim
due
hf
data
hospit
support
ecclesia
survey
case
report
hf
insur
case
minim
payment
includ
review
claim
file
total
case
gave
suffici
inform
includ
analysi
panel
expert
result
pe
found
case
proceed
base
hf
case
origin
hf
complain
end
proceed
exclus
base
error
therapi
diagnost
case
initi
hf
design
though
precis
describ
case
could
classifi
hf
perspect
pe
furthermor
expert
made
profession
opinion
loss
occurr
realli
base
hf
case
evalu
like
hf
case
unlik
could
classifi
retrospect
entir
case
appear
surgeri
report
gynaecolog
type
infect
wound
infect
case
follow
gastroenter
sepsi
frequent
describ
hf
nonsteril
surgeri
error
treatment
lead
mean
cost
per
case
conclus
evalu
show
hf
minor
impact
notif
claim
furthermor
low
rate
claim
hf
could
assess
realli
hf
retrospect
often
detail
inform
determin
hf
could
collect
retrospect
infect
control
measur
taken
control
outbreak
multiresist
gramneg
bacteria
object
emerg
gramneg
multidrugresist
bacteria
mdr
increas
concern
health
care
set
urgent
necess
implement
prevent
control
strategi
mdr
elucid
efficaci
measur
taken
control
outbreak
mdr
perform
systemat
review
method
outbreak
report
emerg
mdr
identifi
search
pubm
outbreak
databas
use
meshterm
acinetobact
e
coli
klebsiella
pneumonia
stenotrophomona
pseudomona
aeruginosa
multiresist
outbreak
control
period
studi
describ
infect
control
measur
includ
experiment
studi
investig
effect
prevent
measur
detect
result
overal
paper
analyz
report
outbreak
involv
patient
pt
median
fatal
case
mean
mortal
pt
infect
other
colon
mean
durat
outbreak
month
month
acinetobact
baumanii
klebsiella
esbl
account
outbreak
control
measur
includ
environment
decontamin
icu
activ
surveil
colon
educ
program
staff
singl
cohort
isol
antimicrobi
use
recommend
report
ward
close
control
outbreak
control
measur
activ
surveil
colon
associ
outbreak
compris
less
patient
median
conclus
studi
compar
differ
control
measur
prove
efficaci
immedi
implement
control
measur
may
prevent
temporari
closur
ward
limit
outbreak
highrisk
area
mdr
screen
admiss
interv
screen
discuss
control
studi
investig
effect
differ
control
measur
need
aim
recruit
polymorphonuclear
neutrophil
pmn
site
inflamm
play
essenti
role
immun
defenc
import
pmn
migrat
tissu
phagocytosi
invad
microorgan
activ
human
pmn
antibodi
induc
upregul
express
howev
enzym
involv
signal
pathway
still
unknown
therefor
aim
studi
investig
possibl
particip
tyrosin
kinas
signal
cascad
method
effect
two
tyrosin
kinas
inhibitor
express
analys
stimul
activ
antibodi
inhibitor
genistein
broadrang
tyrosin
kinas
inhibitor
compound
specif
egfr
kinas
inhibitor
six
eight
whole
blood
sampl
differ
healthi
volunt
incub
inhibitor
differ
concentr
min
ad
antibodi
final
concentr
sampl
taken
sever
interv
min
express
analys
flow
cytometri
use
specif
pelabel
antibodi
pmn
distinguish
leukocyt
mean
forward
sideward
scatter
statist
analysi
base
wilcoxon
test
use
spss
result
express
inhibit
genistein
compound
concentrationdepend
manner
genistein
decreas
express
compound
decreas
express
p
case
conclus
major
part
signal
pathway
activ
lead
express
depend
activ
differ
tyrosin
kinas
experi
show
inhibit
express
activ
also
occur
tyrosin
kinas
inhibitor
licens
treatment
eg
chronic
myelogen
leukemia
isoflavon
genistein
found
food
consid
phytoestrogen
broadrang
tyrosin
kinas
inhibitor
investig
relat
possibl
applic
cancer
treatment
investig
ist
influenc
function
macrophag
particular
respect
interact
candida
albican
wherea
treatment
macrophag
genistein
influenc
phagocytosi
c
albican
pretreat
c
albican
genistein
significantli
increas
phagocytosi
activ
murin
cell
line
addit
could
show
genistein
treat
c
albican
increas
product
cytokin
cell
wall
mainli
respons
activ
c
albican
phagocytosi
exposur
cell
wall
analyz
flow
cytometri
howev
increas
exposur
due
genistein
treatment
observ
suppos
genistein
could
target
one
histidin
kinas
c
albican
involv
cell
wall
integr
virul
stress
respons
inhibit
osmot
stress
lead
enhanc
glycerol
product
determin
glycerol
concentr
genistein
treatment
c
albican
found
slightli
increas
thu
genistein
influenc
c
albican
enhanc
immun
defenc
mechan
murin
macrophag
effect
could
least
partli
due
histidin
kinas
inhibitori
effect
filari
parasit
transmit
insect
vector
therefor
enter
bodi
skin
howev
minor
proport
infect
larva
abl
develop
adult
thymu
activationregul
chemokin
tarc
produc
varieti
cell
among
dendrit
cell
endotheli
cell
fibroblast
ideal
place
first
cell
interact
filari
worm
enter
via
insect
vector
skin
initi
innat
adapt
immun
respons
howev
littl
known
mechan
earli
local
event
filari
infect
determin
defici
lead
higher
parasit
burden
compar
heterozygot
control
day
post
infect
rodent
filaria
litomosoid
sigmodonti
could
detect
differ
cellular
influx
cytokin
respons
pleural
caviti
final
destin
filaria
differ
parasit
load
present
alreadi
day
point
earli
respons
respons
parasit
surviv
parasitolog
phenotyp
associ
greater
influx
degranul
mast
cell
skin
addit
higher
vascular
permeabl
express
lymphangiogenesi
factor
found
parasitolog
outcom
vascular
permeabl
could
revers
inhibit
mast
cell
degranul
cromolyn
find
reveal
mast
cell
migrat
inhibit
therebi
aggrav
larval
establish
probabl
reduct
vascular
permeabl
skin
vessel
quantit
analysi
mhc
class
irestrict
antigen
present
listeria
monocytogenesderiv
antigen
suggest
put
instabl
bacteri
translat
product
sole
sourc
antigen
peptid
graulinghalama
g
geginat
institut
medizinisch
mikrobiologi
und
hygien
medizin
mannheim
der
heidelberg
mannheim
germani
rapid
antigen
degrad
prerequisit
mhc
class
irestrict
present
recognit
infect
cell
pathogenspecif
cell
instabl
viral
bacteri
translat
product
implic
substrat
rapid
process
present
antigen
peptid
context
mhc
class
molecul
instabl
translat
product
either
structur
alter
eg
prematur
ctermin
truncat
structur
intact
misfold
contrast
truncat
translat
product
misfold
translat
product
easili
differenti
properli
fold
protein
due
these
experiment
limit
appli
mathemat
model
antigen
process
janda
geginat
j
theor
biol
estim
rel
contribut
instabl
versu
stabl
variant
listeria
monocytogenesderiv
cell
antigen
process
cell
epitop
nonlinear
regress
analysi
publish
experiment
data
suggest
antigen
peptid
deriv
put
instabl
form
intracellular
halfliv
approxim
one
minut
account
roughli
molecul
remark
quantit
analysi
also
indic
major
stabl
molecul
intracellular
halfliv
minut
play
role
substrat
process
antigen
peptid
explor
function
toxoplasmosi
balbc
wildtyp
wt
mice
infect
gondii
cyst
wherea
mice
succumb
infect
day
post
infect
wt
mice
surviv
day
post
infect
histopatholog
examin
reveal
mice
significantli
increas
parasit
load
compar
wt
anim
impair
parasit
control
mice
result
necrot
toxoplasma
enceph
uninfect
wt
mice
harbour
equal
low
number
tcell
b
cell
macrophag
granulocyt
brain
upon
infect
gondii
leukocyt
popul
increas
brain
strain
mice
howev
number
cell
higher
wt
anim
addit
number
gondiispecif
cell
initi
reduc
spleen
brain
mice
reach
compar
number
wt
anim
shortli
death
mice
number
b
cell
also
reduc
brain
infect
reduc
express
cell
parallel
reduc
product
gondiispecif
igg
igm
antibodi
serum
cerebrospin
fluid
mice
analysi
signal
pathway
cell
gondiiinfect
mice
reveal
impair
activ
pathway
indic
reduc
express
pikk
rel
mice
activ
mapk
pathway
significantli
affect
reduc
express
perk
pjun
although
increas
express
pfo
mice
find
show
import
surviv
effici
parasit
control
well
protect
b
cell
respons
toxoplasmosi
superantigen
play
role
staphylococcu
aureu
bacteremia
staphylococcu
aureu
superantigen
sag
highli
potent
cell
mitogen
caus
agent
toxic
shock
syndrom
food
poison
aureu
strain
sag
pattern
highli
variabl
date
role
sag
bacteremia
well
defin
analyz
whether
sag
play
role
bacteremia
investig
aureu
strain
antisag
antibodi
respons
case
aureu
bacteremia
iv
drug
user
ageand
sexmatch
nonaddict
aureu
isol
analyz
spagenotyp
sag
gene
pattern
neutral
capac
sera
diagnosi
day
four
week
thereaft
day
test
sag
cocktail
produc
respect
infect
strain
well
panel
repres
recombin
sag
rise
neutral
antibodi
titer
indic
sag
produc
infect
genet
analysi
confirm
previou
observ
strain
harbor
sag
gene
link
staphylococc
lineag
isol
iv
drug
user
nonaddict
differ
sag
gene
pattern
interestingli
staphylococc
lineag
spatyp
agr
sea
seb
sek
seq
much
preval
among
bacteremia
strain
iv
drug
user
nonaddict
iv
drug
user
neutral
antibodi
sag
alreadi
onset
bacteremia
like
due
previou
encount
infect
strain
frequent
observ
rise
antibodi
titer
infect
surprisingli
patient
strain
show
elev
neutral
antibodi
level
conclus
rise
neutral
antibodi
titer
sag
aureu
bacteremia
indic
sag
produc
infect
howev
toxic
effect
sag
like
frequent
neutral
specif
antibodi
neuron
express
requir
protect
neuron
apoptosi
inhibit
intracerebr
hyperinflamm
prevent
death
host
chronic
toxoplasma
enceph
u
deckert
k
w
institut
medic
microbiolog
univers
magdeburg
magdeburg
germani
depart
neuropatholog
univers
cologn
germani
infect
immunocompet
mammal
gondii
induc
chronic
infect
brain
gondii
cyst
persist
neuron
escap
elimin
immun
system
immunodefici
individu
infect
reactiv
result
lethal
toxoplasma
enceph
te
te
parasit
primarili
control
infiltr
b
cell
also
brain
resid
cell
may
contribut
control
diseas
howev
mechan
brain
resid
cell
lead
protect
vulner
brain
chronic
te
larg
unknown
previou
studi
could
show
express
astrocyt
mice
critic
surviv
te
present
studi
analyz
function
neuron
te
infect
gondii
mice
lack
neuron
synapsincr
flfl
die
significantli
earlier
chronic
phase
infect
control
mice
death
synapsincr
cre
flfl
due
sever
enceph
larger
inflammatori
lesion
higher
number
inflammatori
leukocyt
addit
te
synapsincr
flfl
mice
result
substanti
apoptosi
neuron
vicin
inflammatori
lesion
also
brain
area
without
inflamm
vitro
apoptosi
neuron
also
significantli
increas
upon
infect
gondii
stimul
tnf
compar
express
neuron
interestingli
intracerebr
parasit
burden
increas
synapsincr
flfl
mice
indic
immunoregulatori
role
neuron
import
antiparasit
function
tumor
vaccin
use
heterolog
antigen
deliveri
recombin
salmonella
surgeri
chemotherapi
radiat
classic
therapi
cancer
recent
vaccin
tumor
becam
attract
altern
prevent
therapeut
strategi
protect
virus
intracellular
bacteria
also
tumor
mhc
class
irestrict
antigen
present
crucial
induc
tcell
respons
characterist
salmonella
enterica
serovar
typhimurium
abl
invad
phagocyt
nonphagocyt
cell
intern
gramneg
bacteria
remain
confin
salmonellacontain
vesicl
scv
thu
isol
cytosol
environ
host
cell
recent
develop
new
vaccin
strategi
use
salmonella
type
iii
secret
system
transloc
protein
directli
cytosol
antigenpres
cell
dendrit
cell
macrophag
result
effici
induct
specif
tcell
first
step
toward
new
immunotherapi
malign
cell
evalu
potenti
salmonella
induc
prophylact
cellmedi
antitumor
immun
highli
aggress
murin
fibrosarcoma
vivo
protect
studi
reveal
mice
remain
cancerfre
challeng
anoth
approach
construct
salmonella
strain
transloc
immunogen
epitop
vascular
endotheli
growth
factor
receptor
via
group
alreadi
shown
antitumor
effect
dna
vaccin
prevent
effect
angiogenesi
inhibit
tumor
growth
member
tyrosin
protein
kinas
famili
upregul
prolifer
endotheli
cell
tumor
vasculatur
play
major
role
tumor
neoangiogenesi
induct
specif
salmonellainduc
cell
immun
respons
prevent
tumor
angiogenesi
reduc
lung
metastasi
artifici
metastasi
model
mous
helicobact
pylori
recogn
cancerogen
bacteri
agent
human
associ
gastriti
peptic
ulcer
gastric
cancer
immunoevas
immunomodulatori
mechan
underli
chronic
persist
bacterium
activ
proinflammatori
effect
lifelong
h
pylori
infect
suscept
host
may
trigger
drive
cancerogenesi
contrast
tumorigen
virus
frequent
possess
factor
influenc
host
ubiquitinproteasom
system
up
purpos
subvert
immun
respons
noth
yet
known
potenti
effect
h
pylori
respect
major
h
pylori
isol
worldwid
possess
pathogen
island
pai
cagpai
involv
product
chronic
inflamm
context
infect
hypothes
cagpai
may
influenc
host
cell
ubiquitin
pathway
influenc
h
pylori
wild
type
isogen
mutant
lack
complet
cagpai
singl
pai
protein
host
deubiqutin
enzym
test
coincub
experi
variou
human
gastric
epitheli
cell
line
known
deubiquitin
enzym
dub
identifi
activ
human
gastric
cell
line
influenc
h
pylori
infect
express
activ
defin
cellular
up
protein
name
dub
hausp
clearli
determin
cagdepend
well
cagindepend
effect
activ
express
deubiquitin
enyzm
observ
infect
cell
result
basi
investig
potenti
h
pylori
modul
cellular
up
function
helicobact
flagellin
evad
physic
bind
bind
epitheli
cell
influenc
cellular
signal
flagellin
chronic
gastric
pathogen
helicobact
pylori
relat
bacteria
shown
deploy
low
potenti
activ
proinflammatori
signal
gastric
intestin
epitheli
cell
possess
activ
tolllik
receptor
flagellin
numer
pathogen
nonpathogen
bacteri
speci
potent
activ
human
innat
immun
system
proinflammatori
respons
bind
evas
respons
appear
potent
strategi
persist
bacteria
h
pylori
evad
human
innat
adapt
immun
reaction
possibl
downmodul
cancerprotect
respons
mechan
flagellar
immun
evas
h
pylori
known
show
coprecipit
bind
assay
h
pylori
flagellin
flaa
flab
low
activ
induc
activ
releas
via
evad
stabl
physic
bind
still
bind
human
mous
cell
moreov
h
pylori
flagellin
induc
extens
signal
gastric
epitheli
cell
assess
microarray
hybridis
rt
pcr
order
assess
contribut
signal
event
primari
mous
embryon
fibroblast
mef
mice
employ
activ
assay
primari
mef
compar
microarray
hybridis
show
regul
event
induc
h
pylori
flagellin
predominantli
independ
result
discuss
context
novel
propos
intracellular
flagellin
sensor
nodlik
receptor
show
cellular
signal
induc
helicobact
flagellin
function
independ
lyme
borreliosi
systemat
diseas
caus
infect
spirochet
genu
borrelia
burgdorferi
transmit
human
bite
infect
tick
europ
mainli
ixod
ricinu
four
human
pathogen
b
burgdorferi
speci
current
recognis
europ
b
burgdorferi
sensu
stricto
b
garinii
b
afzelii
b
spielmanii
lyme
borreliosi
multisystem
diseas
predomin
involv
skin
joint
nervou
system
due
wide
spectrum
clinic
manifest
challeng
lyme
borreliosi
serodiagnosi
base
support
clarif
clinic
suspicion
accord
miq
din
juli
recommend
perform
lyme
borreliosi
serolog
two
step
sensit
screen
assay
follow
confirmatori
test
examin
borderlin
posit
sera
lyme
borreliosi
serodiagnosi
character
sever
difficulti
due
fals
neg
result
earli
lyme
borreliosi
case
antibodi
persist
crossreact
antibodi
microorgan
latter
describ
exampl
herp
viru
infect
particularli
ebv
bacteri
infect
like
syphili
lyme
borreliosi
miq
recommend
perform
syphili
screen
test
eg
tpha
exclud
fals
posit
due
cross
react
antibodi
treponema
pallidum
develop
line
immunoassay
base
dinand
miqrelev
lyme
borreliosi
antigen
plu
marker
primari
ebv
vca
syphili
infect
togeth
nation
refer
center
borrelia
evalu
product
call
borrelia
europ
line
plu
evalu
compris
sensit
aspect
well
specif
product
special
focu
syphili
sera
sensit
serum
antibodi
borrelia
earli
manifest
sera
neuroborreliosi
patient
specif
healthi
blood
donor
specif
syphili
sera
increas
significantli
due
implement
primari
ebv
sera
specif
could
improv
use
vca
antigen
offer
use
improv
qualiti
insur
serolog
diagnosi
lyme
borreliosi
j
scharnert
c
g
heusipp
schmidt
zentrum
molekularbiologi
der
zmbe
institut
infektiologi
germani
pathogen
gramneg
bacteria
frequent
employ
type
iii
secret
system
transloc
effector
protein
directli
target
cell
compromis
innat
immun
respons
host
identifi
character
abil
recombinantli
express
yopm
pathogen
yersinia
enterocolitica
penetr
host
cell
local
cytosol
without
requir
addit
factor
lipid
raftassoci
uptak
yopm
appear
distribut
cytoplasm
accumul
around
nucleu
target
cell
molecular
analysi
use
sever
truncat
version
yopm
reveal
ntermin
yopm
mediat
transloc
host
cell
moreov
domain
also
capabl
deliv
heterolog
cargo
green
fluoresc
protein
gfp
yope
interestingli
found
cell
penetr
yopm
downregul
transcript
sever
proinflammatori
cytokin
etc
mrna
level
antiinflammatori
significantli
alter
analysi
potenti
interfer
yopm
signal
transduct
pathway
involv
inflammatori
respons
reveal
inhibitori
effect
signal
found
yopm
inhibit
phosphoryl
inhibitor
hela
cell
consequ
proteasom
degrad
phosphoryl
subunit
decreas
moreov
investig
potenti
therapeut
abil
antiinflammatori
effector
protein
yopm
appli
vitro
model
inflammatori
bowel
diseas
ibd
himec
human
intestin
microvascular
endotheli
cell
preincub
yopm
subsequ
stimul
poli
c
analysi
qrtpcr
reveal
strong
reduct
poli
c
induc
transcript
due
yopm
find
strongli
suggest
potenti
therapeut
applic
yopm
inflammatori
condit
schmidt
brodess
n
schnitzler
k
brandenburg
j
object
chemotaxi
central
mechan
human
polymorphonuclear
leukocyt
pmn
local
reach
site
infect
investig
chemotaxi
scientif
diagnost
reason
hamper
methodolog
problem
accord
heit
et
al
suitabl
assay
quantit
qualit
examin
chemotaxi
underagaros
cell
migrat
assay
howev
assay
frequent
associ
complet
lack
small
amount
migrat
cell
activ
pmn
crucial
migrat
combin
effect
gentl
pmn
isol
method
modif
protocol
heit
et
al
method
combin
dextran
sediment
subsequ
percol
centrifug
percol
gradient
use
pmn
isol
heparin
blood
puriti
pmn
activ
pmn
via
determin
measur
use
flowcytometri
compar
heit
et
al
percentag
agaros
decreas
cell
number
decreas
x
x
cell
per
assay
count
migrat
cell
measur
walk
distanc
cell
done
use
axiovis
softwar
zeiss
result
migrat
assay
lead
reproduc
clear
posit
result
fmlp
posit
control
clear
neg
result
neg
control
assay
conduct
n
compar
heit
et
al
observ
fivefold
increas
migrat
cell
provid
suffici
cell
number
adequ
statist
analysi
conclus
method
establish
reliabl
sensit
migrat
assay
might
contribut
wider
use
chemotaxi
assay
scienc
diagnost
may
contribut
increas
knowledg
understand
import
function
pmn
neutrophil
granulocyt
first
line
cellular
defens
pathogen
microorgan
play
crucial
role
innat
immun
known
francisella
f
tularensi
caus
agent
tularemia
abl
evad
kill
human
neutrophil
infect
human
granulocyt
f
strain
differ
virul
aim
identifi
process
within
granulocyt
interf
infect
identifi
interfer
exclus
mediat
virul
strain
f
human
neutrophil
isol
heparin
venou
blood
neutrophil
infect
five
differ
f
strain
includ
highli
moder
virul
well
attenu
avirul
strain
respect
rna
isol
minut
post
infect
employ
gene
express
profil
use
human
genom
plu
array
affymetrix
accord
standard
protocol
microarray
data
valid
quantif
sever
rrna
experi
qpcr
cytokin
releas
measur
cultur
supernat
use
luminexbas
bead
array
technolog
gener
hostpathogen
interact
result
modul
transcript
maschineri
host
immun
respons
cell
death
process
differ
neutrophil
gene
express
induc
distinct
strain
could
also
observ
strike
differ
lack
increas
level
tnf
mrna
neutrophil
infect
virul
strain
f
tularensi
f
holarctica
respect
compar
increas
level
lesser
avirul
f
strain
versu
fold
chang
cytokin
level
cell
cultur
supernat
support
micro
array
result
lack
increas
level
tnf
suggest
virul
f
strain
interfer
inflammatori
respons
neutrophil
therebi
possibl
dysregul
process
chemoattract
neutrophil
respiratori
respons
apoptosi
role
transcript
regul
antimicrobi
activ
mast
cell
k
heinemann
c
okumura
v
nizet
von
mast
cell
mc
multifunct
highli
activ
tissuedwel
cell
play
promin
role
wide
varieti
import
biolog
process
evid
emerg
cell
critic
compon
host
defens
pathogen
support
varieti
intraand
extracellular
antimicrobi
function
howev
detail
cellular
signal
event
mediat
process
infect
still
complet
understood
transcript
regul
hypoxiainduciblefactor
hif
recent
discov
play
critic
role
modul
bactericid
capac
phagocyt
macrophag
neutrophil
sought
investig
role
antimicrobi
activ
mc
use
model
lead
human
pathogen
staphylococcu
aureu
streptococcu
pyogen
treatment
human
mc
line
murin
bonemarrowderiv
mc
agonist
iron
chelat
allow
posttransl
stabil
accumul
hif
significantli
increas
antimicrobi
activ
human
murin
mc
corrobor
observ
treatment
cell
hifantagonist
echinomycin
abl
abolish
effect
differenti
whether
induct
hif
promot
extracellular
versu
intracellular
mc
antimicrobi
activ
cytochalasin
use
inhibit
mc
bacteri
phagocytosi
cytochalasin
reduc
antimicrobi
activ
indic
import
induc
extracellular
antimicrobi
activ
particular
cell
type
data
shed
new
light
role
mc
host
defens
bacteri
infect
provid
new
therapeut
opportun
har
uniqu
characterist
cell
type
enhanc
local
innat
immun
respons
cmv
viremia
diseas
amongst
deleteri
complic
allogen
stem
cell
transplant
increas
morbid
mortal
control
cmv
transplant
attribut
function
compet
cmv
specif
cell
although
cmv
specif
cell
reconstitut
within
sever
week
stem
cell
transplant
origin
remain
far
unclear
de
novo
cell
gener
via
thymu
take
place
earlier
six
month
post
transplant
studi
haematolog
patient
undergo
allogen
patient
undergo
autolog
stem
cell
transplant
addit
routin
perform
weekli
screen
cmv
dna
perform
weekli
screen
cmv
specif
cell
flow
cytometri
cytokin
releas
assay
compar
patient
autolog
transplant
patient
undergo
allogen
stem
cell
transplant
prolong
time
detect
cmv
specif
cell
versu
week
allogen
transplant
patient
influenc
cmv
serolog
statu
incid
gvhd
condit
regimen
myeloabl
vesu
reduc
intens
condit
cmv
viremia
could
identifi
p
ns
comparison
phenotyp
cmv
specif
cell
stem
cell
transplant
indic
pool
cmv
specif
cell
compris
termin
differenti
neg
lymphocyt
p
compar
noncmv
specif
cell
follow
analysi
stem
cell
transplant
reconstitut
cmv
specif
cell
mainli
attribut
expans
termin
differenti
neg
lymphocyt
contrast
expans
remain
noncmv
specif
cell
stem
cell
transplant
domin
posit
lymphocyt
p
conclus
cmv
specif
immunoreconstitut
mainli
attribut
expans
termin
differenti
lymphocyt
aim
natur
regulatori
cell
essenti
immun
homeostasi
infect
control
garp
repres
key
receptor
human
hi
deriv
regulatori
treg
cell
control
via
posit
feedbackloop
probstkepp
et
al
jcmm
press
sinc
micrornadepend
regul
identifi
compon
treg
cell
function
jem
embo
rep
ask
whether
mirna
critic
involv
regul
feedback
loop
method
analyz
express
pdzmutant
wt
garp
ectop
express
antigenspecif
th
cell
togeth
comparison
treg
cell
mirna
express
profil
garpreprogram
th
cell
compar
th
control
treg
cell
hierarch
cluster
significantli
regul
mirna
use
identifi
similar
mirna
profil
differenti
express
mirna
confirm
quantit
pcr
qpcr
result
analysi
wt
pdzmutant
garp
transduc
th
cell
reveal
higher
level
garp
protein
express
mutant
garp
although
induc
similar
level
hierarch
cluster
significantli
regul
mirna
reveal
micornaom
garp
transduc
th
cell
similar
treg
cell
compar
control
parent
th
cell
result
establish
depend
mirnaom
differenti
express
select
mirna
confirm
qpcr
conclus
wt
pdzmutant
garp
reprogram
th
cell
toward
treglik
constitut
express
associ
induct
mirnasignatur
similar
mirnaom
treg
cell
date
reveal
new
insight
regul
feedback
loop
potenti
novel
mirna
biomark
potenti
therapeut
target
treg
cell
infect
control
allogen
stem
cell
transplant
becom
standard
treatment
variou
haematolog
cancer
howev
intens
condit
chemotherapi
irradi
lead
regularli
long
phase
immunosuppress
aggrav
concomit
deplet
potenti
alloreact
donor
cell
situat
reactiv
cytomegaloviru
cmv
member
herp
viru
famili
frequent
lifethreaten
complic
treatment
antivir
agent
limit
cost
extens
induct
drug
resist
partial
sever
side
effect
make
new
therapeut
approach
highli
desir
develop
revers
mhcclass
multim
streptam
allow
direct
ex
vivo
isol
cmvspecif
cell
cmvposit
stem
cell
donor
donorderiv
pbmc
stain
beadcoat
streptam
follow
magnet
cell
separ
use
clinimac
subsequ
revers
multim
bind
resolv
result
reagentfre
cmvspecif
cell
product
highli
enrich
cell
immedi
transfer
usual
even
dayinto
patient
describ
first
experi
clinic
test
technolog
remark
even
transfer
cell
approx
readili
detect
cell
popul
detect
short
vivo
prolifer
indic
high
prolif
capac
directli
isol
minim
manipul
cell
low
dose
transfer
streptamerisol
cell
might
combin
benefit
induc
function
cmvspecif
immun
respons
minim
risk
potenti
fatal
gvhd
arnold
sayi
hitzler
e
kohler
mueller
institut
fuer
molekular
krebsforschung
univ
zuerich
zuerich
switzerland
helicobact
pylori
gram
neg
bacterium
colon
approx
half
world
popul
chronic
infect
h
pylori
associ
gastric
duoden
ulcer
gastric
adenocarcinoma
mucosaassoci
lymphoid
tissu
lymphoma
studi
mechan
underli
persist
infect
vs
vaccineinduc
clearanc
well
mechan
lead
helicobacterinduc
gastric
diseas
includ
gastric
cancer
monitor
gastriti
gastric
cancer
precursor
lesion
time
experiment
infect
mice
find
preneoplast
chang
result
immunopatholog
driven
effector
tcell
wild
type
also
adopt
transfer
tcrab
mice
b
subset
tcell
requir
clearanc
infect
upon
vaccin
subsequ
challeng
c
ifng
product
requir
deplet
treg
mous
induc
spontan
clearanc
suggest
treg
facilit
persist
gastric
infect
data
suggest
addit
nont
regulatori
cell
type
induc
produc
upon
ligat
also
contribut
persist
infect
vivo
find
age
time
infect
determin
helicobact
colon
level
well
extent
gastric
patholog
mice
infect
neonat
period
develop
toler
infect
colon
sever
order
magnitud
higher
mice
infect
adult
remain
free
preneoplast
patholog
toler
perman
maintain
adulthood
sustain
presenc
antigen
interven
antibiot
therapi
break
toler
deplet
treg
model
propos
age
infect
conjunct
genet
environment
factor
influenc
polar
determin
gastric
cancer
risk
staphylococcu
aureu
promin
human
pathogen
establish
persist
infect
within
host
despit
antibiot
treatment
cystic
fibrosi
patient
especi
affect
staphylococc
persist
infect
abil
aureu
persist
host
complex
process
host
well
bacterium
adopt
variou
mechan
bring
immun
equilibrium
defin
factor
contribut
bacteri
persist
help
identif
altern
therapeut
drug
target
achiev
bacteri
clearanc
affect
patient
substanti
drawback
understand
factor
lack
vivo
model
recapitul
differ
aspect
persist
process
studi
develop
murin
model
aureu
persist
infect
aureu
strain
persist
month
kidney
mice
intraven
inocul
infect
local
rather
system
shown
low
serum
level
inflammatori
cytokin
chronic
infect
mice
develop
antigenspecif
immun
respons
aureu
evid
prolif
respons
splenic
b
cell
antigenspecif
stimul
howev
fact
b
nk
cellsdefici
mice
develop
persist
infect
allow
higher
level
bacteri
replic
wildtyp
anim
indic
adapt
immun
respons
partial
contribut
contain
infect
histolog
examin
kidney
tissu
isol
chronic
infect
mice
show
persist
staphylococci
may
surviv
defenc
mechan
resid
within
abscess
fullyaccess
immun
system
understand
role
abscess
play
microarray
analysi
kidney
tissu
perform
gene
express
profil
analys
million
human
tropic
countri
infect
filari
nematod
harbor
intracellular
bacteri
endosymbiont
genu
wolbachia
rickettsial
previous
shown
deplet
wolbachia
lead
higher
percentag
adult
worm
death
compar
ivermectin
primarili
microfilaricid
studi
examin
develop
onchocerca
volvulusspecif
immun
respons
antiwolbachi
treatment
onchocerciasi
patient
ghana
west
africa
provid
evid
cellular
immun
respons
increas
treatment
cours
doxycyclin
detail
level
whole
blood
assay
stimul
onchocerca
volvulu
crude
extract
elev
macrofilaricid
therapi
compar
microfilaricid
treatment
underscor
higher
ratio
observ
local
mrna
level
onchocercoma
doxycyclin
treat
patient
interestingli
patient
doxycyclin
therapi
display
significantli
fewer
new
onchocercoma
month
treat
ivermectin
data
line
current
hypothesi
macrofilaricid
therapi
remov
sourc
immunosuppress
molecul
staphylococcu
aureu
infect
bruhn
tg
loof
goldmann
e
medina
infektionsimmunologi
helmholtzzentrum
infektionsforschung
braunschweig
germani
staphylococcu
aureu
lead
caus
infect
worldwid
upon
invas
aureu
first
confront
sophist
innat
defens
mechan
host
dendrit
cell
dc
central
mediat
innat
cognat
immun
system
cell
sever
role
earli
stage
infect
includ
control
bacteri
replic
produc
cytokin
chemokin
activ
recruit
addit
cell
studi
investig
relev
dc
host
defens
aureu
vitro
studi
demonstr
aureu
induc
matur
bone
marrowderiv
dc
shown
upregul
costimulatori
molecul
releas
cytokin
activ
particip
dc
innat
immun
respons
aureu
demonstr
timedepend
recruit
dc
observ
spleen
mice
intraven
infect
aureu
dc
isol
spleen
system
infect
mice
harbor
viabl
aureu
microorgan
indic
direct
interact
aureu
dc
vivo
infect
contribut
dc
host
defens
pathogen
investig
use
toxin
receptor
dtr
transgen
mice
dc
transient
deplet
vivo
treatment
low
dose
dt
ablat
dc
result
earli
mortal
lower
capac
control
bacteri
growth
lung
furthermor
acut
ablat
dc
complet
abolish
product
indic
product
cytokin
infect
limit
dc
evid
dc
contribut
host
defens
aureu
provid
improv
resist
infect
exhibit
mice
adopt
transfer
vitromatur
dc
result
present
contribut
understand
earli
event
infect
onset
protect
aureu
yersinia
pseudotuberculosi
employ
type
iii
secret
system
target
sever
virul
factor
yersinia
outer
protein
yop
directli
cytosol
eukaryot
cell
protein
transloc
machineri
mediat
abil
yersinia
resist
phagocytosi
requir
sustain
extracellular
bacteri
replic
recent
public
laboratori
use
yope
carrier
molecul
secret
transloc
listeriolysin
llo
listeria
monocytogen
demonstr
transloc
chimer
yopello
cytosol
macrophag
pseudotuberculosi
result
induct
codomin
antigenspecif
tcell
respons
oral
immun
mice
therefor
address
requir
process
mhc
class
ii
present
chimer
yope
protein
transloc
cytosol
macrophag
data
demonstr
yersinia
abil
counteract
exogen
mhc
class
ii
antigen
present
secret
hybrid
yope
action
wildtyp
yope
yoph
absenc
exogen
mhc
class
ii
antigen
present
altern
pathway
identifi
yope
fusion
protein
origin
cytosol
endogen
antigen
process
pathway
sensit
inhibitor
phagolysosom
acidif
macroautophagi
neither
requir
function
proteasom
transport
associ
antigen
present
thu
autophagydepend
mechan
macrophag
abl
compens
yopeyophmedi
inhibit
endosom
mhc
class
ii
antigen
present
pathway
exogen
antigen
first
report
demonstr
autophagi
might
enabl
host
mount
mhc
class
iirestrict
cell
respons
transloc
bacteri
virul
factor
local
immun
respons
human
tubercul
lung
lesion
b
cell
cofunct
macrophag
antigenpres
cell
produc
specif
antibodi
g
kosmiadi
v
trusov
smirnova
ulrich
immunolog
central
tuberculosi
research
institut
berlin
germani
pulmonolog
moscow
citi
hospit
moskau
germani
tuberkulosesekt
kochmetschnikowforum
berlin
germani
mechan
effector
immun
immunolog
correl
tuberculosi
larg
unknown
studi
local
immun
respons
mycobacterium
tuberculosi
infect
human
lung
tissu
could
cast
light
onto
mechan
aim
studi
morpholog
function
immun
cell
infiltr
tbinfect
lung
human
cell
infiltr
infect
lung
identifi
section
use
monoclon
antibodi
mycobacteri
load
infiltr
inflammatori
cell
load
lung
studi
show
patient
tuberculoma
cultiv
tuberculosi
could
hardli
detect
rtpcr
result
alway
show
dnapres
tissu
macrophag
number
correl
directli
phagocyt
capac
correl
invers
tuberculosi
load
lung
show
infiltr
lymphocyt
differ
phenotyp
well
macrophag
antigen
present
cell
place
chaotic
rather
organ
manner
within
granulomat
tissu
bear
marker
activ
differenti
capabl
prolifer
cytokin
product
synthesi
specif
igg
iga
igm
antibodi
patient
high
mycobacteri
load
produc
instead
local
immun
respons
lymphoid
folliclelik
structur
lung
tissu
associ
diagnosi
tuberculoma
activ
cavitari
tuberculosi
indic
activ
role
time
result
suggest
mycobacteri
infect
induc
organ
immun
cell
morpholog
discern
folliclelik
structur
bear
featur
tertiari
lymphoid
organ
analog
found
autoimmunityaffect
tissu
propos
tertiari
lymphoid
organ
orchestr
local
immun
respons
mycobacteria
human
b
cell
play
import
role
regul
local
contain
mycobacteria
stutz
h
kessler
meissner
dalpk
dept
hygien
medic
microbiolog
univers
heidelberg
heidelberg
germani
dept
parasitolog
univers
heidelberg
heidelberg
germani
toxoplasma
gondii
intracellular
parasit
cope
microbicid
action
previous
report
parasitemedi
induct
suppressor
cytokin
signal
protein
contribut
inhibit
signal
show
virul
type
type
ii
strain
induc
inhibit
nitric
oxid
product
effect
independ
stimul
tolllik
receptor
alter
trif
defici
mice
howev
block
cell
invas
use
defici
parasit
complet
abolish
induct
nitric
oxid
suppress
induct
report
depend
egr
transcript
factor
inde
found
type
type
ii
strain
induc
manner
depend
map
kinas
analyz
addit
effect
macrophag
surprisingli
observ
type
ii
strain
inhibit
mediat
secret
upregul
mhcclass
ii
effect
could
observ
infect
well
uninfect
cell
affect
use
invas
defect
knockout
parasit
interfer
induct
antigen
present
viabl
parasit
direct
cell
contact
necessari
ad
solubl
excret
secret
antigen
esa
toxoplasma
gondii
reproduc
latter
inhibitori
effect
induc
result
prove
toxoplasma
gondii
make
use
two
differ
mode
escap
activ
one
mode
strain
depend
reli
activ
cell
invas
induct
one
induc
micronem
secret
upon
contact
cell
proinflammatori
cytokin
import
induc
tcell
differenti
toward
phenotyp
mice
lack
strong
defect
cellmedi
immun
respons
result
high
suscept
infect
intracellular
pathogen
includ
leishmania
major
listeria
monocytogen
toxoplasma
gondii
present
work
show
variou
tlr
agonist
induc
express
bone
marrow
deriv
dendrit
cell
bmdc
differ
extent
high
induct
observ
stimul
intermedi
induct
stimul
weak
induct
observ
stimul
vivo
experi
use
depend
model
murin
subcutan
leishmaniasi
treatment
mice
ligand
lp
lta
show
signific
influenc
cours
infect
contrast
cpgdna
applic
similar
scheme
deviat
immun
respons
result
contain
infect
indic
miss
footpad
swell
use
pharmacolog
inhibitor
differ
knockout
model
map
kinas
kinas
irf
signal
pathway
could
rule
caus
differ
tlr
induc
express
bmdc
stimul
bmdc
use
differ
tlr
ligand
result
strike
differ
kinet
activ
lp
induc
rapid
shortliv
activ
rela
wherea
cpg
stimul
result
prolong
rela
activ
promot
evid
given
differ
activ
involv
differenti
induct
stimul
variou
tlr
agonist
c
speth
g
rambach
dum
mohsenipour
r
c
spite
progress
antimycot
therapi
cerebr
aspergillosi
still
associ
lethal
nearbi
incapac
cerebr
immun
system
limit
fungal
replic
indic
aspergillu
dispos
effici
mechan
escap
immun
attack
sinc
complement
central
player
cerebr
immun
aim
elucid
fungal
complement
evas
mechan
develop
strategi
undermin
process
grow
cerebrospin
fluid
csf
pathogen
speci
aspergillu
shown
interfer
antifung
complement
attack
secret
proteas
degrad
variou
complement
protein
solubl
protein
three
complement
activ
pathway
elimin
furthermor
complement
receptor
surfac
immun
cell
affect
consequ
fungal
proteas
secret
includ
strong
reduct
new
opson
fungal
hypha
well
remov
alreadi
deposit
complement
factor
furthermor
phagocytosi
aspergillu
conidia
microglia
less
effici
secret
fungal
proteas
futur
inhibit
suppress
proteas
may
hope
act
support
therapeut
measur
reason
divers
nutrient
supplement
test
abil
prevent
secret
fungal
proteas
distinct
carbohydr
phosphat
iron
compound
show
effect
variou
inorgan
organ
nitrogen
sourc
downregul
proteolyt
activ
amino
acid
particular
interest
put
therapeut
sinc
repres
endogen
substanc
cn
turn
effect
number
nitrogen
atom
within
molecul
seem
crucial
relev
concentr
glutamin
arginin
fulfil
variou
function
brain
act
compar
low
concentr
appear
therefor
promis
candid
therapi
g
proteincoupl
receptor
sens
bacteri
peptid
toxin
direct
neutrophil
toward
higli
pathogen
virul
emerg
communityassoci
methicillinresist
staphylococcu
aureu
camrsa
highli
pathogen
aureu
depend
recent
discov
phenolsolubl
modulin
psm
peptid
toxin
combin
capac
attract
lyse
neutrophil
molecular
basi
psmstimul
neutrophil
recruit
remain
unknown
demonstr
human
g
proteincoupl
receptor
whose
function
previous
remain
elus
sens
psm
nanomolar
concentr
initi
exuber
proinflammatori
neutrophil
respons
camrsa
specif
block
receptor
delet
psm
gene
camrsa
led
sever
diminish
capac
neutrophil
detect
camrsa
thu
innat
immun
system
use
previous
unrecogn
mechan
sens
highli
virul
bacteri
pathogen
g
proteincoupl
receptor
repres
attract
target
new
antiinfect
antiinflammatori
strategi
acid
sphingomyelinas
asmas
hydrolys
sphingomyelin
major
lipid
compon
noncytoplasm
membran
leaflet
endosom
phagosom
lysosom
essenti
site
antimicrobi
activ
macrophag
contrast
wild
type
wt
macrophag
macrophag
asmas
mice
inactiv
phagocytos
listeria
monocytogen
lm
despit
normal
activ
oxid
bactericid
effector
mechan
thu
analys
role
asmas
nonoxid
bactericid
effector
mechan
macrophag
asmas
macrophag
phagosom
contain
lm
remain
posit
late
phagosom
marker
acquir
significantli
less
lysosom
marker
parallel
significantli
reduc
transfer
fluid
phase
marker
bactericid
cathepsin
b
l
lysosom
phagosom
contain
lm
asmas
macrophag
consequ
lm
rapidli
inactiv
asmas
macrophag
escap
phagosom
recruit
actin
massiv
prolifer
cytosol
next
ask
whether
lm
secondarili
sequest
autophagi
asmas
macrophag
infect
asmas
wt
macrophag
lm
induc
similar
shift
inact
activ
indic
similar
induct
autophagi
addit
intracellular
lm
colocalis
asmas
wt
macrophag
min
pi
howev
percentag
lm
colocalis
significantli
drop
asmas
macrophag
min
pi
indic
lm
escap
autophagosom
asmas
wt
macrophag
lm
doubleposit
significantli
less
frequent
asmas
wt
macrophag
indic
impair
matur
autophagosom
autolysosom
conclus
asmas
contribut
antimicrobi
activ
macrophag
facilit
fusion
phagosom
autophagosom
lysosom
introduct
intestin
graftversushostdiseas
igvhd
major
caus
morbid
mortal
allogen
stem
cell
transplant
acut
inflammatori
respons
tissu
destruct
colon
aggrav
gut
bacteri
sens
via
tolllikereceptor
tlr
underli
mechan
yet
poorli
understood
method
prior
transplant
day
wt
isogen
mice
receiv
treosulfan
day
cyclophosphamid
mgkg
mice
transplant
bone
marrow
cell
splenocyt
balbcorigin
specif
inhibit
activ
mice
inject
inhibitori
oligonucleotid
iodn
ip
day
gvhdscore
intestin
immun
cell
popul
assess
accord
macroscop
score
histopatholog
investig
colon
section
respect
result
investig
igvhd
reveal
transplant
wildtyp
wt
mice
stem
cell
balbc
mice
result
sever
igvhd
indic
apoptosi
tissu
damag
inflamm
colon
contrast
igvhd
significantli
amelior
mice
mice
number
tcell
neutrophil
apoptot
cell
colon
significantli
reduc
compar
wt
mice
addit
mice
show
improv
surviv
importantli
intestin
apoptosi
inflammatori
respons
effect
suppress
treatment
wt
mice
antagonist
ip
conclus
summari
result
underlin
pivot
role
sens
igvhd
may
offer
option
molecular
treatment
prevent
strategi
devast
diseas
format
extracellular
trap
et
phagocyt
cell
recent
recogn
novel
import
mechan
host
immun
respons
infect
structur
consist
nuclear
dna
backbon
associ
antimicrobi
peptid
amp
entrap
kill
variou
microb
aim
studi
determin
whether
augment
phagocyt
et
may
serv
novel
therapeut
approach
bacteri
infectionsrec
abl
demonstr
statin
inhibitor
coenzym
hmgcoa
reductas
rate
limit
enzym
cholesterol
biosynthesi
effici
induc
format
et
differ
phagocyt
neutrophil
macrophag
vitro
statintr
phagocyt
show
enhanc
kill
methicillinresist
staphylococcu
aureu
streptococcu
agalactia
well
salmonella
typhimurium
cytochalasin
treatment
inhibit
phagocytosi
inhibit
bacteri
kill
statintr
cell
indic
extracellular
site
action
determin
statintreat
abl
enhanc
product
et
vivo
investig
effect
statin
therapi
bacteri
clearanc
use
mous
model
aureusinduc
pneumonia
mice
fed
standard
chow
standard
chow
supplement
simvastatin
challeng
intranas
subleth
dose
aureu
strain
newman
agreement
vitro
data
significantli
ampcontain
et
found
airway
alveolar
space
aureusinfect
mice
treat
simvastatin
compar
control
group
furthermor
simvastatintr
mice
exhibit
significantli
reduc
bacteri
load
histolog
organ
damag
lung
tissu
compar
control
mice
h
infect
data
rais
excit
possibl
stimul
et
use
novel
therapeut
approach
enhanc
bacteri
clearanc
invad
pathogen
act
host
defenc
protein
niemann
bertl
n
spehr
mf
brodd
h
robenek
k
jurk
c
von
eiff
g
peter
c
heilmann
b
background
platelet
part
immun
defenc
system
interact
bacteria
pathogen
fungi
protozoa
platelet
activ
lead
immedi
exocytosi
granular
constitu
releas
platelet
microbicid
protein
platelet
kinocidin
known
act
microorgan
well
observ
defici
mice
suffer
extens
acut
organ
pneumonia
prompt
us
studi
whether
might
involv
host
defenc
method
effect
scrambel
control
peptid
aureu
candida
albican
growth
cell
wall
permeabl
test
quantit
cultur
enumer
coloni
form
unit
flow
cytometri
electron
microscopi
freezefractur
replica
result
exposur
eight
aminoacid
peptid
ctermin
domain
yield
signific
reduct
viabil
microorgan
control
peptid
glycin
instead
valin
effect
freez
fractur
replica
reveal
pore
format
flow
cytometr
analysi
show
treatment
promot
accumul
membraneimperm
nucleic
acid
stain
propidium
iodid
pi
indic
loss
membran
potenti
permeabl
conclus
show
antimicrobi
activ
differ
test
system
microorgan
aureu
c
albican
control
peptid
major
platelet
secret
protein
might
act
host
defenc
protein
reichschupk
k
warnek
p
altmey
dermatologisch
klinik
bochum
bochum
germani
object
first
studi
investig
risk
factor
persist
mrsa
leg
ulcer
outpati
systemat
open
prospect
singl
centr
survey
review
data
base
patient
method
outpati
mrsa
colon
least
week
leg
ulcer
includ
survey
retrospect
data
analysi
therapi
leg
ulcer
carri
silvercontain
wound
dress
patient
recommend
appli
antisept
erad
measur
accord
recommend
inpati
treatment
sinc
reimburs
cost
antisept
health
insur
fund
imposs
germani
implement
recommend
left
patient
mrsa
consid
persist
detect
least
one
month
recommend
erad
therapi
result
patient
mrsa
could
success
erad
mrsae
could
mrsap
result
show
signific
benefit
antisept
bodi
wash
decontamin
mrsae
mrsap
disadvantag
regular
contact
pet
mrsae
mrsap
tendenc
longer
persist
ulcer
vs
month
mrsa
colon
area
bodi
vs
possibl
risk
factor
seen
conclus
studi
indic
import
antisept
measur
extend
beyond
wound
erad
mrsa
outpati
placebocontrol
studi
larger
studi
popul
necessari
dynam
distribut
antibiot
suscept
e
coli
univers
hospit
set
retrospect
analysi
year
baier
w
pfister
k
boden
e
straub
institut
medic
mircobiolog
jena
jena
germani
background
success
manag
bacteri
infect
depend
larg
quick
correct
chemotherapi
sinc
result
antibiot
test
may
avail
h
clinician
decis
depend
data
gener
perman
survey
antibiot
suscept
local
set
analys
dynam
e
coli
resist
sinc
respect
differ
clinic
set
patient
age
sex
infect
site
method
million
record
select
repres
anaesthet
medic
intens
care
unit
neurolog
n
urolog
ward
u
paediatr
p
geriatr
g
depart
copi
strain
exclud
result
number
isol
e
coli
strain
per
year
grew
anaesthet
icu
n
n
show
trend
set
p
ciprofloxacin
cip
resist
rate
rr
rais
less
almost
u
less
dynam
p
n
g
ampicillin
amp
rr
highest
follow
u
g
p
n
bli
improv
amprr
follow
u
g
p
n
piperacillintazobactam
piptaz
sensit
compar
amp
rr
u
g
n
p
show
increas
past
year
baselin
u
rr
ceftriaxon
ceftazidim
cefepim
cotrim
rr
amp
carbapenem
doxycyclin
aminoglycosid
e
coli
frequent
isol
men
u
women
g
rr
cip
piptaz
higher
e
coli
men
u
g
n
delta
ciprr
lower
sampl
periph
site
sputum
vs
blood
cultur
conclus
monitor
antibiot
suscept
essenti
guid
local
adapt
calcul
chemotherapi
present
case
report
patient
probabl
simultan
acquir
hepat
b
hiv
lue
infect
haart
therapi
viral
load
significantli
reduc
laboratori
studi
situat
show
atyp
kinet
hbv
specif
paramet
hbsag
detect
time
hbv
viral
load
first
test
low
iuml
sampl
hbvspecif
paramet
includ
pcr
neg
conclus
rtinhibitor
haart
also
supress
hbv
replic
haart
antihbc
fals
neg
hivpati
haart
requir
hbv
diagnost
antihbc
also
hbsag
includ
prion
diseas
human
creutzfeldtjakob
diseas
cjd
variant
cjd
character
neuron
accumul
patholog
protein
prpsc
believ
infecti
agent
pathogenesi
host
encod
cellular
prion
protein
prpc
convert
prpsc
remark
resist
standard
inactiv
procedur
effici
decontamin
requir
harsh
condit
mani
medic
devic
damag
condit
prevent
diseas
transmiss
great
demand
product
friendli
decontamin
procedur
relat
medic
instrument
well
product
food
safeti
preserv
method
describ
mostli
combin
predenatur
proteolysi
studi
pursu
techniqu
report
prpsc
decontamin
method
consist
enzymat
treatment
commerci
avail
purifi
proteas
systemat
follow
proteolys
degrad
effici
apprais
immunoblot
elisa
applic
sensit
precipit
techniqu
unlik
studi
evalu
applic
prpsc
degrad
method
differ
prion
protein
isol
strain
deriv
differ
speci
may
consider
vari
stabil
resist
result
emphas
combin
predenatur
follow
serial
enzymat
treatment
promis
tool
prion
decontamin
effect
dri
temperatur
deterg
remov
proteinac
materi
hollow
needl
analys
use
highli
sensit
immunopcr
assay
perfect
reprocess
medic
instrument
devic
warrant
total
remov
contamin
infecti
agent
primari
prevent
diseas
transmiss
hospit
particular
respect
infecti
prion
proteinac
agent
known
prpsc
caus
transmiss
spongiform
encephalopathi
tse
creutzfeldtjakob
diseas
ist
variant
form
vcjd
human
prpsc
deriv
host
encod
cellular
prion
prpc
notabl
resist
standard
decontamin
procedur
remain
infecti
risk
iatrogen
transmiss
emphas
actual
prpsc
detect
skelet
muscl
cjd
patient
presenc
blood
preclin
phase
vcjd
incub
thu
remov
proteinac
materi
surgic
devic
great
import
effect
reprocess
elimin
howev
sever
hamper
eg
contamin
allow
dri
onto
instrument
surfac
studi
analys
two
differ
effect
firstli
protein
bind
hollow
needl
surfac
contamin
brain
tissu
suspens
mean
dri
time
temperatur
secondli
protein
remov
absenc
presenc
deterg
effac
prpc
indic
protein
detect
novel
highli
sensit
immunopcr
assay
achiev
sensit
enhanc
least
two
order
magnitud
compar
elisa
procedur
carri
ident
condit
data
demonstr
current
move
instrument
rins
solut
low
concentr
deterg
consider
minim
soil
adher
instrument
steril
assess
steril
wrap
termin
steril
medic
devic
steril
assur
level
h
dunkelberg
u
schmelz
allg
hygien
und
umweltmedizin
goettingen
germani
aim
studi
offer
method
correl
microbi
barrier
effici
packag
microbi
challeng
packag
encount
transport
storag
use
method
evalu
whether
barrier
properti
packag
suffici
maintain
steril
transport
storag
sal
order
determin
microbi
barrier
properti
develop
exposur
chamber
method
period
atmospher
pressur
chang
hpa
exposur
airborn
microorgan
micrococcu
luteu
barrier
properti
specifi
logarithm
reduct
valu
lrv
calcul
microbiolog
challeng
transport
packag
comput
program
develop
wwwmicrobialevaluationofsterilebarriersystemscom
paramet
airborn
microbi
content
chang
temperatur
air
pressur
enter
order
apprais
microbiolog
challeng
logarithm
reduct
valu
lrv
steril
barrier
system
compar
lrv
requir
microbi
challeng
transport
storag
contain
test
mean
exposur
chamber
method
coloni
growth
could
observ
agar
plate
laid
base
contain
assum
contain
cool
atmospher
pressur
chang
period
hpa
time
due
weather
store
constant
temperatur
volum
air
enter
contain
cm
result
consid
probabl
accept
risk
insteril
lrv
requir
result
contain
experiment
confirm
lrv
correspondingli
contain
would
meet
requir
accord
sal
given
storag
condit
present
procedur
allow
characteris
microbi
qualiti
wrap
steril
product
level
sal
first
detect
clostridium
difficil
ribotyp
bochum
germani
confirm
slpa
sequenc
kaas
f
szabado
h
tix
ander
sg
gatermann
abteilung
medizinisch
mikrobiologi
bochum
bochum
germani
object
due
increas
virul
reliabl
detect
c
difficil
pcr
ribotyp
necessari
germani
c
difficil
pcr
ribotyp
describ
southwest
method
c
difficil
cultur
stool
sampl
hospit
patient
use
select
media
c
difficil
isol
test
presenc
tcdb
pcr
suscept
test
erythromycin
moxifloxacin
use
screen
ribotyp
isol
resist
erythromycin
moxifloxacin
character
duplex
pcr
cdta
cdtb
perform
isol
posit
result
type
pcr
ribotyp
accord
stubb
et
al
result
suggest
ribotyp
perform
slpa
tcdc
sequenc
confirm
result
result
tcdb
posit
c
difficil
isol
resist
erythromycin
moxifloxacin
collect
april
decemb
could
demonstr
gene
binari
toxin
cdta
cdtb
isol
pcr
ribotyp
gave
band
pattern
ribotyp
refer
strain
isol
isol
show
slpa
sequenc
typic
ribotyp
delet
posit
tcdc
gene
three
case
c
difficil
ribotyp
occur
hospit
ward
remain
case
found
differ
hospit
mean
age
case
year
rang
conclus
first
time
case
c
difficil
ribotyp
could
demonstr
area
isol
carri
gene
binari
toxin
cdta
cdtb
delet
gene
neg
regul
toxin
product
tcdc
exoproteom
bacteri
pathogen
repres
key
reservoir
virul
factor
genom
sequenc
shown
differ
isol
particular
speci
includ
danger
human
pathogen
staphylococcu
aureu
display
signific
variat
gene
repertoir
potenti
secret
virul
factor
notabl
compar
genom
analys
far
overlook
possibl
differ
actual
biogenesi
virul
factor
present
data
analysi
clinic
strain
aureu
isol
bovin
human
host
differ
diseas
pattern
analyz
deriv
exoproteom
genet
variat
mlst
clondiag
diagnost
microarray
strain
demonstr
within
singl
speci
exoproteom
composit
vari
extrem
result
genom
plastic
express
heterogen
furthermor
provid
evid
virul
factor
express
profil
necessarili
reflect
clonal
distanc
clinic
isol
base
genom
data
clinic
staphylococcu
lugdunensi
isol
phenotyp
genotyp
divers
f
layer
b
pasemann
b
ghebremedhin
ka
moder
w
witt
nation
refer
centr
staphylococci
robert
kochinstitut
wernigerod
germani
institut
medic
microbiolog
ottovonguerick
univers
magdeburg
germani
introduct
lugdunensi
coagulaseneg
staphylococcu
speci
con
abl
caus
seriou
infect
human
bacteraemia
endocard
softtissu
infect
therefor
regard
pathogen
con
speci
besid
reliabl
identif
knowledg
genotyp
divers
particular
interest
method
strain
isol
variou
type
patient
specimen
differ
clinic
depart
oneyear
period
identifi
lugdunensi
routin
laboratori
diagnost
phenotyp
profil
also
determin
panel
select
test
eg
includ
enzymat
reaction
antibiot
resist
isol
also
screen
presenc
tannasegen
tana
estim
genotyp
divers
pfge
smaidigest
chromosom
dna
perform
result
isol
identifi
lugdunensi
isol
belong
con
speci
use
refer
centr
panel
select
charact
panel
also
reveal
variou
genotyp
pattern
lugdunensisisol
con
lugdunensi
neg
tana
howev
tana
detect
lugdunensi
isol
sma
pfge
reveal
six
pulsotyp
one
predomin
pulsotyp
conclus
phenotyp
divers
slugdunensi
isol
found
autom
identif
system
often
incorrect
complementari
laboratori
test
need
tanagen
marker
lugdunensi
requir
investig
pfge
show
low
degre
genom
divers
lugdunensi
may
indic
pfge
reliabl
epidemiolog
investig
concern
speci
furthermor
compar
related
pattern
suggest
rather
clonal
structur
lugdunensi
studi
describ
evalu
two
commerci
real
time
pcr
assay
duplica
legionella
pneumophila
duplica
mycoplasma
pneumonia
euroclon
distribut
virotech
gmbh
germani
allow
detect
respiratori
pathogen
well
pcr
inhibitor
respiratori
sampl
use
smart
cycler
apparatu
result
compar
two
inhous
taqman
pcr
dumk
et
al
j
clin
sensit
assay
genom
equival
ge
pneumonia
ge
l
pneumophila
cohort
clinic
sampl
patient
document
respiratori
infect
analyz
includ
sampl
patient
pneumonia
infect
sampl
patient
legionella
speci
infect
sampl
patient
streptococcu
pneumonia
infect
posit
specimen
correctli
detect
identifi
respect
duplica
kit
falseposit
result
observ
neg
sampl
document
inhous
assay
standard
microbiolog
method
one
sampl
posit
legionella
bozemanii
correctli
identifi
neg
l
pneumophila
euroclon
pcr
result
demonstr
euroclon
assay
sensit
specif
conveni
rapid
detect
identif
pneumonia
l
pneumophila
clinic
sampl
patient
respiratori
infect
summer
season
incid
gramneg
bacteria
icu
f
schwab
p
gastmeier
b
schroerenboersch
e
meyer
institut
hygien
environment
medicin
univers
medicin
berlin
germani
object
look
associ
season
temperatur
incid
densiti
pathogen
intens
care
unit
icu
particip
sari
surveil
antimicrobi
use
antimicrobi
resist
intens
care
unit
method
conduct
prospect
unit
base
surveil
german
icu
juli
june
incid
rate
ratio
confid
interv
calcul
season
winter
januarymarch
spring
apriljun
summer
julyseptemb
autumn
octoberdecemb
addit
timeseri
analys
autoregress
integr
move
averag
arima
model
dynam
regressor
use
estim
associ
incid
densiti
pathogen
season
temperatur
result
report
data
patient
day
pd
pathogen
incid
densiti
ie
number
pathogen
per
pd
gramneg
pathogen
show
signific
season
variat
incid
densiti
paeruginosa
pae
e
coli
eco
abaumannii
aci
significantli
higher
autumn
winter
eg
incid
densiti
aci
higher
summer
winter
incid
densiti
pae
eco
aci
kpn
follow
chang
temperatur
one
two
month
conclus
signific
higher
incid
densiti
gramneg
pathogen
observ
summer
autumn
find
may
implic
infect
control
choic
empir
antibiot
therapi
describ
case
hyperinfect
syndrom
hivinfect
patient
therapi
concept
also
review
relev
literatur
strongyloid
stercorali
intestin
nematod
caus
human
infect
specif
life
cycl
among
intestin
nematod
stercorali
uniqu
abil
complet
life
cycl
insid
host
asexu
autoinfect
cycl
stercorali
infect
may
asymptomat
year
owe
low
parasit
load
diagnost
method
microscop
examin
bronchial
alveolar
lavag
stool
ivermectin
new
antihelminth
drug
seem
promis
treatment
stercorali
nevertheless
research
evalu
necessari
immunocompromis
host
autoinfect
cycl
result
potenti
fatal
hyperinfect
syndrom
malta
one
highest
incid
methicillinresist
staphylococcu
aureu
mrsa
europ
howev
limit
type
data
avail
order
analys
local
situat
fortyf
isol
mater
die
hospit
msida
malta
characteris
use
diagnost
microarray
common
strain
also
known
isol
sporad
strain
includ
two
isol
pvlposit
european
clone
one
isol
italian
clonesouth
german
epidem
strain
one
isol
viennahungarianbrazilian
epidem
strain
one
isol
ten
isol
belong
novel
clonal
complex
spatyp
strain
strain
carri
gene
sccmec
iv
element
meca
delta
mecr
ugpq
dc
well
novel
allel
ccrab
fusid
acid
resist
element
also
harbour
gene
enterotoxin
sea
egc
enterotoxin
locu
well
nine
ten
isol
gene
encod
toxic
shock
syndrom
toxin
enterotoxin
c
l
sec
sel
presenc
mrsa
strain
suggest
foreign
import
intens
travel
activ
malta
variou
european
countri
strain
appear
restrict
malta
yet
put
consequ
bacteri
infect
pertussi
toxininduc
permeabil
cerebr
endotheli
barrier
g
seidel
j
schult
k
l
greun
schmidt
institut
infektiologi
zentrum
molekularbiologi
der
germani
bloodbrainbarri
bbb
maintain
homeostasi
cn
critic
line
defens
pathogen
potenti
inflict
damag
host
encephalopathi
lead
neurolog
disord
associ
respiratori
tract
infect
whoop
cough
caus
bordetella
pertussi
decis
virul
factor
b
pertussi
pertussi
toxin
pt
exclus
disrupt
integr
bbb
therefor
might
play
role
onset
secondari
complic
analyz
whether
ptinduc
transient
disrupt
barrier
integr
endotheli
cell
enhanc
transloc
bacteria
use
human
brain
microvascular
endotheli
cell
hbmec
vitro
twocompart
tissu
cultur
model
surrog
model
bbb
permeabl
hors
radish
peroxidas
hrp
substanti
increas
transendotheli
resist
ter
decreas
upon
incub
pt
treatment
pt
greatli
enhanc
travers
meningitiscaus
pathogen
escherichia
coli
neisseria
meningitidi
streptococcu
pneumonia
across
hbmec
barrier
adhes
assay
demonstr
enhanc
attach
bacteria
pttreat
hbmec
investig
respons
adhes
molecul
endotheli
surfac
show
increas
concentr
protein
immunofluoresc
studi
western
blot
upon
incub
pt
invas
transloc
assay
demonstr
surviv
e
coli
monocyt
macrophag
transloc
bacteriacontain
macrophag
enhanc
pt
find
favour
trojan
hors
mechan
possibl
addit
rout
also
transloc
vivo
thu
e
coli
avoid
host
defens
mechan
prolifer
blood
tissu
maintain
high
level
bacteremia
therefor
studi
point
possibl
addit
effect
pt
enhanc
cerebr
infect
recent
matrix
assist
laser
desorpt
ionis
time
flight
mass
spectrometri
malditof
ms
introduc
new
method
bacteri
identif
method
straightforward
faster
cheaper
compar
mani
method
nevertheless
littl
data
publish
yet
concern
clinic
import
strain
aureu
aim
studi
evalu
new
identif
method
compar
molecular
refer
method
speci
identif
consecut
collect
clinic
noncopi
isol
methicillinsuscept
methicillinresist
aureu
examin
malditofm
flexcontrol
biotyp
softwar
databas
bruker
dalton
bremen
germani
use
calcul
process
analyt
data
methicillin
suscept
aureu
strain
character
use
meca
pcr
orfx
pcr
hagen
et
al
confirm
speci
diagnosi
methicillinresist
isol
doubt
neg
result
orfx
pcr
confirm
meca
pcr
diagnost
specif
malditof
ms
high
strain
identifi
aureu
regardless
meca
statu
averag
score
valu
sd
achiev
isol
accord
manufactur
instruct
indic
good
speci
identif
bacteri
differenti
staphylococci
use
malditof
ms
technolog
highli
specif
indic
aureu
identif
use
malditof
ms
excel
altern
expens
time
consum
molecular
biolog
goldstandard
pcr
furthermor
time
identif
dramat
reduc
compar
biochem
identif
risk
necrot
enterocol
nec
preterm
infant
reduc
probiot
feed
howev
protect
mechan
presum
associ
chang
gut
flora
still
unknown
present
prospect
random
crossov
studi
analyz
bacteri
genom
preterm
infant
stool
sampl
initi
week
probiot
supplement
infloran
lactobacillu
acidophilum
bifidobacterium
infanti
given
daili
total
three
week
group
week
group
week
preterm
infant
gestat
age
week
low
birthweight
includ
clinic
data
monitor
eg
antibiot
treatment
feed
volum
weight
gain
complic
fortun
case
nec
found
studi
patient
bacteri
popul
stool
sampl
analyz
patient
group
denatur
gradient
gel
electrophoresi
dgge
follow
univers
pcr
use
modifi
forward
primer
gcclamp
total
sampl
analyz
therebi
abl
detect
chang
domin
bacteri
popul
patient
bacteri
type
perform
sequenc
analysi
specif
band
expect
bacteri
dna
could
amplifi
initi
stool
sampl
except
follow
week
individu
pattern
variou
bacteri
popul
evolv
howev
intermitt
chang
although
specif
band
lactobacillu
acidophilum
bifidobacterium
infanti
rare
detect
found
signific
chang
bacteri
popul
stool
sampl
without
probiot
supplement
observ
may
indic
protect
effect
probiot
supplement
associ
indirect
effect
gut
flora
composit
mader
peschel
medic
microbiologi
hygien
depart
univers
germani
bacteria
eukaryot
methionin
start
trna
formyl
formyltransferas
fmt
lead
formyl
ntermini
newli
synthes
bacteri
protein
formyl
group
subsequ
split
deformylas
def
essenti
bacteri
protein
inhibit
def
antibiot
actinonin
relat
antibiot
regard
attract
new
approach
antimicrobi
therapi
staphylococcu
aureu
bacteri
pathogen
note
bacteri
formyl
peptid
fp
repres
pathogenassoci
molecular
pattern
pamp
human
innat
immun
system
neutrophil
sens
fp
formyl
peptid
receptor
fpr
respond
chemotact
migrat
mediat
releas
remain
unclear
whether
treatment
aureu
actinonin
affect
releas
fp
studi
demonstr
subinhibitori
concentr
actinonin
lead
consider
increas
proinflammatori
capac
aureu
human
pmn
respond
higher
level
releas
chemotact
migrat
intracellular
calcium
ion
flux
supernat
actinonintr
aureu
cultur
compar
nontreat
cultur
use
fprtransfect
cell
line
fmtdefici
aureu
mutant
confirm
increas
leukocyt
respons
actinonintr
aureu
depend
fprmediat
sens
fp
data
underscor
role
fp
import
pamp
indic
inhibit
basic
bacteri
process
antibiot
critic
side
effect
innat
immun
inflamm
develop
easili
applic
adherencephagocytosi
assay
staphylococcu
aureu
whole
blood
j
jungmann
bajric
bischoff
herrmann
l
von
institut
medic
microbiolog
hygien
univers
saarland
hospit
homburgsaar
germani
staphylococcu
aureu
sa
lead
caus
acut
well
chronic
persist
andor
recurr
infect
pathogenesi
determin
bacteri
virul
factor
innat
cellular
immun
factor
develop
sawhol
blood
wb
adhes
phagocytosi
assay
base
upon
coincub
viabl
sa
cell
constitut
express
green
fluoresc
protein
sagfp
heparin
anticoagul
wb
perform
vitro
test
prove
straightforward
close
mimic
physiolog
situat
bacteri
phagocytosi
presenc
natur
opsonin
ie
antibodi
complement
order
distinguish
adher
intern
follow
wbsagfp
coincub
shake
lysostaphin
digest
appli
quantit
analysi
sa
adhes
variou
white
blood
cell
analyz
flow
cytometri
base
cell
morpholog
discrimin
sagfp
adhes
intern
polymorphonuclear
leukocyt
pmn
monocyt
mo
lymphocyt
lc
respect
addit
distinct
band
tcell
subset
achiev
use
specif
antibodi
expect
highest
adhes
intern
rate
obtain
profession
phagocyt
cell
adhes
pmn
intern
pmn
adhes
mo
intern
mo
interestingli
adhes
uptak
also
observ
certain
lc
bcell
subset
intern
tcell
upon
comparison
differ
gfp
clinic
laboratori
sa
isol
strain
elev
reduc
newman
adherenceintern
capac
could
identifi
result
donor
independ
demonstr
use
wb
differ
healthi
volunt
conclus
novel
facsbas
wbsa
adherencephagocytosi
assay
prove
standard
reproduc
applic
test
use
wb
well
sa
isol
patient
variou
condit
acut
chronic
sa
diseas
current
ongo
staphylococcu
aureu
one
abund
caus
infect
bone
well
prosthet
implant
total
knee
arthroplasti
tke
total
hip
arthroplasti
tha
infect
result
protract
ailment
well
need
amput
affect
limb
remov
implant
order
determin
aureu
strain
abl
caus
bone
infect
specialis
clonal
complex
certain
combin
virul
adhes
factor
associ
condit
isol
patient
bone
infect
characteris
use
microarray
detect
ca
gene
genotyp
data
compar
previous
characteris
sampl
popul
healthi
carrier
ejcmid
isol
belong
differ
clonal
complex
cc
domin
also
common
healthi
control
overrepres
bone
compar
carriag
isol
contrast
common
among
healthi
carrier
rare
among
patient
isol
clear
differ
carriag
patient
isol
found
regard
mscramm
capsul
type
superantigen
toxin
instanc
gene
encod
toxic
shock
syndrom
toxin
found
patient
control
capsul
type
note
patient
carriag
isol
contrast
staphylokinas
found
patient
isol
control
pvl
detect
patient
isol
carrier
data
show
specialis
bone
clone
essenti
aureu
caus
bone
infect
howev
appear
less
invas
overrepres
bone
infect
underli
reason
still
need
clarifi
direct
identif
microorgan
bactalert
blood
cultur
system
use
matrixassistedlaserdesorptionionis
timeofflight
mass
spectometri
michel
h
tix
kaas
gatermann
f
szabado
depart
medic
microbiolog
bochum
germani
identif
bacteria
grow
blood
cultur
help
distinguish
contamin
caus
agent
may
use
guid
therapi
matrixassistedlaserdesorptionionis
timeofflight
mass
spectometri
malditof
ms
shown
rapid
method
bacteri
identif
studi
direct
identif
bactalert
biomerieux
franc
blood
cultur
system
malditof
ms
evalu
clinic
isol
isol
grown
overnight
agar
media
identifi
biomerieux
franc
serv
standard
overal
cultur
posit
sampl
includ
sampl
show
biotyperscor
sampl
score
sampl
nontyp
due
low
score
isol
typeabl
sampl
identif
malditof
standard
blood
cultur
sampl
malditof
identif
correct
miss
coinfect
addit
bacteri
speci
one
sampl
ecoli
predict
malditof
aureu
cultur
maldiresult
rapid
identif
relev
therapeut
recommend
rapid
identif
bacteria
malditof
ms
use
bactalert
system
succesful
sampl
result
initi
modif
therapi
identifi
bacteria
despit
high
rate
nontyp
sampl
malditof
ms
seem
applic
bactalert
blood
cultur
system
score
specif
data
indic
bactalert
system
direct
identif
malditof
ms
use
addit
cultur
method
sometim
expedit
therapeut
recommend
thrippleton
w
von
stein
n
nischik
k
pfeffer
cr
mackenzi
miacom
diagnost
gmbh
miacom
diagnost
gmbh
germani
institut
medic
microbiolog
hospit
hygien
univers
clinic
heinrichheineunivers
germani
applic
molecular
biolog
techniqu
stool
sampl
alway
hamper
errat
natur
matrix
inhibit
enzymat
reaction
amplif
techniqu
appli
amplifi
dna
fragment
alreadi
success
destroy
organ
may
mislead
clinic
relev
precis
util
fish
technolog
util
dnabeacon
identifi
pathogen
directli
posit
blood
cultur
establish
requir
enzymat
reaction
intrigu
appli
dnabeacon
identif
bacteri
pathogen
directli
stool
sampl
report
success
design
applic
dnabeacon
prompt
identif
bacteria
caus
enter
novel
approach
design
beacon
made
enabl
control
open
close
hairpin
loop
found
target
sequenc
could
allow
ventur
atrich
region
rrna
find
novel
specif
sequenc
beacon
design
detect
e
coli
ehec
shigella
thermophil
campylobact
salmonella
yersinia
enterocolytica
clostridium
difficil
novel
sequenc
found
provid
requir
specif
one
except
e
coli
sequenc
specif
e
coli
shigella
sequenc
detect
e
coli
addit
assay
util
beacon
simultan
slide
easi
distinguish
doubl
posit
shigella
singl
posit
e
coli
specimen
new
beacon
design
also
enabl
gener
ehecspecif
probe
direct
sequenc
rrna
procedur
simplic
assay
allow
routin
screen
relev
stool
sampl
presenc
absenc
respect
organ
brief
centrifug
suspend
stool
sampl
remov
bulk
debri
assay
complet
min
sensit
specif
assay
respect
clostridium
difficil
diagnosi
cultur
pcr
fenner
c
lens
katz
h
petersen
microbiolog
mvz
labor
dr
fenner
und
kollegen
hamburg
germani
gold
standard
diagnosi
c
difficil
detect
toxigen
c
difficil
cultur
besid
cytotox
test
howev
cultur
c
difficil
toxin
test
cultur
time
consum
consid
toxin
test
stool
specimen
fals
neg
reliabl
criteria
test
diagnos
toxigen
c
difficil
support
neg
predict
valu
detect
antigen
glutam
dehydrogenas
gdh
c
difficil
reliabl
tool
detect
toxin
gene
c
difficil
stool
specimen
use
pcr
etablish
yet
allow
fast
result
establish
appropri
therapi
stool
sampl
test
c
difficil
toxin
ab
elisa
cdiffspecif
enzym
glutam
dehydrogenas
antigen
gdh
cultur
perform
c
difficileagar
tcdb
gene
c
difficil
detect
use
pcrthe
pcr
method
adapt
realtim
pcr
lightcycl
result
sampl
posit
c
difficil
toxin
ab
stool
toxigen
c
difficil
cultur
yield
posit
pcr
result
sampl
neg
result
toxin
antigen
test
stool
growth
cultur
show
neg
pcr
sampl
neg
c
difficil
toxin
ab
posit
c
difficil
antigen
gdh
stool
specimen
toxigen
c
difficil
cultur
show
posit
pcr
result
sampl
result
combin
pcr
neg
one
sampl
show
neg
result
toxin
antigen
test
stool
growth
cultur
posit
pcr
resultanoth
sampl
show
neg
result
toxin
antigen
test
stool
toxigen
c
difficil
cultur
posit
pcr
result
conclus
result
obtain
use
pcr
tcdb
gene
c
difficil
show
almost
exact
result
establish
method
detect
toxigen
c
difficil
avail
within
two
half
hour
sampl
prepar
includ
pcr
replac
reliabl
time
consum
method
high
detect
limit
verifi
toxigen
c
difficil
clinic
signific
pneumocysti
jirovecii
carinii
pneumonia
pcp
major
caus
ill
death
immunocompromis
host
therefor
earli
detect
treatment
import
reduc
morbid
mortal
among
patient
bg
cell
wall
compon
pneumocysti
jirovecii
variou
medic
relev
fungi
cours
infect
bg
releas
serum
public
last
year
suggest
serum
measur
bg
could
promis
new
tool
diagnosi
pcp
unfortun
public
either
case
report
limit
number
patient
examin
reason
perform
retrospect
studi
patient
diagnos
pcp
last
year
clinic
present
immunofluoresc
giemsa
stain
pcr
bronchoalveolar
lavag
fluid
bal
one
serum
sampl
per
patient
examin
presenc
bg
fungitel
assay
pneumocystisdna
nest
pcr
nest
pcr
serum
posit
patient
sensit
bg
level
greater
cutoff
pgml
found
serum
patient
two
patient
posit
immunofluoresc
bal
neg
bg
sensit
specif
neg
predict
valu
posit
predict
valu
furthermor
case
bg
level
posit
bal
perform
indic
diagnosi
could
made
earlier
almost
patient
show
high
level
bg
pgml
peak
level
pgml
observ
median
concentr
pgml
correl
concentr
bg
posit
pcr
serum
summari
serum
bg
measur
reliabl
indic
pcp
could
use
earli
diagnost
test
patient
risk
pcp
bal
perform
microbi
recontamin
slice
prepackag
boil
sausag
cook
ham
gener
challeng
problem
studi
aim
improv
hygien
situat
cut
processunit
cook
ham
uvcradi
knife
surfac
cabinet
slicingmachin
total
bacteria
count
slice
packag
cook
ham
sampl
well
grit
sampl
determin
spatula
rub
method
plate
count
agar
air
born
bacteria
air
slice
room
analys
rc
plu
air
sampler
hycon
contact
slide
biotest
bacteria
speci
determin
apisystem
biomerieux
uvc
radiat
perform
uvc
tube
form
type
total
output
max
intens
max
ambient
temperatur
limit
power
dissip
w
current
flow
suppli
voltag
compar
total
bacteria
count
cook
ham
cook
cfug
count
test
slice
indic
ham
grit
accumul
cut
area
mainli
caus
microbi
contamin
within
slice
process
sampl
ham
slice
near
grit
one
right
side
slicer
machin
reveal
contamin
rate
cfugthi
grit
expos
total
bacteria
count
higher
cfug
domin
lactobacillu
fermentum
l
curvatu
leuconostoc
mesenteroid
air
born
bacteri
contamin
count
test
could
exclud
order
reduc
bacteri
load
uvcradi
implement
slice
machin
avoid
soil
lamp
grid
optim
area
radiat
uvclamp
locat
cabinet
rotat
knife
cook
ham
slice
radiat
indic
reduc
bacteri
count
test
cfug
compar
slice
ham
without
conclus
uvc
radiat
reduc
hamgrid
relat
bacteri
contamin
slice
prepackag
cook
ham
advanc
effect
might
access
combin
uvcradi
process
integr
clean
system
probiot
bacteria
protect
cultur
prepackag
acid
delicatessen
salad
e
kostadinowa
knoblauch
l
hornkessl
c
beermann
food
technolog
univers
appli
scienc
fulda
fulda
germani
qualiti
assur
w
brandenburg
gmbh
co
ohg
dreieich
germani
microbi
food
spoilag
prepackag
acid
delicatessen
salad
predominantli
due
yeast
contamin
studi
aim
establish
lactic
acid
bacteria
bifidobacteria
probiot
characterist
order
protect
egg
coleslaw
salad
cultur
pichia
contamin
microbi
contamin
experi
perform
incub
product
cfug
lactobacillu
reuteri
cfug
bifidobacterium
bifidum
togeth
challeng
cfug
pichia
etchellsii
count
aerob
microorgan
lactic
acid
bacteria
bifidobacteria
yeast
well
phvalu
awvalu
content
acet
acid
examin
product
expiri
date
salad
store
total
count
speci
specif
count
perform
pour
plate
method
awvalu
measur
use
electr
hygromet
acet
acid
content
enzymat
determin
egg
salad
phvalu
inocul
bacteria
speci
could
establish
count
cfug
day
cultiv
phvalu
increas
acet
acid
content
decreas
gkg
awvalu
sensori
textur
product
remain
constant
yeast
prolifer
rate
signific
gasproduct
could
influenc
coleslaw
salad
phvalu
bifidobacterium
bifidum
could
cocultur
togeth
lactobacillu
reuteri
day
cultiv
phvalu
increas
acet
acid
content
decreas
gkg
awvalu
sensori
textur
product
remain
constant
independ
protectioncultur
yeast
prolifer
could
inhibit
day
endcount
cfug
conclus
establish
probiot
bacteria
acid
delicatessen
salad
depend
phvalu
improv
cocultur
differ
speci
although
product
characterist
could
influenc
productprotect
potenti
probiot
bacteria
yeast
limit
need
investig
object
soda
fountain
sf
produc
cool
carbon
water
tap
water
suppli
conveni
way
provid
patient
employe
drink
water
use
sf
reduc
storag
space
wast
transportrel
emiss
compar
suppli
bottl
water
howev
microbi
contamin
water
sf
occur
may
endang
immunocompromis
patient
univers
medic
center
freiburg
sf
current
use
method
water
sampl
obtain
startup
biannual
thereaft
result
evalu
accord
german
drink
water
regul
gdwr
accept
number
coloni
form
unit
cfu
exceed
cfuml
analysi
repeat
new
sampl
sampl
still
posit
pathogen
bacteria
high
coloni
count
detect
sampl
sf
put
servic
neg
sampl
obtain
mainten
disinfect
result
sampl
sf
analys
met
criteria
gdwr
remain
latter
sampl
exceed
accept
number
cfu
posit
coliform
bacteria
p
aeruginosa
posit
coliform
excess
cfu
count
enterococci
e
coli
found
pathogen
list
gdwr
identifi
sampl
rate
nonconform
sampl
drop
steadili
conclus
stateoftheart
soda
fountain
feasibl
altern
addit
bottl
water
howev
standard
clean
disinfect
mainten
procedur
continu
surveil
implement
ensur
safe
oper
use
highrisk
area
recommend
sinc
identifi
pathogen
may
endang
suscept
patient
replac
activ
carbon
filter
particl
filter
done
may
contribut
decreas
nonconform
sampl
immunofluoresc
studi
nheb
produc
bacillu
cereu
gruber
didier
bock
r
dietrich
e
chair
hygien
technolog
milk
depart
veterinari
scienc
veterinari
faculti
ludwigmaximiliansunivers
munich
germani
bacillu
cereu
ubiquit
soil
inhabit
produc
enterotoxin
caus
two
differ
kind
food
poison
emet
form
caus
cereulid
ringshap
dodecadepsipeptid
two
threecompon
enterotoxin
complex
call
hemolysinbl
hbl
consist
compon
b
nonhemolyt
enterotoxin
nhe
contain
nhea
nheb
nhec
well
singl
protein
cytotoxin
k
made
respons
diarrhoeal
food
poison
syndrom
present
studi
focuss
nheb
suppos
bind
compon
nhe
complex
fulllength
ntermin
truncat
fragment
nheb
establish
e
coli
express
system
bind
vero
cell
demonstr
fulllength
protein
fragment
lack
maximum
amino
acid
use
immunofluoresc
microscopi
kroj
k
creuzburg
h
schmidt
institut
lebensmittelwissenschaft
und
biotechnologi
hohenheim
stuttgart
germani
shiga
toxinproduc
escherichia
coli
stec
repres
heterogen
group
zoonot
pathogen
appear
differ
high
risk
food
like
ground
beef
raw
milk
raw
sausag
enterohemorrhag
e
coli
ehec
pathogen
subgroup
stec
caus
wateri
bloodi
diarrhea
hemolyt
urem
syndrom
human
be
consumpt
raw
undercook
food
littl
known
behavior
ehec
ground
beef
aim
work
identif
character
gene
offer
abil
surviv
process
storag
high
risk
food
use
antibiot
base
vivo
express
technolog
ivet
want
detect
gene
express
vivo
adapt
bacteria
environment
condit
case
meat
model
standard
laboratori
condit
therefor
genom
librari
e
coli
strain
repres
one
critic
serotyp
worldwid
construct
vector
contain
promoterless
chloramphenicol
acetyltransferas
gene
select
promot
activ
experiment
condit
result
plasmid
clone
nalidix
acid
resist
mutant
laboratori
strain
e
coli
better
reisol
clone
ground
beef
librari
consist
x
clone
averag
insert
size
bp
repres
approxim
redund
genom
furthermor
ground
beef
model
low
background
microbiota
x
cfug
ivet
screen
establish
system
suitabl
analysi
vivo
express
gene
work
support
grant
foodborn
zoonot
infect
human
german
feder
ministri
educ
research
bmbf
et
al
yet
case
sever
listeriosi
report
immuncompromis
also
previous
healthi
person
aur
et
al
thu
aim
studi
make
contribut
actual
risk
potenti
contamin
raw
beef
pork
respect
byproduct
listeria
spp
l
monocytogen
march
novemb
total
meat
sampl
analys
qualit
vida
system
presenc
listeria
spp
l
monocytogen
l
monocytogen
posit
sampl
confirm
cultur
method
sampl
analys
obtain
seven
differ
slaughterhous
southern
germani
listeria
spp
found
sampl
sampl
contain
l
monocytogen
sampl
kidney
lung
neg
l
monocytogen
highest
occurr
listeria
spp
l
monocytogen
obtain
rumen
sampl
posit
result
respect
highest
contamin
rate
listeria
spp
found
bovin
sampl
porcin
sampl
show
highest
rate
l
monocytogen
contamin
studi
presenc
listeria
spp
l
monocytogen
raw
meat
lower
report
studi
known
product
support
growth
l
monocytogen
pose
potenti
risk
consum
hand
consumpt
meat
meat
product
caus
concern
mostli
meat
consum
undergo
treatment
supposedli
erad
listeria
infect
enterohaemorrhag
escherichia
coli
ehec
consid
import
sever
bacteri
diseas
worldwid
vida
ecpt
new
method
base
specif
phage
captur
techniqu
detect
e
coli
applic
method
examin
minc
beef
sampl
artifici
contamin
nonvirul
e
coli
strain
contamin
level
g
sampl
per
level
provid
institut
pasteur
de
lill
control
sampl
use
enumer
total
materi
count
sampl
incub
h
buffer
pepton
water
bpw
prior
perform
vida
ecpt
assay
ml
sampl
heat
min
posit
result
confirm
non
heat
bpw
isol
ctsmac
chromogen
ct
id
plate
follow
agglutin
latex
api
test
iso
method
use
refer
method
total
bacteri
count
x
cfug
vida
ecpt
gave
posit
result
confirm
select
agar
plate
definit
neg
result
one
neg
sampl
show
distinctli
higher
rel
fluoresc
valu
neg
result
sampl
confirm
posit
select
agar
plate
refer
method
detect
despit
applic
immunomagnet
separ
h
incub
sampl
definit
neg
clearli
posit
although
accompani
flora
sampl
high
vida
ecpt
method
shown
effici
screen
instrument
detect
ehec
bear
advantag
reduc
analysi
time
arcobact
spp
aerotoler
campylobacterlik
organ
isol
anim
human
butzleri
cryaerophilu
skirrowii
three
common
speci
associ
human
gastroenter
speci
frequent
found
poultri
carcass
thu
pose
possibl
risk
human
infect
via
consumpt
contamin
meat
product
isol
method
use
timeconsum
therefor
speci
differenti
phenotyp
test
give
frequent
incorrect
result
studi
arcobact
spp
detect
identifi
genotyp
method
pcr
poultri
sampl
southern
germani
total
sampl
raw
poultri
meat
poultri
product
studi
sampl
enrich
select
bouillon
microaerophil
condit
h
prior
dna
extract
prepman
arcobact
spp
detect
use
pcr
target
rrna
arcobact
spp
associ
human
diseas
identifi
multiplex
pcr
base
five
primer
target
rrna
sequenc
product
detect
use
gelelectrophoresi
arcobact
detect
sampl
process
sampl
neg
butzleri
cryaerophilu
skirrowii
identifi
sampl
respect
duck
goos
sampl
contamin
buzleri
skirrowii
found
chicken
sampl
five
chicken
sampl
buzleri
cryaerophilu
detect
preval
arcobact
spp
high
raw
chicken
turkey
duck
sampl
low
raw
goos
sampl
butzleri
frequent
identifi
speci
undercook
poultri
product
could
import
sourc
human
buzleri
infect
evalu
use
genotyp
method
increas
relev
enteropathogen
b
cereu
particularli
largescal
cater
facil
lead
grow
demand
fast
reliabl
detect
method
addit
frequent
appli
cellular
immunolog
test
b
cereu
toxin
recent
molecular
biolog
method
detect
underli
toxin
gene
implement
routin
analysi
date
convent
singleplex
multiplex
pcr
method
gene
potenti
enteropathogen
toxin
nhe
hbl
cereulid
well
two
singleplex
realtim
pcr
specif
nhe
nheb
cereulid
ce
publish
compar
convent
pcr
system
faster
sensit
realtim
pcr
repres
advantag
technolog
possibl
easi
autom
omiss
cumbersom
postpcr
detect
procedur
eg
gel
electrophoresi
present
studi
deal
develop
multiplex
realtim
pcr
simultan
detect
b
cereu
toxin
gene
hbld
nhea
ce
purpos
pcr
protocol
base
sybr
green
subsequ
melt
temperatur
tm
analysi
design
novel
method
establish
use
well
character
b
cereu
strain
previous
test
immunolog
cellular
biomolecular
assay
develop
pcr
shown
facil
fast
reliabl
method
contractresearchproject
bundeswehr
medic
servic
detect
molecular
character
shiga
toxin
produc
escherichia
coli
food
sampl
slanec
fruth
k
creuzburg
h
schmidt
institut
lebensmittelwissenschaft
und
biotechnologi
hohenheim
stuttgart
germani
robert
kochinstitut
bereich
wernigerod
wernigerod
germani
shiga
toxin
produc
eschericha
coli
stec
caus
spectrum
human
diseas
rang
wateri
bloodi
diarrhea
life
threaten
intestin
complic
hemolyt
urem
syndrom
transmiss
anim
reservoir
human
occur
mainli
raw
undercook
food
besid
product
shiga
toxin
stx
stec
express
number
accessori
virul
factor
whose
distribut
vari
among
differ
stec
strain
studi
want
assess
spectrum
virul
profil
foodborn
stec
determin
preval
stec
sampl
differ
high
risk
food
like
minc
meat
raw
sausag
local
retail
supermarket
well
raw
milk
dairi
milk
collect
plant
addit
stec
strain
analyt
author
obtain
stec
strain
serotyp
stxsubtyp
presenc
virul
gene
eae
iha
cdtv
subab
ehxa
espp
nlea
cif
determin
besid
stx
iha
ehxa
subab
espp
detect
frequent
five
strain
eaeposit
three
latter
strain
belong
enterohemorrhag
e
coli
ehec
serogroup
contain
virul
gene
composit
typic
ehec
result
studi
show
ehec
found
rare
investig
food
howev
frequent
detect
iha
ehxa
subab
rais
question
isol
gener
consid
harmless
work
support
grant
foodborn
zoonot
infect
human
german
feder
ministri
educ
research
bmbf
institut
medizinisch
mikrobiologi
magdeburg
magdeburg
germani
host
cell
invas
campylobact
jejuni
report
one
primari
reason
tissu
damag
human
molecular
mechan
wide
unclear
shown
c
jejuni
trigger
membran
ruffl
eukaryot
cell
follow
invas
specif
manner
first
tip
follow
flagellar
end
bind
c
jejuni
host
fibronectin
import
process
mediat
cadf
infect
assay
reveal
c
jejuni
bound
invad
cell
effici
isogen
cadf
mutant
suggest
bind
cadf
extracellular
fibronectin
may
trigger
intracellular
signal
facilit
host
cell
entri
order
verifi
hypothesi
use
mous
knockout
fibroblast
deriv
fibronectin
focal
adhes
kinas
srcyesfyn
mice
studi
c
jejuniinduc
signal
invas
found
host
cell
factor
inde
requir
maxim
invas
pathogen
use
specif
gtpasemodifi
toxin
inhibitor
silenc
rna
sirna
gtpase
express
construct
show
small
rho
gtpase
rhoa
involv
c
jejuni
invas
agreement
observ
observ
timedepend
activ
c
jejuni
final
demonstr
activ
gtpase
involv
cadf
one
bacteri
factor
independ
pathogen
factor
includ
cdt
plasmid
pvir
capsular
gene
adhesin
thu
cadf
bifunct
protein
trigger
bacteri
bind
host
cell
well
signal
lead
gtpase
activ
effici
host
cell
invas
collect
result
suggest
c
jejuni
invad
host
target
cell
uniqu
mechan
activ
rho
gtpase
member
cadfbind
fibronectin
play
crucial
role
entri
process
despit
progress
adjuv
chemotherapi
recent
decad
pancreat
cancer
remain
common
caus
death
worldwid
bacteri
toxin
specif
bind
cell
surfaceexpos
glycosphingolipid
gsl
potenti
novel
therapi
determin
express
globotriaosylceramid
shiga
toxin
receptor
human
pancreat
adenocarcinoma
tissu
lipid
extract
match
pair
cancer
adjac
normal
tissu
pancreat
cancer
patient
investig
thinlay
chromatographi
tlc
overlay
assay
combin
novel
mass
spectrometri
approach
local
immunofluoresc
microscopi
cryosect
malign
correspond
healthi
tissu
sampl
pancreat
adenocarcinoma
show
increas
express
wherea
malign
pancrea
indic
associ
marker
neoplast
transform
also
associ
poor
differenti
g
cancer
tissu
p
mass
spectrometr
analysi
evidenc
enhanc
express
long
short
chain
fatti
acid
malign
tissu
point
presenc
hydroxyl
fatti
acid
propos
import
receptor
target
could
detect
pancreat
adenocarcinoma
immunohistolog
tissu
cryosect
indic
tumorand
neovascularassoci
receptor
result
prompt
consider
shiga
toxin
ist
bsubunit
bsubunitderiv
novel
therapeut
strategi
treatment
challeng
malign
characteris
regulatori
rna
element
put
metdepend
tbox
system
staphylococcu
aureu
staphylococcu
epidermidi
smk
schoenfeld
w
ziebuhr
centr
infect
immun
queen
univers
belfast
belfast
unit
kingdom
noncod
small
rna
srna
recognis
import
player
regulatori
network
control
gene
express
bacteria
thoroughli
studi
escherichia
coli
known
gram
posit
bacteria
far
srna
mostli
display
effect
posttranscript
either
act
via
rnaproteininterfer
via
direct
base
pair
target
mrna
noncod
rna
also
exhibit
intrins
catalyt
activ
describ
put
srna
transcrib
differ
pathogen
aureu
epidermidi
strain
detect
genomewid
search
transcript
larg
intergen
region
transcript
verifi
northern
blot
analysi
rtpcr
quantit
realtim
pcr
polar
experiment
determin
bioinformat
analysi
reveal
two
put
promot
strong
rhoindepend
transcript
termin
neither
ribosom
bind
site
open
read
frame
detect
element
preced
gene
methioninebiosynthesi
analysi
metsrna
sequenc
identifi
highli
conserv
tbox
motif
tbox
regulatori
system
rnabas
transcript
termin
control
system
gramposit
bacteria
often
govern
trna
synthetas
amino
acid
biosynthesi
gene
experi
differ
epidermidi
aureu
strain
indic
metsrna
conserv
speci
transcript
level
vari
among
strain
respons
environment
condit
role
metsrna
metabol
adapt
staphylococci
differ
ecolog
nich
possibl
suitabl
novel
antibiot
target
discuss
virul
human
anim
pathogen
staphylococcu
aureu
multifactori
depend
express
specif
pathogen
factor
includ
toxin
adhesin
digest
toxin
fit
factor
recent
analysi
complet
genom
sequenc
well
compar
transcriptom
proteom
studi
indic
high
degre
variabl
differ
aureu
strain
understand
pathogen
aureu
complex
process
analyz
particular
virul
determin
essenti
appli
relev
vivo
model
although
sever
anim
model
describ
still
unknown
model
relev
evalu
particular
virul
determin
virul
potenti
laboratori
clinic
strain
studi
differ
vivo
model
use
establish
new
vivo
imag
techniqu
base
aureu
strain
express
lux
operon
abl
show
dynam
aureu
infect
subcutan
intramuscular
intraven
infect
noninvas
real
time
sever
virulencerel
factor
evalu
use
techniqu
includ
delet
mutant
global
regul
agra
arl
sara
virul
factor
spa
hla
fnba
fnbb
metabol
factor
purh
putp
gener
virul
potenti
isogen
mutant
depend
particularli
use
infect
model
interestingli
strong
reduct
virul
detect
purh
mutant
suggest
essenti
role
purin
de
novo
biosynthesi
vivo
thu
conclud
essenti
metabol
factor
provid
power
target
possibl
effect
antistaphylococc
treatment
singl
virul
factor
regul
activ
gener
phenomenon
infect
human
pathogen
hypoxia
induc
factor
hif
key
transcript
factor
involv
adapt
process
cell
organ
hypoxia
recent
evid
play
also
crucial
role
inflammatori
infecti
diseas
show
activ
gener
phenomenon
infect
human
pathogen
bacteria
virus
fungi
protozoa
activ
detect
vitro
cellcultur
infect
model
ii
ex
vivo
use
biopsi
human
patient
suffer
skin
infect
iii
vivo
use
periton
intraven
aureu
infect
model
activ
human
pathogen
caus
oxygendepend
mechan
small
coloni
variant
scv
aureu
lead
cellular
hypoxia
activ
final
pharmaceut
inhibit
activ
result
increas
surviv
rate
murin
aureu
periton
model
taken
togeth
studi
reveal
activ
gener
phenomenon
infect
human
pathogen
pathway
might
attract
target
modul
cours
infect
helicobact
pylori
activ
protein
kinas
c
delta
control
raf
map
kinas
signal
role
ag
epitheli
cell
scatter
elong
helicobact
pylori
major
etiolog
agent
develop
chronic
gastriti
duoden
ulcer
gastric
carcinoma
human
virul
h
pylori
strain
harbor
type
iv
secret
system
encod
cag
pathogen
island
inject
caga
protein
gastric
epitheli
cell
lead
actincytoskelet
rearrang
follow
cell
elong
scatter
report
pma
wellknown
cellperm
activ
protein
kinas
c
pkc
induc
remark
similar
cellular
phenotyp
compar
infect
h
pylori
pkc
compris
larg
famili
serinethreonin
kinas
import
multipl
physiolog
process
host
cell
therefor
investig
role
individu
pkc
member
signal
pathway
involv
phenotyp
outcom
use
isoformspecif
silenc
rna
pharmacolog
inhibitor
found
two
isoform
essenti
pmaand
h
pyloriinduc
elong
phenotyp
furthermor
provid
evid
activ
profoundli
stimul
cours
infect
use
activationspecif
antibodi
pkc
phosphoryl
threonin
residu
serin
residu
infect
h
pylori
wildtyp
mutant
show
least
two
bacteri
factor
activ
timedepend
manner
one
caga
immunofluoresc
microscopi
studi
demonstr
phosphoryl
accumul
recruit
dynam
actinstructur
cell
membran
final
show
specif
target
raf
kinas
stimul
kinas
pathway
also
crucial
phenotyp
outcom
thu
anoth
import
mediat
h
pyloriinduc
pathogenesi
immunolog
analysi
yersinia
enterocolitica
infect
suscept
mice
defin
defect
innat
immun
e
vlasova
j
heesemann
maxvonpettenkof
institut
bakteriologi
lmu
germani
yersinia
enterocolitica
pathogen
human
rodent
gramneg
pathogen
yersinia
releas
typic
pathogenassoci
molecular
pattern
pamp
protein
lipopolysaccharid
lp
peptidoglycan
fragment
pg
lipoprotein
lp
yersinia
v
antigen
lcrv
recogn
host
pampreceptor
prr
famili
prr
compris
surfac
receptor
cytosol
receptor
signal
transduct
adaptor
protein
moreov
prr
signal
lead
releas
proinflammatori
cytokin
antiinflammatori
protein
sing
et
al
hoffmann
et
al
prompt
us
investig
komic
defin
defect
innat
immun
suscept
toward
yersinia
cfu
intraperiton
bacteri
load
infect
mice
determin
count
cfu
spleen
wherea
cellular
immun
respons
infect
mice
studi
fac
analysi
immunohistochemistri
respect
found
mice
highli
suscept
mice
moder
suscept
highli
resist
enterocolitica
histolog
analysi
spleen
cryosect
reveal
yersinia
abscess
surround
neutrophil
pmn
cell
popul
increas
resist
mice
data
also
support
fac
analysi
thu
neutrophil
seem
play
decis
part
elimin
yersinia
abscess
format
perspect
go
compar
neutrophil
recruit
site
infect
neutrophil
bactericid
activ
differ
komic
previous
report
toxoplasma
gondii
infect
mice
loos
natur
fear
cat
urin
howev
unclear
whether
behaviour
chang
due
infect
specif
area
brain
especi
area
import
behaviour
eg
amygdala
ii
activ
alter
neuron
function
parasit
iii
ensu
immun
respons
address
question
analyz
balbc
mice
infect
toxoplasma
gondii
cyst
day
behaviour
chang
mri
scan
pet
scan
immunohistochemistri
vivo
thallium
uptak
experi
addit
live
cell
calcium
imag
infect
primari
neuron
also
perform
mri
depict
larg
randomli
distribut
inflammatori
lesion
infect
mice
correl
mri
data
histolog
find
suggest
anatom
foci
infect
occur
therefor
respons
chang
behaviour
immunhistochemistri
show
gondii
infect
mainli
glial
cell
neuron
neuron
posit
stain
toxoplasma
antibodi
without
sign
intracellular
parasit
invas
frequent
axon
contact
neuron
neuron
host
cyst
also
observ
suggest
possibl
influenc
modul
neuron
physiolog
cyst
indic
parasit
activ
modifi
neuron
activ
live
cell
calcium
imag
primari
neuron
cultur
infect
toxoplasma
show
decreas
calcium
signal
upon
excit
glutam
furthermor
thallium
uptak
experi
sign
electr
activ
neuron
host
cyst
dynam
influx
potassium
requir
neuron
activ
might
contribut
chang
behaviour
anim
carri
chronic
toxoplasma
infect
distribut
virul
associ
gene
genet
defin
commens
invas
methicillinresist
staphylococcu
aureu
isol
reveal
associ
eap
blood
cultur
isol
methicillinresist
staphylococcu
aureu
mrsa
found
persist
resid
invas
clinic
isol
molecular
determin
contribut
increas
pathogen
invas
specif
aureu
strain
clear
aim
studi
compar
preval
specif
virul
trait
select
invas
blood
cultur
wound
infect
commens
mrsa
isol
isol
character
use
staphylococc
protein
spa
multilocu
sequenc
type
strain
belong
deduc
clonal
complex
evenli
distribut
invas
commens
isol
strain
carri
accessori
gene
regul
type
staphylococc
cassett
chromosom
mec
type
independ
origin
isol
similarli
gene
encod
adhes
molecul
fnba
clfa
clfb
sdrc
sdrd
sdre
emp
present
invas
commens
strain
almost
toxin
gene
tst
edinb
eta
etb
hla
luk
could
detect
interestingli
extracellular
fibringogen
bind
protein
efb
show
strong
associ
independ
origin
isol
contrast
extracellular
adhes
protein
gene
eap
found
blood
cultur
isol
commens
strain
without
associ
specif
clonal
complex
moreov
mean
quantit
biofilm
product
blood
cultur
isol
significantli
higher
compar
nasal
strain
appar
irrespect
genet
background
specif
virul
determin
associ
invas
mrsa
isol
find
highlight
import
eap
endovascular
mrsa
infect
indic
biofilm
format
capac
link
increas
invas
studi
use
high
throughput
type
technolog
warrant
order
gain
insight
evolut
mrsa
virul
character
streptococcu
gallolyticu
subsp
gallolyticu
isol
deriv
infecti
endocard
patient
compar
anim
isol
hins
vollmer
k
kleesiek
j
dreier
institut
laboratoriumsund
transfusionsmedizin
herzund
diabeteszentrum
nrw
der
bochum
bad
oeynhausen
germani
infecti
endocard
ie
diseas
rise
incid
high
degre
mortal
morbid
rdna
ribotyp
infecti
heart
valv
reveal
signific
relev
streptococcu
gallolyticu
subsp
gallolyticu
caus
agent
ie
littl
known
factor
contribut
pathogenesi
gallolyticu
subsp
gallolyticu
ie
member
group
streptococci
screen
gallolyticu
subsp
gallolyticu
isol
differ
origin
clinic
isol
ie
patient
anim
isol
refer
strain
presenc
virul
factor
pcr
southern
blot
analysi
investig
associ
adhes
invas
differ
gallolyticu
subsp
gallolyticu
strain
vitro
establish
cellcultur
model
use
endotheli
cell
line
addit
analyz
capabl
gallolyticu
subsp
gallolyticu
strain
form
biofilm
vitro
bind
differ
ecm
protein
collagen
ii
iv
fibronectin
laminin
tenascin
vitronectin
fibrinogen
detect
three
potenti
virul
gene
gene
fimb
encod
fibrinogen
bind
factor
present
human
strain
test
miss
two
strain
anim
origin
furthermor
gtf
gene
encod
glycosyltransferas
detect
strain
first
time
potenti
virul
gene
homologu
pilb
gene
sui
code
potenti
pilu
subunit
b
pilb
identifi
gallolyticu
subsp
gallolyticu
also
observ
consider
differ
adhes
invas
potenti
capabl
biofilm
format
abil
bind
ecm
protein
among
differ
strain
howev
specif
correl
strain
origin
virul
factor
biofilm
format
adhes
invas
characterist
observ
far
vivo
evolut
staphylococcu
aureu
chronic
airway
infect
cystic
fibrosi
patient
c
neumann
g
peter
bc
kahl
institut
medizinisch
mikrobiologi
germani
staphylococcu
aureu
major
pathogen
airway
infant
cystic
fibrosi
patient
individu
maintain
infect
throughout
lifetim
observ
patient
infect
aureu
clone
mani
year
aureu
express
varieti
virul
factor
like
toxin
superantigen
cytotoxin
proteas
mscramm
microbi
surfac
compon
recogn
adhes
matrix
molecul
chronic
suppur
airway
infect
lead
lunginsuffici
preterm
death
aureu
enhanc
abil
bind
cf
airway
epithelium
alter
cf
mucu
higher
mucu
osmolar
alter
glycoconjug
composit
airway
cell
bacterium
develop
differ
mechan
escap
normal
host
immun
respons
uniqu
collect
aureu
isol
collect
year
cystic
fibrosi
patient
allow
us
investig
adapt
mechan
aureu
hostil
environ
next
gener
sequenc
sequenc
whole
genom
first
latest
aureu
isol
cystic
fibrosi
patient
analyz
genom
chang
occur
long
term
persist
subsequ
intermedi
isol
isol
patient
investig
result
could
enabl
us
develop
innov
strategi
base
hostpathogen
interact
treat
chronic
aureu
infect
helicobact
pylori
highli
success
humanspecif
gastric
pathogen
induc
patholog
rang
chronic
gastriti
peptic
ulcer
cancer
virul
isol
encod
typeiv
secret
system
form
extracellular
needlelik
pilu
compos
virb
protein
call
accessori
protein
other
protein
assembl
inner
outer
membran
gramneg
bacterium
presum
form
channel
use
inject
bacteri
virul
molecul
target
cell
caga
effector
protein
accomplish
specialis
adhesin
pilu
surfac
cagl
protein
function
ortholog
induc
upon
contact
host
cell
membran
cagl
transport
pilu
surfac
yet
unknown
mechan
interestingli
cagl
carri
classic
rgdmotif
bind
host
cell
integrin
receptor
purifi
wildtyp
mutant
cagl
protein
studi
interact
host
cell
demonstr
purifi
cagl
alon
abl
permit
bind
induc
signal
rgddepend
rgdindepend
fashion
show
cagl
activ
wellknown
host
cell
oncoprotein
src
abl
famili
tyrosin
kinas
inject
caga
intracellular
caga
mimic
cellular
host
protein
bind
activ
numer
eukaryot
factor
induc
variou
phosphorylationdepend
phosphorylationindepend
signal
cascad
latter
includ
induct
membran
dynam
actincytoskelet
rearrang
disrupt
celltocel
junction
well
prolif
proinflammatori
antiapoptot
nuclear
respons
thu
caga
cagl
remark
bacteri
protein
capabl
affect
multipl
host
cell
signal
activ
contribut
signal
h
pylori
pathogenesi
discuss
campylobact
jejuni
gene
import
pathogen
invad
host
cell
campylobact
jejuni
gramneg
spiral
shape
bacterium
major
caus
bacteri
diarrhoea
develop
industri
countri
infect
also
character
fever
abdomin
cramp
rare
case
syndrom
might
emerg
postinfect
complic
screen
transposonbas
mutant
librari
identifi
gene
relat
invas
pathogen
host
cell
therebi
identifi
sever
campylobact
jejuni
mutant
strongli
decreas
invas
sequenc
genom
dna
respect
clone
detect
insert
transposon
gene
togeth
adjac
gene
suppos
serv
singl
chemoreceptor
via
translat
gene
one
function
protein
readthrough
mechan
demonstr
insert
transposon
neither
effect
transcript
upstream
gene
downstream
gene
furthermor
could
restor
capabl
mutant
invad
host
cell
almost
effect
wildtyp
introduc
togeth
introduc
alon
sinc
also
motil
mutant
decreas
compar
wild
type
analyz
alter
motil
complement
mutant
respect
therebi
wild
type
motil
could
complet
reconstitut
introduct
gene
altogeth
result
support
idea
c
jejuni
gene
pseudogen
read
upstream
downstream
gene
creat
one
function
protein
type
ii
secret
system
multiprotein
complex
span
envelop
gramneg
bacteria
dedic
export
protein
previous
identifi
transcript
regul
pypc
associ
highli
pathogen
enterocolitica
strain
show
pypc
autoregul
organ
operon
downstream
gene
furthermor
operon
repress
hn
activ
virul
regul
rova
conserv
pathogen
yersinia
speci
includ
pesti
pseudotuberculosi
highli
pathogen
strain
enterocolitica
possess
second
gene
cluster
term
interestingli
also
associ
transcript
regul
term
pclr
autoregul
furthermor
margin
crossregul
via
pypc
pclr
show
growth
bacteria
deplet
media
result
activ
secret
substrat
pclr
activ
transcript
chiy
gene
code
predict
nacetlyglucosamin
bind
protein
locat
downstream
use
enterocolitica
strain
mutat
andor
system
show
mediat
secret
chiy
addit
data
indic
protein
secret
specif
via
enterocolitica
other
previous
shown
role
late
stage
enterocolitica
infect
mous
model
infect
indic
substrat
specif
function
virul
summari
identifi
uniqu
associ
yt
yersinia
transcript
regul
identifi
first
type
iisecret
protein
enterocolitica
ga
import
human
pathogen
caus
diseas
rang
mild
superfici
infect
skin
mucou
membran
nasopharynx
sever
toxic
invas
diseas
ga
equip
mani
virul
factor
allow
human
pathogen
infect
surviv
host
regul
virul
factor
express
fine
tune
twocompon
sytem
stand
alon
regul
transcriptom
analysi
serotyp
ga
strain
isogen
nra
knock
mutant
reveal
transcript
control
new
ralp
famili
regul
rofalik
protein
regul
type
link
gene
encod
epf
extracellular
protein
factor
streptococcu
sui
plasminogenbind
protein
ga
character
function
virul
associ
role
epf
encod
ere
region
serotyp
ga
strain
delet
epf
insert
mutant
studi
sever
pathogenesisrel
assay
impact
epf
adher
intern
human
keratinocyt
character
abil
mutant
surviv
differ
media
test
hyaluron
acid
capsul
product
determin
plasminogen
bind
assay
intact
bacteria
perform
inactiv
significantli
reduc
adher
ga
human
keratinocyt
epf
mutant
show
decreas
adher
intern
surviv
assay
differ
media
show
mutant
unabl
surviv
human
plasma
blood
serum
wherea
epf
mutat
exclus
affect
whole
blood
surviv
also
demonstr
hyaluron
acid
capsul
mutant
significantli
reduc
furthermor
inactiv
gene
influenc
plasminogen
bind
ga
summari
result
provid
import
transcript
regul
ga
pathogenesi
pathogen
yersinia
speci
engag
plasmidencod
type
iii
protein
secret
system
inject
yop
virul
protein
host
cell
establish
diseas
six
effector
yop
cooper
modul
host
immun
respons
enabl
surviv
extracellular
dissemin
bacteria
host
lymphoid
tissu
yope
cytotoxin
manipul
activ
rhogtpas
disrupt
actin
cytoskeleton
structur
contribut
phagocytosi
resist
yersinia
previous
shown
yope
enterocolitica
serogroup
modifi
polyubiqitin
degrad
ubiquitinproteasom
pathway
host
cell
investig
role
yope
degrad
yersinia
virul
pathogenesi
lysin
polyubiquitin
acceptor
site
wild
type
yope
inactiv
sitedirect
mutagenesi
result
yope
mutant
escap
ubiquitin
proteasom
degrad
infect
host
cell
display
stabil
yope
level
lack
yope
inactiv
accompani
pronounc
cytotox
effect
infect
cell
interestingli
strain
stabil
yope
show
reduc
pathogen
mous
model
infect
comparison
wild
type
yersinia
colon
liver
spleen
delay
diminish
enter
infect
mice
strain
importantli
stabil
yope
associ
reduc
transloc
yop
cultur
yersiniainfect
cell
yope
known
regul
minim
size
yersinia
transloc
pore
propos
increas
intracellular
yope
impair
effici
transloc
yop
effector
indic
enterocolitica
exploit
host
ubiquitin
proteasom
system
destabil
yope
increas
antihost
activ
yop
concomitantli
yersinia
virul
streptococcu
pyogen
group
streptococci
ga
import
human
pathogen
caus
broad
spectrum
diseas
rang
mild
superfici
infect
invas
ill
high
mortal
morbid
rate
abil
ga
caus
differ
diseas
varieti
human
tissu
reli
upon
highli
regul
express
variou
virul
gene
respons
differ
host
environ
infect
search
novel
virul
determin
gener
mutant
librari
ga
serotyp
thu
differ
random
mutagenesi
system
appli
compar
effici
one
tnspcbase
mutagenesi
system
use
gener
ga
mutant
bank
highthroughput
screen
construct
librari
togeth
clinic
isol
deriv
univers
hospit
rostock
target
mutant
strain
carri
identif
surfac
antigen
chang
express
level
polyclon
antibodi
direct
virul
factor
code
fct
fibronectincollagentantigen
mga
genom
region
use
screen
analysi
clone
array
process
data
mutant
modifi
signal
select
genet
studi
direct
sequenc
genom
dna
carri
identif
tnspc
integr
site
led
identif
interest
candid
among
strain
defici
signal
protein
well
protein
involv
cell
envelop
biogenesi
dnaprotein
synthesi
studi
reveal
protein
contribut
pathogenesi
pyogen
moreov
detect
clinic
isol
unregul
express
fibronectinbind
protein
interestingli
associ
skin
infect
even
though
skin
isol
preval
collect
intestin
pathogen
escherichia
coli
import
etiolog
agent
worldwid
caus
broad
spectrum
diseas
especi
develop
countri
diarrhoea
repres
major
public
health
problem
mainli
affect
children
age
five
diarrhoeagen
e
coli
classifi
seven
major
pathotyp
due
virul
factor
profil
pathogenesi
includ
enteropathogen
e
coli
epec
atyp
enteropathogen
e
coli
atec
enterohaemorrhag
e
coli
ehec
shiga
toxinproduc
e
coli
stec
enterotoxigen
e
coli
etec
enteroinvas
e
coli
eiec
enteroaggreg
e
coli
eaec
develop
specif
onestep
multiplex
pcr
mpcr
differenti
identif
intestin
pathogen
e
coli
isol
techniqu
proven
reliabl
tool
examin
virul
factor
profil
potenti
diarrhoeagen
e
coli
strain
isol
patient
live
paulo
brazil
total
isol
patient
investig
via
mpcr
major
strain
harbour
virul
factorencod
gene
assign
eaec
pathotyp
addit
identifi
member
almost
pathogroup
isol
current
character
term
virul
factor
express
profil
effect
tissu
cultur
cell
focu
actin
cytoskeleton
invas
secret
locu
enterocyt
effac
lee
effector
protein
group
perform
transcript
profil
differ
type
model
infect
candida
albican
sampl
oral
caviti
hivposit
patient
model
base
reconstitut
human
oral
epithelium
infect
human
blood
infect
liver
mice
analys
genomewid
gene
express
c
albican
analysi
obtain
transcriptom
data
reveal
high
number
upregul
gene
infect
process
besid
previous
describ
well
character
infectionassoci
gene
larg
number
gene
encod
protein
unknown
function
hypothesis
upregul
gene
might
play
import
role
initi
persist
c
albican
infect
silico
analysi
identifi
set
candid
gene
associ
infect
process
chosen
characteris
begun
systemat
disrupt
gene
homozygot
mutant
alreadi
obtain
number
mutant
gener
shown
alter
hostpathogen
interact
properti
particular
delet
gene
highli
upregul
interact
blood
cell
tissu
invas
display
significantli
reduc
damag
oral
epitheli
endotheli
cell
reduc
surviv
presenc
human
immun
effector
cell
order
elucid
possibl
function
infectionassoci
unknown
function
gene
sever
silico
vitro
analys
perform
bioinformat
analysi
identifi
put
small
heat
shock
domain
predict
protein
sequenc
gene
mutant
shown
sensit
thermal
oxid
membraneperturb
stress
therefor
name
gene
blood
induc
stress
overal
result
describ
novel
candida
albican
gene
involv
stress
adapt
host
pathogen
interact
j
batzilla
j
heesemann
rakin
max
von
pettenkoferinstitut
lmu
muenchen
germani
zoonot
agent
yersinia
enterocolitica
caus
sever
diarrhoea
human
enterocolitica
serogroup
preval
serogroup
raw
pork
report
case
europ
rise
global
relev
genom
highlyvirul
american
serogroup
biotyp
alreadi
sequenc
use
avail
draft
genom
european
isol
serogroup
biotyp
biotyp
genom
comparison
reveal
biotyp
serogroup
specif
differ
sequenc
use
biotypeserotyp
marker
goal
identifi
reason
stronger
nich
adapt
nevertheless
also
higher
abil
emerg
worldwid
pathogen
enterocolitica
serogroup
main
differ
concern
presenc
prophag
lipopolysaccharid
gene
cluster
absenc
complet
plastic
zone
strain
howev
even
singl
gene
absent
either
european
american
strain
may
defin
virul
pattern
respect
biotyp
includ
autotransport
toxin
well
hypothet
protein
focu
develop
panyersinia
pathoarray
diagnost
purpos
final
version
pathoarray
includ
bioand
serogroup
specif
sequenc
also
distinguish
two
highli
pathogen
yersinia
pseudotuberculosi
pesti
moreov
sequenc
virulenceassoci
gene
ad
character
pathogen
isol
human
pathogen
streptococcu
pyogen
respons
varieti
diseas
rang
mild
superfici
infect
skin
mucos
membran
pharynx
sever
invas
andor
toxic
infect
orchestr
express
subset
differ
virul
factor
respons
pathogen
identifi
novel
virul
factor
mutant
librari
serotyp
gener
use
transposonbas
mutagenesi
system
tnspc
system
character
modifi
version
within
suicid
vector
experi
transposit
effici
reveal
high
frequenc
integr
random
insert
event
far
mutant
serotyp
serotyp
gener
screen
mutant
relev
phenotyp
virul
establish
system
base
solid
media
plate
supplement
subleth
dosag
oxid
stress
substanc
msb
menadionesodiumbisulfit
defibrin
sheep
blood
serotyp
could
show
sensit
grow
msbsagar
reveal
suscept
substanc
neg
case
observ
tnspc
mutant
sensit
msb
msb
haemolyt
activ
miss
second
round
screen
perform
select
neg
mutant
andor
msb
sensit
mutant
confirm
phenotyp
addit
agar
plate
increas
concentr
colistinsulph
antimicrobi
peptid
includ
interestingli
observ
correl
resist
colistinsulph
furthermor
found
one
mutant
resist
high
concentr
colistinsulph
msb
sequenc
tnspc
insert
site
current
underway
identifi
affect
gene
molecular
characteris
gene
blaa
ampc
yersinia
enterocolitica
em
schriefer
j
heesemann
max
von
pettenkof
institut
lmu
muenchen
muenchen
germani
yersinia
enterocolitica
biovar
poss
two
chromosom
encod
gene
ampc
blaa
sever
studi
clinic
isol
characteris
regard
blaa
class
constitut
broad
spectrum
penicillas
ampc
class
c
induc
cephalosporinas
studi
gene
inactiv
use
red
recombinas
system
bacteriophag
lambda
homolog
recombin
use
linear
pcr
product
singl
delet
mutant
doubl
delet
mutant
characteris
vitro
compar
enterocolitica
wa
wildtyp
strain
mic
minimum
inhibitori
concentr
defin
antibiot
concentr
result
determin
ampicillin
enterocolitica
wildtyp
mutant
wildtyp
strain
resist
ampicillin
wherea
expect
doubl
delet
mutant
highli
sensit
ampc
delet
mutant
behav
almost
wildtyp
blaa
delet
mutant
almost
doubl
delet
mutant
differ
ampicillin
resist
observ
presenc
virul
plasmid
pyv
effect
ampicillin
resist
betalactamas
mutant
experi
mutant
test
mous
infect
model
compar
wildtyp
strain
aim
experi
elucid
discrep
betalactam
antibiot
resist
enterocolitica
vivo
vitro
scavizzi
et
al
staphylococcu
epidermidi
normal
constitu
healthi
human
skin
microflora
also
lead
caus
sever
infect
hospit
preterm
newborn
immunocompromis
patient
diseaseassoci
isol
shown
previous
capabl
form
biofilm
medic
devic
mostli
mediat
presenc
icaadbc
operon
carri
multipl
copi
staphylococc
element
well
differ
type
sccmec
cassett
confer
resist
oxacillin
mlst
analysi
reveal
major
isol
belong
limit
number
close
relat
icaposit
epidermidi
clone
obvious
widespread
variou
hospit
set
aim
studi
investig
presenc
molecular
epidemiolog
put
pathogen
epidermidi
clone
neonat
intens
care
unit
understand
skin
colonis
process
newborn
multiresist
biofilmform
isol
present
studi
confirm
prior
result
icaand
mecaposit
epidermidi
clonal
lineag
spread
among
patient
staff
moreov
found
great
varieti
novel
scc
type
among
con
suggest
role
bacteria
evolut
novel
resist
trait
staphylococci
find
indic
healthcar
associ
epidermidi
infect
mainli
caus
rang
success
epidem
clonal
lineag
multipl
select
factor
includ
virul
antibiot
resist
capac
detect
broad
varieti
sccmec
cassett
suggest
con
repres
genet
reservoir
background
ongo
evolut
novel
resist
determin
acid
product
human
strain
mutan
streptococci
ms
actinomyc
vitro
situ
aim
studi
measur
acidogen
acidur
ms
vitro
calcul
proportion
amount
acid
plaqu
situ
ms
plaqu
regio
repres
sampl
children
cohort
age
cohort
age
low
clr
high
cari
risk
chrcohort
dmf
isol
preval
determin
acid
product
nmol
h
min
mg
dri
weightnmol
strain
mutan
strain
odontolyticu
ao
naeslundii
determin
wash
bacteri
suspens
late
log
growth
repeat
titrat
experi
constant
ph
automat
titrat
system
radiomet
acidur
determin
ph
ms
produc
ph
nmol
median
produc
ao
signific
lower
amount
acid
sm
produc
ph
comparison
ph
acid
product
decreas
ao
clr
chr
preval
ms
could
estim
preval
chr
total
amount
acid
dental
plaqu
higher
clr
hypothet
amount
acid
dental
plaqu
clr
result
amount
ms
lower
chr
acid
decreas
acid
ms
increas
result
substanti
extens
cari
ecolog
hypothesi
relat
dynam
chang
phenotypicgenotyp
properti
plaqu
bacteria
demineralizationreminer
balanc
cari
process
lactobacilli
lb
consid
secondari
invad
exist
cariou
lesion
specialist
cari
progress
aim
studi
character
preval
lb
speci
differ
stage
cari
progress
soft
hard
dentin
sampl
collect
decidu
molar
stepwis
n
onestep
n
cari
treatment
month
temporari
fill
lb
identifi
select
physiolog
biochem
characterist
ratio
lacticacid
isom
electrophoret
mobil
lacticacid
dehydrogenas
shotgun
mass
map
maldi
mass
spectrometri
lb
isol
soft
dentin
sampl
preval
lb
hard
dentin
collect
cari
excav
reach
week
temporari
fill
month
temporari
fill
mean
total
bacteri
count
cfu
soft
dentin
x
hard
dentin
cari
excav
x
cfu
calcul
x
cfu
x
cfu
x
cfu
found
percentag
lactobacilli
cfu
lb
posit
dentin
sampl
cariou
dentin
five
lb
speci
identifi
l
paracasei
ss
paracasei
l
paracasei
ss
toleran
l
rhamnosu
l
gasseri
l
alimentariu
l
rhamnosu
l
paracasei
ss
paracasei
occur
cari
progress
stage
speci
found
sporad
l
paracasei
ss
paracasei
l
rhamnosu
might
specialist
lb
cariou
progress
genet
determin
pseudomona
aeruginosa
biofilm
develop
difior
r
fischer
establish
bacteri
biofilm
surfac
complex
process
requir
variou
factor
consecut
development
step
report
screen
pseudomona
aeruginosa
nonredund
transposon
insert
mutant
librari
mutant
exhibit
alter
biofilm
phenotyp
analys
capabl
mutant
form
latestag
biofilm
bottom
plate
use
autom
confoc
laser
scan
microscop
uncov
genet
determin
reduc
enhanc
biofilm
product
respect
overal
identifi
mutant
affect
within
gene
encod
hypothet
protein
indic
novel
development
pathway
like
dissect
futur
nevertheless
common
theme
emerg
analysi
gene
predict
function
establish
biofilm
requir
regulatori
compon
involv
surviv
microaerophil
growth
condit
arginin
metabol
ph
homeostasi
dna
repair
system
trimer
autotransport
adhesinbartonella
adhesin
bada
play
decis
role
infect
b
hensela
bada
construct
modularli
consist
head
domain
long
repetit
neckstalk
modul
membran
anchor
domain
analyz
function
particular
bada
domain
detail
gener
bada
delet
mutant
highli
desir
howev
slow
growth
b
hensela
limit
tool
genet
manipul
establish
recombin
express
system
bada
mutant
e
coli
allow
function
analysi
certain
bada
domain
therefor
use
truncat
bada
mutant
lack
neckstalk
modul
bada
exchang
addit
ii
bada
signal
sequenc
e
coli
ompa
signal
sequenc
iii
bada
membran
anchor
yersinia
adhesin
yada
membran
anchor
iv
exchang
modul
use
set
express
vector
construct
clone
sever
e
coli
express
strain
analyz
biolog
function
badahybrid
protein
express
hybrid
protein
form
monom
trimer
detect
via
immunoblot
fluoresc
microscopi
herein
use
e
coli
strain
express
badahybrid
protein
cell
surfac
although
quantit
differ
detect
first
function
analysi
reveal
e
coli
express
bada
hybridprotein
adher
endotheli
cell
less
b
hensela
wildtyp
howev
differ
collagenbind
visibl
compar
e
coli
control
strain
experi
use
recombinantli
express
badamut
allow
investig
badamedi
bacteriahost
cell
interact
greater
detail
loss
cellular
potassium
common
trigger
mapk
activ
vcc
slo
hlya
poreform
toxin
pft
produc
gramposit
gramneg
bacteria
often
import
virul
factor
pathogen
secret
watersolubl
monom
bind
target
cell
oligomer
form
membranepenetr
pore
howev
pft
heterogen
group
made
sever
distinct
structur
class
mammalian
cell
evolv
surviv
program
cope
potenti
lethal
threat
membran
perfor
among
defens
process
mapk
assum
pivot
role
promot
cell
surviv
activ
pft
attribut
osmot
stress
membran
pore
format
also
disturb
ionhomeostasi
reinvestig
issu
inde
prevent
potassium
efflux
strongli
inhibit
activ
cell
attack
aureu
vibrio
cholera
cytolysin
member
famili
pyogen
streptolysin
cdcfamili
e
coli
hlya
rtxfamili
known
hlya
slo
membran
pore
format
induc
calciuminflux
provok
differ
cellular
respons
like
cytokin
synthesi
apoptosi
demonstr
influx
calcium
requir
activ
toxin
furthermor
activ
respons
slo
independ
data
suggest
loss
potassium
decis
trigger
activ
respons
pft
staphylococcu
epidermidi
lead
caus
implantassoci
infect
surfac
colon
crucial
depend
biofilm
format
repres
key
virul
mechan
epidermidi
kda
accumul
associ
protein
aap
mediat
intercellular
adhes
biofilm
format
proteolyt
process
exposur
repetit
domain
b
order
function
intercellular
adhesin
aap
domain
b
must
interact
surfac
structur
neighbour
cell
therefor
aim
studi
identifi
aap
domain
b
ligand
involv
intercellular
adhes
end
use
recombin
aap
domain
b
affin
purifi
bind
partner
crude
prepar
epidermidi
surfac
protein
amongst
candid
mass
spectrometri
identifi
protein
far
unknown
function
refer
aap
associ
staphylococcu
epidermidi
adhesin
aastra
aastra
kda
protein
possess
ntermin
export
motiv
lack
homolog
protein
known
function
analysi
interact
use
recombin
protein
solid
phase
elisa
ligand
blot
experi
valid
specif
aap
domain
b
aastra
interact
addit
independ
aap
aastra
bound
staphylococc
cell
surfac
induc
bacteri
aggreg
biofilm
format
data
suggest
aastra
bona
fide
intercellular
adhesin
aastra
widespread
clinic
signific
epidermidi
isol
catheterrel
blood
stream
prosthet
joint
infect
moreov
aastraspecif
antibodi
detect
sera
patient
infect
relat
aastraposit
epidermidi
isol
indic
aastra
produc
vivo
conclus
identifi
novel
cell
surfac
protein
involv
epidermidi
biofilm
format
potenti
contribut
implant
associ
infect
gramneg
bacterium
legionella
pneumophila
major
caus
communityand
hospitalacquir
pneumonia
infect
lung
macrophag
well
epitheli
cell
multipli
intracellularli
call
replic
stage
switch
transmiss
form
capabl
host
cell
damag
prepar
new
infect
cycl
factor
contribut
first
step
host
cell
infect
ie
adhes
invas
high
extent
unknown
therefor
aim
investig
natur
novel
legionella
adhes
invas
factor
design
lafa
express
highli
upregul
transmiss
phase
bacteria
howev
show
signific
protein
homolog
therefor
seem
legionellaspecif
protein
l
pneumophila
lafaknockout
mutant
show
reduct
invas
adhes
macrophag
epitheli
cell
recombinantli
express
purifi
protein
rais
polyclon
antibodi
first
locat
protein
investig
present
supernat
cell
pellet
interestingli
size
cellassoci
form
kda
correl
gene
size
lafa
protein
cultur
supernat
howev
show
kda
protein
suggest
process
transloc
bacteri
cell
known
type
lss
type
ii
lsp
type
iva
lvh
type
ivb
doticm
l
pneumophila
secret
system
respons
export
therefor
screen
mutant
reduc
lafa
secret
potenti
uncov
determin
import
export
regul
underway
n
meningitidi
induc
endotheli
cell
detach
matrix
cleavag
occludin
role
activ
schubertunkmeir
h
slanina
c
konrad
f
czapek
hebl
frosch
institut
hygien
und
mikrobiologi
germani
crucial
step
pathogenesi
bacteri
mening
interact
endotheli
cell
underli
bloodbrain
barrier
bbb
studi
analyz
physiolog
morpholog
properti
human
brain
microvascular
endotheli
cell
line
hbmec
exposur
n
meningitidi
infect
hbmec
n
meningitidi
result
increas
permeabl
prolong
time
infect
parallel
n
meningitidi
induc
progress
detach
hbmec
underli
matrix
detach
trigger
caspaseindepend
manner
resembl
anoiki
special
mode
apoptosi
induct
adher
cell
lose
contact
extracellular
matrix
strikingli
endotheli
detach
accompani
increas
matrix
metalloproteinas
mmp
activ
supernat
collect
infect
cell
injuri
hbmec
monolay
increas
mmp
activ
requir
direct
cell
contact
detach
increas
mmp
activ
seen
bacteria
place
transwel
membran
addit
infect
cell
releas
cellcellcontact
detail
analysi
reveal
disappear
tight
junction
protein
occludin
cell
peripheri
result
cleavag
lowers
protein
infect
hbmec
occludin
cleavag
attribut
proteolysi
mediat
activ
abrog
activ
abolish
product
occludin
cleavag
fragment
remain
occludin
locat
cell
peripheri
moreov
inhibit
mmp
activ
could
partial
prevent
detach
infect
hbmec
restor
bbb
permeabl
togeth
data
highlight
mmp
play
crucial
role
bbb
pathophysiolog
meningococc
mening
sole
target
subendotheli
basement
membran
ecm
also
alter
tight
junction
compon
identif
character
legionella
pneumophila
hemolysin
k
seipel
e
siegbrecht
flieger
fg
bakteriel
infektionen
robert
kochinstitut
wernigerod
germani
legionella
pneumophila
pathogen
first
describ
caus
agent
possess
varieti
secret
cellassoci
cytolyt
enzym
includ
phospholipas
proteas
potenti
contribut
pathogenesi
studi
aim
identifi
novel
virul
determin
capabl
host
cell
damag
relat
secret
regul
factor
therefor
screen
two
transposon
mutagen
clone
librari
l
pneumophila
strain
corbi
mutant
differ
hemolyt
lipolyt
proteolyt
activ
total
number
clone
strain
screen
detect
mutant
differ
hydrolyt
activ
strain
corbi
found
clone
alter
hydrolyt
properti
screen
mutant
one
mutant
strongli
impair
hemolyt
lipolyt
proteolyt
activ
identifi
knockout
mutant
zinc
metalloproteas
known
contribut
hemolysi
proteolysi
also
lipolysi
via
enzym
activ
insert
analysi
locat
transposon
novel
potenti
virulenceassoci
gene
exampl
protein
involv
aromat
amino
acid
synthesi
select
mutant
analyz
abil
hydrolyz
lipid
well
intracellular
infect
human
environment
host
cell
evalu
impact
affect
gene
virul
l
pneumophila
twenti
year
discoveri
bi
cyclic
digmp
cdigmp
come
recogn
ubiquit
second
messeng
bacteria
cdigmp
regul
number
cellular
function
like
motil
express
virul
factor
biofilm
format
cellular
cdigmp
level
tightli
regul
control
synthesi
degrad
cdigmp
mediat
diguanyl
cyclas
contain
conserv
ggdef
domain
phosphodiesteras
contain
conserv
eal
domain
respect
ggdef
eal
domain
often
fuse
transmembran
andor
signal
input
domain
therebi
cdigmp
link
environment
stimuli
adapt
answer
bacteri
cell
howev
littl
known
molecular
detail
cdigmp
signal
network
date
type
cdigmp
effector
molecul
known
among
pilz
domain
protein
protein
contain
rxxd
motif
first
identifi
alloster
site
product
feedback
inhibit
isit
mani
diguanyl
cyclas
aim
work
identif
character
cdigmp
bind
protein
opportunist
pathogen
pseudomona
aeruginosa
use
cdigmp
coupl
sepharos
isol
cdigmp
bind
protein
analyz
mass
spectrometri
seven
put
candid
identifi
among
other
one
protein
pilz
domain
one
contain
degener
ggdefmotif
isit
motif
rxxd
one
identifi
protein
ggdefeal
domain
protein
current
overexpress
purifi
test
enzym
activ
vitro
addit
phenotyp
correspond
mutant
analyz
order
reveal
cellular
function
protein
illumin
detail
cdigmp
signal
pathway
aim
better
understand
role
cdigmp
virul
one
side
persist
farr
growth
phase
depend
transcript
regul
neisseria
meningitidi
transcript
regul
essenti
process
bacteri
growth
adept
vari
environment
condit
character
express
function
transcript
regul
farr
fatti
acid
resist
regul
neisseria
meningitidi
nm
close
relat
neisseria
gonorrhoea
ng
farr
respons
bacteri
resist
longchain
fatti
acid
palmit
acid
enabl
ng
surviv
mucos
surfac
rich
harm
compon
though
meningococc
farrhomologu
show
high
structur
accord
experi
illustr
meningococc
resist
fatti
acid
depend
farrregul
mechan
analys
growth
behaviour
nm
capsul
knockout
complement
mutant
strain
perform
western
blot
analysi
whole
cell
lysat
observ
similar
growth
behaviour
significantli
higher
express
farr
late
exponenti
phase
level
pora
continu
express
protein
determin
comparison
one
properti
farr
nm
direct
bind
promot
region
adhesin
nada
farabencod
efflux
pump
base
result
gener
minim
bind
sequenc
screen
genom
possibl
bind
pattern
ascertain
whether
gene
direct
control
farr
accomplish
emsa
electrophoret
mobil
shift
assay
howev
direct
proteindnainteract
observ
lead
conclus
bind
farr
regulatori
site
specif
process
summari
say
farr
nm
growth
phase
depend
transcript
regul
respons
fatti
acid
resist
ng
gain
control
gene
regul
specif
character
escherichia
coli
asymptomat
bacteriuria
abu
drive
success
silent
colon
urinari
tract
infect
uti
seriou
diseas
affect
peopl
worldwid
often
caus
uropathogen
e
coli
uti
usual
accompani
symptom
bladder
colon
e
coli
howev
also
asymptomat
ie
asymptomat
bacteriuria
abu
one
wellstudi
abu
strain
e
coli
howev
abu
strain
remain
uncharacter
research
therefor
aim
describ
abu
strain
collect
term
virul
trait
colon
mechan
host
interact
genotyp
phenotyp
experi
studi
reveal
major
abu
isol
belong
major
phylogenet
lineag
carri
mani
virulenceassoci
gene
uropathogen
e
coli
strain
howev
resembl
commens
e
coli
suggest
major
abu
strain
evolv
former
pathogen
variant
lost
abil
induc
signific
mucos
immun
respons
nevertheless
consider
fraction
abu
isol
repres
nonpathogen
commens
e
coli
thu
altern
bacteri
colon
strategi
differ
host
suscept
seem
exist
enabl
variant
effici
colon
bladder
without
symptom
although
mani
abu
isol
carri
gene
code
virul
trait
contribut
symptomat
infect
trigger
host
respons
lost
abil
function
express
virulenceassoci
gene
due
genom
delet
point
mutat
dna
rearrang
result
indic
abu
e
coli
isol
repres
phylogenet
heterogen
group
like
evolv
classic
uropathogen
strain
reduct
genom
evolut
disabl
express
function
virulenceassoci
determin
may
result
success
urinari
tract
colon
without
activ
local
system
inflammatori
respons
pathway
helicobact
pylori
induc
ecadherin
cleavag
disrupt
epitheli
layer
c
weydig
b
hoy
g
carra
g
schneider
wessler
junior
research
group
paulehrlichinstitut
langen
germani
institut
cell
biolog
neurosci
goetheunivers
frankfurt
germani
gastric
epithelium
repres
import
barrier
pathogen
one
architectur
key
player
ecadherinmedi
adher
junction
respons
epitheli
strength
adher
junction
connect
actin
cytoskeleton
neighbour
epitheli
cell
via
homophil
interact
transmembran
protein
ecadherin
howev
helicobact
pylori
hp
develop
strategi
destroy
epitheli
barrier
support
gastriti
ulcer
lymphoma
gastric
cancer
howev
detail
mechan
epitheli
layer
disrupt
well
understood
experi
demonstr
infect
hp
induc
drastic
loss
ecadherinmedi
intercellular
adhes
infect
cell
detect
hpmediat
inhibit
intercellular
adhes
aggreg
assay
use
polar
cell
find
underlin
determin
transepitheli
electr
resist
ter
monitor
decreas
epitheli
barrier
function
hpinfect
cell
within
hour
postinfect
observ
statist
signific
decreas
ter
strongli
declin
hour
infect
hp
function
detect
shed
ecadherin
ectodomain
supernat
infect
cell
western
blot
analys
led
disrupt
intercellular
adhes
fact
observ
hp
enter
intercellular
space
cell
confoc
microscopi
studi
summari
conclud
ecadherin
cleavag
import
step
hp
pathogenesi
allow
hp
pass
epitheli
layer
reach
new
nich
gastric
tract
adapt
novel
immunomagnet
isol
method
analyz
chlamydia
pneumonia
interact
protein
chlamydia
pneumonia
cpn
oblig
intracellular
bacteri
pathogen
develop
within
membran
bound
vacuol
term
inclus
inclus
membran
defin
interfac
pathogen
host
cell
intracellular
replic
critic
learn
composit
inclus
membran
ist
format
chlamydi
growth
order
understand
molecular
mechan
earli
cpn
infect
therefor
develop
novel
techniqu
investig
direct
protein
interact
chlamydia
host
cell
recent
novel
techniqu
isol
endocyt
vesicl
contain
magnet
label
receptorligand
complex
report
key
characterist
techniqu
gentl
mechan
homogen
plasma
membran
follow
magnet
separ
label
organel
subsequ
allow
biochem
detect
compartmentcontain
protein
adapt
method
analyz
direct
proteinprotein
interact
cpninfect
host
cell
use
fac
analysi
could
show
cpn
success
label
biotinyl
lipid
effici
infect
epitheli
cell
investig
confoc
microscopi
coloc
chlamydi
lp
lipidlabel
cpn
confirm
pi
first
attempt
seper
chlamydi
cytoplasm
fraction
use
streptavidin
magnet
bead
abl
isol
label
cpn
use
magnet
chamber
pi
earli
endosom
marker
could
detect
strongli
magnet
chlamydi
fraction
nonmagnet
cytoplasm
fraction
conclus
data
indic
chlamydialhost
interact
appropri
analyz
use
novel
immunomagnet
chlamydia
isol
method
defin
chlamydialhost
interactom
find
suitabl
target
therapeut
intervent
earli
chlamydi
infect
focu
ongo
studi
isol
character
novel
complement
regulatoracquir
surfac
protein
lyme
diseas
spirochet
borrelia
spielmanii
interact
distinct
member
factor
h
protein
famili
well
complement
factor
hrelat
protein
elucid
ligand
affin
blot
elisa
bind
cfh
demonstr
three
homolog
wherebi
one
molecul
bind
complement
regul
addit
cfh
maintain
cofactor
activ
factor
imedi
inactiv
bound
compar
sequenc
analysi
three
bind
nonbind
homolog
identifi
four
conserv
amino
acid
residu
potenti
involv
cfh
bind
howev
replac
three
amino
acid
residu
affect
bind
contrast
substitut
arginin
complet
abrog
bind
effect
strongli
point
essenti
role
residu
interact
cfh
character
advanc
understand
molecular
aspect
complex
natur
hostpathogen
interact
contribut
persist
b
spielmanii
complement
regul
factor
h
mediat
two
step
uptak
mechan
streptococcu
pneumonia
host
epitheli
cell
v
agarw
pf
zipfel
luo
hammerschmidt
abteilung
genetik
der
mikroorganismen
greifswald
greifswald
germani
depart
infect
biolog
leibniz
insitut
natur
product
research
infect
biolog
institut
jena
germani
pneumococc
surfac
protein
c
pspc
key
virul
factor
streptococcu
pneumonia
mediat
adhes
host
cell
promot
immun
evas
host
complement
previous
shown
human
immun
complement
regul
factor
h
bind
pspc
interact
contribut
pneumococc
adher
invas
host
cell
show
factor
h
facilit
two
step
mechan
pneumococc
invas
host
epitheli
cell
inhibit
experi
demonstr
pneumococc
adher
via
bacteri
bound
factor
h
requir
carboxytermin
glycosaminoglycan
bind
site
name
short
consensu
repeat
scr
presenc
small
molecular
weight
glycosaminoglycan
heparin
dermatan
sulphat
also
specif
bind
mab
factor
h
mediat
pneumococc
adher
host
epitheli
cell
significantli
reduc
howev
host
cell
surfac
receptor
essenti
factor
h
promot
ingest
pneumococci
host
cell
block
experi
use
candida
albican
protein
shown
interact
integrin
significantli
reduc
number
invas
bacteria
without
affect
pneumococc
adher
conclus
show
factor
h
mediat
pneumococc
invas
two
step
mechan
involv
host
polyanion
surfac
moiti
integrin
receptor
shiga
toxinproduc
escherichia
coli
respons
cours
diseas
asymptomat
carriag
uncompl
diarrhea
bloodi
diarrhea
lifethreaten
hemolyticurem
syndrom
hu
shiga
toxin
stx
bind
glycosphingolipid
gsl
globotriaosylceramid
globotetraosylceramid
endotheli
cell
repres
high
low
affin
receptor
stx
respect
gsl
assum
locat
primarili
supramolecular
membran
assembl
exoplasm
leaflet
plasma
membran
bind
microdomainassoci
stx
receptor
follow
receptormedi
endocytosi
linchpin
stxcaus
cellular
injuri
order
investig
structur
stx
receptor
ii
qualit
quantit
distribut
differ
type
microdomain
examin
gsl
composit
dissemin
gsl
detergentresist
membran
microdomain
isol
without
deterg
differ
endotheli
cell
line
refloat
insolubl
microdomain
fraction
obtain
sucros
densiti
gradient
ultracentrifug
detect
stx
receptor
distribut
differ
type
gslenrich
microdomain
demonstr
effect
microdomain
stx
receptor
function
disrupt
structur
specif
perform
viabil
assay
cell
cultur
hypothes
mainli
microdomainassoci
stxreceptor
mediat
effici
retrograd
transport
stx
endotheli
cell
case
receptor
plasma
membran
associ
microdomain
toxin
may
degrad
lysosom
abrog
ist
cytotox
action
analysi
membran
microdomain
particularli
characterist
gsl
constitu
help
us
better
understand
initi
stxreceptorinteract
molecular
mechan
may
underli
stxmediat
endotheli
cell
injuri
type
iv
pili
filament
appendag
found
larg
number
pathogen
nonpathogen
bacteria
play
import
role
process
microcoloni
format
adher
eukaryot
cell
biofilm
format
dna
uptak
far
type
iv
pili
describ
human
enteropathogen
yersinia
enterocolitica
previous
identifi
transmembran
transcript
regul
pypb
control
express
virulenceassoci
hrep
proteas
enterocolitica
pypb
gene
locat
directli
upstream
flptad
operon
code
typeiv
pili
mediat
tight
adher
bacteria
could
show
pypb
induc
transcript
flp
operon
respons
type
ivlik
pilu
product
regul
locat
directli
upstream
flptad
operon
specif
enterocolitica
bacteria
harbor
operon
similar
regul
could
detect
use
rtpcr
could
show
gene
compos
flp
operon
arrang
one
transcript
unit
includ
pypb
northern
blot
analysi
togeth
flplacz
transcript
fusion
identifi
addit
promotor
upstream
flp
indic
presenc
transcript
termin
directli
downstream
flp
studi
pili
biosynthesi
use
western
blot
analysi
abl
proof
flp
express
pypb
overproduct
whole
cell
extract
detect
process
flp
supernat
pypb
overproduct
also
lead
flpdepend
microcoloni
format
type
iv
pili
product
howev
detect
pili
electron
microscopi
difficult
might
correspond
vari
matur
flp
nterminu
enterocolitica
compar
pili
bacteria
shiga
toxin
stx
produc
escherichia
coli
stec
caus
diarrhea
hemorrhag
coliti
human
sometim
follow
potenti
fatal
complic
like
neurolog
damag
hemolyticurem
syndrom
hu
stx
produc
intestin
caus
vascular
damag
specif
target
tissu
brain
kidney
result
system
complic
way
stx
enter
circul
transport
gut
target
organ
clarifi
yet
stx
bind
transport
circul
blood
cell
current
discuss
therefor
investig
express
stx
glycosphingolipid
gsl
receptor
globotriaosylceramid
globotetraosylceramid
four
leukocytederiv
cell
line
repres
monocyt
granulocyt
b
lymphocyt
stxreceptor
analyz
thinlay
chromatographi
immunodetect
subsequ
sensit
toward
stx
investig
use
commerci
avail
cytotox
assay
monocyt
cell
line
express
presenc
lack
characterist
featur
b
cell
descend
importantli
cell
granulocyt
descend
lack
globoseri
gsl
result
cytotox
assay
consist
find
viabil
monocyt
cell
line
b
cell
descend
decreas
treatment
stx
wherea
granulocyt
cell
line
remain
resist
upon
stx
exposur
due
lack
stxreceptor
granulocyteand
cell
deriv
cell
line
seem
rather
unlik
granulocyt
cell
could
act
transport
stx
target
endotheli
cell
human
vasculatur
work
fund
graduiertenkolleg
grk
deutsch
forschungsgemeinschaft
outer
membran
protein
opc
form
molecular
bridg
integrin
interact
result
cytoskelet
remodel
uptak
bacteria
postul
src
famili
protein
tyrosin
kinas
ptk
play
crucial
role
process
studi
show
src
ptk
activ
respons
opc
express
n
meningitidi
respons
isogen
opcdefici
mutant
strain
inhibit
src
ptk
activ
gener
tyrosin
kinas
inhibitor
genistein
specif
src
inhibitor
reduc
opcmedi
invas
human
brain
microvascular
endotheli
hbmec
human
embryon
kidney
cell
hek
moreov
overexpress
cellular
src
antagonist
ctermin
src
kinas
csk
also
significantli
reduc
n
meningitidi
invas
src
ptkdefici
fibroblast
impair
abil
internalis
n
meningitidi
show
reduc
phosphoryl
cytoskeleton
decreas
develop
stress
fibr
bacteria
bind
induc
tyrosin
phosphoryl
sever
host
protein
includ
fak
src
substrat
cortactin
taken
togeth
data
demonstr
src
famili
ptk
especi
src
protein
among
import
signal
protein
respons
transfer
signal
activ
integrin
cytoskeleton
thu
mediat
endocytosi
n
meningitidi
brain
endotheli
cell
n
hirschhausen
f
g
peter
c
heilmann
institut
medic
microbiolog
univers
hospit
germani
microbi
genet
univers
hospit
germani
staphylococcu
aureu
among
frequent
isol
pathogen
nosocomi
infect
abil
invad
human
cell
consid
major
reason
extrem
difficult
erad
aureu
infect
use
classic
antibiot
approach
interact
aureu
fibronectinbind
protein
fnbp
integrin
seem
repres
predomin
aureu
intern
mechan
nonprofession
phagocyt
howev
aureu
strain
lack
function
fnbp
still
intern
certain
degre
report
impact
major
aureu
peptidoglycan
hydrolas
atl
attach
intern
nonprofession
phagocyt
mean
elisabas
adher
assay
observ
recombin
atl
effici
bind
immobil
human
fibronectin
fn
eahi
cell
furthermor
suffici
inhibit
aureu
intern
eahi
cell
dosedepend
manner
reveal
flow
cytometri
intern
atldefici
aureu
strain
significantli
reduc
perform
pulldown
assay
subsequ
mass
spectrometri
identifi
respect
host
cell
receptor
atl
heat
shock
cognat
kda
protein
refer
surfaceloc
shown
involv
viru
cell
entri
viru
tissuespread
well
brucella
abortu
intern
preincub
eahi
cell
antibodi
rais
lead
reduct
aureu
intern
wherea
aureu
adhes
cell
affect
result
suggest
aureu
atl
specif
interact
host
cell
interact
repres
novel
aureu
intern
mechan
staphylococcu
aureu
adhesin
eap
emp
requir
staphylococc
adher
human
suprastructur
matrix
fragment
skin
cartilag
staphylococcu
aureu
adher
extracellular
matrix
critic
first
step
aureu
pathogenesi
mediat
multipl
adhesin
overlap
function
role
adhesin
collagen
bind
protein
cna
fibronectin
bind
protein
fnbp
alreadi
well
establish
wherea
function
secret
protein
eap
extracellular
adher
protein
emp
extracellular
matrix
bind
protein
less
clear
investig
interact
eap
emp
monomolecular
matrix
macromolecul
human
skin
cartilag
suprastructur
use
aureu
newman
neg
cna
express
function
fnbp
isogen
singl
mutant
doubl
mutant
character
clinic
isol
demonstr
emp
import
eap
mediat
aureu
bind
extracellular
matrixmolecul
fibronectin
fibrinogen
collagen
howev
adhesin
emp
eap
effici
bind
suprastructur
cartilag
skin
fragment
furthermor
result
suggest
adhesin
essenti
contribut
aureu
adher
extracellular
matrix
result
support
hypothesi
eap
emp
import
adhesin
aureu
diseas
deep
tissu
infect
osteomyel
could
possibl
target
therapeut
intervent
staphylococcu
aureu
sa
opportunist
pathogen
abil
caus
acutefulmin
well
chronicpersist
diseas
sa
lead
caus
superfici
deep
skin
infect
frequent
associ
nonheal
wound
initi
attach
sa
skin
mediat
number
wallbound
adhesin
well
secret
protein
secret
expand
repertoir
adhes
molecul
seram
famili
includ
extracellular
adher
protein
eap
eap
shown
exhibit
particularli
broad
spectrum
activ
includ
immunomodul
antiangiogen
function
interf
rasrafmekerk
cascad
recent
observ
demonstr
eap
intern
endotheli
cell
mediat
uptak
sa
order
find
whether
eap
similar
effect
skin
cell
investig
ist
impact
erkphosphoryl
sa
intern
keratinocyt
observ
extracellular
eap
effect
intern
hacat
keratinocyt
cell
fraction
proteinas
protect
assay
indic
upon
releas
endosom
compart
protein
local
freeli
within
cytosol
moreov
incub
hacat
cell
eap
suppress
growth
factor
stimul
phosphoryl
indic
eap
might
interfer
prolifer
differenti
keratinocyt
interestingli
preincub
hacat
cell
eap
found
substanti
increas
intern
aureu
keratinocyt
signal
extracellular
eap
might
promot
spread
pathogen
within
host
conclus
find
eap
uptak
keratinocyt
conjunct
ist
prove
effect
epitheli
cell
signal
intern
sa
provid
new
aspect
pathomechan
intim
involv
etiolog
sa
dermal
infect
eap
target
intervent
may
therefor
provid
novel
avenu
prevent
treatment
staphylococc
skin
diseas
bacteri
defensin
resist
protein
mprf
consist
separ
domain
lipid
lysinyl
antimicrobi
peptid
repuls
c
ernst
krau
bayer
peschel
staphylococcu
aureu
major
human
pathogen
achiev
resist
cation
antimicrobi
peptid
camp
modifi
anion
phosphatidylglycerol
posit
charg
llysin
result
repuls
camp
lysinyl
mediat
mprf
peschel
et
al
j
expm
transmembran
protein
predict
consist
transmembran
helic
ctermin
cytosol
part
inactiv
mprf
result
loss
lysylphosphatidylglycerol
lpg
increas
inactiv
campproduc
neutrophil
kristian
et
al
infect
immun
attenu
virul
product
lpg
depend
phosphatidylglycerol
lysyltrna
staubitz
et
al
fem
precis
mechan
lpg
biosynthesi
unknown
analyz
strain
express
mprf
truncat
point
mutat
highli
conserv
amino
acid
show
mprf
bifunct
protein
consist
synthas
domain
mediat
phospholipid
lysinyl
flippas
domain
confer
antimicrobi
peptid
resist
well
daptomycin
resist
analysi
variant
mprf
might
lead
new
insight
mechan
lpg
synthesi
transport
outer
leaflet
cell
membran
could
also
help
understand
daptomycin
resist
ultim
character
mprf
may
help
find
inhibitor
mprf
would
render
great
number
bacteri
pathogen
suscept
human
host
defens
could
help
combat
multipl
resist
lpg
produc
bacteria
aureu
pseudomona
aeruginosa
enterococcu
faecali
detail
studi
shown
intermedi
resist
vancomycin
caus
accumul
mutat
confer
increment
increas
resist
interestingli
presenc
antibiot
seem
creat
environment
stress
bacteria
may
lead
induct
mutat
mechan
e
g
bacteri
so
respons
e
coli
induct
so
respons
cell
wall
inhibitor
demonstr
known
trigger
delocalis
element
favour
express
errorpron
polymeras
studi
resist
mechan
intermedi
vancomycin
resist
aureu
visa
strain
pair
strain
display
higher
resist
part
decreas
suscept
vancomycin
caus
insert
gene
tcaa
order
test
whether
presenc
antibiot
lead
mobilis
element
aureu
test
system
measur
transposit
frequenc
employ
system
compris
element
tag
erythromycin
marker
treatment
subinhibitori
concentr
clinic
relev
antibiot
ciprofloxacin
vancomycin
result
increas
transposit
frequenc
aureu
restor
rsbu
presenc
ciprofloxacin
current
transposit
frequenc
rsbumut
strain
strain
show
lower
sigmab
activ
investig
conclus
seem
correl
antibiot
stress
mobilis
staphylococcu
aureu
sa
major
human
pathogen
caus
invas
endovascular
infect
sa
produc
larg
arsen
virul
factor
includ
extracellular
adher
protein
eap
previous
show
eap
import
onset
sustain
endovascular
diseas
interfer
variou
aspect
saendotheli
cell
ec
interact
bacteri
adhes
intern
ec
prolifer
ec
signal
import
virul
factor
includ
hemolysin
result
releas
larg
amount
hemoglobin
approx
mm
per
lyse
erythrocyt
red
blood
cell
rbc
access
ironcontain
heme
otherwis
ironlimit
environ
consid
crucial
bacteri
prolifer
vivo
wherea
high
concentr
heme
degrad
product
toxic
thu
control
heme
releas
rbc
uptak
sa
tightli
regul
howev
hitherto
unknown
whether
endovascular
milieu
sa
exposur
heme
accompani
modif
express
virul
factor
eap
show
sa
strain
newman
low
concentr
hemin
oxid
form
heme
induc
upregul
eap
upregul
found
irrespect
observ
concentr
hemin
growth
rate
sa
alreadi
reduc
higher
concentr
hemin
found
almost
complet
suppress
growth
vitro
previous
shown
express
eap
critic
depend
sae
global
twocompon
regul
sa
exoprotein
virul
factor
express
sinc
hand
activ
sae
locu
known
induc
product
two
major
sa
hemolysin
seem
plausibl
organ
use
sae
regulatori
function
finetun
hemoglobin
releas
hla
hlb
well
express
eap
conclus
effect
heme
sa
eap
express
put
major
import
pathogenesi
endovascular
diseas
work
ongo
analyz
underli
mechan
particularli
role
sae
close
detail
pathogen
bacteria
genu
yersinia
modul
cell
function
transloc
six
effector
protein
yoph
p
e
host
cell
via
type
iii
secret
system
assess
effect
individu
yop
migrat
human
umbil
vein
endotheli
cell
huvec
employ
modular
built
yersinia
monosecret
mutant
found
singl
yop
inhibit
endotheli
cell
migrat
signific
degre
determin
reduct
veloc
cover
distanc
infect
cell
consequ
fulli
virul
yersinia
transloc
yop
highli
effect
block
endotheli
cell
migrat
low
bacteria
cell
ratio
approxim
bacteria
per
cell
wherea
effect
rho
gtpase
modul
yope
tyrosin
phosphatas
yoph
expect
effect
yopm
yopp
cell
migrat
surpris
order
independ
confirm
activ
recombin
yopm
yopp
protein
microinject
cell
furthermor
obtain
activ
profil
yop
determin
express
valu
three
specif
actin
structur
microspik
lamellopodia
stress
fibr
infect
uninfect
cell
min
h
initi
migrat
give
rise
six
paramet
yop
display
specif
activ
profil
wherebi
yope
h
strong
effect
mani
paramet
yopo
p
moder
effect
paramet
final
although
clearli
modul
cell
migrat
least
actin
reorganis
yopm
yopp
contrast
yope
h
inhibit
phagocytosi
yersinia
exclud
gener
effect
cytoskeleton
conclud
yop
influenc
cell
migrat
substrat
potenti
differ
mechan
cooper
yop
molecular
level
caus
extrem
effect
block
cell
migrat
need
elabor
futur
studi
kort
l
marlinghau
sg
gatermann
sakinc
institut
hygien
und
medizinisch
mikrobiologi
bochum
bochum
germani
staphylococcu
saprophyticu
speci
staphylococci
uropathogen
genom
saprophyticu
one
sequenc
staphylococci
posses
dserin
deaminas
enzym
convert
dserin
pyruv
ammonia
amino
acid
dserin
present
rel
high
concentr
human
urin
toxic
bacteriostat
sever
nonuropathogen
bacteria
mean
uncommon
abil
degrad
dserin
may
play
import
role
virul
uropathogen
shown
saprophyticu
grow
media
supplement
dserin
wherea
staphylococci
lack
gene
dserin
deaminas
like
aureu
epidermini
carnosu
test
wild
type
dsdaknockoutmut
gener
allel
replac
cocultur
experi
introduc
tet
plasmid
wild
type
allow
posit
select
strain
wild
type
specif
dsda
mutant
complement
mutant
test
cocultur
equal
cell
densiti
inocul
cfuml
presenc
absenc
dserin
mgml
everi
hour
approxim
gener
mix
popul
dilut
fresh
media
growth
check
cfu
everi
hour
approxim
gener
experi
proceed
least
two
week
gener
addit
gener
time
determin
strain
absenc
dserin
mutant
outcompet
wild
type
wherea
presenc
dserin
wild
type
advantag
compar
mutant
effect
specif
dserin
lserin
use
mutant
outcompet
wild
type
experi
indic
dserin
deaminas
confer
growth
advantag
presenc
dserin
wherea
absenc
mutant
advantag
neumann
b
klein
gatermann
sakinc
institut
hygien
und
mikrobiologi
bochum
bochum
germani
staphylococcu
saprophyticu
gram
posit
coagulaseneg
pathogen
staphylococcu
caus
urinari
tract
infect
young
women
hydrophob
abl
bind
fibronectin
laminin
collagen
hemagglutin
sheep
erythrocyt
surfac
protein
characteris
earli
past
serineaspart
repeat
protein
sdri
contain
longest
sd
repeat
region
describ
far
aa
lpxtgmotif
cell
wall
anchor
member
mscramm
protein
famili
show
typic
abb
domain
structur
sdri
believ
mediat
collagen
bind
hydrophob
sdri
knock
mutant
show
decreas
collagen
bind
reduc
hydrophob
cell
surfac
hydrophob
implic
pathogenesi
saprophyticu
infect
local
domain
respons
collagen
bind
hydrophob
within
sdri
complement
knock
mutant
differ
construct
sdri
lack
either
domain
b
domain
n
domain
sd
domain
complement
strain
saprophyticu
alreadi
test
use
elisa
collagen
type
icoat
microtit
plate
still
show
collagen
bind
compar
wildtyp
except
sd
mutant
therefor
necessari
conduct
test
collagen
bind
recombin
contain
sd
region
sinc
preliminari
result
indic
th
sd
repeat
region
involv
bind
collagen
would
first
describt
involv
bind
sd
repeat
region
sdr
protein
recent
found
aureu
intern
target
cell
like
import
step
cellular
surviv
membraneperfor
focus
fate
intern
toxin
fluoresc
microscopi
variou
time
point
toxin
intern
reveal
slowli
disappear
cell
use
intern
label
demonstr
porecomplex
fraction
monomersunst
oligom
return
target
cell
extracellular
environ
densiti
gradient
centrifug
follow
immun
electron
microscopi
mass
spectroscopi
westernblot
analys
led
conclus
regurgit
context
exosomallik
structur
term
toxosom
knowledg
first
account
dispos
target
cell
bacteri
toxin
sequenti
uptak
exocytosi
object
previous
shown
staphylococcu
aureu
sa
latestationari
growth
surviv
critic
depend
clpc
major
molecular
chaperon
clpc
provid
tricarboxyl
acid
tca
cyclemedi
profound
effect
global
gene
protein
express
pattern
chatterje
et
al
proteom
reduc
tca
cycl
activ
evidenc
thymidinedepend
small
coloni
variant
elev
acet
level
medium
due
loss
acet
consumpt
chatterje
et
al
j
bacteriol
hypothes
acet
acid
metabol
clinic
staphylococc
isol
may
accompani
late
stationari
surviv
persist
pattern
method
phenolr
dyebas
screen
cultur
acet
util
perform
select
strain
character
viabil
well
stationari
growth
acet
geneexpress
profil
result
screen
staphylococc
clinic
isol
sa
isol
display
high
ph
indic
regular
acet
consumpt
within
group
con
substanti
proport
low
ph
elev
acetateassoci
staphylococcu
epidermidi
se
isol
observ
strain
display
reduc
growth
viabil
conclus
non
acetatecatabol
clinic
strain
frequent
se
indic
larg
proport
se
impair
tca
cycl
prolong
surviv
find
potenti
major
implic
understand
staphylococc
persist
infect
oral
caviti
aerob
area
anaerob
nich
constant
temperatur
wet
condit
repres
perfect
habitat
multitud
bacteri
speci
grow
biofilm
structur
besid
physiolog
flora
biofilm
contain
sever
pathogen
respons
chronic
inflammatori
diseas
major
goal
project
elucid
complex
cohabit
biofilm
select
mutan
miti
intermediu
sanguini
salivariu
p
micra
p
gingivali
f
nucleatum
actinomycetemcomitan
repres
assort
oral
streptococci
anaerob
oral
pathogen
studi
architectur
mix
speci
biofilm
clsm
determin
actual
bacteri
number
fac
analysi
recent
construct
fluoresc
protein
express
vector
insert
investig
bacteria
use
fluorochrom
hcred
dsrm
eyfp
egfp
ecfp
clone
best
output
test
sever
promotor
preca
pgyra
taken
pyogen
ptet
pblaz
aureu
time
lap
movi
could
show
growth
biofilm
format
mutan
stabl
red
fluoresc
time
anoth
approach
studi
elucid
quorum
sens
via
biofilm
task
luxsmut
current
construct
mutant
clarifi
interspeci
commun
connect
develop
multispeci
biofilm
studi
reveal
growth
phase
speci
depend
releas
might
correl
find
transwel
analysi
could
show
chang
biofilm
mass
sever
bacteria
miti
obtain
new
luxsmut
success
sequenc
luxsregion
miti
intermediu
salivariu
complet
setup
allow
us
studi
structur
tempor
develop
oral
biofilm
commun
staphylococcu
aureu
sa
versatil
harm
pathogen
hospitaland
communityacquir
infect
intracellular
persist
import
strategi
immun
escap
sa
chronic
infect
howev
adhes
internalis
sa
may
differ
variou
cell
type
sa
strain
assay
address
phenomena
tend
cumbersom
facilit
analysi
report
new
flow
cytometr
assay
analysi
sa
adhes
internalis
result
fac
analysi
yield
substanti
differ
sagfp
adher
internalis
hff
eahi
howev
differ
also
found
low
high
cell
passag
especi
primari
cell
elev
adher
valu
alway
associ
augment
internalis
rate
suggest
adher
crucial
step
subsequ
internalis
prolong
incub
time
day
presenc
gentamicin
demonstr
timedepend
sa
elimin
howev
intracellular
longterm
persist
detect
cell
type
analys
thu
far
conclus
novel
fac
assay
prove
sa
adhes
intern
depend
type
nonprofession
phagocyt
investig
method
allow
investig
impact
specif
sa
factor
adhes
intern
use
mutant
librari
introduct
ro
mediat
carbonyl
protein
indic
protein
age
known
bacteri
speci
staphylococcu
aureu
sa
moreov
escherichia
coli
carbonyl
protein
cp
thought
detect
degradationresist
aggreg
state
sa
shown
latestationari
growth
surviv
critic
depend
chaperon
clpc
provid
tricarboxyl
acid
tca
cyclemedi
profound
effect
global
gene
protein
express
chatterje
et
al
proteom
therefor
hypothes
latestationari
growth
sa
protein
carbonyl
may
also
modifi
function
clpc
tca
cycl
activ
method
protein
prepar
sa
cell
harvest
h
h
protein
carbonyl
assay
monitor
use
carbonylationind
hydrazon
dnp
method
assay
coupl
proteom
analysi
identifi
specif
cp
use
lc
nanoesi
msm
result
contrast
e
coli
exponenti
h
latephas
h
grown
sa
contain
mainli
solubl
cp
furthermor
carbonyl
content
strain
increas
time
cultur
interestingli
clpc
mutant
exhibit
lower
level
carbonyl
content
compar
wt
albeit
similar
amount
total
aggreg
protein
addit
gel
electrophoresi
indic
differ
carbonyl
higher
wt
lower
clpc
mutant
specif
cp
band
detect
clpc
mutant
proteom
analysi
confirm
one
major
cp
import
tcacycl
enzym
conclus
first
studi
confirm
clpc
atpas
specif
involv
sa
oxid
carbonyl
regul
protein
qualiti
control
clpc
may
key
element
staphylococc
senesc
particularli
prolong
time
bacteri
life
encount
sessil
andor
persist
staphylococc
popul
first
shown
streptomyc
coelicolor
rex
sens
redox
state
cell
via
bind
nadh
nad
result
activationrepress
regul
lead
chang
express
profil
gene
involv
respir
virul
sitedirect
mutat
hemb
gene
staphylococcu
aureu
shown
result
electrondefici
mutant
display
smallcoloni
variant
scv
phenotyp
limit
data
avail
signific
rex
aureu
therefor
rex
rex
hemb
doubl
mutant
construct
aureu
background
character
strain
phenotyp
transcritpom
approach
well
murin
abscess
model
mutant
show
haemolysi
pigment
blood
agar
compar
parent
strain
significantli
differ
express
gene
compar
gene
significantli
downand
gene
upregul
two
import
global
regul
virul
agr
sara
found
significantli
downregul
result
decreas
express
virul
factor
includ
fibronectinbind
protein
b
extracellular
proteas
contrast
repressor
toxin
rot
found
slightli
upregul
doubl
mutant
show
slight
downregul
agr
lesion
abscess
model
evok
differ
significantli
appear
size
conclus
profound
interact
regul
anaerob
gene
virul
regul
agr
sara
observ
addit
chang
abil
coordin
regul
switch
aerob
anaerob
metabol
also
impair
abil
rex
mutant
form
abscess
murin
model
final
delet
rex
aureu
attenu
virul
might
repres
therapeut
target
vitro
infect
studi
tradit
conduct
cell
cultur
monolay
two
dimension
system
infect
simul
challeng
system
respect
pathogen
microorgan
limit
model
restrict
dimension
contrast
three
dimension
host
tissu
environ
differ
overal
cell
morpholog
mode
migrat
adhes
result
condit
publish
variou
eukaryot
cell
type
use
similar
condit
shown
yersinia
enterocolitica
prototyp
extracellularli
replic
pathogen
exhibit
uniqu
growth
behaviour
collagen
gel
resembl
vivo
coloni
format
infect
tissu
thu
establish
model
infect
studi
shed
new
light
interpret
insight
obtain
model
set
highli
flexibl
model
analysi
infecti
process
three
dimension
collagen
gel
allow
dynam
imag
interact
pathogen
bacteria
eukaryot
cell
use
confoc
laser
scan
microscopi
model
adapt
divers
cell
sourc
provid
profession
phagocyt
cell
line
leukocyt
isol
blood
precisioncut
tissu
slice
even
serv
live
cell
imag
infect
tissu
spleen
liver
intestin
preliminari
studi
perform
use
divers
enterocolitica
e
coli
aureu
strain
role
yersinia
outer
protein
yop
adhesin
infecti
key
event
could
success
visualis
present
first
result
contribut
differ
growth
state
enterocolitica
phagocytosi
migratori
behaviour
cell
death
primari
immun
cell
taken
togeth
model
valuabl
tool
reveal
cellular
process
cours
interact
immun
cell
bacteri
coloni
pneumococc
surfac
protein
c
pspc
major
virul
factor
adhesin
streptococcu
pneumonia
pneumococci
interact
polymer
ig
receptor
pigr
recent
shown
rho
famili
gtpase
akt
play
critic
role
pigrmedi
pneumococc
uptak
studi
relationship
pneumococc
ingest
host
cell
via
pspciniti
mechan
intracellular
calcium
signal
calcium
ion
ca
present
high
concentr
lung
fluid
play
major
role
maintain
host
cell
homeostasi
level
intracellular
calcium
ca
measur
load
pigrexpress
epitheli
cell
indoam
dye
follow
incub
paraformaldehyd
pfa
fix
pneumococci
recoveri
phase
incub
pfafix
wildtyp
pspcdefici
pneumococci
significantli
increas
ca
host
cell
pspcpigr
mediat
increas
ca
independ
phospholipas
c
pretreat
cell
phospholipas
cinhibitor
affect
increas
ca
use
addit
pharmacolog
inhibitor
demonstr
high
intracellular
calcium
level
neg
regul
pneumococc
ingest
host
cell
pretreat
epitheli
cell
baptaam
cell
permeabl
calcium
chelat
egta
ca
chelat
agent
significantli
increas
pneumococc
uptak
epitheli
cell
dosedepend
manner
contrast
host
cell
pretreat
thapsigargin
increas
ca
inhibit
ca
atpas
ermembran
demonstr
signific
reduct
uptak
importantli
use
inhibitor
alter
adher
pneumococci
host
cell
taken
togeth
data
suggest
put
defens
mechan
employ
host
cell
increas
intracellular
calcium
level
respons
pneumococc
infect
import
human
pathogen
enterohemorrhag
escherichia
coli
ehec
caus
spectrum
foodborn
intestin
diseas
rang
wateri
diarrhea
hemorrhag
coliti
case
infect
follow
hemolyt
urem
syndrom
similar
number
enter
bacteria
ehec
transloc
effector
protein
host
cell
via
type
iii
secret
system
ttss
effector
protein
ttss
encod
pathogen
island
term
locu
enterocyt
effac
lee
essenti
characterist
attach
effac
lesion
intestin
mucosa
ehec
infect
addit
larg
number
nonle
encod
type
iii
effector
identifi
one
nlea
nonle
encod
effector
encod
cryptic
induc
prophag
wide
distribut
among
pathogen
e
coli
aim
studi
character
regul
phageencod
nleavari
ehec
strain
order
visual
activ
nleapromot
replac
gene
luciferas
luc
report
sitedirect
mutagenesi
base
result
mutant
luc
construct
delet
mutant
lack
gene
protein
possibl
regulatori
function
express
nlea
therebi
found
signific
decreas
nleaexpress
mutant
delet
ler
grla
gene
contrast
signific
increas
nleaexpress
shown
complement
delet
mutant
respect
wildtyp
gene
analyz
mode
regul
ler
regul
gelshift
assay
establish
show
direct
bind
promot
region
nlea
summari
result
obtain
studi
support
thesi
integr
lermedi
regulatori
circuit
type
iii
effector
gene
streptococcu
mutan
gram
posit
commens
human
oral
caviti
major
caus
tooth
decay
dental
cari
also
caus
subacut
endocard
mutan
shown
bind
human
plasminogen
via
surfacebound
enolas
benefit
mutan
bind
host
plasminogen
investig
quantifi
host
protein
degrad
fibrin
dissolut
activ
host
plasmin
bound
bacteri
surfac
plasmin
promot
degrad
extracellular
matrix
protein
fibrinogen
fibronectin
demonstr
immunoblot
analysi
surfac
associ
plasmin
mutan
moreov
effici
degrad
vitro
gener
fibrin
aggreg
significantli
enhanc
bacteri
transmigr
fibrin
matrix
studi
two
chamber
infect
model
structur
analysi
mutan
enolas
xray
crystallographi
reveal
similar
homooctamer
assembl
shown
pneumococc
enolas
plasminogen
overlay
assay
indic
delet
two
ctermin
lysin
previous
propos
repres
plasminogen
bind
site
impair
plasminogen
bind
confirm
similar
result
pneumococc
enolas
surprisingli
delet
sequenc
fydngvyd
mutan
enolas
equival
intern
plasminogen
bind
site
fydkerkvyd
pneumonia
also
impair
plasminogen
bind
despit
overal
structur
homolog
two
protein
work
identifi
lysin
residu
involv
plasminogen
bind
mutan
enolas
current
progress
hertlein
v
sturm
k
ohlsen
p
jakob
institut
molekular
infektionsbiologi
germani
experimentel
physik
germani
recent
analys
staphylococc
virul
determin
predominantli
perform
vitro
project
studi
dynam
staphylococcu
aureu
infect
use
noninvas
vivo
magnet
reson
imag
mri
techniqu
high
field
mri
method
allow
identif
character
inflamm
monitor
staphylococc
infect
anim
longitudin
fashion
provid
full
data
set
high
spatial
resolut
excel
soft
tissu
contrast
first
investig
establish
muscl
abscess
mous
model
staphylococcu
aureu
sinc
local
infect
high
bacteri
number
optim
mri
protocol
optim
visual
local
size
infect
establish
mri
sinc
rather
sensit
earli
tissu
chang
caus
infect
approach
abl
detect
oedema
format
even
earli
stage
infect
addit
develop
new
imag
platform
fmri
show
potenti
backgroundfre
identif
imag
immun
cell
involv
inflamm
process
fmri
perform
vivo
label
immun
cell
perfluorin
carbon
pfc
exploit
mechan
phagocytosi
track
cell
host
migrat
via
f
mri
approach
abl
detect
accumul
f
mr
signal
side
infect
support
strong
evid
macrophag
activ
summari
even
earli
stage
develop
seem
mri
potenti
provid
new
insight
process
hostpathogen
interact
deliv
import
inform
evalu
futur
antiinfect
agent
kaim
et
al
radiolog
circul
bdhapatd
operon
involv
phb
metabol
virul
l
pneumophila
p
aurass
flieger
bakteriel
infektionen
robert
kochinstitut
wernigerod
germani
legionella
pneumophila
caus
agent
fatal
pneumonia
intracellular
parasit
eukaryot
cell
environ
colon
replic
amoeba
inhal
human
bacteria
infect
alveolar
cell
way
mechanist
similar
amoeba
infect
addit
legionella
doticm
type
ivb
protein
secret
system
ist
effector
sever
compound
essenti
hostcel
infect
exploit
search
novel
legionella
virul
factor
employ
new
screen
techniqu
allow
fast
screen
sever
thousand
clone
transposon
mutagen
legionella
librari
therebi
isol
clone
harbour
resist
cassett
within
bdhapatd
operon
analyz
locu
genet
function
recogn
ist
role
legionella
lipid
metabol
virul
toward
amoeba
macrophag
aurass
et
al
operon
encod
two
enzym
one
show
homolog
sinorhizobium
meliloti
dehydrogenas
bdha
patd
patatinlik
phospholipas
plp
famili
protein
present
data
show
l
pneumophila
bdha
possess
dehydrogenas
activ
lipid
granul
stain
fourier
transform
infrar
spectroscopi
ftir
experi
show
bdhapatd
knock
mutant
contain
increas
amount
phb
granul
therefor
operon
involv
util
storag
compound
remark
l
pneumophila
bdhapatd
mutant
infect
castellanii
amoeba
macrophag
uneffici
show
dramat
reduc
replic
host
cell
model
conclud
bdhapatd
operon
import
l
pneumophila
virul
show
first
time
direct
link
lipid
metabol
virul
l
pneumophila
rg
gerlach
link
sequenc
sada
salmonella
enterica
sv
typhimurium
typhimurium
encod
put
protein
homolog
trimer
autotransport
adhesin
like
yada
genu
yersina
sinc
yada
allow
invas
invasin
mutant
strain
bada
mediat
adher
extracellular
matrix
protein
want
know
whether
sada
express
function
typhimurium
might
effect
sada
overexpress
address
question
mutant
report
strain
construct
typhimurium
nctc
luciferas
report
fusion
sada
made
previous
publish
express
kinet
record
wildtyp
wt
background
well
strain
defici
ompr
hila
sira
rpo
order
overexpress
sada
put
promot
substitut
salmonella
pathogen
island
invfpromot
recombin
mutant
strain
result
strain
analyz
western
blot
wb
immunofluoresc
microscopi
use
sadapolyclon
serum
invas
assay
carri
previous
describ
polar
mdck
cell
linesexpress
analysi
show
averag
express
luciferas
fusion
fold
higher
sada
luc
construct
suggest
form
operon
compar
luciferas
fusion
within
siie
luc
promot
activ
still
fold
lower
late
logarithm
growth
phase
delet
mention
regul
molecul
result
higher
report
activ
compar
wt
background
min
lb
cultur
use
invfpromot
express
sada
band
kda
detect
wb
like
correspond
sada
monomerfoc
point
bacteri
surfac
could
detect
microscopi
structur
present
background
sada
mutant
wt
control
strain
howev
overexpress
sada
suffici
compens
loss
siie
invas
assay
inactiv
sada
result
signific
reduct
abil
invad
cell
line
result
indic
sada
express
similar
condit
like
encod
put
lipoprotein
could
play
role
sada
secret
still
unclear
sadaoverexpress
strain
noninvas
spite
sada
mutant
strain
show
reduc
invas
rate
one
could
interpret
result
siie
could
requir
initi
contact
sada
could
requier
later
step
invas
process
background
role
poreform
staphylococcu
aureu
toxin
pantonvalentin
leukocidin
pvl
sever
necrot
diseas
cloud
due
conflict
data
epidemiolog
studi
communityassoci
methicillinresist
aureu
camrsa
infect
murin
diseasemodel
method
use
neutrophil
differ
speci
evalu
cytotox
effect
pvl
comparison
staphylococc
cytolyt
compon
furthermor
studi
impact
pvl
product
express
pvl
heterolog
nonvirul
staphylococc
speci
appli
clinic
isol
includ
strain
pvlneg
mutant
find
demonstr
pvl
induc
rapid
activ
cytolysi
human
rabbit
neutrophil
murin
simian
cell
contrast
phenolsolubl
modulin
psm
newli
identifi
group
cytolyt
staphylococc
compon
lack
speciesspecif
product
pvl
staphylococc
strain
caus
rapid
prematur
cell
death
human
neutrophil
differ
physiolog
program
cell
death
neutrophil
follow
phagocytosi
degrad
virul
bacteria
interpret
taken
togeth
result
queri
infectionmodel
mice
nonhuman
primat
elucid
impact
pvl
data
clearli
demonstr
pvl
import
cytolyt
role
suscept
speci
includ
human
neutrophil
major
implic
pathogenesi
camrsa
infect
legionella
pneumophila
serogroup
strain
express
virulenceassoci
epitop
recogn
monoclon
antibodi
mab
dresden
panel
high
endem
relev
legionnair
diseas
airborn
transmiss
cool
tower
shower
involv
larg
bacteri
cluster
grow
pack
insid
protozoan
host
cell
eg
acanthamoeba
castellani
matter
studi
five
strain
explor
distinct
complex
lp
architectur
use
convent
confoc
laser
scan
microscopi
focuss
primarili
differ
strain
strain
four
differ
serogroup
character
use
antibodi
investig
growthphasedepend
examin
lpsepitop
quantit
elisa
four
ten
lpsepitop
three
differ
strain
found
signific
growthphas
depend
chang
lpsdensiti
bacteri
surfac
accord
aim
find
differ
examin
strain
abl
build
larg
particl
complex
spheric
lpsarchitectur
furthermor
observ
larg
bacteri
particl
particular
lpsstructur
appear
insid
cystform
amoeba
describ
differ
lpstype
bacteri
surfac
seem
variou
function
among
use
strain
indic
differ
quantiti
qualiti
form
larg
particl
therefor
suggest
abil
form
cluster
account
high
infecti
potenc
strain
mayb
high
hydrophob
properti
mab
recogn
epitop
enhanc
airborn
transmiss
assum
larg
cluster
pack
encyst
natur
host
cell
high
biocid
resist
staphylococcu
aureu
smallcoloni
variant
scv
repres
slowgrow
subpopul
frequent
involv
chronic
infect
recent
nonproteincod
rna
npcrna
found
act
key
regulatori
player
respons
environment
chang
far
npcrna
identifi
staphylococci
detect
mostli
comput
base
approach
sinc
growth
ratespecif
express
observ
bacteri
npcrna
identif
npcrna
candid
perform
appli
total
aureu
rna
isol
differ
growth
phase
isogen
clinic
strain
pair
display
normal
scv
phenotyp
two
separ
cdna
librari
construct
total
cdna
clone
randomli
sequenc
analys
blastn
databas
search
express
novel
npcrna
experiment
valid
confirm
northern
blot
analys
aureu
phenotypespecif
express
four
npcrna
found
three
identifi
novel
npcrna
specif
express
normal
phenotyp
one
npcrna
candid
origin
antisens
strand
alkalin
phosphatas
precursor
iii
phob
encod
gene
involv
inorgan
ion
transport
metabol
one
small
npcrna
candid
origin
antisens
strand
open
read
frame
hypothet
proteincod
gene
shown
specif
express
scv
phenotyp
novel
npcrna
growth
phasespecif
regul
scv
major
downregul
late
growth
phase
first
time
classif
npcrna
base
differenti
express
normal
scv
phenotyp
aureu
establish
thu
role
npcrna
might
assum
regul
diverg
phenotypeassoci
behaviour
metabol
aureu
intracellular
pathogen
legionella
pneumophila
complex
life
style
uptak
natur
host
cell
monocyt
follow
pregnant
paus
insid
phagosom
transmiss
infect
phenotyp
switch
replic
noninfect
type
sever
multipl
step
bacteria
motil
lyse
host
cell
abl
start
next
infect
cycl
respons
genom
element
describ
almost
detail
aim
studi
investig
delet
mutant
regulatori
element
differ
lp
express
compar
wild
type
test
strain
csra
flaa
flia
leta
milx
rposmut
strain
cultiv
liquid
media
exponenti
postexponenti
growth
phase
repres
replic
noninfect
phase
transmiss
infecti
phase
insid
host
cell
respect
cellwal
bound
shed
lp
test
elisa
quantif
six
differ
lpsepitop
express
serogroup
epitop
recogn
mab
well
mab
influenc
mutant
neither
cellwal
bound
shed
lp
phase
variabl
also
valid
assum
structur
essenti
bacteria
lp
carri
epitop
mab
phase
variabl
express
except
mab
lp
compon
shed
demonstr
fail
influenc
modul
earli
host
cell
phagosom
nevertheless
mab
overexpress
postexponenti
growth
phase
virulenceassoci
mab
phase
variabl
express
shed
compar
wild
type
concentr
lp
fivefold
higher
releas
lp
fraction
taken
togeth
lp
express
influenc
known
regulatori
gene
favourit
legionellalp
cofactor
virul
develop
staphylococcu
aureu
import
human
pathogen
endovascular
diseas
take
acut
destruct
cours
andor
develop
chronic
infect
high
relaps
rate
despit
good
activ
antimicrobi
substanc
vitro
infect
often
difficult
treat
might
due
complex
infect
process
endovascular
tissu
work
use
endotheli
cell
investig
impact
differ
aureu
strain
two
highli
virul
isol
laboratori
strain
cowan
defect
agrsystem
strain
equal
invas
endotheli
cell
found
intracellularli
larg
differ
abil
induc
inflammatori
respons
microarray
analysi
reveal
wildtyp
isol
upregul
huge
number
gene
includ
mani
gene
involv
innat
immun
contrast
cowan
fail
express
import
virul
factor
relat
agrsystem
toxin
enzym
induc
dramat
chang
endotheli
gene
express
agrdefect
strain
commonli
recov
colon
infect
might
repres
strategi
aureu
hide
intracellularli
without
provok
host
immun
system
result
relaps
infect
bam
complex
highli
conserv
multiprotein
machin
requir
assembl
barrel
outer
membran
protein
complex
compos
essenti
integr
outer
membran
protein
bama
formerli
four
accessori
lipoprotein
bamb
bama
bamd
essenti
yersinia
adhesin
yada
prototyp
new
class
nonfimbri
adhesin
trimer
auotransport
adhesin
consist
head
stalk
barrel
membran
anchor
play
major
role
pathogen
enter
pathogen
yersinia
enterocolitica
order
investig
role
bama
biogenesi
taa
express
yada
bamadeplet
strain
e
coli
result
degrad
yada
indic
bama
essenti
express
biogenesi
yada
bama
demonstr
recogn
cterminu
omp
exchang
nine
ctermin
amino
acid
yada
glycin
use
sitedirect
mutagenesi
mutat
posit
cterminu
yada
result
yada
degrad
e
coli
wildtyp
degrad
rescu
e
coli
mutant
strain
defici
degp
prepar
outer
membran
fraction
trypsin
degrad
assay
immunofluoresc
autoagglutin
studi
demonstr
yada
mutant
assembl
take
place
outer
membran
despit
action
degp
reduc
bama
recognit
protein
express
conclud
bama
essenti
biogenesi
yada
recogn
hydrophob
residu
especi
posit
also
posit
yada
cterminu
howev
taa
obvious
differ
recognit
pattern
bama
exist
compar
omp
phoe
monophas
multidrugresist
salmonella
enterica
serovar
strain
becam
novel
serotyp
germani
associ
larg
diffus
outbreak
increas
need
hospit
congener
strain
observ
outbreak
luxembourg
austria
singl
case
franc
strain
harbour
prophag
belong
mainli
phage
type
accord
anderson
phage
type
scheme
final
extens
similar
stm
genom
specif
size
fliaflib
intergen
region
base
pcr
method
describ
echeita
et
al
prompt
us
classifi
monophas
variant
typhimurium
variant
repres
isol
typhimurium
strain
germani
search
genom
differ
monophas
strain
close
relat
biphas
typhimurium
strain
result
detect
novel
kb
genom
island
within
thrw
trna
locu
exhibit
lower
gc
content
compar
genom
vs
multiplex
pcr
discrimin
free
prophag
occupi
island
contain
thrw
locu
reveal
presenc
island
test
strain
sequenc
analysi
identifi
potenti
open
read
frame
show
high
dna
similar
enterobacteri
phage
sequenc
sequenc
shigella
boydii
shigella
dysenteria
avian
pathogen
e
coli
protein
level
sever
high
similar
found
includ
integras
put
membran
dna
transfer
protein
well
put
transcript
activ
e
coli
furthermor
helicas
domain
acetylcholin
receptor
subunit
sh
dysenteria
phage
inject
protein
avian
pathogen
ecoli
phage
relat
protein
biolog
function
novel
island
respect
virul
investig
schulz
c
albertweissenberg
c
buchries
k
express
virul
factor
genet
link
express
flagellum
legionella
pneumophila
show
flagellin
flaa
altern
sigma
factor
flia
involv
invas
replic
legionella
host
cell
identifi
yet
known
regul
gene
flagellar
regulon
silico
analysi
show
high
homolog
gene
involv
flagellar
regulon
known
legionella
pneumophila
strain
nonpneumophila
strain
get
insight
regul
cascad
level
gene
protein
express
time
analyz
select
gene
via
revers
transcriptionpcr
via
western
blot
flia
also
involv
express
virul
trait
preliminari
studi
analys
gene
flia
regulon
addit
start
identifi
analys
regul
involv
express
flia
creat
mutant
fliadepend
gene
compar
flia
mutant
phenotyp
virul
factor
analys
urinari
tract
infect
uti
repres
major
health
problem
industri
countri
major
communityacquir
nosocomi
uti
human
caus
uropathogen
escherichia
coli
upec
crucial
step
initi
persist
infect
requir
attach
colon
microb
surfac
uroepitheli
tissu
medic
devic
e
g
cathet
antigen
surfacedisplay
autotransport
protein
frequent
express
nonpathogen
pathogen
e
coli
describ
mediat
autoaggreg
bacteri
cell
biofilm
format
howev
contrast
virul
factor
uro
pathogen
e
coli
role
pathogenesi
well
understood
henc
character
differ
variant
e
coli
commens
upec
isol
compar
structur
analyz
transcript
regul
studi
contribut
hostbacterium
interact
multipl
allel
frequent
found
pathogen
e
coli
nucleotid
sequenc
express
allel
may
variabl
indic
encod
protein
differ
function
contribut
adhes
eukaryot
cell
compon
extracellular
matrix
although
mani
variant
upec
promot
autoaggreg
biofilm
format
role
uro
virul
still
remain
elucid
face
irondefici
condit
host
bacteria
evolv
multifactori
strategi
scaveng
effect
growth
limit
factor
iron
secret
low
molecularweight
compound
call
siderophor
abl
bind
ferric
iron
highest
affin
constitut
crucial
virul
factor
host
pathogen
interact
sinc
upec
synthes
four
siderophor
differ
characterist
perform
transcript
analysi
investig
regulatori
interplay
siderophor
system
three
upec
role
model
strain
mean
realtim
pcr
assay
upec
grown
differ
environment
condit
obtain
transcript
profil
relev
iron
uptak
system
repres
gene
encod
iron
receptor
feed
assay
manipul
singl
iron
uptak
system
reveal
new
cooper
compensatori
activ
interestingli
transcript
level
catechol
siderophor
link
heme
uptak
wherea
yersiniabactin
system
strongli
connect
ferric
citrat
transport
stimul
one
singl
siderophor
system
result
strong
downregul
altern
iron
uptak
system
appli
condit
mimick
vivo
effect
specif
pathogenesi
urinari
tract
infect
eg
biofilm
format
discov
strong
upregul
fyua
iron
code
yersiniabactin
salmochelin
receptor
respect
mutant
gene
lead
signific
reduct
biofilm
format
vitro
vivo
analysi
upec
intracellular
bacteri
commun
show
upregul
iron
uptak
system
differ
transcript
profil
strain
work
highlight
heterogen
complex
regulatori
interplay
iron
uptak
system
upec
discov
addit
function
siderophor
relev
pathogenesi
urinari
tract
infect
apart
iron
acquisit
novel
gene
cluster
control
fatti
acid
composit
lipoteicho
acid
glycolipid
staphylococcu
aureu
n
fedtk
mader
peschel
medizinisch
mikrobiologi
und
hygien
germani
lipoteicho
acid
lta
compon
envelop
gramposit
bacteria
glycerolphosph
surfac
polym
embed
cell
membran
via
glycolipidanchor
diglucosyldiacylglycerol
howev
physiolog
role
remain
controversi
lack
ltadefici
mutant
recent
lta
gene
characteris
play
role
elongationprocess
glycerolphosph
subunit
lta
backbon
describ
novel
gene
cluster
seem
involv
lta
biosynthesi
analysi
columnpurifi
lta
reveal
differ
bind
characterist
compar
wild
type
lta
might
due
alter
structur
mutant
eg
fatti
acid
composit
anchor
moreov
microanalysisdata
point
toward
role
ltab
gene
fatti
acid
biosynthesi
identif
human
integrin
host
cell
receptor
neisseria
meningitidi
adhesin
nada
v
j
heesemann
n
ackermann
max
von
pettenkoferinstitut
lmu
germani
oligomer
coiledcoil
oca
adhesin
famili
compris
novel
class
nonfimbri
adhesin
consist
ntermin
head
stalk
form
coil
coil
highli
conserv
ctermin
membran
anchor
domain
prototyp
famili
trimer
lollipopshap
yersinia
adhesin
yada
recent
yadarel
adhesin
identifi
neisseria
meningitidi
isol
call
nada
also
demonstr
nada
mediat
cell
adhes
invas
howev
host
receptor
identifi
nada
yet
n
meningitidi
endow
sever
adhesin
pathogen
mice
use
enterocolitica
studi
role
nada
host
cell
interact
mous
pathogen
use
recombin
protein
lack
membran
anchor
human
integrin
express
cell
line
identifi
human
integrin
key
receptor
nada
farwesternblot
inhibit
assay
integrin
block
antibodi
demonstr
recombin
protein
bind
directli
specif
beta
subunit
human
integrin
adher
assay
encapsul
nadaposit
nadaneg
n
meningitidi
strain
integrin
express
cell
reveal
similar
cellassoci
indic
involv
addit
meningococc
adher
factor
contrast
full
length
nada
express
trimer
form
surfac
enterocolitica
mutant
shown
mediat
interact
human
integrin
express
cell
result
adher
intern
yersinia
result
demonstr
enterocolitica
suitabl
toolbox
system
analysi
adhes
properti
nada
reveal
human
integrin
function
import
receptor
nada
structur
domain
divers
evolut
trimer
autotransport
adhesin
p
szczesni
lupa
link
max
planck
insitut
entwicklungsbiologi
max
planck
gesellschaft
germani
bacteri
adhes
play
crucial
role
pathogenhost
interact
work
focus
mainli
one
class
adhesin
gramneg
bacteria
known
trimer
autotransport
adhesin
taa
gener
structur
taa
follow
headstalkanchor
architectur
head
primari
mediat
attach
autoagglutin
stalk
taa
seem
serv
spacer
allow
head
protrud
far
bacteri
cell
surfac
membran
anchor
betabarrel
pore
host
autotransport
function
abl
export
type
head
stalk
domain
cell
surfac
keep
anchor
outer
membran
taa
modular
natur
small
set
frequent
repetit
head
stalk
domain
basi
structur
function
divers
produc
interact
databas
dataa
includ
annot
domain
properti
crystal
larg
number
repres
domain
eg
sada
salmonella
thyphimurium
bada
bartonella
hensela
solv
structur
head
domain
involv
fibronectin
bind
pathogen
organ
must
constantli
modifi
virul
determin
face
adapt
host
defens
simpli
preserv
statu
quo
case
taa
variabl
made
possibl
highli
repetit
natur
gene
facilit
recombin
enabl
combinatori
reshuffl
larg
number
equival
modul
presum
lead
divers
taa
observ
proteobacteria
tschumi
c
nai
auchli
p
hunzik
p
gehrig
p
keller
grau
p
sander
medizinisch
mikrobiologi
zurich
switzerland
function
genom
center
univers
zurich
zurich
switzerland
lipoprotein
gramneg
gramposit
bacteria
carri
thioether
bound
diacylglyceryl
differ
fatti
acid
amidebound
group
univers
conserv
cystein
escherichia
coli
ntermin
acyl
catalyz
nacyltransferas
lnt
use
e
coli
lnt
queri
blastp
search
identifi
put
lnt
gene
also
mycobacteria
mycobacterium
tuberculosi
lipoprotein
lppx
heterolog
express
mycobacterium
smegmati
nacyl
ntermin
cystein
wherea
lppx
express
smegmati
lnt
aph
knockout
mutant
access
ntermin
sequenc
western
blot
analys
truncat
tag
form
lppx
indic
smaller
size
kda
lnt
aph
mutant
compar
parent
strain
malditoftof
analys
lppx
prove
presenc
diacylglyceryl
modif
strain
parent
strain
lnt
aph
mutant
nacyl
found
smegmati
parent
strain
complement
lnt
aph
mutant
tuberculosi
restor
nacyl
substrat
nacyl
fatti
acid
two
fatti
acid
diacylglyceryl
residu
identifi
tuberculostear
acid
respect
demonstr
first
time
knowledg
mycobacteri
lipoprotein
triacyl
gene
respons
nacyl
smegmati
tuberculosi
open
read
frame
annot
tuberculosi
respect
fiedler
pritzschk
b
kreikemey
institut
medizinisch
mikrobiologi
virologi
und
hygien
rostock
rostock
germani
streptococcu
pyogen
group
streptococci
ga
import
human
pathogen
caus
wide
varieti
diseas
rang
mild
superfici
infect
skin
throat
life
threaten
system
invas
diseas
sequela
ga
equip
mani
virul
factor
allow
bacteria
infect
persist
within
host
cell
infect
ga
expos
differ
host
environ
chang
nutrit
condit
potenti
affect
central
metabol
bacterialik
lactic
acid
bacteria
lab
pyogen
gener
prefer
appli
energet
rather
ineffici
homolact
acid
ferment
pathway
atp
per
molecul
glucos
although
genom
encod
complet
enzymat
setup
mix
acid
ferment
atp
per
molecul
glucos
determin
impact
homolact
acid
ferment
growth
perform
virul
pyogen
compar
l
lactat
dehydrogenas
ldh
neg
mutant
correspond
wild
type
strain
knock
hardli
affect
growth
rate
nutrient
rich
media
led
mix
acid
ferment
result
strain
analysi
virulenceassoci
abil
ldhstrain
reveal
increas
biofilm
format
abil
decreas
adher
intern
human
keratinocyt
decreas
surviv
rate
human
blood
surviv
human
blood
could
restor
wild
type
level
ad
lactat
blood
sampl
human
serum
neither
ldh
knock
addit
lactat
caus
chang
bacteri
surviv
indic
impact
homolact
acid
ferment
cellular
compon
blood
result
show
homolact
acid
ferment
crucial
success
growth
ga
nutrient
rich
media
repres
advantag
surviv
human
blood
clearli
indic
direct
crosslink
central
metabol
pathogen
ga
chipchip
approach
uncov
cooper
target
bind
pseudomona
aeruginosa
rpo
quorum
sens
regul
lasr
rhlr
v
jensen
j
schmidt
bruchmann
r
geffer
pseudomona
aeruginosa
stationari
phase
altern
sigma
factor
rpo
govern
complex
regulon
channel
cellular
respons
sever
environment
stress
redirect
transcript
initi
sinc
rpo
also
control
quorumsens
gene
express
p
aeruginosa
aim
studi
elucid
interdepend
rpo
quorum
sens
regulatori
network
search
direct
rpo
target
promot
sequenc
perform
chromatin
immunoprecipit
coupl
p
aeruginosa
genom
microarray
chipchip
use
genomewid
approach
identifi
rpo
bind
site
high
reproduc
categor
target
sequenc
reveal
larg
subset
harbour
rpo
bind
sequenc
motif
andor
respect
downstream
gene
previous
shown
transcript
regul
rpo
howev
also
identifi
subset
target
lack
common
rpo
motif
bound
rpo
presenc
lasr
lasr
rhlr
sinc
lexabas
protein
interact
system
reveal
lasr
rpo
directli
interact
find
accommod
previou
model
complex
relationship
rpo
quorum
sens
also
open
window
elucid
transcript
regulatori
mechan
rpo
bacteri
pathogen
transcript
regul
highli
conserv
nevertheless
fulfil
diverg
function
relat
bacteria
show
marrlik
transcript
regul
farr
contribut
differ
lifestyl
neisseria
meningitidi
neisseria
gonorrhoea
close
relat
speci
highli
adapt
respect
human
host
nich
n
meningitidi
mainli
act
commens
rare
becom
invas
contrast
oblig
pathogen
n
gonorrhoea
demonstr
farr
mediat
fatti
acid
resist
n
gonorrhoea
present
n
meningitidi
bind
meningococc
farab
promot
region
howev
n
meningitidi
delet
farr
lead
fatti
acid
resist
analys
identifi
farr
repress
protein
n
meningitidi
absent
n
gonorrhoea
protein
meningococcu
specif
adhesin
vaccin
compon
nada
like
acquir
horizont
gene
transfer
use
electrophoret
mobil
shift
assay
prove
meningococc
farr
specif
bind
nada
promot
region
sixteen
base
pair
palindrom
repeat
present
farab
well
nada
promot
region
character
exact
bind
site
consensu
sequenc
establish
derepress
nada
result
significantli
higher
associ
mutant
strain
epitheli
cell
downregul
nada
express
may
enabl
n
meningitidi
keep
balanc
pathogen
nada
respons
adher
host
cell
immun
evas
repress
highli
immunogen
adhesin
might
administ
persist
infect
henc
farr
gain
control
meningococcu
specif
gene
involv
host
colon
thu
contribut
differ
nich
adapt
pathogen
neisseria
investig
chlamydia
trachomati
metabol
within
host
cell
nadh
fluoresc
lifetim
imag
szaszak
p
steven
w
solbach
g
j
seper
analyz
chlamydi
metabol
host
cell
render
imposs
due
oblig
intracellular
development
cycl
studi
present
novel
method
enabl
separ
analysi
host
cell
chlamydi
metabol
live
cell
use
nadh
fluoresc
lifetim
imag
flim
twophoton
microscopi
chlamydia
trachomati
infect
cell
character
metabol
activ
host
pathogen
nadh
key
cofactor
enzym
energi
product
suppos
import
chlamydi
inclus
host
cell
util
chlamydi
atp
synthesi
chang
nadh
fluoresc
lifetim
abund
shown
reflect
divers
protein
bind
nadh
therefor
indic
differ
nadhspeci
alter
metabol
found
mark
differ
nadh
fluoresc
lifetim
host
cell
intracellular
chlamydi
inclus
indic
uniqu
metabol
chlamydia
inhibit
mitochondri
respiratori
chain
complex
host
cell
decreas
metabol
also
chlamydia
accord
nadh
flim
data
interestingli
inhibit
mitochondri
complex
iii
differ
affect
intracellular
growth
progeni
chlamydia
thu
complex
inhibit
effect
size
chlamydi
inclus
recoveri
rate
reduc
complex
iii
inhibit
decreas
size
form
chlamydi
inclus
infecti
pathogen
specul
chlamydi
inclus
harbour
divers
nadhspeci
might
allow
select
target
chlamydi
energi
consumpt
prevent
intracellular
chlamydi
growth
genom
databas
provid
exhaust
annot
publicli
avail
eukaryot
eubacteri
archaeal
virral
genom
million
protein
broad
set
bioinformat
algorithm
particular
complet
sequenc
genom
refer
sequenc
collect
refseq
cover
pedant
process
pipelin
speed
order
magnitud
util
precalcul
similar
inform
store
similar
matrix
protein
simap
databas
ist
possibl
process
newli
sequenc
genom
immedi
becom
avail
provid
complet
annot
base
interpro
pedant
freeli
access
academ
user
http
pedantgsfd
expand
power
resourc
compar
way
choos
alreadi
avail
strain
pathogen
bacteria
coxiella
burnetii
causal
agent
q
fever
worldwidedistribut
zoonosi
gene
model
annot
refseq
organismn
rather
heterogeni
due
differ
group
detail
level
time
mask
region
thu
provid
new
set
help
new
excel
gene
model
predict
programm
prodig
top
automat
annot
protein
pedant
system
ortomcl
cluster
tcoffe
multipl
align
perform
studi
evolutionari
differ
next
standard
detect
secret
protein
typ
targetp
develop
new
bioinformat
tool
detect
secreat
protein
typ
iii
iv
also
high
potenti
pathogen
factor
coverag
al
pathway
syntheni
genom
region
compar
detail
graphic
extens
integr
gbrows
viewer
comper
genom
resourc
access
togeth
http
mipsgsfdegenreprojcbdb
role
intraspeci
recombin
spread
pathogen
island
within
escherichia
coli
speci
schubert
p
darlu
clermont
wieser
g
magistro
c
horizont
gene
transfer
key
step
evolut
bacteri
pathogen
besid
phage
plasmid
pathogen
island
pai
subject
horizont
transfer
transfer
mechan
pai
within
certain
bacteri
speci
differ
speci
still
well
understood
studi
focus
highpathogen
island
hpi
pai
wide
spread
among
extraintestin
pathogen
e
coli
serv
model
horizont
transfer
pai
gener
appli
phylogenet
approach
use
multilocu
sequenc
type
hpiposit
neg
natur
e
coli
isol
repres
speci
divers
infer
mechan
horizont
hpi
transfer
within
e
coli
speci
strain
partial
nucleotid
sequenc
hpiencod
gene
housekeep
gene
genom
backbon
well
dna
fragment
immedi
upstream
downstream
hpi
compar
reveal
hpi
sole
vertic
transmit
recombin
larg
dnafrag
beyond
hpi
play
major
role
spread
hpi
within
e
coli
speci
support
result
phylogenet
analys
experiment
demonstr
hpi
transfer
differ
e
coli
strain
fplasmid
mediat
mobil
sequenc
chromosom
dna
region
immedi
upstream
downstream
hpi
recipi
strain
indic
hpi
transfer
integr
togeth
hpiflank
dna
region
donor
strain
result
studi
demonstr
first
time
conjug
transfer
homolog
dna
recombin
play
major
role
horizont
transfer
pathogen
island
within
speci
e
coli
knauer
n
binai
wessler
junior
research
group
paulehrlich
institut
langen
germani
gastric
epithelium
repres
first
barrier
human
pathogen
helicobact
pylori
hp
causal
link
gastric
inflamm
neoplasia
invitro
hp
induc
drastic
epitheli
cell
migrat
impli
disintegr
mucos
epithelium
sinc
less
known
cellular
mechan
focuss
signal
network
lead
hpinduc
motogen
respons
pathogen
factor
caga
cytotoxinassoci
gene
hp
crucial
factor
host
cell
migrat
caga
inject
type
iv
secret
system
follow
tyrosin
phosphoryl
mediat
src
abl
kinas
phosphocaga
involv
regul
certain
actin
bind
protein
local
focal
adhes
mediat
contact
extracellular
matrix
cellular
actin
cytoskeleton
identifi
actin
bind
protein
vasp
vasodilatorstimul
phosphoprotein
import
signal
molecul
hpinduc
cell
migrat
previous
describ
bind
acta
protein
listeria
allow
effici
bacteri
propuls
cytoplasm
hpinfect
epitheli
cell
vasp
phosphocaga
local
focal
adhes
complex
mediat
contact
extracellular
matrix
actin
cytoskeleton
motil
cell
immunoprecipit
analys
reveal
cagadepend
induct
serinethreonin
phosphoryl
vasp
downregul
vasp
express
use
specif
sirna
overexpress
phosphorylationresist
vasp
mutant
block
epitheli
cell
elong
data
implic
coordin
role
tyrosin
phosphoryl
caga
vasp
regul
highli
dynam
focal
adhes
motil
epitheli
cell
yersinia
enterocolitica
multifunct
tool
analyz
effector
differ
bacteri
pathogen
n
ackermann
k
j
heesemann
max
von
pettenkof
institut
lmu
germani
cytoskeleton
regulatori
compon
common
target
infect
pathogen
bacteria
recent
effector
shigella
map
epec
ehec
assembl
one
singl
famili
small
gtpase
rhoa
mimick
protein
share
common
motif
wxxxe
construct
heterolog
protein
fusion
n
terminu
yope
gtpase
mimick
protein
gener
yersinia
specif
substrat
enterocolitica
wac
wac
harbour
plasmid
use
toolbox
get
insight
function
map
physiolog
context
compar
cell
transfect
studi
demonstr
mediat
inject
heterolog
mimet
protein
host
cell
function
cellular
rho
gtpase
pathway
membran
ruffl
stress
fibr
microspik
gener
rhoa
map
respect
indic
cellular
function
furthermor
promot
depend
invas
wac
wac
nonphagocyt
cell
contrast
prevent
intern
mediat
invasin
promot
depend
uptak
via
suggest
interfer
pathway
addit
simultan
mediat
inject
either
rhoa
cleav
yopt
also
suppress
bacteri
uptak
suggest
function
antagon
domin
yopt
effect
contrast
simultan
inject
yope
gap
activ
differ
ratio
result
competit
counter
effect
taken
togeth
yersinia
toolbox
use
studi
function
sole
bacteri
effector
differ
bacteri
speci
set
defin
genom
background
yersinia
v
agarw
hammerschmidt
abteilung
genetik
der
mikroorganismen
greifswald
greifswald
germani
streptococcu
pneumonia
commens
human
nasopharynx
abl
invad
mucos
respiratori
cell
pspc
pneumococc
surfac
protein
interact
polymer
immunoglobulin
receptor
pigr
promot
bacteri
adher
invas
epitheli
cell
intern
pneumococci
requir
coordin
action
actin
cytoskeleton
rearrang
retrograd
machineri
pigr
recent
shown
pigrmedi
pneumococc
entri
process
depend
cooper
activ
rho
famili
gtpase
akt
assess
role
protein
tyrosin
kinas
ptk
mitogenactiv
protein
kinas
mapk
pspcpigr
initi
adher
invas
show
especi
src
famili
ptk
extracellular
signalregul
kinas
erk
cjun
ntermin
kinas
jnk
essenti
pneumococc
invas
mitogenactiv
protein
kinas
mapk
involv
pharmacolog
inhibitor
ptk
mapk
respect
genet
interfer
src
ptk
function
caus
signific
reduct
pigrmedi
pneumococc
invas
addit
pneumococc
ingest
host
cell
induc
activ
jnk
agreement
activ
jnk
ist
target
molecul
dnabind
protein
cjun
activ
also
show
function
activ
src
ptk
essenti
activ
upon
pneumococc
infect
conclus
data
illustr
import
coordin
signal
src
ptk
jnk
pspcpigrmedi
uptak
pneumococci
host
epitheli
cell
chlamydia
trachomati
protein
target
small
gtpase
induc
reorgan
host
cell
actin
cytoskeleton
rho
gtpase
import
molecular
switch
crucial
function
innat
adapt
immun
target
sever
bacteri
cytotoxin
chlamydia
trachomati
genit
serovar
caus
sexual
transmit
diseas
encod
put
chlamydi
effector
protein
share
homolog
clostridi
glucosyl
toxin
cgt
cgt
glucosyltransferas
glucosyl
small
gtpase
rhora
famili
result
actin
reorgan
homolog
cgt
base
dxd
motif
essenti
glucosyltransferas
activ
cgt
demonstr
ectop
express
induc
reorgan
actin
cytoskeleton
hela
cell
similar
cgt
competit
studi
use
dxdmutant
provid
evid
share
common
substrat
common
function
toxin
b
clostridium
difficil
coexpress
glucosylationresist
constitut
activ
mutant
revert
morpholog
chang
induc
contrast
similar
mutant
rhoa
could
revers
effect
cytoskeleton
taken
togeth
result
indic
target
hostcel
regulatori
molecul
lead
like
glucosyl
inactiv
small
gtpase
reorgan
actin
cytoskeleton
aureu
archetyp
bacteri
pore
form
toxin
pft
key
virul
factor
secret
major
clinic
isol
aureu
toxin
monom
bind
target
cell
oligomer
form
small
pore
plasma
membran
contrast
sever
small
toxin
thought
remain
plasmamembran
target
cell
reach
intracellular
compart
commun
shown
microscopi
biochem
techniqu
cell
intern
aureu
pore
preporestag
dynamindepend
way
function
studi
suggest
uptak
toxin
essenti
step
cellular
recoveri
membran
perfor
rejman
lipinski
j
heymann
karla
tf
meyer
heuer
molekular
biologi
mpi
infektionsbiologi
berlin
germani
chlamydia
trachomati
acquir
essenti
nutrient
includ
sphingolipid
host
cell
precis
mechan
underli
transport
process
complet
understood
shown
previous
c
trachomati
infect
caus
fragment
golgi
apparatu
golgi
fragment
trigger
chlamydiadepend
truncat
golgi
matrix
protein
inhibit
process
specif
proteas
inhibitor
block
golgi
fragment
inhibit
bacteri
growth
sphingolipid
acquisit
furthermor
could
show
fragment
golgi
knockdown
giantin
infect
boost
chlamydia
progeni
data
indic
structur
ga
regul
chlamydia
propag
rab
protein
import
small
gtpase
control
golgi
structur
chlamydia
recruit
specif
rab
protein
inclus
therefor
hypothes
rab
protein
might
regul
chlamydiainduc
golgi
fragment
use
rna
interfer
approach
screen
rab
protein
inhibit
chlamydiainduc
golgi
fragment
interestingli
knockdown
two
rab
protein
regul
retrograd
transport
block
chlamydiainduc
golgi
fragment
furthermor
decreas
bacteri
replic
studi
indic
rab
protein
import
regul
chlamydi
propag
golgi
structur
yersinia
enterocolitica
ye
evad
immun
system
host
inject
yersinia
outer
protein
yop
via
type
three
secret
system
host
cell
studi
report
system
compris
hybrid
protein
fluoresc
stain
sensit
cleavag
use
track
yop
inject
cell
cultur
experiment
ye
mous
infect
model
cell
cultur
experi
use
sirna
inhibitor
demonstr
integrin
mediat
signal
rhogtpas
rhoa
crucial
yop
inject
demonstr
yop
transloc
process
need
activ
modul
host
cell
demonstr
infect
splenocyt
suspens
vitro
inject
yop
appear
occur
randomli
type
leukocyt
indic
detect
yop
inject
use
marker
bacteria
cell
interact
vivo
upon
infect
mice
highest
total
number
yopinject
cell
repres
b
cell
particularli
follicular
b
cell
follow
neutrophil
dendrit
cell
macrophag
suggest
distinct
cellular
tropism
ye
ye
public
grant
meningococc
hrpb
protein
identifi
integr
outer
membran
transport
tpsb
superfamili
mediat
secret
cognat
hrpa
protein
via
call
twopartn
secret
pathway
due
outer
membran
local
hrpb
protein
repres
potenti
target
host
immun
system
colon
diseas
shown
previous
analyz
collect
meningococc
carrier
isol
hrpb
gene
present
virtual
clonal
complex
n
meningitidi
contrast
hrpa
protein
display
consider
degre
ctermin
sequenc
variat
hrpb
protein
seem
highli
conserv
meningococc
strain
assess
whether
hrpb
protein
elicit
antibodi
respons
invas
infect
sera
patient
recov
meningococc
diseas
analyz
presenc
specif
antibodi
western
blot
purifi
hrpb
specif
igg
antibodi
could
detect
major
sera
analyz
identifi
epitop
immunodomin
region
within
hrpb
protein
peptid
microarray
slide
spot
overlap
peptid
cover
complet
hrpb
sequenc
probe
patient
sera
accord
threedimension
model
hrpb
structur
overlap
peptid
correspond
put
extracellular
loop
identifi
main
target
antibodi
respons
antibodi
direct
loop
detect
reconvalesc
sera
respect
whether
antibodi
target
meningococc
hrpb
protein
protect
invas
diseas
address
studi
object
cystic
fibrosi
cf
autosom
recess
disord
incid
caucasian
pseudomona
aeruginosa
predomin
bacteri
pathogen
cf
grow
within
hypox
biofilm
cf
lung
caus
chronic
infect
associ
inflamm
studi
investig
effect
hypoxia
activ
proinflammatori
transcript
factor
alveolar
epitheli
cell
respons
stimul
heat
inactiv
p
aeruginosa
method
lung
epitheli
cell
incub
heat
inactiv
p
aeruginosa
cfuml
minut
hour
atmospher
oxygen
follow
exposur
nuclear
cytosol
level
famili
member
target
gene
determin
immunoblot
result
incub
cell
heat
inactiv
p
aeruginosa
clearli
increas
nuclear
protein
level
manner
profoundli
amplifi
either
epitheli
cell
hypoxia
hypox
bacteria
stimul
innat
immun
alveolar
epitheli
cell
larg
mediat
three
tolllik
receptor
incub
cell
tolllik
receptor
specif
agonist
flagellin
increas
level
manner
also
amplifi
hypoxia
conclus
data
indic
microenvironment
hypoxia
major
determin
pulmonari
epitheli
inflammatori
respons
p
aeruginosa
infect
investig
signal
molecul
particip
respons
reveal
new
target
antiinflammatori
therapi
cystic
fibrosi
approx
case
per
annum
sepsi
septic
shock
main
caus
death
noncardiolog
intens
care
unit
germani
recent
year
new
concept
develop
regard
sepsi
traumat
patient
consequ
imbalanc
immun
system
hyperreact
state
later
result
anerg
compensatori
situat
eap
belong
new
group
secret
aureu
adhesin
seram
previous
shown
interfer
inflammatori
angiogen
respons
inhibit
leukocyt
recruit
block
rasactiv
effect
eap
inflammatori
respons
primari
endotheli
cell
monocyt
alon
combin
pamp
lp
lta
mdp
examin
abil
block
erkpathway
activ
found
particularli
interfer
fast
immun
respons
thu
express
procoagul
tissu
factor
approx
half
huvec
lpsstimul
pbmc
qrt
earli
pbmc
complet
block
lp
effect
hr
stimul
elisa
strongli
inhibit
eap
hand
respons
like
late
lpsstimul
pbmc
hr
hr
express
lpsstimul
huvec
pbmc
strongli
enhanc
doubl
qrt
proinflammatori
effect
may
due
crosslink
sensit
blockag
inhibitori
mab
inhibit
pathway
involv
endotoxintoler
huvec
irakm
synthesi
pbmc
taken
togeth
previou
observ
inhibit
leukocyt
adhes
transmigr
interfer
vascular
permeabl
increas
least
vitro
eap
effect
counteract
hyperreact
state
time
develop
anerg
compensatori
situat
could
attenu
vivo
studi
indic
test
antisept
potenc
protein
streptococcu
pneumonia
gramposit
pathogen
acquir
human
plasminogen
convert
host
plasminogen
activ
serin
proteas
plasmin
pneumococc
enolas
glycolyt
moonlight
enzym
major
plasminogen
bind
protein
locat
cytoplasma
also
associ
cell
surfac
pneumococci
addit
two
ctermin
locat
lysin
amino
acid
residu
intern
plasminogen
bind
motif
fydkerkvi
identifi
former
studi
pivot
plasminogen
bind
site
octamer
pneumococc
enolas
studi
effect
pneumococc
adher
host
cell
presenc
host
cell
bound
plasminogen
eukaryot
epitheli
endotheli
cell
bind
human
plasminogen
concentrationdepend
manner
analys
flow
cytometri
cell
cultur
infect
studi
pneumococc
adher
eukaryot
cell
significantli
increas
presenc
plasminogen
contrast
pneumococc
intern
eukaryot
cell
effect
plasminogen
plasminogenmedi
adher
pneumococci
host
cell
significantli
inhibit
lysin
amino
acid
analogu
epsilonamino
caproic
acid
eaca
suggest
role
lysin
bind
site
kringl
domain
plasminogen
moreov
synthet
peptid
repres
intern
plasminogen
bind
epitop
pneumococc
enolas
reduc
significantli
plasminogen
mediat
pneumococc
adher
host
cell
adher
pneumococc
mutant
produc
enolas
delet
lysin
residu
cterminu
significantli
reduc
compar
wildtyp
pneumococci
reduct
plasminogen
initi
adher
even
signific
pneumococci
produc
enolas
without
plasminogenbind
activ
result
demonstr
essenti
role
intern
plasminogen
bind
site
enolas
plasminogenmedi
adher
human
cell
clash
clone
distinct
geograph
distribut
emerg
subclon
francisella
tularensi
holarctica
germani
central
europ
e
seibold
e
zeman
wd
splettstoess
abteilung
immunologi
und
epidemiologi
institut
mikrobiologi
der
bundesewehr
germani
francisella
f
tularensi
holarctica
caus
agent
tularemia
endem
northern
hemispher
subdivid
biovar
biovar
ii
accord
erythromycinsuscept
recent
studi
reveal
spread
emerg
subclon
franc
spain
determin
possibl
spread
subclon
within
germani
test
f
holarctica
isol
germani
nearbi
countri
genoand
phenotyp
method
f
holarctica
isol
cover
virtual
endem
area
germani
isol
nearbi
countri
select
studi
type
isol
mlva
test
presenc
subclonespecif
delet
marker
convent
pcr
addit
rdna
sequenc
determin
isol
test
erythromycin
suscept
distinct
geograph
distribut
f
holarctica
isol
observ
isol
western
germani
consist
share
genet
characterist
delet
mlvatyp
francoiberian
subclon
erythromycinsensit
biovar
contrast
isol
northeast
germani
show
distinct
genet
characterist
delet
distinct
mlva
type
erythromycinresist
biovar
ii
addit
characterist
highli
correl
singl
nucleotid
substitut
rdna
sequenc
isol
interestingli
mix
f
studi
help
close
signific
gap
distribut
pattern
f
holarctica
europ
phylogent
studi
isol
germani
belong
francoiberian
subclon
shed
light
ist
origin
spread
high
correl
rdna
genotyp
erythromycin
resist
may
indic
direct
function
link
genet
marker
observ
phenotyp
klare
u
gering
c
fleig
w
witt
g
werner
infecti
diseas
robert
koch
institut
wernigerod
branch
wernigerod
germani
sever
ill
intens
care
immunocompromis
patient
risk
acquir
infect
facult
pathogen
e
faecium
furthermor
infect
multiand
vancomycinresist
isol
e
faecium
vre
increasingli
preval
among
german
hospit
patient
sinc
result
molecular
type
mlva
aflp
mlst
allow
differenti
isol
accord
ecolog
background
defin
hospitalacquir
e
faecium
haefm
significantli
often
isol
outbreak
cluster
infect
colon
worldwid
howev
method
mlva
aflp
mlst
timeconsum
labori
costintens
cheap
quick
reliabl
test
defin
haefm
isol
highli
desir
challeng
near
absenc
genom
knowledg
previou
studi
suggest
put
candid
marker
mani
distribut
among
haefm
esp
hyl
other
appear
allel
variant
complic
establish
pcror
hybridizationbas
test
acm
scm
genom
comparison
use
microarray
identifi
insert
element
exclus
distribut
among
test
clinic
e
faecium
favour
element
suitabl
marker
haefm
includ
hospitalacquir
vre
initi
test
efm
strain
clinic
commens
origin
confirm
excel
predict
valu
haefm
base
data
introduc
pcrbase
screen
sampl
sent
laboratori
enterococci
octob
may
efm
microbiolog
laboratori
german
hospit
test
isol
esp
hyl
vre
conclus
result
initi
studi
routin
screen
indic
wide
preval
haefm
clinic
case
germani
addit
preval
predict
vancomycin
resist
appear
exclus
among
haefm
clone
smallpox
outbreak
last
epidem
europ
w
bommer
tropenmedizinisch
beratungszentrum
tropenkrank
reisend
und
germani
year
old
muslim
priest
return
pilgrimag
mekka
medina
via
iraq
villag
provinc
kosovo
februari
next
day
arriv
fell
ill
fever
shiver
fatigu
visitor
rel
friend
eleven
fell
ill
day
fever
characterist
vesicular
erupt
bodi
took
day
diagnosi
smallpox
made
doctor
mekka
pilgrim
show
exanthema
revaccin
infect
one
year
later
person
kosovo
provinc
show
typic
erupt
got
sever
diseas
patient
die
travel
northern
yugoslavia
stay
one
day
kosovo
start
second
chain
infect
smallpox
outsid
kosovo
one
first
new
case
diagnos
penicillin
allergi
demonstr
sever
medic
doctor
student
unusu
exanthema
caus
penicillin
later
patient
die
hemorrhag
form
smallpox
infect
contact
person
die
last
epidem
smallpox
europ
tragic
requir
total
fatal
case
infect
person
film
show
impress
differ
clinic
stage
smallpox
diseas
well
campaign
epidem
final
outbreak
brought
end
burckhardt
maier
zimmermann
hygien
institut
heidelberg
heidelberg
germani
bruker
dalton
gmbh
bremen
germani
januari
decemb
klebsiella
pneumonia
produc
carbapenemas
isol
patient
univers
hospit
due
still
uncommon
resist
pattern
outbreak
suspect
confirm
subsequ
contain
ten
isol
outbreak
patient
one
patient
colonis
two
phenotyp
differ
isol
underw
type
pfge
addit
outbreak
isol
epidemiolog
unrel
k
pneumonia
isol
analys
malditof
ms
order
estim
util
outbreak
investig
contrast
pfge
malditof
ms
proteinbas
fast
cheap
addit
strain
easili
ad
analysi
later
stage
strain
cultiv
blood
agar
extract
formicacidethanol
method
seri
spectra
strain
gener
use
bruker
dalton
microflex
mass
spectromet
standard
softwar
packag
maldi
biotyp
three
type
analysi
perform
dendrogramm
gener
subtyp
composit
correl
index
three
method
correctli
differenti
outbreak
strain
epidemiolog
unrel
strain
howev
relationship
member
outbreak
group
differ
method
method
erad
measl
remain
import
somewhat
optimist
public
health
goal
conduct
studi
among
pupil
hassloch
rhineland
palatin
assess
knowledg
attitud
practic
regard
measl
vaccin
order
identifi
vaccinationgap
caus
structur
questionnair
cover
demograph
vaccin
statu
reason
nonvaccin
opinion
vaccin
relat
statement
hand
pupil
grade
hauptschul
realschul
gymnasium
descript
analys
vaccin
rate
depend
school
type
grade
reason
nonvaccin
inform
sourc
complement
multivari
regress
look
factor
conduc
vaccin
questionnair
return
pupil
known
vaccin
statu
vaccin
measl
unvaccin
pupil
forgotten
get
immunis
male
femal
vaccin
vaccin
rate
hauptschul
realschul
gymnasium
grader
vaccin
measl
compar
grader
pupil
name
gp
sourc
inform
measl
follow
tv
school
internet
name
five
pupil
inform
sourc
multivari
regress
tetanu
vaccin
higher
grade
male
visit
higher
school
type
posit
associ
vaccin
measl
although
tetanu
vaccin
statist
signific
level
observ
differ
vaccin
rate
depend
grade
school
type
vaccin
campaign
especi
focu
pupil
enter
hauptschul
bring
vaccin
level
threshold
need
erad
coxiella
burnetii
caus
agent
q
fever
diseas
sourc
endem
outbreak
germani
last
decad
accord
low
infect
dose
via
aerosol
rout
one
bacteria
could
caus
infect
cluster
infect
alway
seen
could
identifi
sourc
infect
materi
asymptomat
goat
cow
sheep
shed
larg
amount
microorgan
eg
birth
lamb
season
placenta
materi
human
infect
subclin
diagnosi
often
delay
typic
specif
antibodi
detect
via
elisaift
confirm
diagnosi
back
trace
infect
one
possibl
identifi
sourc
outbreak
initi
countermeasur
addit
forens
microbiolog
bacteria
get
also
import
light
bioterror
coxiella
burnetii
regard
potenti
bioterrorist
agent
recent
develop
modifi
vntrmethod
variabl
number
tandem
repeat
coxiella
burnetii
isol
analys
cultur
human
anim
materi
germani
twelv
differ
genotyp
could
identifi
one
case
could
link
human
isol
sheep
strain
larg
outbreak
soest
infect
person
differ
vntrmarker
use
could
divid
german
strain
region
cluster
clear
correl
could
drawn
genotyp
accord
clinic
ill
acut
chronic
diseas
respect
anim
speci
first
genom
type
collect
german
coxiella
burnetii
strain
vntr
power
tool
classif
coxiella
isol
back
trace
infect
sourc
kochinstitut
wernigerod
wernigerod
germani
background
todat
data
methicillinresist
staphylococcu
aureu
mrsa
strain
namibia
first
studi
analyz
dissemin
seriou
pathogen
preval
mrsa
clonal
divers
aureu
strain
method
aureu
isol
obtain
clinic
specimen
major
specimen
sputum
pu
throat
nasal
swab
urin
differ
clinic
oshakati
windhoek
namibia
isol
underw
antibiot
suscept
test
toxin
gene
analysi
multilocu
sequenc
type
agr
group
spa
type
mrsa
sccmec
type
perform
result
aureu
isol
methicillinresist
isol
inpati
specimen
medic
paediatr
depart
major
mrsa
strain
belong
clonal
complex
spatyp
spread
clinic
oshakati
windhoek
less
frequent
mrsa
st
mrsa
strain
type
sccmec
iv
group
agr
respiratori
isol
frequent
identifi
mrsa
remark
antibiot
resist
profil
penicillinoxacillincotrimoxazolerifampicintobramycin
detect
mssa
strain
heterogen
phenoand
genotyp
analysi
mssa
isol
penicillinresist
nearli
addit
toward
cotrimoxazol
tetracyclin
conclus
clonal
complex
mrsa
predominantli
detect
differ
clinic
oshakati
windhoek
besid
mrsa
strain
approx
multiresist
mrsa
strain
express
toxin
gene
sea
sej
lukpv
associ
seriou
respiratori
infect
requir
specif
treatment
emphas
abil
strain
produc
seriou
ill
staphylococcu
aureu
major
caus
skin
soft
tissu
infect
abscess
furuncl
bacteria
also
frequent
colon
human
skin
mucosa
without
caus
symptom
us
highli
virul
communityassoci
mrsa
rapidli
spread
caus
sever
skin
soft
tissu
infect
immun
compet
person
except
larg
unclear
degre
bacteri
factor
eg
genotyp
virul
gene
repertoir
host
factor
determin
outcom
aureu
host
interact
elucid
contribut
bacteri
factor
aureu
furunculosi
analyz
protein
spa
deriv
genotyp
virul
gene
pattern
pantonvalentineleukocidin
pvl
exfoli
toxin
superantigen
agr
preval
lysogen
phage
aureu
isol
adult
patient
recurr
abscess
furuncl
compar
control
aureu
strain
healthi
nasal
carrier
strain
collect
szczecin
poland
genotyp
reveal
furunculosi
isol
belong
clonal
cluster
contrast
colon
strain
belong
p
prototyp
furunculosi
strain
spatyp
carri
gene
pvl
enterotoxin
gene
cluster
egc
agr
type
iv
lack
gene
methicillinresist
meca
pvl
highli
preval
among
furunculosi
strain
differ
lineag
vs
p
strictli
link
phage
contrast
exfoli
toxin
superantigen
associ
furunculosi
spot
sampl
pediatr
clinic
show
also
caus
recurr
abscess
children
northern
germani
conclus
highli
virul
major
caus
abscess
furuncl
staphylococc
virul
furunculosi
determin
clonal
lineag
pvl
toxin
molecular
type
multidrugresist
acinetobact
baumannii
veterinari
specimen
kreder
e
prengerberninghoff
l
dijkshoorn
van
der
reijden
g
baljer
institut
hygien
infecti
diseas
anim
justusliebigunivers
giessen
giessen
germani
depart
infecti
diseas
leiden
univers
medic
centr
leiden
netherland
today
member
genu
acinetobact
wellknown
play
signific
role
colon
infect
human
patient
admit
hospit
taxonom
reason
main
three
clinic
relev
speci
baumannii
genom
speci
gen
sp
gen
sp
one
environment
speci
calcoaceticu
link
togeth
calcoaceticusa
baumannii
complex
whose
repres
distinguish
base
phenotyp
attribut
increas
isol
rate
multidrugresist
acinetobact
strain
german
veterinari
clinic
impuls
determin
speci
involv
aim
amplifi
ribosom
dna
restrict
analysi
use
restrict
pattern
test
strain
identifi
baumannii
isol
three
gen
sp
isol
one
strain
uniqu
pattern
could
classifi
subsequ
isol
type
puls
field
gel
electrophoresi
determin
epidemiolog
relationship
use
endonucleas
apai
group
ident
threshold
level
establish
strain
related
main
cluster
uniqu
profil
could
identifi
within
cluster
compris
largest
amount
strain
subclust
could
assess
similar
among
strain
find
confirm
comparison
genom
profil
obtain
select
amplif
restrict
fragment
aflp
conclus
margin
genet
varieti
among
epidem
baumannii
strain
insid
german
veterinari
clinic
could
detect
close
relationship
anim
isol
might
suggest
epidem
spread
veterinari
clinic
sinc
natur
habitat
baumannii
still
unknown
favour
investig
assess
whether
anim
may
potenti
habitat
speci
h
petryhansen
tew
dannehl
hc
flem
j
wingend
biofilm
centr
depart
aquat
microbiolog
univers
duisburgessen
duisburg
germani
p
aeruginosa
opportunist
pathogen
found
ubiquit
water
soil
environ
occurr
p
aeruginosa
water
system
potenti
threat
human
health
contamin
water
system
p
aeruginosa
routin
recogn
convent
cultur
method
genotyp
method
macrorestrict
combin
pulsedfield
gel
electrophoresi
allow
analysi
genet
relationship
p
aeruginosa
isol
use
local
sourc
contamin
studi
p
aeruginosa
isol
collect
aquat
environ
eleven
drink
water
system
swim
pool
five
technic
water
system
germani
strain
isol
select
media
identifi
biochem
system
api
ne
genet
relationship
isol
analys
compar
pfge
pattern
strain
similar
pfge
pattern
defin
one
clone
cluster
analysi
show
differ
clone
number
isol
includ
singl
clone
type
vari
one
major
cluster
compos
isol
three
differ
water
system
neither
geograph
tempor
correl
isol
studi
compar
repres
strain
clone
c
earlier
describ
major
p
aeruginosa
clone
common
patient
aquat
habitat
appl
environ
microbiol
three
examin
isol
belong
clone
c
pfge
analysi
studi
show
examin
water
distribut
system
one
domin
clone
p
aeruginosa
exist
clone
differ
clone
c
found
also
lower
frequenc
studi
show
water
distribut
system
anoth
clone
predomin
clostridium
difficil
isol
recov
patient
suspect
suffer
clostridium
difficileassoci
diarrhoea
cdad
cologn
univers
sever
teach
hospit
novemb
analyz
molecular
techniqu
ie
repetit
sequencebas
pcr
reppcr
diversilab
surfac
layer
protein
gene
sequenc
type
slpast
pcr
type
presenc
paloc
gene
tcda
tcdb
tcdc
well
delet
within
tcdc
gene
pcr
type
presenc
binari
toxin
gene
cdta
cdtb
type
result
recov
isol
compar
repres
set
local
riboslpatyp
previous
isol
slpast
identifi
four
group
isol
near
ident
sequenc
type
isol
group
three
isol
uniqu
slpa
sequenc
surprisingli
five
isol
nontyp
slpast
reppcr
identifi
five
cluster
within
similar
cut
isol
addit
ten
isol
show
similar
isol
method
identifi
major
cluster
isol
indic
spread
strain
among
teach
hospit
investig
studi
period
wherea
slpast
reppcr
result
mostli
congruent
type
tcdab
tcdc
delet
cdtab
gener
consist
slpast
reppcr
group
none
strain
studi
sampl
relat
c
difficil
report
caus
recent
outbreak
north
america
europ
find
clearli
show
monitor
clinic
isol
reppcr
slpast
reveal
outbreak
otherwis
detect
surveil
system
hospit
c
richter
kaas
sg
gatermann
f
szabado
depart
medic
microbiolog
bochum
germani
daili
routin
differenti
speci
coagulaseneg
staphylococci
con
import
detect
infect
matrixassistedlaserdesorptionionis
timeofflight
mass
spectrometri
malditof
ms
might
inexpens
method
rapid
identif
bacteri
speci
aim
studi
valid
method
comparison
biochem
molecular
method
clinic
isol
clinic
relev
con
speci
test
strain
includ
studi
clinic
isol
identifi
use
biomerieux
franc
molecular
identif
perform
equivoc
result
sampl
prepar
duplic
case
doubt
biotyp
score
less
retest
malditof
ms
except
slight
modif
cultur
sampl
prepar
sampl
prepar
accord
manufactur
instruct
identif
proteom
data
sampl
calcul
use
biotyp
softwar
bruker
dalton
overal
speci
found
isol
good
identif
seen
epidermidi
haemolyticu
saprophyticu
ssp
saprophyticu
schleiferi
ssp
schleiferi
succinu
ssp
succinu
sciuri
ssp
scuiri
howev
low
score
less
detect
cohnii
warneri
identifi
haemolyticu
subspeci
identif
fail
capiti
homini
concern
accuraci
similar
identif
compar
refer
method
malditof
ms
abl
differenti
correctli
huge
number
con
speci
differ
certain
subspeci
compar
biochem
molecular
standard
easi
inexpens
method
improv
accuraci
time
result
clinic
diagnost
microbiolog
laboratori
unlik
peritonsillar
abscess
pta
primarili
treat
surgic
recurr
tonsil
rt
often
treat
tonsillectomi
seri
fail
drug
therapi
attempt
underli
reason
lack
success
conserv
therapeut
approach
still
well
understood
prospect
studi
tonsil
specimen
patient
rt
patient
pta
examin
presenc
extraand
intracellular
pathogen
bacteria
use
antibiot
protect
assay
staphylococcu
aureu
isol
rtpatient
character
pulsedfield
gel
electrophoresi
spatyp
mscrammgenepcr
abil
biofilm
format
test
cell
invas
confirm
flow
cytometr
invas
assay
fluoresc
insitu
hybrid
fish
immunohistochemistri
signific
diffenc
two
patient
group
preval
aureu
haemophilu
influenza
haemophilu
parainfluenza
aureu
predomin
speci
rtpatient
base
upon
antibiot
protect
assay
result
nearli
aureu
strain
locat
insid
predominantli
epitheli
cell
confirm
immunohistochemistri
fish
mscrammgenepcr
identifi
fibronectin
bind
protein
isol
give
hint
capabl
cell
invas
result
intern
assay
confirm
aureusisol
invas
strain
mere
colon
collagenor
fibronectin
coat
aureusisol
respect
abl
form
consider
biofilm
mass
mscrammgenepattern
biofilm
format
capabl
penicillinsuscept
show
clear
arrang
within
differ
pfgeclustersspacc
result
demonstr
aureu
common
caus
rt
indic
aureu
use
intracellular
locat
surviv
effect
antibiot
host
immun
respons
enterohemorrhag
escherichia
coli
ehec
highli
pathogen
subgroup
shiga
toxinproduc
e
coli
caus
diarrhea
hemolyt
urem
syndrom
epidemiolog
temporarili
limit
cluster
often
character
fingerprint
method
name
pulsedfield
gel
electrophoresi
epidemiolog
clonal
distribut
ehec
infect
year
remain
unknown
therefor
analyz
ehec
strain
isol
germani
sinc
use
multiplelocu
variablenumb
tandemrepeat
vntr
analysi
mlva
epidemiolog
unrel
ehec
strain
per
year
randomli
chosen
strain
collect
start
strain
investig
use
pulsenet
mlva
scheme
center
diseas
control
prevent
atlanta
usa
phylogenet
analys
perform
use
minimumspan
tree
mst
tool
ridom
seqspher
softwar
version
beta
ridom
gmbh
mlva
type
differ
two
less
loci
cluster
group
vntrloci
specif
biodivers
total
strain
rang
distinct
allel
found
investig
loci
result
differ
mlva
profil
null
allel
found
four
eight
loci
frequenc
concern
strain
cluster
base
mlva
profil
assign
strain
group
contain
isol
addit
sever
clone
occur
mst
exhibit
two
clonal
group
consist
isol
period
year
indic
highli
adapt
clone
evolutionarili
success
persist
conclus
mlva
enabl
first
time
comprehens
view
clonal
distribut
ehec
germani
presenc
success
clone
indic
necess
close
host
adapt
corrobor
sourcesink
dynam
pathogen
research
bacillu
anthraci
biolog
weapon
began
year
ago
sinc
occurr
amerithrax
letter
usa
threat
bioterror
push
scientist
spotlight
forens
microbiolog
especi
bacillu
anthraci
forens
challeng
differenti
endem
infect
intent
releas
order
make
possibl
accur
reliabl
typingmethod
well
databas
requir
context
bioterrorist
attack
multi
locu
variabl
number
tandem
repeat
vntr
analysi
base
marker
evidenc
collect
spore
belong
genet
cluster
ame
strain
mlva
investig
sever
defin
region
base
nucleotid
repeat
structur
directli
attach
repeat
copi
number
may
differ
strain
strain
combin
repeatcopi
number
multipl
genet
loci
gener
strain
specif
typingpattern
year
type
pattern
isol
nearli
world
investig
publish
achiev
higher
discrimin
power
sever
laboratori
extend
exist
system
marker
studi
investig
collect
b
anthraci
strain
isol
republ
bulgaria
soil
anim
determin
mlva
pattern
use
modifi
vntrmethod
marker
van
ert
el
al
compar
result
use
upgma
unweight
pair
group
method
arithmet
mean
cluster
method
exist
data
differ
strain
world
global
context
bulgarian
isol
form
novel
uniqu
cluster
differ
significantli
isol
geograph
close
relat
region
addit
two
new
allel
marker
could
observ
forens
microbiolog
bacillu
anthraci
use
genom
base
type
system
mlva
power
trace
infect
back
normal
clinic
case
also
suspect
bioterror
scenario
c
winter
w
scharf
schauer
f
freyburg
f
von
loewenich
institut
medizinisch
mikrobiologi
und
hygien
freiburg
freiburg
germani
anaplasma
phagocytophilum
gramneg
oblig
intracellular
bacterium
transmit
ixod
sp
tick
caus
febril
ill
human
anim
sheep
cattl
hors
dog
cat
roe
deer
regard
potenti
reservoir
host
contrast
unit
state
human
granulocyt
anaplasmosi
hga
rare
diseas
europ
although
pathogen
seem
widespread
tickand
animalpopul
bacterium
grow
convent
media
detect
depend
microscop
molecular
serolog
method
clear
date
europ
whether
hga
underreport
whether
strain
specif
pathogen
potenti
circul
address
question
analyz
genet
differ
phagocytophilum
strain
variou
speci
sequenc
bp
rrna
gene
sampl
human
hors
dog
cat
sheep
cattl
european
bison
roe
deer
red
deer
clear
associ
rrna
gene
sequenc
sampl
origin
found
contrast
analysi
total
open
read
frame
phagocytophilumspecif
ank
gene
reveal
strong
associ
ank
gene
cluster
host
speci
investig
whether
reflect
phylogenet
related
strain
develop
multi
locu
sequenc
type
mlst
scheme
phagocytophilum
analysi
concaten
housekeep
gene
sequenc
reveal
roe
deer
sampl
clearli
separ
host
speci
thu
roe
deer
probabl
reservoir
human
infect
hand
european
sequenc
human
dog
hors
highli
relat
unit
state
isol
north
america
form
distinct
cluster
might
reflect
differ
geograph
origin
given
homolog
european
american
strain
conclud
hga
occur
germani
staphylococcu
aureu
one
preval
bacteri
pathogen
caus
subclin
mastiti
infect
mammari
gland
seriou
diseas
threaten
mammal
particular
dairi
cattl
caus
enorm
cost
dairi
industri
gain
insight
host
specif
aureu
ist
virul
epidemiolog
clonal
relationship
well
distribut
express
virul
gene
differ
aureu
strain
analys
present
studi
aureu
isol
involv
either
bovin
isol
human
isol
mastiti
characteris
genet
epidemiolog
studi
utilis
well
establish
multilocussequencetyp
mlst
techniqu
moreov
agr
type
presenc
virul
resist
gene
determin
use
diagnost
microarray
detail
analysi
host
specif
sequenc
analys
gene
high
rate
nonsynonym
substitut
among
homolog
gene
pair
sequenc
bovin
aureu
strain
diverg
sequenc
divers
bovin
associ
aureu
isol
done
purpos
select
follow
gene
fnba
spa
sstc
final
virul
gene
express
isol
analys
gelbas
proteom
approach
comparison
extracellular
protein
pattern
reveal
high
heterogen
clinic
isol
observ
variabl
exoproteom
mainli
caus
genom
plastic
unpreced
gene
express
variat
data
impli
genom
studi
focuss
virul
gene
conserv
pattern
need
complement
protein
express
analys
assess
virul
potenti
bacteri
pathogen
like
aureu
clinic
microbiologist
frequent
baffl
impress
capabl
pathogen
bacteria
acquir
novel
trait
antimicrobi
resist
howev
actual
rate
nucleotid
substitut
entir
gene
complex
mobil
genet
element
gain
lost
bacteri
popul
yet
determin
present
studi
show
clone
methicillinresist
staphylococcu
aureu
mrsa
caus
ongo
epidem
hospit
infect
accumul
measur
divers
within
two
decad
base
serial
timestructur
sampl
dna
sequenc
taken
popul
use
coalesc
method
calcul
diverg
time
reconstruct
date
episod
histori
includ
recent
demograph
bottleneck
subsequ
popul
expans
addit
compar
genom
indic
histori
complex
phage
dynam
therapi
control
cystic
fibrosi
cf
lung
inflamm
biochem
marker
urgent
need
therefor
investig
lactat
sputum
cf
patient
suitabl
marker
outcom
cf
lung
exacerb
treatment
sputum
adult
cf
patient
without
exacerb
lactat
concentr
determin
spectrophotometr
patient
hall
patient
florenc
cf
center
lactat
determin
exacerb
iv
antibiot
treatment
patient
lung
function
paramet
measur
use
either
viasi
jaeger
bodyplethysmograph
hall
portabl
zan
morgan
spiromet
florenc
cf
sputum
specimen
lactat
detect
rang
mmoll
cf
patient
without
exacerb
lactat
valu
correl
neg
wherea
fvc
correl
coeffici
lower
exacerb
patient
hall
lactat
decreas
exacerb
mmoll
treatment
decreas
lactat
correl
fvc
increas
patient
florenc
valu
vs
lactat
treatment
fvc
thu
two
independ
lung
function
determin
could
demonstr
amelior
lung
function
valu
correl
decreas
lactat
lactat
cf
sputum
determin
noninvas
sever
time
day
may
use
treatment
control
stabl
exacerb
cf
patient
inexpens
investig
use
routin
equip
antibiot
well
antiinflammatori
therapi
reflect
chang
lactat
valu
especi
exacerb
thu
lactat
promis
marker
therapi
control
cf
lung
infect
inflamm
sputum
patient
cystic
fibrosi
cf
next
facult
anaerob
p
aeruginosa
also
oblig
anaerob
prevail
unknown
whether
oblig
anaerob
contribut
cf
lung
pathogen
thu
investig
influenc
oblig
anaerob
growth
p
aeruginosa
sputum
hall
cf
patient
frequent
occur
anaerob
veillonella
spp
staphylococcu
saccharolyticu
peptococcu
spp
streptococcu
constellatu
str
milleri
dilut
strain
separ
x
cfuml
x
cfuml
incub
anaerob
togeth
p
aeruginosa
strain
x
cfuml
let
grow
anaerob
bench
oxygen
trypton
soy
broth
tsb
day
thereaft
determin
bacteria
even
low
concentr
oblig
anaerob
suffici
surviv
coincub
p
aeruginosa
veillonella
spp
str
constellatu
dilut
time
well
saccharolyticu
dilut
time
reach
nearli
concentr
undilut
p
aeruginosa
day
growth
wherea
veillonella
spp
saccharolyticu
influenc
p
aeruginosa
cell
number
str
constellatu
scale
count
upon
surviv
lowdos
oblig
anaerob
may
explain
oxygen
consumpt
p
aeruginosa
constant
concentr
presenc
oblig
anaerob
veillonella
spp
saccharolyticu
explain
fact
microorgan
consum
oxygen
wherea
growth
reduct
caus
str
constellatu
coincid
competit
oxygen
comsumpt
microaerophil
bacterium
abil
form
biofilm
critic
factor
chronic
infect
pseudomona
aeruginosa
made
bacterium
model
organ
respect
biofilm
format
studi
describ
new
previous
unrecogn
role
human
cation
host
defens
peptid
addit
key
role
modul
innat
immun
respons
weak
antimicrobi
activ
potent
inhibit
format
bacteri
biofilm
vitro
occur
low
physiolog
meaning
concentr
microgml
far
requir
kill
inhibit
growth
mic
microgml
also
affect
exist
pregrown
p
aeruginosa
biofilm
similar
result
obtain
use
bovin
neutrophil
peptid
indolicidin
inhibitori
effect
biofilm
format
detect
use
subinhibitori
concentr
mous
peptid
cramp
share
ident
polymyxin
b
bovin
bactenecin
homolog
use
microarray
followup
studi
abl
demonstr
affect
biofilm
format
decreas
attach
bacteri
cell
stimul
twitch
motil
influenc
two
major
quorum
sens
system
la
rhl
lead
downregul
gene
essenti
biofilm
develop
wuviru
clinic
data
data
microbi
colon
patient
enrol
risk
factor
analysi
perform
result
hbovdna
detect
ebv
dna
patient
result
posit
rate
viral
load
genom
equival
geq
ml
hbov
rang
geqml
geqml
ebv
patient
test
viru
posit
suffer
significantli
pulmonari
exacerb
preceed
year
sd
vs
sd
furthermor
colon
p
aeruginosa
aureu
aspergillu
fumigatu
infin
patient
significantli
often
posit
mrsa
clinic
data
see
tabl
background
patient
cystic
fibrosi
suffer
chronic
suppur
airway
infect
lead
lung
insuffici
preterm
death
staphylococcu
aureu
one
first
one
preval
pathogen
colon
infect
airway
cfpatient
often
mani
year
clone
method
studi
aureu
isol
collect
multicent
studi
initi
determin
paramet
dissect
aureu
colon
infect
cfpatient
molecular
type
spa
sequenc
toxin
profil
sease
eta
etb
tst
segsej
pvl
includ
agr
specif
group
determin
multiplex
pcr
result
aureu
isol
specimen
nose
throat
sputum
nasal
lavag
cultur
patient
analyz
spa
sequenc
reveal
patient
carri
clone
patient
clone
respect
patient
carri
individu
clone
addit
clone
share
patient
centr
patient
centr
patient
centr
isol
posit
follow
gene
sea
sec
sed
eta
tst
seg
seh
sei
sej
agri
agrii
agriii
agriv
conclus
patient
carri
least
individu
clone
airway
specimen
clone
share
sever
patient
mani
isol
posit
exfoli
toxin
eta
pyrogen
superantigen
sei
detect
gene
indic
virul
potenti
aureu
background
cf
adhesin
profil
molecular
analysi
sequenti
staphylococcu
aureu
strain
isol
chronic
airway
infect
cystic
fibrosi
patient
limit
knowledg
known
adapt
process
occur
persist
host
aim
assess
degre
adapt
aureu
isol
two
patient
year
old
chronic
infect
aureu
year
investig
method
singl
multiplex
pcr
perform
follow
adhesin
fnba
fnbb
clfa
clfb
cna
sdrd
sdrc
sdre
molecular
type
isol
perform
pulsedfield
gel
electrophoresi
pfge
determin
agrspecif
group
biofilm
format
assess
microtitr
biofilm
assay
result
pfge
allow
distinguish
six
three
differ
aureu
strain
first
second
patient
respect
subtyp
due
fragment
pattern
differ
strain
first
patient
belong
agr
group
strain
iii
iv
strain
strain
second
patient
agr
group
ii
iv
pcr
strain
posit
fnba
fnbb
clfa
clfb
sdrc
posit
cna
differ
size
amplicon
strain
subtyp
cna
fnba
fnbb
clfa
clfb
strain
neg
sdrd
sdre
conclus
pcr
analysi
strain
identifi
show
differ
amplicon
size
special
adhesin
indic
chang
repeat
area
assumingli
due
adapt
microorgan
hostil
environ
longterm
persist
acknowledg
studi
support
grant
dfg
cystic
fibrosi
cf
pseudomona
aeruginosa
pa
mutat
strain
may
lead
rapid
select
variant
specif
adapt
hostil
environ
inflam
cf
lung
compar
proteom
transcriptom
analysi
sequenti
isogen
nonmut
mutat
isol
identifi
chang
physiolog
pa
cf
lung
surviv
increas
express
sever
gene
involv
predominantli
microaerob
metabol
well
tcacycl
glyoxyl
shunt
energi
metabol
found
analysi
perform
laczreport
gene
fusion
interestingli
type
oxidas
oprf
nitrat
uptak
idh
icd
isocitr
dehydrogenas
report
significantli
increas
oxygenrestrict
condit
lb
wherea
himd
integr
host
factor
nuoa
nadh
dehydrogenas
report
reveal
signific
upregul
oxygenrestrict
condit
use
artifici
sputum
medium
use
mimic
milieu
cf
airway
secret
thu
gene
compris
potenti
key
marker
hypox
lung
adapt
pa
moreov
specif
activ
icd
idh
isoenzym
analys
oxygenlimit
condit
interestingli
anaerob
condit
particular
icd
aerob
condit
particular
idh
contribut
isocitr
dehydrogenas
activ
addit
silico
analysi
gene
reveal
put
bind
motif
anaerob
regul
anr
promot
region
gene
verifi
role
anr
microaerob
regul
gene
band
shift
experi
gener
mutat
anr
stabl
also
oxygenrich
condit
summari
result
suggest
oprf
idh
icd
himd
nuoa
gene
may
involv
metabol
adapt
pa
microaerob
condit
cf
mucu
hypermut
antibiot
resist
thymidinedepend
smallcolonyvari
staphylococcu
aureu
besier
j
zander
bc
kahl
p
kraiczi
v
brade
thymidinedepend
small
coloni
variant
tdscv
staphylococcu
aureu
cultur
respiratori
secret
patient
suffer
cystic
fibrosi
cf
associ
chronic
treatmentresist
infect
characterist
well
varieti
mutat
thymidyl
synthas
encod
thya
gene
respons
thymidin
depend
suggest
morpholog
variant
hypermut
verifi
hypothesi
analyz
mutat
phenotyp
differ
aureu
phenotyp
particular
cfderiv
tdscv
cfderiv
isol
normal
phenotyp
ncv
noncf
ncv
compar
analysi
show
cf
isol
significantli
higher
mutat
rate
noncf
isol
tdscv
turn
harbor
significantli
strong
hypermut
mutat
rate
cf
noncf
ncv
moreov
antimicrobi
resist
nonbetalactam
antibiot
includ
gentamicin
ciprofloxacin
erythromycin
fosfomycin
rifampin
significantli
preval
tdscv
cf
noncf
ncv
context
note
macrolid
resist
usual
mediat
mobil
genet
element
confer
half
macrolideresist
tdscv
point
mutat
gene
encod
rrna
sequenc
analysi
mut
mutl
gene
involv
dna
mismatch
repair
gramposit
bacteria
reveal
hypermut
cf
isol
especi
tdscv
mutl
gene
often
truncat
due
frameshift
mutat
conclus
data
provid
direct
evid
tdscv
hypermut
hypermut
appar
favor
acquisit
antibiot
resist
facilit
bacteri
adapt
longterm
persist
pseudomona
aeruginosa
owe
ist
capabl
thrive
varieti
environment
condit
ist
modular
genom
phenotyp
adapt
chronic
infect
patient
suffer
cystic
fibrosi
p
aeruginosa
easili
adapt
environ
develop
variant
show
increas
resist
toward
host
immun
defens
antimicrobi
treatment
clinic
laboratori
experi
shown
p
aeruginosa
form
genet
divers
commun
gener
insur
effect
render
popul
flexibl
toward
environment
condit
sinc
underli
genet
variat
rang
insert
delet
larg
part
chromosom
singl
nucleotid
polymorph
snp
essenti
challeng
determin
complet
genotyp
analys
distinct
morpholog
variant
occur
reproduc
day
incub
p
aeruginosa
soft
agar
plate
variant
exhibit
larg
differ
motil
biofilm
format
remain
stabl
differ
cultur
condit
suggest
variat
might
caus
genet
differ
compar
genom
hybrid
cgh
variant
recent
describ
whole
genom
dnamicroarray
detect
genet
variat
limit
snp
detect
sensit
potenti
small
genet
differ
might
miss
therefor
one
variant
select
analys
illumina
genom
analyz
inde
singl
nucleotid
exchang
could
detect
within
type
iv
fimbrial
precursor
gene
pila
allel
confirm
present
independ
isol
suggest
strong
link
allel
phenotyp
demonstr
applic
microarray
base
compar
genom
hybrid
next
gener
sequenc
unravel
genet
determin
phenotyp
variant
cystic
fibrosi
cf
lung
diseas
pseudomona
aeruginosa
conquer
challeng
environ
character
chronic
inflamm
mucu
plug
recurr
antibiot
treatment
comparison
isogen
nonmut
mutat
cf
isol
p
aeruginosa
show
isol
endstag
cf
lung
diseas
character
particular
adapt
metabol
pathogen
among
adapt
chang
probabl
select
prevail
growth
condit
hypox
cf
mucu
found
significantli
hyperexpress
endstag
like
best
lungadapt
mutat
strain
p
aeruginosa
show
amino
acid
homolog
small
heat
shock
protein
ibpa
e
coli
small
heat
shock
protein
shsp
serv
helper
protein
bind
denatur
protein
facilit
subsequ
refold
atpdepend
major
heat
shock
protein
hsp
hsp
stabil
protect
intracellular
protein
chaperon
may
also
act
proteas
degrad
consequ
heat
oxid
environment
stress
present
littl
known
molecular
mechan
shsp
elucid
role
ibpa
cf
lung
adapt
investig
regul
relev
p
aeruginosa
ibpa
stress
condit
expect
predomin
chronic
infect
cf
lung
lacz
report
gene
assay
found
high
ibpa
promot
activ
low
oxygen
condit
artifici
sputum
medium
asm
use
mimic
composit
cf
mucu
moreov
determin
growth
surviv
ibpa
transposon
mutant
rel
express
ibpa
gene
proteom
ibpa
mutant
anaerob
oxid
heat
stress
condit
data
indic
ibpa
may
play
import
role
persist
p
aeruginosa
stress
cf
lung
yersinia
enterocolitica
common
pathogen
type
found
human
anim
especi
fatten
pig
trimethoprimsulfamethoxazol
tetracyclin
fluoroquinolon
gentamicin
chloramphenicol
recommend
use
complic
yersiniosi
emerg
antimicrobi
resist
recognis
among
zoonot
pathogen
includ
enterocolitica
thu
aim
work
studi
resist
pattern
antimicrobi
agent
among
enterocolitica
strain
isol
differ
origin
antimicrobi
resist
pattern
enterocolitica
strain
collect
germani
switzerland
sweden
croatia
studi
agar
disc
diffus
method
clsi
strain
origin
human
nonhuman
sourc
pig
wild
boar
monkey
pork
product
ampicillin
amoxicillinclavulan
acid
aztreonam
cefotaxim
ciprofloxacin
chloramphenicol
colistin
erythromycin
furazolidon
gentamicin
nalidix
acid
streptomycin
tetracyclin
trimethoprim
trimethoprimsulfamethoxazol
sulfamethoxazol
test
sporad
resist
amoxicillinclavulan
acid
furazolidon
occur
germani
switzerland
sweden
croatian
human
strain
resist
amoxicillinclavulan
acid
resist
streptomycin
sulfamethoxazol
observ
among
strain
differ
sourc
sporad
resist
trimethoprim
trimethoprimsulfamethoxazol
detect
germani
switzerland
strain
resist
erythromycin
human
strain
pig
strain
sensit
ampicillin
enterocolitica
strain
suscept
antimicrobi
agent
small
differ
resist
pattern
strain
observ
ak
schink
k
kadlec
schwarz
institut
farm
anim
genet
friedrichloefflerinstitut
fli
neustadtmariense
germani
bftgermvet
studi
escherichia
coli
isol
dogscat
n
hors
n
swine
n
test
suscept
antimicrobi
agent
broth
microdilut
accord
clsi
document
among
antimicrobi
agent
test
follow
antibiot
includ
penicillin
g
ampicillin
oxacillin
amoxicillinclavulan
acid
cephalothin
cefazolin
cefoperazon
ceftiofur
cefquinom
identifi
potenti
produc
extend
spectrum
esbl
ampicillinresist
e
coli
isol
subject
initi
screen
cefotaxim
resist
subsequ
phenotyp
confirmatori
test
use
ceftazidimeceftazidimeclavulan
acid
cefotaximecefotaximeclavulan
acid
disk
recommend
clsi
total
put
esblproduc
e
coli
isol
identifi
approach
analysi
concentr
e
coli
isol
canin
respiratori
tract
infect
isol
resist
antibiot
test
amoxicillinclavulan
acid
well
gentamicin
neomycin
tetracyclin
chloramphenicol
enrofloxacin
sulfamethoxazoletrimethoprim
carri
two
plasmid
ca
kb
confer
ampicillin
resist
upon
transform
conjug
respect
analysi
identifi
blatem
gene
ca
plasmid
esbl
gene
type
bla
ctxm
ca
plasmid
suscept
test
blactxmcarri
transconjug
reveal
thatexcept
resist
none
aforement
resist
properti
associ
plasmid
sequenc
analysi
blactxm
gene
flank
region
confirm
subtyp
moreov
complet
insert
sequenc
well
part
insert
sequenc
identifi
upstream
region
part
mrxmph
operon
downstream
region
k
kadlec
schwarz
institut
farm
anim
genet
friedrichloefflerinstitut
fli
neustadtmariense
germani
methicillinresist
staphylococcu
aureu
mrsa
isol
identifi
pet
companion
anim
also
foodproduc
anim
contrast
wealth
data
mrsa
swine
compar
littl
known
mrsa
associ
bovin
mastiti
mainli
due
fact
strain
actual
occur
rare
veterinari
routin
diagnost
novemb
januari
six
mrsa
isol
independ
case
bovin
mastiti
identifi
lower
saxoni
six
strain
carri
gene
meca
sccmec
type
v
cassett
four
isol
type
cassett
one
isol
sccmec
type
remain
isol
could
determin
pcr
assay
use
six
isol
relat
apaimacrorestrict
pattern
nontyp
smai
pfge
analysi
result
spa
type
show
five
isol
remain
isol
suscept
test
reveal
addit
resist
six
isol
resist
tetracyclin
via
gene
tet
present
either
alon
combin
tet
k
andor
tet
l
three
isol
resist
macrolideslincosamid
one
carri
gene
erm
c
one
gene
erm
c
erm
one
gene
erm
b
trimethoprim
resist
detect
four
isol
three
harbour
novel
trimethoprim
resist
gene
dfrk
gentamicin
resist
detect
singl
isol
carri
gene
aacaaphd
plasmid
profil
protoplast
transform
experi
identifi
small
erm
c
encod
plasmid
kb
plasmid
kb
tet
k
two
isol
larger
plasmid
carri
tet
l
dfrk
base
phenoand
genotyp
characterist
six
mrsa
isol
bovin
mastiti
close
resembl
porcin
isol
observ
suggest
transfer
strain
differ
anim
speci
compar
analysi
differ
virul
factor
enterococcu
spp
anim
environment
human
sourc
aibinu
r
ebbel
odugbemi
w
koenig
b
ghebremedhin
med
microbiol
magdeburg
germani
med
microbiol
para
cmul
lago
nigeria
background
enterococci
usual
part
normal
flora
gastrointestin
tract
human
anim
howev
consist
case
sever
infect
patient
vancomycinresist
enterococci
vre
virul
enterococci
method
analyz
virul
factor
aggreg
substanc
encod
gelatinas
gele
cytolysin
cyla
enterococc
surfac
protein
esp
e
faeciumhyaluronidas
hyl
enterococci
isol
nigerian
anim
chicken
pig
cattl
human
environment
specimen
perform
multiplexpcr
antibiot
susceptibl
test
use
vancomycinresist
confirm
etest
result
isol
e
faecium
e
faecali
express
gele
approx
enterococc
isol
express
one
environment
e
faecali
isol
express
esp
one
anim
e
faecium
isol
posit
hyl
erythromycin
quinudalfopristin
resist
one
third
tetracyclin
resist
conclus
resist
result
essenti
treament
monitor
epidemiolog
enterococci
multiplexpcr
reveal
diffus
gele
among
five
virul
gene
distribut
among
anim
human
environment
isol
emerg
human
espposit
strain
nevertheless
one
environment
espposit
e
faecali
isol
lago
lagoon
detect
elucid
futur
background
consid
daili
increas
drug
resist
variou
virus
novel
antivir
compound
extract
natur
resourc
due
fewer
side
effect
alway
import
research
present
studi
investig
antivir
activ
hot
water
extract
green
seawe
caulerpa
sertularioid
collect
coastal
water
bushehr
persian
gulf
herp
simplex
viru
type
method
hot
water
extract
green
seawe
caulerpa
sertularioid
steril
autoclav
filtrat
method
determin
ist
cytotox
concentr
valu
effect
extract
inhibit
replic
examin
vero
cell
cultur
result
extract
show
antivir
activ
attach
entri
viru
vero
cell
also
post
attach
stage
viru
replic
inhibitori
concentr
valu
autoclav
extract
attach
post
attach
stage
respect
valu
filter
extract
attach
post
attach
stage
respect
valu
autoclav
filter
extract
respect
conclus
hot
water
extract
caulerpa
sertularioid
persian
gulf
antivir
effect
feral
urban
rat
carrier
multiresist
e
coli
guenther
grobbel
j
beutlich
r
ulrich
b
guerra
lh
wieler
c
ewer
institut
mikrobiologi
und
tierseuchen
freie
berlin
berlin
germani
abteilung
biologisch
sicherheit
bundesinstitut
risikobewertung
berlin
germani
institut
neue
und
neuartig
tierseuchenerreg
friedrich
institut
greifswald
germani
occurr
frequenc
antimicrobi
resist
escherichia
coli
strain
feral
rat
rattu
norvegicu
test
pilot
studi
sampl
collect
citi
area
berlin
germani
e
coli
isol
fecal
sampl
screen
suscept
ampicillin
streptomycin
gentamicin
chloramphenicol
tetracyclin
spectinomycin
via
agardilut
method
isol
show
multipl
resist
phenotyp
process
via
agar
diffus
method
mic
test
determin
resist
profil
antimicrobi
substanc
wide
use
human
veterinari
medicin
addit
phenotyp
resist
survey
perform
pcr
base
detect
common
resist
gene
get
knowledg
phylogenet
background
e
coli
isol
also
perform
multi
locu
sequenc
type
mlst
analysi
high
rate
e
coli
isol
rat
intestin
exhibit
multiresist
phenotyp
resist
antimicrobi
substanc
includ
betalactam
aminoglycosid
fluoroquinolon
tetracyclin
sulfonamid
resist
occur
frequent
doxcyclin
betalactam
ticarcillin
cefalexin
ampicilin
none
investig
isol
resist
carbapenem
meropenem
imipenem
one
multiresist
isol
show
extend
spectrum
beta
lactamas
esbl
product
bla
type
sequenc
type
st
determin
via
mlst
includ
expecrel
st
contain
isol
assign
st
also
enclos
uropathogen
invas
e
coli
new
emerg
clone
current
dissemin
across
globe
find
indic
common
occurr
antimicrobi
resist
e
coli
strain
rodent
urban
set
urg
epidemiolog
studi
futur
extend
spectrum
produc
escherichia
coli
anim
face
new
emerg
multiresist
clone
increas
preval
extend
spectrum
esbl
ctxm
type
enterobacteriacea
particularli
e
coli
consider
contribut
therapi
failur
impair
infect
control
human
veterinari
medicin
although
report
presenc
esbl
produc
e
coli
livestock
household
anim
knowledg
preval
phylogenet
background
strain
rather
scarc
therefor
took
phenotyp
esbl
produc
strain
isol
urinari
tract
wound
infect
indic
dog
cat
hors
last
month
studi
correspond
bla
gene
pcr
sequenc
analysi
isol
found
carri
gene
differ
ctxm
type
mainli
take
account
total
number
e
coli
isol
differ
clinic
site
host
speci
esbl
produc
e
coli
differ
ctxmtype
detect
preval
isol
hors
e
coli
urinari
tract
dog
cat
mic
test
isol
differ
antimicrobi
agent
reveal
pattern
multiresist
phylogenet
analysi
assign
strain
differ
sequenc
type
st
includ
attain
worldwid
attent
due
intercontinent
spread
addit
produc
strain
ont
st
accumul
esblproduc
strain
differ
host
countri
possess
ident
ctxmand
otyp
ont
hnt
remain
determin
whether
strain
belong
st
clonal
relat
therebi
repres
new
emerg
clonal
group
esbl
produc
e
coli
bear
potenti
spread
among
anim
human
acinetobact
baumannii
veterinari
specimen
kreder
e
prengerberninghoff
g
baljer
institut
hygien
infecti
diseas
anim
justusliebigunivers
giessen
giessen
germani
bacteria
genu
acinetobact
predominantli
baumannii
wellknown
nosocomi
pathogen
respons
lifethreaten
diseas
immunocompromis
human
patient
abil
develop
resist
variou
antimicrobi
agent
major
caus
treatment
failur
veterinari
medicin
public
deal
occurr
pathogen
potenti
acinetobact
speci
sp
anim
notwithstand
consider
isol
rate
anim
veterinari
clinic
object
studi
phenotyp
identif
anim
acinetobact
isol
assess
antimicrobi
suscept
statu
investig
perform
acinetobact
strain
isol
dog
cat
hors
guinea
pig
budgerigar
cow
clinic
environ
sampl
phenotyp
character
genu
level
includ
test
modifi
accord
bouvet
grimont
use
test
strain
identifi
baumannii
remain
organ
nona
baumannii
sp
suscept
antimicrobi
agent
repres
differ
antibiot
class
evalu
agar
diffusionandor
broth
microdilut
test
accord
clsi
guidelin
isol
resist
penicillin
oxacillin
cephalosporin
lincosamid
phenicol
rifamycin
makrolid
fusid
acid
resist
fluoroquinolon
aminoglycosid
sulfonamid
colistin
occur
isol
imipenem
polymyxin
b
show
vitro
activ
strain
data
reveal
baumannii
domin
speci
among
anim
isol
studi
addit
high
number
strain
multipl
antimicrobi
resist
anim
veterinari
clinic
point
organ
potenti
nosocomi
pathogen
apart
human
also
veterinari
medicin
carbapenem
resist
nosocomi
gramneg
pathogen
base
variou
resist
mechan
slightli
increas
minimum
inhibitori
concentr
mic
observ
carbapenem
therapi
often
due
increas
product
efflux
pump
loss
porin
outer
membran
protein
omp
preval
acquisit
differ
carbapenemas
gene
plasmid
transfer
result
carbapenem
resist
enterobacteriacea
kpc
enzym
main
caus
carbapenem
resist
report
molecular
analysi
multidrugresist
isol
differ
gramneg
speci
carbapenemresist
isol
klebsiella
spp
enterobact
cloaca
pseudomona
aeruginosa
collect
differ
german
hospit
isol
etest
metallobetalactamas
posit
macrorestrict
analysi
reveal
two
k
pneumonia
ident
pcr
sequenc
carbapenemas
gene
identifi
one
p
aeruginosa
isol
contain
like
carbapenemas
furthermor
esbl
gene
well
plasmidmedi
quinolon
resist
determin
qnr
detect
sever
strain
blavim
qnr
gene
enterobacteriacea
strain
success
transfer
e
coli
recipi
carbapenem
resist
gramneg
pathogen
still
rare
germani
result
confirm
emerg
spread
variou
speci
alarm
multidrugresist
isol
easi
transfer
resist
determin
among
differ
enterobacteri
speci
therefor
surveil
multidrugresist
strain
strict
hygien
manag
necessari
prevent
exacerb
resist
situat
near
futur
kaas
f
szabado
h
tix
ander
sg
gatermann
abteilung
medizinisch
mikrobiologi
bochum
bochum
germani
background
therapeut
option
enterobacteriacea
limit
due
increas
preval
quinolon
resist
extend
spectrum
betalactamas
esbl
around
half
esbl
isol
area
carri
aac
ibcr
shown
previou
studi
aim
current
work
character
plasmid
harbour
esbl
select
esbl
strain
collect
method
collect
e
coli
n
k
pneumonia
n
esbl
strain
character
pulsedfield
gel
electrophoresi
seqeuenc
esbl
gene
e
coli
k
pneumonia
strain
chosen
plasmid
character
plasmid
transform
e
coli
select
cefotaxim
ceftazidim
contain
agar
presenc
esbl
transform
check
doubl
disk
synergi
test
cotransf
resist
nonbetalactam
antibiot
test
disk
diffus
pcr
subsequ
restrict
analysi
perform
detect
aac
ibcr
result
transform
carri
eight
two
one
one
nine
strain
carri
aac
ibcr
resist
nonbetalactam
antibiotica
cotransf
nine
transform
tobramycin
resist
found
transform
wherea
show
resist
gentamicin
sulfamethoxazoltrimethoprim
chloramphenicol
doxycyclin
conclus
high
proport
esbl
strain
area
posit
aac
ibcr
work
could
demonstr
aac
ibcr
carri
plasmid
esbl
consider
proport
isol
also
reflect
cotransf
tobramycin
resist
resist
gen
cepahalosporin
salmonella
due
acquisit
resist
gene
plasmidmedi
esbl
gene
well
ampc
gene
occur
frequent
report
molecular
analysi
cephalosporinresist
isol
salmonella
cephalosporinresist
isol
salmonella
enterica
ser
typhimurium
n
infanti
typhi
paratyphi
b
enterid
kentucki
panama
mikawasima
virchow
subspeci
select
strain
collect
german
nation
refer
laboratori
salmonella
isol
show
esblphenotyp
pcr
sequenc
esbl
gene
identifi
macrorestrict
analysi
reveal
enterica
ser
typhimurium
isol
hospit
five
feder
state
ident
retrospect
found
strain
three
fecal
specimen
swine
one
enterica
ser
typhi
isol
iraqi
woman
return
abroad
strain
contain
plasmidmedi
quinolon
resist
determin
isol
esbl
gene
qnr
gene
success
transfer
e
coli
recipi
esblproduc
salmonella
still
rare
germani
strain
anim
origin
import
countri
alarm
easi
transfer
resist
determin
among
differ
enterobacteri
speci
therefor
urgent
need
surveil
cephalosporinresist
salmonella
human
anim
food
prevent
dissemin
ensur
therapeut
success
treatment
sever
infect
typhoid
fever
c
herrmann
r
schaumann
ac
rodloff
tigecyclin
glycylcyclin
antibiot
develop
meet
current
challeng
antimicrobi
chemotherapi
especi
impos
mrsa
esblposit
enterobacteriacea
recent
data
show
tigecyclin
unaffect
resist
mechan
oper
tetracyclin
tet
furthermor
esbl
product
also
associ
higher
resist
rate
tigecyclin
claim
investig
present
studi
employ
recent
clinic
isol
e
coli
isol
select
tet
resist
mic
esbl
product
carri
etest
determin
employ
cefotaxim
ceftazidim
without
inhibitor
thereaft
tigecyclin
mic
strain
determin
eleven
e
coli
strain
select
studi
tet
suscept
esbl
posit
tet
resist
esbl
posit
r
tet
suscept
esbl
neg
tet
resist
esbl
neg
r
respect
tigecyclin
mic
distribut
group
suggest
tet
resist
isol
display
tendenc
higher
tigecyclin
mic
compar
tet
suscept
isol
howev
tendenc
current
statist
signific
investig
enterobacteriacea
necessari
compar
result
seen
e
coli
recent
year
product
extend
spectrum
esbl
e
coli
significantli
increas
human
veterinari
medicin
primarili
due
spread
ctxmtype
esbl
among
ctxm
enzym
current
shown
frequent
one
world
recent
enzym
identifi
clonal
relat
group
e
coli
isol
character
multi
locu
sequenc
type
st
otyp
name
shown
group
esblproduc
e
coli
emerg
dissemin
differ
contin
major
focu
human
popul
one
report
presenc
anim
name
dog
urinari
tract
infect
portug
trace
possibl
spread
emerg
pathogen
among
anim
popul
investig
ctxmproduc
e
coli
isol
dog
cat
hors
rabbit
american
kestrel
phylogenet
background
resist
pattern
therebi
demonstr
possibl
similar
human
isol
sequenc
analys
blactxm
gene
reveal
almost
equal
proport
type
multi
locu
sequenc
type
enabl
strain
assign
differ
st
detect
strain
appeal
isol
differ
european
countri
urinari
tract
wound
infect
dog
one
hors
sequenc
analysi
blactxm
gene
confirm
presenc
type
strain
otyp
ont
macrorestrict
pattern
either
ident
close
relat
similar
confirm
clonal
relationship
strain
result
suggest
transmiss
clonal
relat
group
e
coli
like
occur
human
anim
esbl
produc
isol
remain
suscept
cephamycin
egcefoxitin
carbapenem
preval
vari
greatli
site
anoth
time
given
site
studi
investig
preval
tem
esbl
produc
e
coli
isol
materi
method
use
e
coli
strain
isol
variou
clinic
materi
esbl
product
investig
doubl
disc
synergi
test
isol
bacteri
strain
test
resist
amoxicillinclavulan
acid
ceftriaxon
cefepim
imipenem
meropenem
perform
disc
diffus
method
temderiv
enzym
determin
use
polimeras
chain
reaction
isol
posit
accord
doubl
disc
synergi
test
result
presenc
tem
type
esbl
detect
e
coli
isol
antibiot
suscept
isol
determin
esbl
produc
e
coli
isol
tem
posit
tem
neg
shown
suscept
carbapenem
determin
low
rate
vitro
suscept
antibiot
conclus
determin
blatem
gene
half
amount
esbl
produc
e
coli
isol
hospit
research
shown
carbapenem
effect
medicin
temderiv
nontem
deriv
esbl
produc
e
coli
isol
think
result
use
epidemiolog
research
futur
research
support
fund
gazi
univers
increas
number
clostridium
difficil
infect
cdi
observ
within
past
year
c
difficl
exhibit
resist
erythromycin
moxifloxacin
ribotyp
predominantli
found
bavaria
southeastern
germani
recent
accumul
cdi
observ
cold
period
previous
shown
erythromycin
moxifloxacin
predominantli
prescrib
season
indic
use
antibiot
treatment
respiratori
infect
present
studi
compar
data
consumpt
variou
antibiot
class
outpati
region
number
patient
exhibit
c
difficil
toxin
tcd
posit
stool
sampl
found
neg
correl
cephalosporin
class
atc
index
rank
correl
coeffici
r
sensit
penicillin
combin
sulfonamid
trimethoprim
includ
deriv
macrolid
posit
correl
notic
second
gener
cephalosporin
combin
penicillin
includ
inhibitor
quinolon
regard
associ
quinolon
prescript
detail
compar
low
posit
correl
coeffici
calcul
moxifloxacin
r
levofloxacin
r
howev
strong
posit
correl
coeffici
r
p
observ
ciprofloxacin
interestingli
c
difficil
isol
found
region
resist
ciprofloxacin
suggest
increas
use
ciprofloxacin
may
contribut
increas
number
cdi
wide
accept
increas
use
antibiot
select
bacteri
resist
drug
given
hand
known
restrict
use
antibiot
necessarili
guarante
declin
resist
rate
present
data
prescript
folic
acid
antagonist
ciprofloxacin
bavarian
southeastern
germani
outpati
also
number
signific
e
coli
isol
urin
sampl
proport
e
coli
resist
cotrimoxazol
ciprofloxacin
monitor
sum
ciprofloxacin
folic
acid
antagonist
prescript
stay
constant
howev
prescript
number
ciprofloxacin
increas
folic
acid
antagonist
decreas
suggest
appar
shift
treatment
urinari
infect
toward
ciprofloxacin
observ
period
proport
e
coli
resist
ciprofloxacin
increas
cotrimoxazol
increas
sinc
also
proport
e
coli
simultan
exhibit
resist
ciprofloxacin
plu
cotrimoxazol
increas
increas
use
ciprofloxacin
seem
facilit
select
resist
cotrimoxazol
even
use
declin
direct
result
cotrimoxazol
resist
urinari
e
coli
suscept
ciprofloxacin
hand
ciprofloxacin
resist
e
coli
suscept
cotrimoxazol
proport
remain
low
summari
bavaria
ciprofloxacin
increasingli
use
treatment
urinari
infect
outpati
develop
result
mark
increas
e
coli
exhibit
resist
cotrimoxazol
combin
ciprofloxacin
plu
cotrimoxazol
altogeth
pcr
ribotyp
clostridium
difficil
proven
valuabl
tool
identif
variou
strain
comparison
strain
c
difficil
ribotyp
identifi
hypervirul
strain
recent
also
c
difficil
ribotyp
suggest
exhibit
increas
pathogen
laboratori
locat
northern
bavaria
perform
microbiolog
analys
hospit
ambulatori
physician
recent
studi
c
difficil
ribotyp
frequent
isol
patient
region
contrast
c
difficil
found
sporad
ribotyp
isol
studi
distribut
c
difficil
pcr
ribotyp
isol
within
januari
march
examin
within
period
patient
suffer
cdi
observ
comparison
first
three
month
previou
year
patient
notic
indic
increas
cdi
median
age
patient
year
femal
male
c
difficil
bacteria
isol
inpati
therefor
consid
health
care
associ
percent
isol
differ
health
care
facil
contrast
percent
isol
variou
physician
obvious
communityassoci
total
ribotyp
identifi
pcr
ribotyp
agreement
previou
studi
ribotyp
still
predomin
strain
howev
isol
ribotyp
ribotyp
found
within
observ
period
far
data
show
expect
number
cdi
per
year
alreadi
overrun
first
three
month
pcr
ribotyp
predomin
also
hypervirul
ribotyp
found
region
occurr
macrolideresist
mycoplasma
pneumonia
strain
germani
r
dumk
h
von
baum
c
e
jacob
institut
medizinisch
mikrobiologi
und
hygien
technisch
dresden
dresden
germani
abteilung
medizinisch
mikrobiologi
und
hygien
ulm
ulm
germani
mycoplasma
pneumonia
mp
one
common
caus
communityacquir
infect
human
upper
lower
respiratori
tract
lead
sever
longlast
interstiti
pneumonia
accord
fact
mycoplasma
cell
wallless
bacteria
macrolid
case
first
choic
antibiot
treatment
mp
infect
resist
macrolid
base
point
mutat
domain
v
rrna
gene
mp
occurr
macrolideresist
shown
recent
studi
japan
china
mp
strain
investig
resist
comprehens
overview
worldwid
macrolideresist
hamper
problem
cultiv
mp
strain
success
establish
refer
laboratori
use
molecular
method
like
realtim
pcr
offer
possibl
cultureindepend
characteris
circul
mp
strain
includ
resist
first
studi
mainli
investig
respiratori
tract
sampl
adult
patient
molecular
method
order
detect
actual
macrolideresist
mpposit
specimen
addit
investig
strain
isol
patient
differ
age
includ
get
comprehens
survey
macrolideresist
mp
time
germani
total
respiratori
tract
specimen
adult
outpati
confirm
mp
pneumonia
sampl
patient
strain
isol
germani
test
macrolideresist
use
pcr
realtim
pcr
sequenc
rrna
gene
mp
respiratori
tract
sampl
strain
found
resist
result
indic
limit
neglig
import
macrolideresist
mp
investig
popul
requir
monitor
macrolid
suscept
isol
strain
test
respiratori
sampl
molecular
method
g
valenza
frosch
abel
horn
institut
hygien
und
mikrobiologi
germani
total
clinic
campylobact
strain
c
jejuni
c
coli
c
lari
collect
test
antimicrobi
suscept
erythromycin
ciprofloxacin
doxycyclin
meropenem
campylobact
isol
resist
ciprofloxacin
doxycyclin
none
resist
erythromycin
meropenem
howev
campylobact
isol
intermedi
suscept
erythromycin
mic
mgl
data
confirm
valu
macrolid
drug
chois
treatment
sever
campylobact
infect
nevertheless
antimicrobi
suscept
test
alway
perform
j
fakhari
g
ebrahimipour
laleh
faculti
biolog
scienc
gc
shahid
beheshti
univers
tehran
iran
faculti
scienc
shahid
beheshti
univers
tehran
iran
need
new
antibiot
becom
increas
appar
last
year
rise
antibiot
resist
bacteria
aim
studi
isol
bacteria
digest
system
iran
endem
slug
produc
antimicrobi
compon
antimicrobi
effect
sampl
done
slug
digest
system
bacteria
isol
nutrient
agar
accord
coloni
morpholog
color
identif
bacteria
done
phylogeni
method
standard
biochem
test
detect
antimicrobi
activ
agar
diffus
test
standard
test
organ
steril
antibiot
assay
disk
soak
supernat
cultur
broth
strain
put
plate
standard
test
organ
check
afterward
inhibit
zone
extract
antimicrobi
compon
chloroform
nhexan
ethyl
acet
use
solvent
mix
supernat
antimicrobi
test
done
solvent
wateri
phase
four
bacteria
isol
best
bacterium
select
studi
bacterium
oblig
aerob
gram
neg
coccubasilshap
catalaseposit
oxidaseposit
produc
greenblu
pigment
mention
bacterium
seem
affin
standard
test
organ
analys
show
antimicrobi
product
nonpolar
due
high
antimicrobi
effect
bacterium
well
incresc
need
new
antibiot
purif
identif
antimicrobi
compon
seem
necessari
introduc
new
medicin
sourc
objekt
aim
studi
examin
oral
pathogen
odontogen
abscess
gingiv
infiltr
suscept
moxifloxacin
mxf
levofloxacin
lvx
penicillin
pen
amoxicillinclavulan
acid
amxcla
doxycyclin
dox
clindamycin
cli
patient
method
prospect
random
doubleblind
multicent
phase
ii
trial
compar
efficaci
toler
mxf
cli
treatment
odontogen
abscess
inflammatori
infiltr
analysi
microbi
paramet
part
secondari
endpoint
result
two
hundr
five
bacteria
isol
patient
viridan
streptococci
prevotella
spp
neisseria
spp
streptococcu
angin
group
hemolyt
streptococci
anaerob
bacteria
pathogen
suscept
mxf
follow
amxcla
lvx
pen
cli
dox
angin
group
hemolyt
streptococci
detect
significantli
frequent
patient
abscess
compar
patient
infiltr
four
patient
within
infiltr
group
therapi
failur
follow
cli
viridian
streptococci
neisseria
spp
could
detect
resist
cli
conclus
studi
mxf
show
convinc
vitro
vivo
activ
odontogen
bacteria
compar
cli
justifi
use
treatment
odontogen
abscess
infiltr
analys
clearli
indic
angin
group
hemolyt
streptococci
associ
odontogen
abscess
viridian
streptococci
neisseria
spp
play
decis
role
pathogenesi
odontogen
infiltr
hdp
human
consist
amino
acid
characteris
disulfidstabil
structur
highli
cation
peptid
net
charg
interfer
simultan
differ
membranebound
process
staphylococcu
aureu
strain
especi
cell
wall
biosynthesi
lead
effect
kill
bacteri
cell
sass
et
al
sass
et
al
submit
studi
efficaci
clinic
isol
aureu
obtain
inform
strainspecif
variat
may
contribut
colon
host
pathogen
therefor
persist
strain
pair
replac
replac
strain
well
isol
new
occur
mrsa
strain
chosen
mic
determin
measur
cell
surfac
charg
analys
transcript
respons
treatment
identifi
substanti
differ
result
demonstr
grar
vrar
two
compon
regulatori
system
abc
transport
vrade
play
import
role
appropri
staphylococc
hdp
counteract
sinc
e
g
mutat
grar
system
strongli
enhanc
suscept
toward
antimicrobi
compound
target
cell
wall
biosynthesi
cell
membran
synergist
antimicrobi
activ
folic
acid
antagonist
nucleosid
analog
j
zander
besier
h
ackermann
ta
wichelhau
institut
medizinisch
mikrobiologi
johann
wolfgang
frankfurt
main
germani
institut
biostatistik
johann
wolfgang
frankfurt
frankfurt
main
germani
antimicrobi
activ
folic
acid
antagonist
suppos
counteract
elev
extracellular
thymidin
concentr
damag
host
tissu
therefor
studi
aim
screen
nucleosid
analog
impair
bacteri
util
extracellular
thymidin
analyz
combin
antimicrobi
activ
trimethoprimsulfamethoxazol
sxt
divers
nucleosid
analog
staphylococcu
aureu
evalu
antimicrobi
spectrum
sxt
combin
nucleosid
analog
show
sever
nucleosid
analog
particular
halogen
deriv
substanti
impair
bacteri
util
extracellular
thymidin
aureu
timekil
method
reveal
combin
restor
antimicrobi
activ
sxt
presenc
thymidin
lead
bactericid
effect
even
concentr
nucleosid
analog
moreov
combin
sxt
show
broad
spectrum
activ
presenc
thymidin
compris
sever
gramposit
gramneg
bacteria
conclus
data
provid
direct
evid
antimicrobi
activ
sxt
significantli
improv
presenc
thymidin
combin
nucleosid
analog
recent
number
staphylococcu
aureu
infect
show
trend
higher
percentag
commun
aquir
case
compar
hospit
aquir
one
risk
sever
aureu
infect
therefor
longer
problem
restrict
health
care
unit
also
present
everi
day
life
consequ
continu
rapid
develop
spread
resist
mechan
pathogen
commonli
appli
antibiot
constitut
major
challeng
concern
discoveri
design
new
antibacteri
substanc
among
varieti
compound
belong
class
bisquaternari
naphthalimid
one
substanc
meanwhil
name
show
remark
antimicrobi
effect
gramposit
bacteria
exampl
staphylococcu
strain
minim
inhibitori
concentr
mic
aureu
strain
aureu
strain
epidermidi
strain
compar
microarray
experi
antibiot
known
mode
action
perform
gain
insight
mechan
purpos
ciprofloxacin
dnagyras
inhibitor
gentamycin
inhibitor
protein
synthesi
oxacillin
inhibitor
cell
wall
synthesi
appli
number
well
type
gene
signif
upor
downregul
treatment
bacteri
cultur
similar
result
obtain
treatment
ciprofloxacin
similar
result
obtain
compar
radioact
whole
cell
label
experi
record
activ
caus
integr
radioact
label
thymidin
strongli
decreas
supplement
ciprofloxacin
cultur
drawn
conclus
studi
bisquaternari
naphthalimid
interfer
dna
metabol
gramposit
bacteria
b
arntjen
heisig
p
heisig
pharmaceut
biolog
microbiolog
univers
hamburg
hamburg
germani
vitro
select
e
coli
wt
ciprofloxacin
yield
slowli
grow
highlevel
fluoroquinolon
resist
hlfqr
mutant
mutat
gene
gyra
parc
marr
grow
mutant
without
select
pressur
result
mutant
show
wtlike
growth
rate
partial
loss
mar
phenotyp
dna
sequenc
analysi
mar
loc
reveal
two
differ
point
mutat
mara
thu
studi
aim
investig
impact
mara
mutat
phenotyp
compens
mutant
mara
point
mutat
introduc
chromosom
parent
strain
wt
ist
marr
delet
deriv
wtiii
sitedirect
mutagenesi
yield
mic
determin
absenc
presenc
nasalicyl
sal
activ
mara
express
delet
marr
slightli
increas
growth
rate
wtiii
compar
wt
mara
point
mutat
alon
slight
reduc
influenc
doubl
time
wt
wtiii
respect
antibiot
suscept
mic
mic
decreas
twofold
fourfold
mara
mutant
wt
wt
iii
respect
addit
nasalicyl
result
increas
mic
fourfold
wt
wt
iii
correspond
mara
mutant
mar
phenotyp
includ
hlfqr
revert
two
differ
mara
point
mutat
leav
growth
rate
nearli
unaffect
indic
essenti
role
mar
gene
develop
stabl
hlfqr
emerg
antimicrobi
drug
resist
enorm
public
concern
due
increas
risk
delay
treatment
infect
increas
length
hospit
stay
substanti
increas
cost
care
high
risk
fatal
outcom
prerequisit
develop
effect
therapi
altern
detail
understand
divers
bacteri
mechan
underli
drug
resist
especi
problemat
gramneg
bacteria
pseudomona
aeruginosa
pathogen
provid
impress
chromosomallyencod
mechan
intrins
resist
well
potenti
mutat
gain
resist
current
antibiot
studi
screen
comprehens
harvard
nonredund
librari
p
aeruginosa
mutant
either
exhibit
increas
decreas
resist
antibiot
commonli
use
clinic
approach
identifi
sever
gene
whose
inactiv
sensitis
bacteria
toward
broad
spectrum
differ
antimicrobi
uncov
novel
genet
determin
resist
variou
class
antibiot
knowledg
enhanc
bacteri
suscept
exist
antibiot
novel
resist
marker
modifi
resist
express
may
lay
foundat
effect
therapi
altern
basi
develop
new
strategi
control
problemat
multiresist
gramneg
bacteria
calcul
interpret
result
synerg
defin
fici
indiffer
fici
antagon
fici
result
test
perform
sa
reveal
signific
effect
contrast
synerg
observ
strain
caz
cro
pt
imp
respect
likewis
vast
major
test
perform
ef
strain
reveal
indiffer
effect
dap
plu
rif
synergist
one
strain
test
perform
efm
reveal
signific
effect
synergi
observ
strain
rif
amp
gen
van
one
strain
amk
conclus
gener
dap
combin
antibacteri
drug
show
synergist
effect
particular
caz
howev
may
synergist
effect
sa
dap
comb
rif
amp
may
use
treatment
efm
infect
vitro
activ
tigecyclin
compar
multicentr
surveil
trial
introduct
glycylcyclin
germani
introduct
first
surveil
trial
conduct
gtest
tigecyclin
first
glycylcyclin
exhibit
excel
vitro
activ
mani
gramposit
gramneg
organ
howev
data
suscept
tigecyclin
compar
introduct
new
class
antibiot
germani
miss
tigecyclin
indic
treatment
complic
skin
skin
structur
infect
complic
intraabdomin
infect
method
multicentr
trial
suscept
clinic
isol
frequent
encount
bacteri
speci
recov
wound
intraabdomin
specimen
blood
test
tigecyclin
antimicrobi
agent
gtest
ii
isol
collect
medic
microbiolog
laboratori
throughout
germani
suscept
pattern
determin
use
microdilut
method
central
laboratori
result
suscept
bacteri
isol
collect
gtest
ii
determin
compar
data
obtain
gtest
tigecyclin
demonstr
unchang
high
invitro
activ
gramposit
gramneg
organ
includ
multiresist
strain
contrast
rate
vancomycinresist
enterococci
among
enterococcu
faecium
isol
almost
doubl
reach
addit
increas
resist
cefotaxim
escherichia
coli
klebsiella
pneumonia
went
along
rise
extendedspectrum
betalactamaseproduc
strain
respect
among
acinetobact
baumannii
group
isol
increas
resist
imipenem
appar
conclus
accord
data
obtain
multicentr
surveil
trial
context
steadili
rise
rate
organ
resist
variou
antibiot
class
tigecyclin
repres
suitabl
treatment
option
linezolidresist
enterococcu
faecium
strain
mic
isol
tracheal
secret
patient
month
intens
care
unit
total
month
hospit
patient
discharg
rehabilit
much
better
condit
molecular
pcr
sequenc
analysi
e
faecium
isol
reveal
linezolid
resist
associ
point
mutat
rdna
transvers
mutat
previous
describ
caus
linezolid
resist
clinic
enteroccci
isol
rapid
emerg
resist
linezolid
e
faecium
isol
contradict
previou
report
indic
resist
aris
prolong
therapi
antibiot
interestingli
linezolidresist
e
faecium
isol
week
termin
linezolid
therapi
kind
unusu
sinc
linezolid
resist
far
describ
occur
linezolid
therapi
gramposit
bacterium
staphylococcu
aureu
caus
wide
rang
diseas
caus
hospitalaquir
infect
worldwid
due
increas
resist
standard
antibiot
treatment
highli
desir
develop
novel
antiinfect
strategi
pathogen
one
major
risk
factor
develop
infect
pathogen
colon
skin
approxim
human
popul
carri
bacterium
anterior
nose
unsymptomat
immun
system
weaken
eg
hiv
patient
immun
suppress
organ
transplant
colon
lead
infect
origin
microflora
aureu
abl
secret
varieti
adhes
factor
enabl
bacteri
cell
adher
extracellular
matrix
plasma
protein
host
project
aim
identifi
develop
compound
interfer
adher
aureu
epitheli
cell
prevent
interrupt
colon
skin
therefor
establish
adhes
assay
util
autom
microscop
determin
bacteri
adher
eukaryot
cell
novel
quantif
method
suitabl
highthroughput
screen
establish
valid
method
present
aim
incid
tularemia
low
minim
infecti
dose
caus
agent
francisella
tularensi
still
consid
one
concern
bioterrorist
weapon
recommend
postexposur
prophylaxi
therapi
base
reliabl
suscept
data
due
lack
european
data
need
result
clsiapprov
manner
method
determin
antibiot
suscept
select
f
tularensi
holarctica
isol
origin
germani
austria
franc
spain
european
countri
use
commerci
avail
custom
broth
microdilut
test
system
micronaut
merlin
germani
furthermor
includ
strain
opportunist
pathogen
francisella
philomiragia
unusu
strain
genu
francisella
test
panel
compris
antibiot
includ
chloramphenicol
ciprofloxacin
erythromycin
gentamicin
levofloxacin
streptomycin
tetracyclin
result
expect
mic
observ
consist
publish
data
studi
investig
antimicrobi
suscept
f
tularensi
isol
although
erythromycin
recommend
therapeut
drug
tularemia
observ
two
geograph
distinct
group
f
tularensi
holarctica
isol
overlap
small
region
germani
contrast
francisella
tularensi
sever
strain
francisella
philomiragia
found
resist
toward
quinolon
tetracyclin
conclus
perform
accord
clsi
criteria
studi
contribut
reliabl
data
antibiot
suscept
pattern
european
francisella
isol
furthermor
standard
methodolog
use
test
suspici
coloni
clinic
specimen
therapeut
guidanc
gentamicin
streptomycin
prefer
therapi
francisella
philomiragiainfect
immunocompromis
patient
preval
antimicrobi
resist
antisept
disinfect
preserv
steril
lead
format
special
sourc
hospitalacquir
infect
biocid
solut
hospit
strain
microorgan
emerg
surviv
multipli
therefor
monitor
resist
biocid
among
hospit
microorgan
actual
task
medicin
minim
bacteriocid
concentr
mbc
disinfect
determin
lysoformin
spezial
lysoformin
neoform
plu
sonata
rel
strain
microorgan
isol
larg
hospit
saintpetersburg
russia
suspens
method
use
micropanel
assess
activ
disinfect
index
activ
use
calcul
criterion
case
mbc
disinfect
test
strain
lowest
work
concentr
recommend
instruct
use
biocid
case
recommend
minim
concentr
biocid
exceed
mbc
less
time
thu
strain
resist
test
disinfect
none
test
strain
nt
found
resist
neoform
plu
observ
reveal
shelf
life
work
solut
recommend
manufactur
alway
case
activ
work
solut
one
disinfect
reduc
store
proper
condit
th
day
store
biocid
solut
activ
enterobact
cloacea
klebsiella
pneumonia
although
manufactur
recommend
shelf
life
work
solut
amount
day
thu
disinfect
well
case
steril
import
much
control
output
valid
process
toward
end
necessari
control
appear
resist
strain
time
chang
disinfect
l
marlinghau
kort
sg
gatermann
sakinc
institut
hygien
und
medizinisch
mikrobiologi
bochum
bochum
germani
approach
character
dserinetransport
saprophyticu
construct
analysi
singl
doubleand
tripleknockout
mutant
select
marker
saprophyticu
limit
search
addit
resist
determin
clinic
isol
found
tetracyclin
resist
saprophyticu
strain
isol
sequenc
plasmid
belong
usual
found
staphylococcu
aureu
staphylococcu
epidermidi
name
plmt
like
consist
bp
gccontent
differ
manifest
mismatch
includ
gap
result
amino
acid
exchang
gene
repc
pre
tetk
interest
tetk
gene
code
tetracyclin
efflux
pump
may
use
select
marker
gener
mutantstrain
transform
plasmid
staphylococcu
carnosu
saprophyticu
becam
tetracyclineresist
amplifi
tetk
gene
plu
promotor
region
via
pcr
ligat
mutagenesi
construct
clone
shuttl
vector
saprophyticu
transform
construct
tetracyclineresist
show
tetk
activ
saprophyticu
shown
singl
tetk
copi
chromosom
aureu
caus
tetracyclin
resist
expect
saprophyticu
permit
use
tetk
new
tool
genet
manipul
must
note
one
import
caus
urinari
tract
infect
young
women
may
tetracyclineresist
clinic
saprophyticu
isol
ca
resist
tetracyclin
stain
possess
tetkgen
nonsuscept
trend
streptococcu
pneumonia
southeastaustria
tenyear
period
hoenigl
g
feierl
e
leitner
l
masoud
e
marth
grisold
div
infecti
diseas
dept
med
med
univ
graz
graz
austria
inst
hygien
microbiol
environment
med
med
univ
graz
graz
austria
antibiot
resist
streptococcu
pneumonia
pneumonia
increas
worldwid
vari
within
geograph
region
therefor
retrospect
analysi
resist
pneumonia
period
ten
year
conduct
method
total
nondupl
pneumonia
isol
identifi
institut
hygien
microbiolog
environment
medicin
medic
univers
graz
austria
subsequ
test
antibiot
suscept
penicillin
resist
rate
mic
mgl
found
consist
low
pneumonia
isol
non
suscept
pneumococci
mic
mgl
mgl
increas
resist
remark
erythromycin
clindamycin
tetracyclin
resist
increas
trimethoprimsulfamethoxazol
increas
resist
found
chinolon
overal
resist
rate
studi
period
contrari
previous
publish
data
resist
penicillin
remain
constant
low
level
studi
period
accord
intern
trend
increas
resist
erythromycin
clindamycin
tetracyclin
trimethoprimsulfamethoxazol
found
wherea
resist
chinolon
persist
low
level
result
penicillin
resist
underlin
use
local
surveil
monitor
spread
pathogen
desper
need
new
therapeut
approach
notori
antibioticresist
bacteria
staphylococcu
aureu
led
quest
new
antibacteri
target
structur
lead
compound
howev
new
potenti
target
identifi
difficult
identifi
promis
lead
compound
recent
year
character
antibacteri
properti
synthet
compound
tpbc
recent
success
use
protect
biomateri
deviserel
infect
demonstr
tpbc
potent
bactericid
activ
mani
bacteri
pathogen
human
cell
affect
high
concentr
attempt
elucid
mode
action
tpbc
analyz
metabolom
profil
tpbctreat
aureu
cultur
obtain
strong
evid
interfer
tpbc
central
bacteri
pyruv
metabol
detail
biochem
analys
demonstr
tpbc
block
effici
eii
subunit
bacteri
pyruv
dehydrogenas
complex
pdhc
previous
never
consid
antimicrobi
target
henc
studi
reveal
pdhc
attract
target
novel
antibiot
tpbc
relat
compound
moreov
demonstr
power
recent
develop
metabolom
techniqu
analyz
mode
action
antimicrobi
introduct
antibiot
frequent
prescrib
primari
care
acut
upper
respiratori
tract
infect
urti
without
warrant
eg
common
cold
flu
physician
regularli
mention
patient
expect
reason
prescript
better
judgement
littl
known
regard
preval
expect
germani
potenti
caus
factor
influenc
knowledg
attitud
method
novemb
person
regist
larg
market
research
compani
invit
complet
onlin
questionnair
multipl
choic
likertscal
expect
toward
physician
concern
prescript
antibiot
knowledg
attitud
regard
effect
use
antibiot
context
urti
calcul
rel
frequenc
answer
stratifi
demograph
variabl
use
logist
regress
analysi
identifi
determin
expect
prescript
antibiot
suffer
common
cold
result
total
person
male
age
year
particip
respons
report
use
antibiot
absolut
necessari
prescript
antibiot
expect
common
cold
pneumonia
among
predictor
expect
antibiot
prescript
common
cold
follow
opinion
common
cold
flu
effect
treat
antibiot
reduct
ipd
children
result
german
nation
immun
program
pneumococc
conjug
vaccin
object
evalu
impact
immun
children
pneumococc
conjug
vaccin
dose
start
juli
serotyp
specif
incid
ipd
germani
use
captur
recaptur
analysi
method
ipd
case
children
report
two
independ
sourc
microbiolog
laboratori
pediatr
hospit
serotyp
perform
nation
refer
center
streptococci
age
serotyp
specif
incid
rate
base
captur
recaptur
estim
combin
two
report
sourc
result
children
period
jul
eight
report
case
caus
serotyp
comparison
jul
reduct
signific
serotyp
vs
vs
vs
serotyp
case
serotyp
increas
vs
incid
ipd
children
decreas
pre
vaccin
postvaccin
reduct
incid
attribut
signific
reduct
children
age
group
incid
serotyp
strongli
reduc
incid
nonvaccin
serotyp
remain
stabl
conclus
two
year
introduct
reduct
report
case
ipd
vaccin
serotyp
children
almost
incid
ipd
children
reduc
wherea
signific
increas
incid
nonvaccin
serotyp
observedthi
reflect
success
vaccin
programm
possibl
higher
serotyp
rate
may
explain
observ
increas
report
case
nonvaccin
serotyp
report
epidemiolog
analysi
suspect
mrsaoutbreak
univers
hospit
southern
germani
infect
control
staff
report
cluster
nosocomi
mrsa
case
icu
within
one
week
investig
patient
histori
reveal
transfer
patient
icua
icub
ongo
outbreak
suspect
addit
screen
icu
staff
initi
member
test
posit
mrsa
epidemiolog
analysi
use
spa
type
perform
mrsa
isol
reveal
two
independ
outbreak
one
patient
icu
spa
type
anoth
outbreak
patient
staff
member
icu
b
howev
remain
staff
member
colon
differ
mrsa
strain
relat
two
outbreak
strain
use
spatyp
method
could
dissect
suspect
outbreak
two
independ
cluster
includ
two
staff
member
obviou
clonal
relationship
addit
could
prove
remain
mrsaposit
staff
member
involv
outbreak
scenario
origin
assum
sum
investig
clearli
show
spatyp
use
tool
rapid
analysi
suspect
mrsaoutbreak
qualiti
network
euregio
mrsanet
aim
prevent
spread
mrsa
dutchgerman
border
area
sinc
common
approach
admiss
screen
risk
patient
establish
network
hospit
implement
supervis
public
health
author
hospit
agre
perform
aureu
protein
spa
type
everi
first
mrsa
isol
patient
blood
cultur
isol
type
result
collect
central
databas
sinc
euregio
pigfarm
high
socioeconom
impact
special
attent
paid
isol
clonal
complex
cc
eg
spa
type
increas
prescript
broadspectrum
antibiot
regard
facilit
select
multiresist
germ
surveil
outpati
antibiot
use
might
contribut
effort
made
prevent
spread
methicillinresist
aureu
mrsa
within
region
network
euregio
mrsanet
issu
address
offer
train
session
mrsa
antibiot
awar
gener
practition
cooper
associ
statutori
health
insur
physician
westphalialipp
kvwl
repres
german
part
euregio
region
north
rhinewestphalia
furthermor
possibl
reimburs
mrsa
erad
therapi
outpati
creat
present
first
data
compar
use
select
antibiot
outpati
care
medic
doctor
euregio
kvwl
region
region
data
outpati
prescript
antibiot
base
defin
daili
dose
ddd
collect
kvwl
analyz
year
order
compar
prescript
differ
antibiot
like
fluoroquinolon
mupirocin
euregio
whole
kvwl
region
use
cochran
armitag
trend
test
altogeth
total
ddd
day
per
inhabit
prescrib
follow
respect
increas
total
number
antibiot
number
fluorochinolon
prescript
significantli
lower
euregio
compar
whole
kvwl
region
contrast
number
mupirocin
prescript
increas
significantli
euregio
kvwl
region
desir
euregio
tend
prudent
antibiot
use
increas
number
mupirocin
prescript
among
outpati
reflect
grow
demand
facilit
new
refund
possibl
increas
implement
mrsa
erad
therapi
outpati
care
german
physician
role
antibiot
therapi
resist
germani
attitud
intervent
e
velasco
w
espelag
noll
barger
eckmann
abteilung
infektionsepidemiologi
robert
koch
institut
berlin
germani
introduct
md
import
role
alongsid
contribut
factor
rise
consumpt
well
resist
certain
treatment
conduct
nation
survey
md
germani
assess
behaviour
influenc
antibiot
prescrib
potenti
relat
intervent
address
antibiot
resist
method
repres
sampl
compris
md
differ
practic
specialti
stationari
ambulatori
set
feder
state
survey
question
focus
md
experi
antibiot
use
intervent
improv
resist
questionnair
distribut
particip
via
state
medic
associ
result
among
survey
respond
n
respons
rate
report
prescrib
antibiot
daili
indic
least
weekli
survey
md
report
think
prescrib
practic
influenc
antibiot
resist
region
md
found
import
continu
improv
use
antibiot
industri
independ
expert
provid
consult
audit
feedback
md
found
import
provis
region
coverag
antibiot
resist
appropri
feedback
practic
md
found
import
provis
antibiot
regul
prescript
appropri
feedback
practic
md
conclus
mani
md
prescrib
antibiot
often
believ
practic
may
affect
antibiot
resist
md
valu
inform
intervent
surveil
order
support
respons
use
antibiot
find
compliment
nation
german
antibiot
resist
strategi
surveil
system
develop
monitor
antibiot
use
resist
eckmann
noll
feig
e
velasco
b
schweickert
g
kraus
abteilung
infektionsepidemiologi
robert
koch
institut
berlin
germani
introduct
method
continu
surveil
antibiot
resist
precondit
creat
guidelin
antibiot
therapi
ar
provid
structur
resist
data
includ
data
minim
inhibit
concentr
interpret
data
sir
stratifi
use
norm
collect
clinic
relev
pathogen
found
stationari
ambulatori
medicin
data
stratifi
sourc
clinic
subject
aim
region
demonstr
aggreg
data
publicli
present
ar
websit
close
forum
particip
laboratori
sampl
hospit
sampl
medic
practic
transmit
result
e
coli
isol
aureu
isol
often
isol
pathogen
preliminari
result
e
coli
resist
cefotaxim
ciprofloxacin
respect
stationari
medicin
respect
ambulatori
practic
k
pneumonia
resist
cefotaxim
stationari
medicin
ambulatori
practic
comparison
e
coli
resist
ciprofloxacin
lower
stationari
ambulatori
p
aeruginosa
resist
ceftazidim
piperacillin
imipenem
ciprofloxacin
stationari
medicin
ambulatori
medicin
respect
oxacillin
resist
aureu
reach
stationari
medicin
ambulatori
practic
conclus
consist
previou
find
across
pathogen
investig
resist
antibiot
clearli
preval
hospit
outpati
health
careexpans
continu
surveil
system
allow
repres
interpret
epidemiolog
situat
identif
trend
germani
median
erythromycin
use
account
total
macrolid
use
interdisciplinari
icu
medic
surgic
icu
median
percentag
macrolid
total
antibiot
use
rang
interdisciplinari
rang
medic
rang
surgic
icu
conclus
erythromycin
use
antibiot
also
system
act
prokinet
drug
eg
treat
postop
adynam
ileu
patient
undergo
abdomin
surgeri
howev
recent
cochran
report
state
erythromycin
show
homogen
consist
absenc
effect
prokinet
drug
therefor
seem
worthwhil
revis
indic
erythromycin
use
macrolid
use
account
consider
total
antibiot
use
icu
erythromycin
use
promot
spread
antibiot
resist
known
risk
factor
mrsa
appropri
antibiot
therapi
prior
c
difficil
infect
onset
three
multivari
model
abl
demonstr
bed
occup
rate
gener
ward
signific
influenc
incid
nosocomi
mrsa
incid
nosocomi
esbl
incid
cdi
similarli
monthli
averag
length
stay
intens
care
unit
icu
show
signific
influenc
three
incid
conclus
overcrowd
gener
ward
long
period
icustay
could
identifi
drive
factor
incid
hospit
acquir
infect
hospit
set
role
immunemodulatori
function
semimatur
dendrit
cell
ecn
e
coli
abl
significantli
reduc
adher
epec
cell
line
although
inhibit
capac
two
strain
differ
found
papfimbria
one
major
differ
genom
two
strain
howev
delet
papoperon
e
coli
signific
effect
inhibit
epec
adher
compar
wild
type
e
coli
describ
though
delet
papoperon
result
enhanc
express
type
fimbria
also
suspect
mediat
adhes
ecn
therefor
current
delet
fimbriaeencod
foc
operon
aim
annihil
epec
adhes
inhibit
part
probiot
effect
ecn
vsl
clinic
relev
probiot
mixtur
context
inflammatori
bowel
diseas
ibd
protect
mechan
activ
bacteri
structur
unknown
present
studi
analys
bacteri
strainspecif
antiinflammatori
effect
vsl
intestin
epitheli
cell
iec
protect
mechan
vsl
context
ileal
colon
inflamm
vsl
select
inhibit
tnfinduc
secret
tcell
chemokin
interferoninduc
protein
modek
cell
lactobacillu
casei
l
casei
cell
surfac
protein
well
pmsfsensit
secret
protein
identifi
activ
compon
vsl
suggest
bacteri
proteas
play
role
inhibit
l
casei
fail
block
tnfinduc
gene
transcript
wherea
secret
tcell
transmigr
inhibit
kineticand
pulsechas
experi
well
brefeldin
ainduc
blockad
export
machineri
show
l
casei
impair
initi
product
decreas
intracellular
stabil
inhibit
vesicular
traffick
inhibit
express
mimick
inhibitori
effect
l
casei
find
suggest
l
casei
impair
vesicular
pathway
import
secret
follow
subsequ
degrad
proinflammatori
chemokin
preand
post
wean
feed
studi
reveal
vsl
protect
tnf
mice
contrast
vsl
feed
mice
result
significantli
reduc
cecal
inflamm
consist
protein
express
reduc
primari
cecal
epitheli
cell
demonstr
intestin
segment
specif
effect
probiot
intervent
correl
protein
express
nativ
epithelium
l
caseiinduc
posttransl
degrad
iec
found
new
probiot
mechan
contribut
antiinflammatori
effect
vsl
n
kramko
c
cichon
l
greun
schmidt
infectiolog
institut
westfaelischewilhelm
univers
germani
one
key
question
gut
immun
distinguish
commens
harm
microb
direct
immun
respons
toward
need
rout
though
epitheli
cell
constitut
first
cellular
barrier
microbi
infect
phagocyt
play
essenti
role
fight
pathogen
work
focus
human
dendrit
cell
dc
monocyt
main
predecessor
dc
intestin
barrier
dc
antigen
present
cell
phagocyt
abil
potent
induc
regulatori
cell
treg
popul
therefor
import
toler
induct
toward
commens
speci
achiev
yet
fulli
understood
present
studi
investig
whether
human
monocytederiv
dc
might
interact
respond
differenti
infect
pathogen
escherichia
coli
epec
probiot
e
coli
nissl
e
coli
strain
respons
dc
investig
employ
viabil
use
flow
cytometri
immunofluoresc
dna
microarray
analysi
cocultur
model
includ
dc
epitheli
cell
also
use
studi
aspect
infect
process
antiinflammatori
activ
b
bifidum
strain
ragcolit
mice
bifidobacteria
sever
benefici
effect
host
straindepend
antiinflammatori
activ
variou
strain
speci
bifidobacteria
previous
shown
group
vitro
experi
use
lpschalleng
cell
analys
antiinflammatori
effect
strain
b
bifidum
good
adhes
properti
intestin
epitheli
cell
mous
model
murin
coliti
transfer
tcell
popul
wild
type
congen
mice
lead
develop
coliti
mediat
thelper
type
cell
due
lack
matur
regulatori
tcell
mice
placebocontrol
set
one
group
mice
n
receiv
b
bifidum
cfu
per
anim
pb
follow
immedi
transfer
tcell
two
control
group
receiv
placebo
one
group
also
transfer
tcell
induc
coliti
feed
probiot
placebo
continu
three
time
week
weight
record
day
anim
sacrif
antiinflammatori
effect
feed
b
bifidum
strain
assess
measur
weight
length
dissect
colon
histolog
score
colon
tissu
sampl
quantit
real
time
pcr
variou
proinflammatori
cytokin
addit
composit
bacteri
flora
mice
analys
denatur
gradient
gel
electrophoresi
activ
endogen
matrix
metalloproteinas
mmp
play
import
role
pathogenesi
chronic
intestin
inflamm
studi
investig
influenc
bacteriaderiv
proteas
develop
intestin
inflamm
monoassoci
experi
wild
type
wt
defici
mice
enterococcu
faecali
e
faecali
strain
reveal
increas
mrna
express
level
bacteri
gelatinas
e
gele
condit
experiment
coliti
character
role
bacteri
proteas
pathogenesi
intestin
inflamm
monoassoci
wt
mice
week
e
faecali
strain
isogen
mutant
strain
gele
delet
fsrb
delet
lack
gele
express
histopatholog
analysi
reveal
signific
reduct
distal
proxim
colon
tissu
patholog
absenc
bacteri
gele
transwel
experi
concentr
condit
media
cm
e
faecali
demonstr
tremend
decreas
ter
valu
murin
intestin
epitheli
cell
line
wherea
gele
defici
mutant
strain
affect
barrier
integr
consist
result
purifi
proteolyt
activ
gele
caus
dramat
decreas
ter
valu
well
support
hypothesi
gele
impair
barrier
integr
intestin
epithelium
context
identifi
barrier
relat
protein
ecadherin
potenti
target
gele
show
e
faecalisderiv
gelatinas
e
contribut
develop
experiment
coliti
mice
transwel
cultur
gele
led
impair
epitheli
barrier
integr
suggest
bacteri
proteas
contribut
pathogenesi
intestin
inflamm
order
establish
success
pathogen
acut
recurr
infect
streptococcu
pyogen
group
streptococcu
ga
pass
layer
resid
microflora
gain
access
final
target
epitheli
cell
upper
human
respiratori
tract
comparison
interact
pyogen
salivariu
two
strain
orali
member
physiolog
microflora
done
find
new
promis
candid
probiot
bacteria
pyogen
infect
treatment
cocultur
experi
direct
indirect
contact
well
bacteriocin
assay
reveal
salivariu
inhibit
pyogen
growth
stronger
orali
sem
clsm
analys
show
pyogen
establish
member
mix
speci
biofilm
salivariu
orali
vitro
howev
orali
act
like
substrat
pyogen
mix
speci
biofilm
wherea
salivariu
becom
domin
strain
mix
speci
biofilm
pyogen
addit
salivariu
orali
protect
epitheli
host
cell
pyogen
inflict
damag
introduc
two
hour
pyogen
infect
adherenceintern
cytotox
assay
use
cell
eukaryot
cell
model
sem
analys
show
salivariu
act
probiot
via
suppress
pyogen
growth
develop
protect
biofilm
top
eukaryot
target
cell
contrast
orali
induc
protect
eukaryot
cell
without
cell
adhes
biofilm
format
alter
host
immunitycytoskeleton
factor
surfac
protein
proteas
chaperon
base
transcriptom
data
analysi
interact
gramneg
probiot
intestin
epitheli
cell
perspect
inflammatori
bowel
diseas
treatment
k
veltman
hummel
c
cichon
schmidt
depart
infectiolog
zmbe
germani
gastrointestin
tract
harbour
complex
microbi
ecosystem
engag
continu
crosstalk
host
balanc
relationship
intestin
epitheli
cell
iec
gut
microb
disturb
result
activ
mucos
immun
system
contribut
develop
inflammatori
bowel
diseas
ibd
use
cell
cultur
model
analyz
cellular
respons
iec
coincub
gramnegativ
probiot
strain
ecoli
nissl
colon
mutant
urogen
strain
abu
take
account
ibd
may
develop
defect
barrier
function
base
affymetrix
microarray
data
infect
iec
focuss
protein
apic
junction
complex
ajc
ecadherin
occludin
protein
therefor
gener
barrier
function
also
regul
protein
level
differ
pkc
isoform
use
transepitheli
resist
ter
monolay
read
system
monitor
epitheli
barrier
function
barrier
function
enforc
probiot
ecoli
disrupt
epec
infect
howev
could
reestablish
incub
gramnegativ
probiot
analysi
mirna
express
febit
iec
coincub
probiot
confirm
transcript
regul
import
protein
ajc
apoptosi
mechan
inflammatori
respons
studi
reveal
cellular
respons
iec
specif
induc
gramnegativ
probiot
ecoli
strain
insight
molecular
mechan
eg
mirna
foster
develop
new
strategi
treatment
gastrointestin
diseas
gnotobiot
mice
wildtyp
mice
monocolon
escherichia
coli
mpk
develop
coliti
wherea
mice
colon
bacteroid
vulgatu
mpk
nt
furthermor
b
vulgatu
mpk
prevent
e
coli
mpk
induc
coliti
previou
work
show
monocolon
b
vulgatu
lead
enrich
semimatur
tolerogen
lamina
propria
dendrit
cell
lpdc
character
low
express
intermedi
express
mhcclassii
might
due
differ
lipida
structur
aerob
anaerob
bacteria
might
account
weaker
tolllik
receptor
signal
b
vulgatu
monocolon
investig
influenc
intestin
microbiota
surfac
express
lpdc
germfre
b
vulgatu
e
coli
monocolon
wild
type
mice
fac
stain
bone
marrow
deriv
dendrit
cell
bmdc
lpdc
detect
bmdc
stimul
variou
bacteria
featur
differ
lipida
structur
impact
lipida
activ
marker
dc
analys
use
anaerob
p
gingivali
b
vulgatu
aerob
e
e
e
lipida
e
lack
one
fatti
acid
e
substitut
fatti
acid
natur
p
gingivali
bmdc
stimul
anaerob
bacteria
stronger
surfac
express
bmdc
stimul
wildtyp
mutant
stimul
e
led
weaker
regul
compar
wildtyp
mutant
bmdc
stimul
p
gingivali
b
vulgatu
reveal
reduc
mhcclassii
surfac
express
compar
bmdc
stimul
differ
e
coli
strainsalter
lipida
structur
substitut
fatti
acid
e
suffici
alter
surfac
intern
bmdc
wherea
state
activ
stay
analyz
invas
properti
probiot
strain
escherichia
coli
nissl
j
hassk
c
brandt
f
gunzer
institut
medic
microbiolog
hygien
medic
faculti
carl
gustav
caru
tu
dresden
dresden
germani
probiot
charact
escherichia
coli
nissl
ecn
demonstr
numer
studi
although
respons
molecular
mechan
still
investig
probiot
ecn
wide
use
therapeut
agent
treatment
sever
gastrointestin
disord
ulcer
coliti
market
trade
name
mutaflor
use
drug
human
requir
high
therapeut
safeti
especi
sinc
ecn
use
treatment
diarrhea
infant
sever
studi
support
safeti
issu
wellcharacter
strain
nevertheless
studi
publish
recent
show
invas
potenti
ecn
germfre
mice
howev
remain
unclear
properti
consid
risk
factor
regard
safeti
ecn
even
featur
probiot
behavior
vitro
experi
intestin
epitheli
cell
line
enabl
us
quantifi
invas
ecn
invas
assay
use
indic
ecn
moder
invas
lovo
cell
wherea
invas
assay
perform
comparison
highli
invas
strain
salmonella
typhimurium
noninvas
strain
escherichia
coli
futur
studi
microscop
techniqu
help
us
visual
character
invas
potenti
probiot
ecn
j
wagen
schaller
dermatolog
univers
hospit
tuebingen
tuebingen
germani
commens
yeast
candida
albican
present
oral
caviti
healthi
human
mainag
fungicaus
diseas
human
gener
c
albican
part
normal
microflora
becom
pathogen
host
immun
system
weak
sever
probiot
lactobacillu
speci
known
exert
inhibit
andor
protect
effect
c
albican
infect
vivo
vitro
therefor
choos
l
rhamnosu
gg
investig
role
speci
localis
c
albican
infect
mucos
innat
immun
system
use
model
system
localis
candidiasi
base
reconstitut
human
oral
epithelium
rhe
investig
number
differ
aspect
hostcandida
interact
well
effect
host
immun
respons
result
indic
protect
role
l
rhamnosu
gg
model
rhe
treat
candida
lactobacilli
show
significantli
lower
level
lactat
dehydrogenas
ldh
use
marker
cell
damag
compar
ldhlevel
rhe
treat
candida
also
confirm
light
microscopi
epithelium
cocultur
candida
lactobacilli
resembl
untreat
control
wherea
epithelium
cultur
candida
alon
strongli
damag
furthermor
l
rhamnosu
gg
seem
reduc
proinflammatori
cytokin
respons
rhe
toward
candida
infect
addit
regul
also
modul
use
l
rhamnosu
gg
interestingli
heat
inactiv
lactobazilli
show
effect
candida
infect
mucos
immun
respons
like
live
lactobazilli
l
rhamnosu
gg
exert
protect
effect
model
local
oral
candidiasi
might
mediat
modul
tlr
regul
identif
protein
enabl
escherichia
coli
establish
mous
intestin
j
vogelscheel
ca
alpert
w
engst
g
loh
blaut
gastrointestin
microbiolog
german
institut
human
nutrit
nuthet
germani
vivo
growth
condit
intestin
bacteria
differ
cultiv
media
analyz
bacteri
proteom
aim
gain
inform
respons
intestin
bacteria
variou
factor
host
environ
investig
use
mice
monoassoci
escherichia
coli
simplifi
model
hypothes
bacteri
adapt
reflect
modifi
bacteri
protein
express
twodimension
differ
gel
electrophoresi
follow
electrospray
ionizationtandem
mass
spectrometri
use
identifi
protein
differenti
express
e
coli
collect
cecal
content
mice
monoassoci
bacteri
speci
e
coli
grown
anox
condit
complex
medium
reflect
substrat
composit
anim
diet
protein
highest
rel
differ
abund
aspart
carbamoyltransferas
nsuccinocarboxamid
synthas
play
role
biosynthesi
purin
pyrimidin
hypothes
avail
nucleotid
cecum
diminish
prompt
e
coli
induc
enzym
synthesi
nacetylneuramin
lyas
threefold
upregul
cecum
enzym
catalyz
cleavag
nacetylneuramin
acid
form
pyruv
upregul
probabl
reflect
util
host
glycoprotein
e
coli
nacteylneuramin
lyas
key
success
establish
e
coli
gut
character
role
bacteri
candid
protein
colon
process
construct
mutant
devoid
mention
protein
result
indic
intestin
substrat
avail
key
factor
success
colon
gastrointestin
tract
harbour
complex
microbi
ecosystem
engag
continu
crosstalk
host
result
balanc
relationship
intestin
epitheli
cell
iec
gut
microb
balanc
disturb
lead
activ
mucos
immun
system
contribut
develop
inflammatori
bowel
diseas
ibd
use
transepitheli
electr
resist
ter
monolay
coincub
gramposit
probiot
bacteria
read
system
monitor
barrier
integr
base
differenti
regul
gene
take
account
ibd
may
develop
defect
intestin
barrier
function
focuss
gene
encod
adher
junction
ecadherin
protein
data
indic
barrier
function
subject
regul
differ
adher
junction
protein
gramposit
probiot
bacteria
depth
transcript
analysi
focuss
mirna
express
preliminari
result
reveal
differ
rna
molecul
affect
differ
lactobacilli
speci
protein
level
investig
regul
adher
junction
protein
assess
phosphoryl
reaction
differ
pkc
isoform
appear
modul
barrier
function
epitheli
cell
novel
upregul
coincub
cell
gramposit
lactobacilli
ecadherin
coloc
novel
respons
l
acidophilu
gener
speak
regul
barrier
function
subject
presenc
also
activ
differ
pkc
isoform
depend
impact
differ
gramposit
probiot
bacteria
studi
reveal
cellular
respons
iec
specif
induc
probiot
lactobacilli
insight
molecular
mechan
foster
develop
new
strategi
treatment
gastrointestin
diseas
eg
ibd
deliveri
biolog
activ
recombin
interleukin
escherichia
coli
use
differ
modifi
bacteri
transport
system
gram
neg
bacteria
use
differ
transport
system
protein
secret
extracellular
environ
project
aim
engin
escherichia
coli
vehicl
intestin
deliveri
antiinflammatori
cytokin
interleukin
emerg
promis
option
treatment
inflammatori
bowel
diseas
variou
bacteri
transport
system
evalu
abil
secret
biolog
activ
form
promis
export
system
e
coli
transport
gener
secret
pathway
use
leader
peptid
outer
membran
protein
f
ompf
e
coli
complet
operon
clone
base
vector
except
hemolysin
gene
replac
modifi
gene
contain
linker
hemolysin
signal
peptid
nucleotid
sequenc
end
linker
encod
potenti
cleavag
site
outer
membran
proteas
e
coli
thu
enabl
process
signal
peptid
transloc
process
export
secdepend
gener
secret
pathway
achiev
clone
codon
optim
version
gene
ompf
leader
peptid
sequenc
end
base
plasmid
secret
process
recombin
confirm
elisa
western
blot
analysi
differ
cell
fraction
biolog
activ
recombin
verifi
prolifer
assay
use
depend
murin
mast
cell
line
immunolog
assay
measur
product
lp
activ
monocyt
follow
incub
recombin
conclus
modifi
bacteri
transport
system
enabl
e
coli
secret
biolog
activ
recombin
thu
render
suitabl
carrier
deliveri
potenti
therapeut
intestin
commens
microflora
requir
differenti
nklti
cell
sano
mortha
v
bui
k
oberl
c
johner
diefenbach
immh
univers
freiburg
freiburg
germani
maxplanckinstitut
immunobiolog
maxplanckinstitut
immunobiolog
freiburg
germani
mucos
immun
system
intestin
separ
singl
layer
epitheli
cell
vast
array
microb
cue
commens
microflora
need
maintain
epitheli
homeostasi
molecular
cellular
ident
cue
unclear
show
signal
commens
microflora
contribut
differenti
lymphocyt
popul
coexpress
stimulatori
nk
cell
receptor
transcript
factor
constitut
produc
interleukin
il
emerg
cell
depend
express
indic
cell
may
nk
cell
rather
deriv
lymphoid
tissueinduc
lti
cell
interestingli
cell
locat
togeth
cell
within
cryptopatch
small
intestin
cell
popul
constitut
produc
regul
epitheli
express
protein
involv
antimicrobi
protect
epitheli
surfac
tissu
regener
eg
regiii
protein
mice
genet
lack
develop
cryptopatch
epitheli
express
regiii
protein
crypt
strongli
diminish
propos
releas
cryptopatchresid
cell
promot
mucos
homeostasi
lactobacillu
reuteri
transient
activ
intestin
epitheli
cell
mice
complex
microbiota
earli
stage
colon
monoassoci
germfre
anim
colitogen
probiot
bacteri
strain
trigger
intestin
epitheli
cell
iec
activ
hostderiv
feedback
mechan
character
impact
singl
nonpathogen
bacteri
strain
intestin
epithelium
presenc
establish
microbiota
inocul
reconstitut
lacotobacillusfre
rlf
mice
wk
age
lactobacillu
reuteri
primari
iec
small
intestin
l
reuteriinocul
control
rlf
mice
isol
inocul
follow
gene
express
analysi
realtim
pcr
affymetrix
microarray
well
electrophores
sdspage
peptid
mass
fingerprint
via
malditof
ms
gene
express
proinflammatori
cytokin
chemokin
includ
interleukin
il
protein
macrophag
inflammatori
protein
transient
induc
wherea
gene
express
level
regulatori
protein
tollinteract
protein
decreas
addit
target
protein
chang
steadyst
protein
express
level
identifi
l
reuteri
colon
consist
absenc
histopatholog
l
reuteriinduc
activ
primari
iec
return
control
level
inocul
rlf
mice
capabl
l
reuteri
directli
trigger
epitheli
cell
activ
confirm
small
iec
cultur
use
murin
cell
line
modek
result
clearli
indic
intestin
epithelium
reactiv
toward
environment
chang
induc
commens
bacteri
strain
l
reuteri
even
presenc
alreadyestablish
microbiota
induct
transient
iec
activ
may
help
maintain
mucos
homeostasi
recent
studi
administ
readminist
non
colon
strain
l
reuteri
wash
phase
studi
iec
respons
second
exposur
strain
proport
two
major
intestin
bacteri
phyla
bacteroidet
firmicut
chang
obes
human
anim
model
obes
propos
mechan
bacteri
contribut
obes
includ
higher
polysaccharid
util
efficaci
higher
de
novo
hepat
lipogenesi
reduc
express
fastinginduc
adipos
factor
fiaf
convent
germfre
mice
aim
identifi
bacteri
speci
influenc
host
energi
metabol
dietari
factor
contribut
effect
germfre
convent
mice
fed
either
low
fat
lf
high
fat
hf
diet
germfre
mice
hf
diet
higher
energi
uptak
lower
energi
expenditur
convent
control
result
higher
bodi
weight
bodi
fat
content
germfre
convent
mice
fed
hf
diet
macronutri
proport
differ
carbohydr
fatti
acid
composit
germfre
mice
gain
less
bodi
weight
convent
anim
detect
higher
fiaf
mrna
level
intestin
mucosa
germfre
anim
fail
demonstr
elev
fiaf
protein
level
quantif
bacteria
use
oligonucleotid
probe
firmicut
bacteroid
reveal
dramat
chang
microbiota
composit
induc
chang
diet
standard
chow
purifi
experiment
diet
mice
fed
standard
chow
total
bacteria
detect
three
probe
percentag
decreas
anim
fed
lf
diet
hf
diet
respect
sequenc
analysi
taxonom
assign
rrna
gene
fragment
reveal
erysipelotrichacea
strongli
increas
respons
hf
diet
noth
known
role
bacteri
famili
intestin
conclud
hostbacteria
interact
influenc
energi
metabol
type
dietari
carbohydr
fat
modifi
interplay
host
bacteria
adher
properti
probiot
e
coli
strain
nissl
regard
human
gut
biopsi
human
epitheli
cell
line
troge
inst
molekular
infektionsbiologi
germani
e
coli
strain
nissl
ecn
probabl
one
best
studi
probiot
administ
contribut
health
although
mani
find
mechan
probiot
effect
much
known
adher
human
surfac
perform
adhes
assay
cryosect
human
gut
biopsi
differ
human
epitheli
cellslin
ecn
abl
adher
cryosect
human
gut
tissu
adhes
effici
depend
gut
part
observ
high
adhes
rate
termin
ileum
colon
descenden
wherea
adhes
colon
ascenden
colon
transversum
low
addit
could
show
adhes
effici
ecn
could
markedli
decreas
addit
polygalturonicacid
pectic
oligosaccharid
test
differ
ecnmut
abl
demonstr
express
flagella
necessari
success
adhes
cryosect
human
gut
biopsi
flicdelet
mutant
nonadher
contrast
mutant
ecn
adher
also
effici
celllin
howev
surprisingli
decreas
adhes
effici
flicdelet
mutant
indic
anoth
structur
must
respons
effect
adhes
human
epitheli
celllin
therefor
test
adhesindefici
mutant
also
exclud
capsul
curli
play
role
adhes
result
indic
ecn
use
differ
adhesin
depend
surfac
adher
express
flagella
import
attach
crypt
human
gut
respons
structur
adhes
human
epitheli
cell
go
identifi
probiot
microorgan
benefit
host
strengthen
barrier
digest
tract
modul
immun
respons
prevent
pathogen
infect
previou
effort
us
research
gener
germfre
lepidopteran
larva
demonstr
exist
healthpromot
bacteria
insect
gut
laboratori
cultiv
metagenom
enumer
carri
identifi
probiot
bacteria
gut
egyptian
cotton
leafworm
spodoptera
littorali
unexpectedli
low
number
bacteria
speci
identifi
laboratoryrear
insect
speci
metabol
activ
bacteri
commun
vari
locat
locat
digest
tract
time
time
insect
age
insect
shift
one
food
sourc
anoth
high
intestin
escherichia
coli
number
ibd
patient
indic
import
role
organ
chronic
gut
inflamm
especi
virul
e
coli
genotyp
frequent
detect
ibd
aim
find
whether
gut
inflamm
ibd
mous
model
associ
particular
e
coli
strain
addit
want
explor
bacteri
trait
involv
adapt
e
coli
inflammatori
condit
gut
intestin
content
tissu
materi
taken
differ
age
interleukin
defici
mice
respect
wild
type
anim
inflamm
caecum
colon
detect
anim
eighth
week
life
accompani
decreas
intestin
microbi
divers
compar
healthi
wild
type
anim
sequenc
analysi
bacteri
rrna
gene
indic
mice
harbour
significantli
higher
proport
e
coli
blautia
producta
entercoccu
gallinarum
gut
healthi
control
cultur
base
molecular
approach
show
intestin
number
e
coli
significantli
increas
age
mice
compar
wild
type
anim
anim
colon
one
singl
e
coli
strain
belong
virulenceassoci
phylogenet
group
high
number
virul
fit
associ
gene
detect
strain
genom
real
time
pcr
analysi
e
coli
virul
gene
use
bacteri
rna
isol
caecal
content
week
old
wild
type
mice
reveal
moreov
neuc
gene
involv
capsul
synthesi
strain
fold
upregul
inflammatori
condit
find
suggest
capsul
possibl
involv
adapt
isol
e
coli
strain
inflammatori
condit
murin
gut
ecn
well
defin
probiot
strain
effect
maintain
remiss
ulcer
coliti
rembacken
id
aim
studi
explor
safeti
aspect
frequent
use
probiot
strain
immun
defici
host
therefor
germfre
mice
monocolon
ecn
upon
transplant
cell
healthi
donor
mice
e
coli
nissl
monocolon
mice
die
analysi
bacteri
load
peripher
organ
reveal
massiv
transloc
ecn
contrast
spf
mice
protect
even
though
number
bacteria
intestin
differ
furthermor
ecn
monocolon
mice
show
increas
mortal
rate
indic
cell
essenti
either
inhibit
transloc
clearanc
ecn
peripher
organ
transloc
dissemin
ecn
specif
effect
observ
germfre
mice
monocolon
e
coli
mpk
commens
e
coli
strain
isol
murin
intestin
addit
dissemin
ecn
monocolon
mice
flagella
depend
transloc
ecn
ecn
peripher
organ
compar
transloc
wildtyp
ecn
surprisingli
transplant
cell
germfre
mice
monocolon
ecn
increas
mortal
rate
ecn
dissemin
peripher
organ
also
indic
cell
seem
essenti
inhibit
transloc
ecn
clear
dissemin
ecn
indepth
character
humanflora
associ
rodent
model
colon
efficaci
stabil
transplant
human
bacteri
commun
experiment
anim
model
specif
human
diseas
particularli
gutassoci
pathogen
condit
studi
potenti
clinic
intervent
evalu
sever
humanflora
associ
hfa
rodent
model
creat
purpos
howev
import
recogn
hfa
model
equal
strength
weak
must
taken
consider
select
relev
model
studi
specif
human
condit
studi
evalu
popul
efficaci
qualiti
stabil
transplant
human
bacteri
commun
germfre
rat
gf
mice
antibiotictr
mice
use
stateofart
molecular
biolog
tool
termin
restrict
fragment
length
polymorph
trflp
pyrosequenc
trflp
analysi
follow
ordin
multivari
statist
test
reveal
gf
rat
success
colon
hfa
model
emul
origin
human
microbiota
regard
bacteri
speci
present
distribut
global
differ
observ
differ
strain
gf
rat
gf
mice
rule
overal
colon
influenc
recipi
genet
background
pyrosequenc
analysi
select
repres
sampl
use
assess
detail
bacteri
commun
structur
differ
colon
rodent
model
analysi
give
detail
overview
finescal
qualiti
newli
transplant
human
microbiota
overal
work
provid
first
comprehens
report
show
dynam
colon
complex
human
bacteri
commun
differ
hfa
rodent
model
although
gf
rat
effici
model
accept
level
colon
gf
mice
still
make
model
use
tool
particularli
mani
strain
specif
genet
defici
avail
adopt
transfer
tcell
immunodefici
host
well
known
model
inflammatori
bowel
diseas
develop
coliti
model
associ
accumul
activ
tcell
phenotyp
colon
lamina
propria
result
sever
coliti
factor
drive
tcell
respons
like
exampl
tcell
subset
bacteri
antigen
induc
inflammatori
respons
well
apc
stimul
respons
still
defin
monocolon
germfre
either
b
vulgatu
e
coli
mpk
analyz
specif
pathogen
free
spf
convent
cv
mice
differ
composit
intestin
microbiota
differ
colon
mice
transplant
tcell
healthi
donor
mice
monitor
sign
intestin
inflamm
furthermor
histopatholog
chang
phenotyp
tcell
dc
clp
analyz
spf
mice
show
sign
intestin
inflamm
contrast
cv
mice
develop
sever
coliti
analysi
intestin
microbiota
reveal
induct
coliti
cv
mice
associ
increas
e
coli
decreas
bacteroidet
compar
spf
mice
treatment
cv
mice
b
vulgatu
abl
prevent
induct
coliti
line
abl
detect
significantli
decreas
bacteroid
e
colir
children
suffer
crohn
diseas
data
might
indic
intestin
proport
e
coli
bacteroidet
might
import
factor
induct
prevent
coliti
genet
predispos
host
u
reischl
institut
medic
microbiolog
hygien
univers
hospit
regensburg
regensburg
germani
driven
numer
methodolog
technic
advanc
well
manifold
effort
autom
standard
critic
step
within
sampl
prepar
amplif
sequencespecif
detect
amplicon
nucleic
acidbas
assay
turn
highli
demand
sophist
technolog
routin
analyt
procedur
grow
accept
novel
technolog
field
diagnost
microbiolog
broad
avail
individu
open
platform
perform
exponenti
grow
spectrum
inhous
commerci
prefabr
pcr
nat
assay
gow
demand
appropri
qualiti
control
qc
activ
therefor
program
extern
valid
diagnost
natbas
assay
time
activ
german
societi
hygien
microbiolog
dghm
organ
instand
ev
germani
wwwinstandevd
subset
wellestablish
qualiti
control
initi
term
bacteri
genom
detect
pcr
nat
spectrum
cover
target
organs
expand
perman
present
offer
certifi
profici
test
panel
promin
bacteri
pathogen
semiannu
basi
talk
focu
concept
uniqu
sampl
design
discuss
practic
aspect
well
notic
problem
experienc
past
round
pcrnat
profici
test
neisseria
gonorrhoea
chlamydia
trachomati
bordetella
pertussi
helicobact
pylori
ehec
borrelia
burgdorferi
legionella
pneumophila
salmonella
enteritica
listeria
spp
mrsa
chlamydia
pneumonia
mycoplasma
pneumonia
help
select
exampl
relev
benchmark
summar
overal
assess
result
report
particip
laboratori
depict
valu
test
discrimin
activ
inact
tubercul
infect
still
unclear
patient
pulmonari
extrapulmonari
tuberculosi
tb
test
compar
patient
nonspecif
pulmonari
diseas
patient
symptomat
tubercul
infect
diagnos
clinic
appear
convent
method
microscopi
pcr
cultur
level
gamma
interferon
gi
iuml
median
iuml
measur
quantiferontb
gold
intubetest
thu
low
gi
concentr
especi
iuml
patient
suspect
tb
infiltr
lung
fever
unknown
origin
extrapulmonari
find
suspect
tb
regard
low
probabl
symptomat
tb
infect
group
low
gi
concentr
convent
method
show
neg
result
tb
combin
diagnost
result
hospit
stay
tuberculosi
could
exclud
confirm
neg
predict
valu
low
ig
level
except
patient
proven
tb
immunosuppress
eg
rheumatoid
arthriti
therapi
patient
genet
immunodefici
also
low
gi
concentr
yet
patient
proven
tubercul
lymphadenopathi
mediastinum
neck
extrapulmonari
manifest
tuberculosi
show
high
gi
concentr
iuml
case
report
present
low
level
gi
obvious
associ
low
probabl
activ
tb
wherea
high
level
indic
activ
tb
clinic
sign
diseas
present
nevertheless
convent
microbiolog
test
direct
identif
microorgan
still
remain
method
choic
daili
clinic
routin
lyme
borreliosi
lb
tickborn
disord
caus
spirochet
b
burgdorferi
germani
number
incid
case
estim
rang
annual
lb
remain
primarili
clinic
diagnosi
case
laboratori
support
essenti
lb
gener
respons
antimicrobi
chemotherapi
variabl
clinic
pictur
persist
symptom
follow
treatment
patient
ongo
problem
qualiti
standard
diagnost
test
complic
medic
manag
lb
patient
unfortun
littl
known
result
econom
impact
lb
german
health
care
system
gilead
project
focus
better
character
diseas
burden
medic
cost
lb
germani
analyz
inand
outpati
data
concern
treatment
laboratori
test
provid
german
health
insur
compani
cover
million
member
medic
epidemiolog
econom
data
icdand
ebmcod
current
investig
identifi
total
number
case
definit
suspect
lb
analyz
number
diagnost
test
antibiot
treatment
initi
result
suggest
diagnosi
lb
code
million
insur
member
time
number
hospit
patient
suspect
definit
lb
account
case
number
diagnost
test
order
turn
eia
immunoblot
moreov
total
number
antibiot
treatment
administ
concern
outpati
sector
investig
also
reveal
total
number
eia
immunoblot
reimburs
health
care
provid
studi
first
investig
medic
econom
burden
lb
german
healthcar
system
suggest
high
amount
inappropri
healthcar
servic
find
come
gilead
project
help
assess
econom
current
futur
diseas
manag
prevent
program
toxoplasmapcr
clinic
applic
extern
qualiti
control
reiterowona
arrien
hoerauf
institut
medizinisch
mikrobiologi
immunologi
und
parasitologi
immip
bonn
bonn
germani
pcr
becom
indispens
tool
detect
toxoplasma
gondii
sampl
patient
congenit
ocular
reactiv
infect
clinic
practic
perform
techniqu
influenc
optim
time
sampl
sampl
volum
amount
parasit
nonparasit
dna
sensit
usual
lower
untreat
immunocompet
immunocomprom
patient
exampl
shown
present
toxoplasmapcr
consist
varieti
differ
hous
assay
standard
therefor
extern
qualiti
assess
programm
start
instand
ev
panel
three
blood
sampl
stabil
contain
toxoplasmadna
toxoplasma
genom
equival
tge
tachyzoit
distribut
twice
year
stabil
sampl
gave
reproduc
result
store
room
temperatur
retest
period
three
year
particip
laboratori
mean
per
distribut
prefer
inhous
assay
neither
inhibit
fals
posit
result
report
percentag
correct
result
vari
tgesampl
tachyzoitessampl
protocol
perform
quantit
result
particip
differ
wide
singl
protocol
prove
superior
other
conclus
extern
qualiti
control
blood
sampl
promis
step
toward
valid
toxoplasmapcr
clinic
practic
refer
materi
may
help
increas
sensit
improv
standard
consist
goal
miq
initi
establish
improv
german
diagnost
standard
field
medic
microbiolog
purpos
expert
consensu
reach
everi
gener
topic
specif
analyt
procedur
includ
preanalyt
issu
basic
extend
microbiolog
analysi
diagnost
laboratori
report
interpret
aspect
well
qualiti
assur
consensu
statement
support
extens
literatur
review
final
revis
new
standard
edit
approv
support
medic
societi
respect
field
revis
period
rang
year
depend
extent
diagnost
develop
specif
field
current
sever
miq
project
close
public
includ
revis
nucleic
acid
amplif
techniqu
miq
parasit
diseas
miq
mycobacteria
miq
infect
skin
subcutan
tissu
miq
lower
respiratori
tract
infect
miq
well
new
miq
project
ocular
infect
myopericard
valid
microbiolog
laboratori
advanc
stage
revis
miq
project
gastrointestin
infect
new
miq
project
periton
symposium
select
aspect
recent
publish
almost
publish
miq
interest
larger
audienc
present
moreov
report
current
statu
recognit
miq
standard
awmf
final
use
dghm
confer
approach
specialist
revis
first
public
miq
project
genit
infect
multiresist
bacteria
miq
procedur
qualiti
standard
integr
part
qualiti
assur
initi
deutsch
gesellschaft
hygien
und
mikrobiologi
provid
solid
expertand
literaturebas
practic
recommend
applic
diagnost
microbiolog
laboratori
pig
possibl
reservoir
human
corynebacterium
ulceran
infect
identif
corynebacterium
strain
porcin
nasal
swab
high
fibronectinbind
capac
purifi
evalu
quantit
elisabas
bind
test
phei
possess
higher
fibronectinbind
abil
four
amino
acid
variat
peptid
posit
phei
respons
higher
affin
fibronectin
addit
gelatin
collagen
could
inhibit
fibronectinbind
capac
polypeptid
howev
inhibit
impact
caus
gelatin
collagen
higher
phei
haemaphysali
qinghaiensi
distinct
tick
speci
china
transmit
pathogen
like
theileria
babesia
sheep
goat
yak
cattl
major
econom
burden
anim
husbandri
china
therefor
search
immunolog
control
way
tick
two
cdna
librari
h
qinghaiensi
construct
either
adult
tick
egg
posit
clone
name
screen
polyclon
immun
sera
six
reactiv
clone
fulllength
cdna
sequenc
clone
amplif
cdna
end
race
sequenc
analys
indic
four
clone
encod
myosin
alkali
light
chain
like
protein
calreticulin
troponin
subunit
ribosom
protein
respect
two
clone
novel
gene
tick
tick
salivari
glandassoci
protein
express
profil
determin
rtpcr
cdna
synthes
egg
larva
nymph
adult
western
blot
use
express
purifi
recombin
protein
show
could
recogn
polyclon
immun
sera
gener
immun
rabbit
tick
salivari
gland
extract
react
hyperimmun
sera
h
qinghaiensisinfect
rabbit
strongli
suggest
protein
conceal
antigen
tick
reactiv
recombin
protein
latter
sera
suggest
protein
expos
antigen
tick
antitick
immun
recombin
protein
evalu
laboratori
rear
sheep
vaccin
confer
signific
protect
immun
compar
control
protein
induc
reduct
amount
egg
laid
tick
moreov
immun
sheep
led
decreas
hatch
capabl
egg
result
show
promis
candid
tick
vaccin
molecul
control
h
qinghaiensi
annual
report
nation
refer
center
streptococci
rr
reinert
van
der
linden
nation
refer
centr
streptococci
institut
medic
microbiolog
univers
hospit
rwth
aachen
germani
year
nrc
receiv
streptococc
isol
identif
part
epidemiolog
studi
number
isol
slightli
higher
year
show
continu
accept
refer
center
isol
includ
studi
invas
pneumococc
diseas
children
adult
invas
group
streptococc
diseas
colon
pregnant
women
group
b
streptococci
two
new
analys
establish
serotyp
pcr
superantigen
determin
use
multiplex
pcr
strong
focu
surveil
german
pneumococc
vaccin
program
clear
reduct
ipd
caus
isol
vaccin
serotyp
seen
among
children
year
age
well
among
adult
antibiot
resist
level
among
pneumococci
chang
introduct
new
breakpoint
penicillin
led
lower
level
resist
among
nonmening
isol
higher
level
resist
among
mening
isol
macrolid
resist
level
gone
among
children
adult
respect
reduct
seem
correl
introduct
vaccin
resist
level
clindamycin
tetracyclin
telithromycin
fluoroquinolon
remain
low
group
streptococci
remain
sensit
toward
penicillin
resist
level
macrolid
clindamycin
remain
low
studi
group
b
streptococc
colon
among
pregnant
women
initi
furthermor
two
studi
acut
otiti
media
studi
pneumococc
carriag
among
children
start
project
nation
refer
centr
helicobact
pylori
n
three
month
written
suscept
test
base
recommend
inform
treatment
scheme
chosen
therapi
outcom
collect
use
standard
questionnair
aim
studi
evalu
erad
therapi
success
given
pattern
antimicrobi
resist
deriv
evidencebas
recommend
suscept
test
base
h
pylori
erad
therapi
nrc
focus
establish
nation
guidelin
helicobact
pylori
gastroduoden
ulcer
diseas
furthermor
nrc
particip
european
multicentr
studi
primari
resist
helicobact
pylori
besid
epidemiolog
studi
nrc
engag
molecular
type
multidrug
resist
strain
protocol
detect
resist
mediat
mutat
rrna
clarithromycin
rrna
tetracyclin
rpob
rifampicinrifabutin
gyragen
quinolon
establish
recent
nrc
first
laboratori
succeed
grow
helicobact
pylori
heterotop
gastric
mucosa
hgm
adult
patient
interest
case
isol
helicobact
feli
child
gastric
biopsi
monthli
data
antimicrobi
use
obtain
computeris
pharmaci
databas
consumpt
ie
antimicrobi
usag
densiti
ad
express
daili
defin
dose
ddd
normalis
per
patientday
pd
result
mean
ad
quinolon
icu
pd
rang
mean
percentag
quinolon
total
antibiot
use
quinolon
consumpt
differ
type
icu
interdisciplinari
medic
surgic
total
quinolon
use
significantli
increas
time
mainli
due
increas
moxifloxacin
pd
ad
moxifloxacin
continu
increas
per
month
wherea
use
ciprofloxacin
levofloxacin
stay
stabl
seven
year
ciprofloxacin
use
levofloxacin
use
pd
conclus
quinolon
use
icu
increas
significantli
base
continu
increas
use
moxifloxacin
quinolon
use
contribut
consider
total
antibiot
use
icu
furthermor
quinolon
administ
hospit
substanti
also
ambulatori
set
veterinari
medicin
therefor
class
antibiot
exert
consider
select
pressur
collater
damag
respect
antibiot
resist
region
confin
distribut
b
meningococci
clonal
complex
caus
major
share
invas
meningococc
diseas
imd
europ
year
germani
plagu
recalcitr
rise
imd
area
around
citi
aachen
popul
border
netherland
lead
incid
previou
collabor
german
dutch
institut
show
respons
clone
type
profil
b
prepar
new
zealand
also
experienc
countrywid
epidem
caus
among
strain
b
start
ultim
find
suggest
despit
high
region
incid
western
germani
spread
outbreak
clone
eastand
southward
taken
place
serum
bactericid
antibodi
sba
aachen
type
strain
use
sera
individu
obtain
vaccin
menzbtm
indic
rise
sbatitr
compar
vaccin
strain
individu
sbatitr
vaccin
conclus
result
indic
clone
profil
b
spread
control
region
investig
menzbtm
might
effect
control
clone
object
signific
region
variat
among
serotyp
invas
pneumococc
diseas
ipd
known
far
data
publish
region
differ
among
ipd
germani
method
popul
laboratori
base
surveil
studi
conduct
germani
collect
data
invas
pneumococc
diseas
children
year
adult
year
isol
identifi
use
standard
procedur
includ
bile
solubl
optochin
sensit
result
studi
isol
includ
isol
obtain
children
year
isol
obtain
adult
year
result
classifi
feder
state
supraregion
trend
illustr
classifi
feder
state
region
among
childhood
isol
common
serotyp
serotyp
coverag
conjug
vaccin
vaccin
vaccin
develop
coverag
respect
coverag
vari
consider
among
feder
state
penicillin
g
resist
observ
mening
case
among
adult
common
serotyp
serotyp
coverag
penicillin
g
resist
observ
mening
case
consider
higher
rate
resist
observ
northeast
region
northwest
south
region
conclus
present
studi
describ
remark
region
variat
ipd
germani
adult
children
may
serv
basi
interpret
chang
ipd
background
gener
recommend
pneumococc
conjug
vaccin
children
year
germani
end
juli
activ
search
detect
listeria
monocytogen
blood
cultur
discov
outbreak
febril
gastroenter
contamin
jelli
pork
u
sagel
huhulescu
j
pichler
f
allerberg
binational
konsiliarlabor
listerien
age
agentur
gesundheit
und
wien
austria
background
detect
listeria
monocytogen
blood
cultur
woman
taken
two
day
daytrip
vienna
bratislava
gave
reason
activ
search
case
particip
daytrip
outbreak
investig
stool
seven
particip
avail
examin
three
yield
l
monocytogen
serovar
ident
pattern
dna
fingerprint
diseas
affect
four
person
eat
homemad
meat
dish
includ
jelli
pork
small
restaur
rural
austria
remain
fell
ill
hour
later
age
median
year
fever
diarrhoea
headach
vomit
myalgia
sore
throat
man
recov
gastroenter
hospitalis
day
meal
due
bacteri
mening
epidemiolog
investig
gave
evid
consumpt
meat
dish
includ
jelli
pork
probabl
caus
outbreak
p
addit
microbiolog
examin
found
l
monocytogen
coloni
form
unit
per
gram
homemad
jelli
pork
strain
distinguish
genotyp
human
isol
activ
search
case
visitor
meal
restaur
yield
group
four
person
woman
husband
ate
jelli
pork
fell
ill
rhombenceph
subsequ
discuss
singl
case
system
listeriainfect
suspici
histori
day
trip
abroad
gave
reason
activ
microbiolog
epidemiolog
assess
austrian
consiliari
laboratori
listeria
outbreak
discov
probabl
sourc
found
addit
case
system
infect
enceph
explain
outbreak
dna
microarraybas
genotyp
legionella
pneumophilaserogroup
c
moneck
p
slicker
r
ehricht
institut
medizinisch
mikrobiologi
tu
dresden
dresden
germani
clondiag
gmbh
jena
germani
legionella
pneumophila
commonli
detect
environment
specimen
caus
pneumonia
legionnair
diseas
transmit
suscept
person
due
ubiquit
preval
legionella
water
suppli
system
strain
isol
patient
environment
sourc
compar
molecular
type
purpos
diagnost
microarray
develop
use
characteris
collect
l
pneumophila
isol
gene
use
target
select
previou
studi
et
al
jmm
includ
gene
associ
lipopolysaccharid
synthesi
variabl
genet
element
comparison
seven
gene
sequencebas
type
sbt
scheme
european
work
group
legionella
infect
gaia
et
al
j
clin
microbiol
ratzow
et
al
j
clin
microbiol
appli
identif
strain
highli
reproduc
discrimin
epidemiolog
concord
dna
array
facilit
rapid
reliabl
detect
strainspecif
determin
condit
use
routin
laboratori
array
use
rapid
highthroughput
type
l
pneumophila
serogroup
rapid
identif
clinic
relev
corynebacteria
speci
matrix
assist
laser
desorpt
ioniz
time
flight
malditof
mass
spectrometri
rapid
reliabl
identif
corynebacterium
diphtheria
c
ulceran
essenti
diagnosi
treatment
diphtheria
diphtherialik
diseas
classic
differenti
suspect
isol
done
biochem
test
time
consum
often
give
unclear
result
recent
matrix
assist
laser
desorpt
ioniz
time
flight
malditof
mass
spectrometri
shown
allow
identif
isol
microorgan
within
minut
therefor
fast
altern
speci
differenti
use
technolog
comparison
classic
microbiolog
molecular
method
identif
corynebacteria
show
use
methodolog
malditof
ms
perform
corynebacterium
spp
strain
isol
human
clinic
veterinari
specimen
period
year
german
consiliar
laboratori
diphtheria
show
ident
result
maldi
technolog
use
provid
refer
databas
standard
pattern
match
algorithm
biotyp
softwar
bruker
dalton
compar
biochem
identif
result
obtain
api
coryn
rpob
gene
sequenc
isol
differ
result
malditof
ms
analysi
remain
strain
confirm
two
isol
identifi
genu
level
biochemistri
identifi
c
amycolatum
c
coylea
respect
conclus
test
corynebacteria
correctli
identifi
malditof
ms
bauer
p
ovelhey
j
verspohl
gf
gerlach
institut
mikrobiologi
stiftung
hochschul
hannov
hannov
germani
institut
biometri
epidemiologi
und
informationsverarbeitung
stiftung
hochschul
hannov
hannov
germani
case
clinic
diseas
caus
shiga
toxinproduc
escherichia
coli
stec
human
especi
enterohemorrhag
escherichia
coli
ehec
report
increas
number
ehec
caus
bloodi
nonbloodi
diarrhoea
hemolyt
urem
syndrom
hu
human
fatal
case
acut
renal
failur
uncommon
small
children
year
age
ehecinfect
human
mostli
associ
preced
consum
raw
milk
raw
meat
product
rumin
addit
sandbox
contamin
water
fruit
juic
close
contact
rumin
report
sourc
infect
littl
known
occurr
stecehec
strain
environ
like
poultri
farm
pet
zoo
especi
germani
therefor
order
investig
ehec
sourc
oral
infect
due
consumpt
unpasteur
milk
raw
meet
sampl
pet
zoo
lay
hen
flock
may
septemb
total
faecal
sampl
speci
goat
sheep
chicken
pig
rabbit
guinea
pig
donkey
fallow
deer
kangaroo
cattl
hors
collect
german
pet
zoo
addit
faecal
sampl
environment
swab
eight
feed
sampl
eight
flock
lay
hen
repres
differ
hous
system
investig
collect
faecal
sampl
treat
immunomagnet
separ
im
sorbitol
neg
coloni
isol
test
presenc
hlya
eaea
gene
multiplex
polymeras
chain
reaction
mpcr
could
isol
ehec
six
pet
zoo
goat
rabbit
pig
four
eight
lay
hen
flock
result
impli
sourc
rumin
product
consid
futur
epidemiolog
studi
concern
ehec
transmiss
rout
subtyp
serin
proteas
autotransport
espp
enterohemorrhag
escherichia
coli
differ
concern
structur
function
j
brockmey
sporkmann
bielaszewska
h
karch
institut
hygien
nation
consult
laboratori
hemolyticurem
syndrom
univers
germani
infect
enterohemorrhag
escherichia
coli
ehec
result
sever
clinic
outcom
hemorrhag
coliti
hemolyt
urem
syndrom
hu
lead
caus
acut
renal
failur
children
though
shiga
toxin
consid
major
virul
trait
ehec
potenti
virul
factor
characteris
recent
year
indic
pathogenesi
ehec
infect
multifactori
process
one
addit
virul
factor
autotransport
protein
espp
extracellular
serin
proteas
plasmidencod
shown
cleav
factor
v
human
blood
coagul
cascad
aim
studi
investig
distribut
structur
polymorph
espp
gene
well
function
implic
respect
variat
protein
level
analys
clinic
isol
shiga
toxinproduc
escherichia
coli
stec
ehec
belong
differ
serotyp
abl
distinguish
five
subtyp
espp
within
serotyp
multipl
strain
analys
contain
espp
allel
notabl
espp
subtyp
display
signific
differ
concern
function
encod
protein
distribut
analys
strain
collect
strongli
associ
highli
virul
serotyp
display
full
autotransport
proteolyt
activ
subtyp
either
secret
proteolyt
inact
moreov
subtyp
mostli
occur
strain
lower
virul
conclus
data
demonstr
high
degre
heterogen
espp
among
strain
investig
lead
lack
proteolyt
activ
transport
function
subtyp
despit
genet
divers
function
properti
espp
remain
unchang
virul
strain
support
role
espp
put
virul
factor
ehec
transmiss
mrsa
human
expos
colon
pig
nonexpos
human
c
cuni
f
layer
w
witt
wernigerod
branch
robert
koch
institut
wernigerod
germani
object
mrsa
wide
dissemin
nasal
colon
among
industri
rais
pig
frequent
nasal
swab
human
directli
expos
pig
also
abl
caus
infect
human
knowledg
transmiss
nonexpos
human
import
prerequisit
assess
potenti
risk
human
address
question
studi
nasal
colon
method
studi
perform
farm
mrsa
colon
pig
human
expos
nonexpos
work
live
farm
furthermor
colon
veterinarian
famili
member
investig
address
dissemin
beyond
farm
nasal
swab
pupil
attend
secondari
school
high
densiti
pig
farm
area
investig
nasal
swab
streak
onto
chromagar
mrsa
select
agar
mrsa
detect
type
mean
spatyp
pcrtype
sccmec
element
antibiot
suscept
test
mic
perform
microbroth
assay
result
human
expos
reveal
nasal
carrier
nonexpos
famili
member
posit
accord
multivari
regress
analysi
risk
acquisit
mrsa
time
greater
expos
human
nonexpos
one
antibiot
treatment
sampl
without
influenc
among
veterinarian
attend
pig
farm
n
nasal
colon
found
famili
veterinarian
expos
human
famili
member
reveal
colon
among
pupil
mrsa
detect
live
pig
farm
conclus
alreadi
observ
studi
european
countri
nasal
colon
human
expos
pig
frequent
also
transmiss
low
frequenc
human
live
contact
spread
beyond
farm
obvious
rare
extraintestin
pathogen
e
coli
expec
easili
distribut
environ
mallard
duck
c
ewer
lh
wieler
p
schierack
guenther
institut
mikrobiologi
und
tierseuchen
freie
berlin
berlin
fachhochschul
lausitz
senfenberg
germani
wild
bird
suppos
perfect
nonpoint
sourc
zoonot
pathogen
differ
studi
investig
composit
intestin
flora
identifi
sever
bacteri
speci
could
pose
consider
threat
human
health
consequ
molecular
type
pathogen
howev
rare
perform
case
e
coli
limit
screen
virul
marker
associ
enteropathogen
epec
enterohemorrhag
e
coli
ehec
contrast
studi
unravel
role
freeliv
wild
bird
distribut
extraintestin
pathogen
e
coli
expec
uropathogen
upec
avian
pathogen
apec
new
born
meningit
e
coli
nmec
environment
sourc
therefor
process
fecal
sampl
mallard
duck
e
coli
investig
uniqu
clone
defin
pfge
virul
genotyp
multi
locu
sequenc
type
mlst
vivo
experi
perform
select
strain
clone
identifi
among
e
coli
recov
multipl
individu
none
strain
harbor
shiga
toxin
gene
gene
link
intestin
pathogen
e
coli
occasion
identifi
contrast
strain
possess
consider
number
vag
link
extraintestin
pathogen
e
coli
expec
includ
code
protectin
iron
acquisit
gene
adhesin
pathogen
potenti
select
strain
confirm
chicken
infect
experi
moreov
select
clone
assign
sequenc
type
st
promin
human
expec
strain
includ
well
ecor
group
highli
link
extraintestin
virul
conclus
mallard
duck
consid
import
reservoir
zoonot
e
coli
strain
thu
serv
substanti
nonpoint
sourc
especi
strain
capabl
caus
extraintestin
diseas
coxiella
burnetii
cb
caus
agent
q
fever
could
use
biolog
weapon
differ
genotyp
system
establish
clinic
implement
differenti
natur
occur
outbreak
bioterrorist
act
sequenc
code
transposas
found
multipl
time
cb
genom
denison
et
al
establish
genotyp
system
base
four
region
analyz
pcr
algorithm
propos
denison
et
al
allow
classif
genom
group
v
accord
six
group
deriv
differ
author
use
plasmid
profil
pcr
restrictionendonucleas
digest
dna
order
accomplish
detail
classif
analyz
seven
publish
cb
genom
sequenc
found
differ
align
could
show
present
least
twice
annot
sequenc
extend
publish
system
group
vispecif
five
addit
test
strain
gene
bank
pcr
common
antisens
primer
bind
insid
element
differ
upstream
locat
sens
primer
specif
taken
togeth
accomplish
detail
classif
cb
strain
nine
group
detect
member
group
v
member
group
vi
member
group
iv
qpr
plasmid
member
group
v
plasmidless
chromosom
plasmid
homologu
divid
group
iii
two
major
group
one
hold
qpdv
plasmid
group
two
group
ii
four
cluster
howev
relat
clinic
symptom
cours
diseas
geograph
origin
host
speci
studi
investig
addit
refin
genotyp
system
still
microarray
chip
platform
sever
element
could
analyz
simultan
one
step
therebi
make
method
suitabl
rodent
new
reservoir
stec
ancestor
defin
possibl
reservoir
function
rodent
occurr
stec
faecal
specimen
rodent
studi
total
e
coli
isol
faecal
specimen
wild
live
rodent
test
stecassoci
gene
stx
eae
escv
locat
pathogen
island
pai
locu
enterocyt
effac
lee
pcr
none
strain
harbour
stx
gene
posit
escv
eae
strain
investig
presenc
epec
gene
bfpb
bundleform
pilu
b
eaf
epec
adher
factor
eaec
gene
asta
three
leeposit
strain
harbor
asta
gene
specif
typic
epec
could
detect
therefor
leeposit
strain
design
atyp
epec
aepec
serotyp
reveal
three
strain
ont
four
strain
ont
nm
one
strain
h
respect
furthermor
test
strain
known
insert
site
stx
lambdoid
phage
pcr
atyp
epec
strain
harbor
intact
insert
site
would
potenti
function
possibl
stec
ancestor
multi
locu
sequenc
type
perform
allow
assign
four
strain
four
one
one
strain
order
gain
dnafingerprintprofil
strain
pulsedfield
gel
electrophoresi
perform
yield
ten
complet
distinguish
pfgepattern
data
argu
wild
rodent
reservoir
stec
howev
rodent
e
coli
harbor
lee
anim
seem
reservoir
diarrheagen
aepec
rodent
aepec
potenti
transduc
stxcarri
phage
serotyp
detect
stec
serotyp
rodent
may
act
carrier
prestec
strain
especi
anim
live
farm
environ
studi
need
function
character
phage
transduc
condit
rodent
aepec
function
level
borrelia
anaplasma
rickettsia
babesia
speci
ixod
ricinu
tick
collect
bird
conserv
island
baltic
sea
tickborn
pathogen
like
borrelia
burgdorferi
sensu
lato
anaplasma
phagocytophilum
rickettsia
spot
fever
group
babesia
ssp
known
caus
varieti
differ
diseas
anim
human
although
gain
import
mani
issu
ecolog
eg
reservoir
host
specif
transmiss
cycl
still
unclear
spring
ixod
ricinu
tick
collect
bird
differ
speci
german
bird
conserv
island
baltic
sea
order
test
borrelia
anaplasma
rickettsia
babesia
ssp
infect
identif
pathogen
perform
pcr
restrict
fragment
length
polymorph
sequenc
analysi
major
bird
posit
tick
european
robin
erithacu
rubecula
thrush
turdu
ssp
borrelia
burgdorferi
sensu
lato
dna
detect
anaplasma
phagocytophilum
rickettsia
ssp
babesia
ssp
tick
sampl
coinfect
differ
pathogen
occur
tick
among
rickettsia
infect
identifi
least
two
differ
speci
r
monacensi
r
helvetica
seven
isol
character
rickettsia
spp
character
babesia
infect
result
b
divergen
b
microti
fact
tick
larva
nymph
infect
b
afzelii
suggest
bird
may
contrast
former
studi
also
serv
reservoir
host
speci
furthermor
bird
presum
involv
transstadi
transmiss
anaplasma
sinc
detect
rickettsia
posit
larva
transmiss
pathogen
bird
tick
possibl
two
bird
infest
one
rickettsia
posit
tick
support
hypothesi
fact
found
babesia
microti
babesia
divergen
altogeth
larva
suggest
bird
might
reservoir
babesia
speci
hildebrandt
k
paulik
sachs
e
straub
institut
medic
microbiolog
medic
univers
laboratori
friedrichschillerunivers
jena
germani
far
data
tick
infect
rate
babesia
spp
distribut
anim
reservoir
germani
great
part
europ
avail
possibl
coinfect
borrelia
spp
tickborn
pathogen
like
babesia
spp
great
import
case
human
diseas
difficulti
diagnosi
treatment
occur
investig
preval
borrelia
burgdorferi
sl
babesia
spp
frequent
visit
forest
region
thuringia
zeitzgrund
near
stadtroda
tick
collect
investig
part
ospa
gene
borrelia
burgdorferi
sl
region
gene
babesia
spp
pcr
character
result
restrict
fragment
length
polymorph
sequenc
overal
infect
borrelia
burgdorferi
sl
infect
rate
vari
nymph
adult
borrelia
garinii
detect
frequent
especi
ospa
type
follow
borrelia
burgdorferi
sensu
stricto
borrelia
afzelii
borrelia
valaisiana
subgroup
borrelia
burgdorferi
sl
borrelia
spielmanii
borrelia
valaisiana
subgroup
ii
borrelia
lusitania
investig
tick
infect
sever
borrelia
spp
babesia
specif
dna
detect
tick
infect
rate
nymph
adult
babesia
microti
slightli
preval
babesia
divergen
two
isol
character
babesia
spp
moreov
borrelia
burgdorferi
sl
infect
tick
coinfect
babesia
spp
first
autochthon
case
human
babesia
microti
infect
europ
report
thuringia
recent
find
point
tick
infect
great
heterogen
borrelia
burgdorferi
sl
speci
ospa
type
also
coinfect
babesia
microti
babesia
divergen
studi
distribut
interfer
pathogen
medic
import
develop
reliabl
diagnost
tool
human
diseas
urgent
need
hildebrandt
sachs
e
straub
institut
medic
microbiolog
medic
univers
laboratori
friedrichschillerunivers
jena
germani
among
tickborn
pathogen
rickettsia
spp
anaplasma
phagocytophilum
less
common
emerg
human
diseas
oblig
intracellular
bacteria
taken
consider
tick
infest
spot
fever
group
rickettsia
describ
far
least
known
pathogen
human
anaplasma
phagocytophilum
caus
agent
human
granulocyt
anaplasmosi
hga
germani
valid
data
organ
preval
tick
medic
import
rare
avail
collect
tick
nymph
male
femal
nymph
male
femal
small
forest
area
thuringia
zeitzgrund
near
stadtroda
frequent
use
recreat
activ
individu
tick
investig
part
citrat
synthas
gene
glta
rickettsia
spp
rrna
gene
anaplasma
phagocytophilum
pcr
identif
result
restrict
fragment
length
polymorph
rflp
sequenc
overal
investig
tick
infect
rickettsia
spp
sequenc
posit
amplicon
rickettsia
helvetica
detect
predominantli
preval
vari
differ
development
stage
nymph
adult
anaplasma
phagocytophilum
specif
dna
detect
tick
infect
rate
nymph
adult
tick
coinfect
rickettsia
spp
anaplasma
phagocytophilum
coinfect
found
frequent
adult
compar
nymph
moreov
seem
yearto
year
variat
tick
infect
result
contribut
data
preval
rickettsia
spp
anaplasma
phagocytophilum
germani
studi
circul
cocircul
pathogen
biotop
interfer
reservoir
factor
influenc
infect
rate
like
climat
condit
need
evalu
import
organ
germani
also
part
europ
accompani
develop
reliabl
diagnost
method
hruzik
w
bohn
k
spekker
w
u
institut
medic
microbiolog
georgaugustunivers
germani
institut
medic
microbiolog
heinrichheineunivers
germani
toxoplasma
gondii
agent
toxoplasmosi
protozoan
parasit
infect
cat
primari
host
also
infect
mani
warmblood
mammal
bird
altern
host
two
differ
stage
rapidli
replic
tachyzoit
dormant
bradyzoit
tachyzoit
mainli
found
earli
stage
infect
wherea
bradyzoit
persist
lifelong
within
cyst
tachyzoit
bradyzoit
known
express
stagespecif
antigen
recombinantli
express
e
coli
total
eight
differ
antigen
first
evalu
separ
immunoblot
assay
defin
serum
pool
patient
acut
latent
infect
without
infect
analyz
individu
diagnost
qualiti
antigen
evalu
regard
abil
react
gondiispecif
iga
igm
igg
antibodi
respect
patient
group
establish
lineblot
assay
simultan
test
differ
antigen
lineblot
assay
current
test
use
tool
diagnos
differ
stage
infect
also
diagnos
differ
clinic
manifest
toxoplasmosi
ie
cerebr
toxoplasmosi
retinochorioid
respect
project
part
support
grant
bmbf
preval
autoaggreg
factor
ehaa
human
anim
pathogen
escherichia
coli
b
middendorf
g
mantel
u
dobrindt
h
karch
mellmann
institut
hygien
germani
institut
molekular
infektionsbiologi
germani
background
enterohemorrhag
escherichia
coli
ehec
highli
pathogen
subgroup
intestin
pathogen
e
coli
ipec
besid
shiga
toxin
stx
major
virul
factor
addit
virul
determin
identifi
recent
describ
autoaggreg
factor
ehaa
autotransport
contribut
format
cell
aggreg
biofilm
furthermor
ehaa
mediat
adhes
primari
epitheli
cell
bovin
termin
rectum
ehaa
highli
preval
among
stec
strain
shiga
toxinproduc
e
coli
distribut
among
e
coli
pathotyp
yet
unknown
method
analyz
strain
husec
refer
collect
http
wwwehecorg
presenc
intern
fragment
passeng
transloc
domain
ehaa
pcr
southern
blot
sequenc
analysi
addit
analysi
extend
set
e
coli
isol
abuuti
bovin
mastiti
repres
expec
extraintestin
pathogen
e
coli
result
total
husec
strain
ehaa
posit
amount
correl
previous
report
preval
among
stec
discrep
pcr
southern
blot
result
observ
contrast
preliminari
result
expec
strain
reveal
bovin
mastiti
isol
encod
ehaa
wherea
preval
among
abuuti
isol
seem
lower
conclus
present
data
demonstr
autoaggreg
factor
ehaa
restrict
ehec
stec
also
wide
distribut
expec
though
contribut
protein
pathogenesi
known
detail
yet
might
particip
colon
human
anim
futur
studi
includ
addit
pathotyp
elucid
origin
role
virul
factor
well
ist
contribut
hu
bartonella
speci
gramneg
fastidi
bacteria
b
hensela
found
cat
transmit
human
via
cat
scratch
bite
human
caus
cat
scratch
diseas
associ
mild
sever
clinic
symptom
preval
bartonellosi
among
human
germani
seem
high
sever
clinic
case
describ
howev
data
b
hensela
preval
cat
anim
rare
object
studi
detect
isol
genet
character
bartonella
speci
blood
obtain
cat
germani
studi
analyz
cat
blood
sampl
north
west
germani
bacteri
cultur
pcr
total
blood
sampl
cultur
posit
result
preval
pcrrestrict
fragment
length
polymorph
identifi
isol
b
hensela
one
isol
b
clarridgeia
furthermor
perform
real
time
pcr
base
citrat
synthas
gen
detect
bartonella
speci
blood
sampl
reveal
much
higher
preval
amplifi
fragment
length
polymorph
type
appli
b
hensela
isol
hannov
isol
studi
dendrogram
gener
allow
identif
two
major
cluster
differ
sub
cluster
isol
hannov
seem
relat
belong
subclust
isol
jena
freiburg
addit
isol
subject
multilocu
sequenc
type
two
clonal
complex
compris
sequenc
type
allel
common
nearli
isol
hannov
repres
individu
sequenc
type
alaria
alata
investig
detect
preval
biolog
reemerg
parasit
k
k
hamedi
kabelitz
e
institut
food
hygien
faculti
veterinari
medicin
univers
leipzig
leipzig
germani
brandenburg
der
havel
germani
landkrei
uckermark
prenzlau
germani
distomum
musculorum
sui
dm
mesocercari
stage
trematod
alaria
alata
intestin
parasit
carnivor
regular
life
cycl
parasit
extend
number
paraten
host
recent
incident
background
find
alata
mesocercaria
meat
wild
boar
initi
reassess
potenti
human
health
risk
pose
parasit
sinc
sever
report
human
larval
alariosi
north
america
publish
parasit
infest
human
manifest
variou
clinic
sign
rang
lowgrad
symptom
diffus
unilater
subacut
neuroretin
anaphylact
shock
lethal
consequ
nearli
case
human
alariosi
could
link
consumpt
handl
game
meat
andor
frog
leg
risk
human
gener
ignor
least
postul
neglig
issu
reemerg
europ
et
al
publish
result
repeat
incident
find
dm
meat
wild
boar
trichinella
inspect
certain
area
croatia
germani
feder
institut
risk
assess
conclud
meat
contain
alata
mesocercaria
regard
unfit
human
consumpt
final
risk
assess
could
given
due
lack
inform
preval
dm
suitabl
trichinella
inspect
method
detect
parasit
wild
boar
meat
backdrop
gener
lack
knowledg
relev
area
alaria
biolog
studi
concentr
press
question
optim
andor
develop
method
reliabl
alaria
mesocercaria
detect
distribut
mesoceraria
within
paraten
host
ie
identif
potenti
predilect
site
particularli
wild
boar
preval
sylvat
popul
anim
respect
introduct
food
chain
hemolyt
porcin
intestin
e
coli
without
virul
associ
gene
typic
intestin
pathogen
e
coli
similar
expec
p
schierack
j
weinreich
c
ewer
barth
fachbereich
bcv
hochschul
lausitz
fh
senftenberg
germani
institut
mikrobiologi
und
tierseuchen
freie
berlin
berlin
germani
institut
hygien
und
infektionskrankheiten
der
tier
giessen
giessen
germani
porcin
intestin
pathogen
e
coli
ipec
especi
hemolyt
ipec
carri
typic
virul
associ
gene
vag
faeg
fana
fasa
feda
code
fimbria
eltbip
code
toxin
intestin
hemolyt
e
coli
without
vag
experienc
much
less
attent
routin
laboratori
diagnost
scientif
character
base
recent
result
hypothes
present
studi
porcin
intestin
hemolyt
e
coli
lack
ipectyp
vag
might
similar
extraintestin
pathogen
e
coli
expec
regard
virul
gene
profil
therefor
test
porcin
intestin
hemolyt
e
coli
without
ipectyp
vag
isol
intestin
clinic
healthi
well
diarrheic
pig
presenc
expectyp
vag
character
affili
major
phylogenet
group
pcr
could
show
sever
hemolyt
strain
predominantli
repres
member
ecor
group
carri
broad
varieti
expectyp
vag
detect
gene
hra
papc
sfafoccd
tsh
mat
chua
fyua
irea
iron
iucd
sitd
cvicva
iss
neuc
kpsmt
ii
trat
asta
vat
hlya
ibea
pic
malx
addit
repres
strain
collect
turn
highli
pathogen
system
chicken
infect
model
conclus
show
porcin
intestin
hemolyt
e
coli
without
ipectyp
vag
share
consider
number
virul
featur
expec
present
intestin
clinic
healthi
diseas
pig
could
easili
transmit
environ
therebi
pose
potenti
risk
human
anim
health
ecolog
multilocular
echinococcosi
import
zoonot
diseas
ardebil
provinc
northwest
iran
naddaf
siavashi
dept
parasitolog
pasteur
institut
iran
iran
alveolar
echinococcosi
caus
metacestod
echinococcu
moltiloculari
lethal
helminthiai
human
confin
northern
hemispher
iran
confirm
ae
case
report
ardebil
provinc
establish
control
program
need
know
ecolog
diseas
serolog
screen
resid
detect
worm
carnivor
histopatholog
studi
rodent
region
perform
studi
firstli
one
thousand
one
hundr
resid
villag
includ
stabl
nomad
complex
moghan
plain
select
randomli
fill
questionnair
ml
blood
sampl
collect
person
sera
examin
use
commerci
kit
elisa
second
part
two
valid
highli
sensit
test
nest
pcr
coproelisa
use
detect
adult
worm
infect
carnivor
includ
red
fox
vulp
vulp
dog
one
jackal
fox
jackal
hunt
government
control
program
region
final
stage
rodent
speci
trap
liver
studi
detect
alveolar
cyst
routin
histopatholog
method
parasitolog
laboratori
pasteur
institut
iran
result
resid
posit
ae
infect
age
group
year
old
case
case
rodent
specimen
differ
speci
trap
region
none
posit
alveolar
cyst
case
carnivor
case
test
coproelisa
case
show
posit
case
confirm
nest
pcr
conclus
comparison
result
studi
previou
one
show
reduc
rate
preval
alveolar
echinococcosi
main
reason
distribut
develop
agricultur
growth
urban
limit
habitat
wild
life
region
evalu
immunochromatograph
test
rapid
reliabl
serodiagnosi
human
tularemia
detect
antif
tularensi
antibodi
serum
differ
mammalian
speci
wd
splettstoess
v
guglielmoviret
e
seibold
p
thullier
depart
immunolog
bundeswehr
institut
microbiolog
munich
germani
antibodi
technolog
group
depart
transmiss
agent
centr
de
recherch
du
servic
de
de
la
tronch
franc
aim
tularemia
highli
contagi
infecti
zoonosi
transmiss
inocul
ingest
inhal
infecti
agent
francisella
f
tularensi
speci
rang
mice
men
shown
develop
clinic
infect
although
serolog
still
consid
cornerston
tularemia
diagnosi
fast
costeffect
assay
could
also
deploy
outbreak
situat
affect
remot
area
countri
limit
resourc
method
overcom
problem
develop
rapid
test
tularemia
serolog
base
later
flow
techniqu
analyz
sera
antibodi
prepar
deriv
human
five
differ
speci
specimen
test
parallel
serum
agglutin
elisa
new
assay
result
novel
test
effici
detect
f
tularensisspecif
antibodi
sera
human
mammalian
speci
nonhuman
primat
pig
rabbit
mous
new
tool
requir
none
minim
laboratori
equip
result
obtain
within
minut
compar
method
microagglutin
shown
specif
elisa
ict
sensit
posit
sera
test
specif
neg
sera
test
human
sera
anim
sera
overal
sensit
posit
sera
test
specif
also
neg
sera
test
conclus
develop
evalu
novel
costeffect
simpl
diagnost
test
detect
f
tularensisspecif
antibodi
serum
human
mammalian
speci
within
minut
besid
confirm
clinic
suspect
tularemia
case
ict
could
also
use
valuabl
tool
monitor
success
vaccin
live
vaccin
strain
contain
lp
eg
lv
detect
seroconvert
individu
anim
outbreak
situat
context
epidemiolog
surveil
program
b
middendorf
von
der
beck
mellmann
institut
hygien
germani
enterohemorrhag
e
coli
ehec
strain
highli
pathogen
subgroup
shiga
toxin
stx
produc
e
coli
stec
caus
sever
human
diseas
includ
bloodi
diarrhea
hemolyt
urem
syndrom
hu
besid
stx
virul
factor
take
part
diseas
develop
investig
presenc
characterist
bacteriocin
natur
antimicrobi
peptid
secret
respect
organ
within
strain
husec
collect
husec
strain
collect
consist
wellcharacter
ehec
isol
http
wwwehecorg
serv
refer
collect
husassoci
ehec
within
collect
presenc
nine
differ
bacteriocin
microcin
colicin
iaib
v
n
investig
use
specif
pcr
dotblot
hybrid
subsequ
pcr
product
sequenc
analysi
total
pcr
husec
strain
contain
least
one
bacteriocin
encod
gene
six
nine
differ
bacteriocin
detect
colicin
v
colicin
n
microcin
detect
crosscheck
dotblot
result
confirm
posit
pcr
result
addit
dotblot
hybrid
gave
posit
signal
strain
addit
gene
result
genotyp
analys
corrobor
divers
within
husassoci
ehec
alreadi
shown
base
sequenc
analys
housekeep
gene
underlin
complex
interact
differ
virul
factor
involv
pathogenesi
hu
futur
studi
includ
phylogenet
analysi
determin
origin
bacteriocin
gene
husec
phenotyp
character
function
analysi
bacteriocin
infect
enterohemorrhag
escherichia
coli
ehec
major
caus
hemolyt
urem
syndrom
hu
shiga
toxin
stx
especi
believ
repres
major
virul
factor
ehec
contribut
hu
pathogenesi
besid
ehecassoci
hu
hereditari
atyp
form
hu
mostli
caus
mutat
complement
regul
aim
present
studi
investig
whether
complement
also
involv
pathogenesi
ehecinduc
typic
hu
either
activ
directli
indirectli
involv
ist
inhibitor
purifi
markedli
activ
complement
via
altern
pathway
found
bind
factor
h
fh
howev
activ
appar
cleavag
destruct
fh
visibl
cofactor
activ
fluid
phase
unaffect
clearli
delay
surfac
attach
fh
essenti
host
cell
protect
bind
studi
use
fh
construct
reveal
bind
short
consensu
repeat
scr
scr
scr
ie
region
involv
surfac
recognit
function
fh
conclus
complement
particular
factor
h
play
import
role
atyp
hu
probabl
also
ehecinduc
hu
enterohemorrhag
escherichia
coli
ehec
highli
pathogen
subgroup
intestin
pathogen
e
coli
caus
hemolyt
urem
syndrom
hu
common
caus
acut
renal
failur
children
worldwid
recent
studi
shown
ehec
genom
static
flexibl
react
quickli
milieu
chang
cours
infect
loos
shiga
toxin
stx
encod
gene
also
gene
yet
unknown
function
aim
studi
character
loss
gain
ehec
gene
infect
studi
genom
chang
wholegenom
microarray
analysi
two
ehec
isol
patient
suffer
hu
perform
first
strain
isol
stool
sampl
acut
phase
infect
followup
strain
isol
day
later
confirm
genet
chang
crosscheck
pcr
total
gene
examin
gene
show
differ
first
subsequ
isol
infect
gene
lost
five
gene
acquir
thirtytwo
gene
locat
genom
island
oi
includ
also
stx
operon
nine
gene
encod
differ
hypothet
protein
microarray
result
eight
gene
clearli
confirm
pcr
remain
gene
clear
loss
gain
gene
detect
pcr
probabl
due
chang
copi
number
studi
confirm
flexibl
ehec
genom
cours
infect
futur
studi
investig
chang
nucleotid
level
use
wholegenom
sequenc
variabl
gene
unknown
function
clarifi
genet
mechan
underli
chang
may
final
lead
better
understand
also
host
factor
contribut
genet
variabl
role
bacteri
gut
microbiota
innat
immun
campylobact
jejuni
infect
investig
mous
model
intestin
inflamm
mm
heimesaat
r
plickert
fischer
ub
bereswil
institut
mikrobiologi
und
hygien
abteilung
mikrobiologi
berlin
campu
benjamin
franklin
berlin
germani
despit
preval
campylobact
jejuni
infect
import
associ
intestin
system
diseas
worldwid
still
unclear
mechan
c
jejuni
caus
diarrhea
inflamm
actual
investig
intestin
innat
immun
respons
toward
commens
gut
bacteria
anim
model
intestin
inflamm
provid
deeper
understand
role
intestin
commens
microflora
correspond
host
receptor
inflammatori
bowel
diseas
howev
detail
insight
c
jejuni
pathogenesi
bacteriahostinteract
restrict
lack
adequ
anim
model
recent
establish
experiment
tool
address
question
c
jejuni
interact
innat
immun
system
determin
potenti
role
commens
gut
bacteria
c
jejuni
infect
oral
infect
experi
reveal
gnotobiot
mice
gener
quintupl
antibiot
treatment
effect
colon
c
jejuni
refer
strain
high
concentr
wherea
mice
normal
flora
complet
erad
pathogen
within
one
day
past
infect
importantli
colon
resist
display
healthi
mice
complet
abrog
intestin
inflamm
mice
acut
ileiti
chronic
coliti
c
jejuni
colon
entir
gastrointestin
tract
transloc
mesenter
lymph
node
spleen
liver
cardiac
blood
conclud
intestin
inflamm
might
predispos
host
infect
gastrointestin
pathogen
might
prevent
implic
patient
chronic
inflammatori
bowel
diseas
emerg
camrsa
infect
human
caus
mrsa
main
reservoir
anim
w
witt
f
layer
c
cuni
wernigerod
branch
robert
koch
institut
wernigerod
germani
object
mrsa
wide
dissemin
nasal
colon
pig
livestock
human
profession
expos
colon
anim
report
emerg
caus
deep
seat
infect
skin
soft
tissu
human
method
mrsa
skin
soft
tissu
infect
human
sent
author
laboratori
german
nation
refer
centr
character
isol
type
mean
spatyp
sccmec
type
microbroth
mic
assay
antibiot
suscept
attribut
spatyp
clonal
complex
perform
mean
burp
algorithm
result
among
mrsa
isol
origin
abscess
furuncl
assign
correspond
preval
camrsa
pvl
frequent
pvl
po
camrsa
associ
particular
spatyp
spa
isol
resist
erythromycin
clindamycin
fusid
acid
partli
also
cotrimoxazol
suscept
linezolid
rifampicin
fusid
acid
fosfomycin
tigecyclin
daptomycin
infect
caus
need
surgic
treatment
human
affect
expos
colon
pig
farmer
veterinarian
conclus
mrsa
abl
caus
deep
seat
infect
human
profession
exposit
livestock
compar
pvlposit
camrsa
reemerg
tularemia
germani
real
increas
incid
consequ
rais
awar
public
health
diagnost
microbiolog
wd
splettstoess
e
seibold
depart
immunolog
bundeswehr
institut
microbiolog
munich
germani
background
sinc
sever
line
evid
indic
increas
tularemia
activ
germani
repres
rise
human
case
grow
number
f
tularensi
infect
divers
anim
speci
tularemia
sever
sometim
fatal
diseas
reason
tri
ascertain
observ
reemerg
due
chang
endemicenzoot
activ
f
tularensi
mainli
relat
increas
applic
novel
improv
diagnost
tool
method
germani
tularemia
report
diseas
human
anim
obtain
analyz
publicli
avail
data
report
case
back
includ
inform
scientif
public
addit
laboratori
record
germani
refer
laboratori
confirm
approxim
human
tularemia
case
last
decad
virtual
infect
anim
sinc
dissect
result
clear
signific
increas
report
tularemia
case
human
well
anim
hare
observ
start
incid
five
time
higher
compar
recent
fiveyear
interv
date
back
highest
annual
incid
occur
year
first
airborn
outbreak
involv
case
notifi
f
tularensi
firstli
isol
blood
five
patient
result
least
one
addit
laboratoryacquir
infect
conclus
although
diagnost
capac
partial
improv
veterinari
well
public
health
clinic
laboratori
emend
sole
explain
rise
report
tularemia
case
human
anim
first
epidemiolog
well
ecolog
studi
reveal
tularemia
certainli
underestim
largescal
longitudin
studi
necessari
explor
whole
extent
sever
zoonosi
germani
recent
cowpox
viru
cpxv
infect
human
europ
transmit
cat
pet
rat
risen
public
awar
rare
zoonosi
base
serosurvey
wild
rodent
regard
primari
reservoir
host
howev
attempt
isol
caus
viru
fail
far
cat
becom
infect
hunt
could
therefor
serv
sentinel
determin
possibl
genet
variat
cpxv
strain
circul
local
wild
rodent
retrospect
studi
analys
formalinfix
paraffinembed
skin
sampl
cat
histolog
proven
cpxv
infect
regard
appear
intracytoplasm
eosinophil
atyp
inclus
bodi
pathognom
marker
cpxv
infect
specimen
collect
differ
part
germani
follow
dna
extract
part
hemagglutinin
ha
gene
bp
could
amplifi
one
specimen
therebi
confirm
diagnosi
cpxv
infect
base
light
microscopi
amplif
entir
open
read
frame
bp
possibl
major
specimen
due
dna
degrad
caus
fixat
formalin
howev
sequenc
part
ha
gene
subsequ
follow
blast
search
allow
identif
cpxv
sequenc
could
alloc
differ
cpxv
genotyp
describ
phylogenet
analysi
infer
geograph
distribut
impos
map
base
known
variat
among
cpxv
isol
central
europ
also
confirm
studi
cpxv
might
origin
central
europ
geograph
hostrel
independ
evolut
might
explain
genet
diverg
seen
today
vaccin
arguabl
success
medic
intervent
becom
mandatori
part
mani
countri
health
care
program
shown
effect
instrument
infecti
diseas
control
develop
launch
novel
vaccin
seen
turn
around
late
trend
trigger
appear
novel
pathogen
appar
stagnat
control
rebound
global
infecti
diseas
pend
threat
pandem
flu
spread
multi
drugresist
pathogen
encourag
progress
made
scientif
field
immunolog
molecular
biolog
genom
hostparasit
interact
also
arena
novel
manufactur
technolog
enabl
facilit
develop
novel
vaccin
vaccin
base
vulner
sometim
outdat
manufactur
sourc
becom
flank
even
replac
novel
cell
cultur
product
seen
introduct
cell
cultur
flu
jev
vaccin
furthermor
genom
approach
help
identifi
protect
antigen
stimul
develop
novel
protein
subunit
vaccin
advanc
clinic
trial
howev
induct
protect
immun
often
fail
due
lack
immunogen
vaccin
antigen
absenc
adjuv
thu
adjuv
recogn
mean
overcom
difficulti
potent
exist
vaccin
also
design
novel
vaccin
hand
also
new
needlefre
deliveri
technolog
potenti
facilit
efficaci
exist
vaccin
enabl
novel
vaccin
virtu
depos
antigen
site
concentr
apc
highest
e
g
epidermi
exampl
novel
skin
patch
deliveri
technolog
develop
demonstr
facilit
efficaci
panflu
vaccin
upon
inject
also
enabl
develop
etec
vaccin
travel
diarrhea
virus
belong
picornavirida
famili
character
positivestrand
rna
genom
kb
pack
capsid
nm
viru
famili
display
import
genet
variabl
recent
mani
new
genotyp
speci
even
genera
identifi
addit
genet
divers
spectrum
associ
diseas
caus
virus
larg
rang
common
cold
poliomyel
enteroviru
genu
prototyp
exampl
heterogen
genet
phenotyp
level
contain
speci
infect
human
includ
rhinoviru
speci
despit
common
genom
featur
rhinovirus
restrict
respiratori
tract
wherea
enterovirus
infect
gastrointestin
tract
spread
site
heart
central
nervou
system
rhinoand
enterovirus
also
character
import
genet
variabl
exemplifi
exist
around
differ
serotyp
recent
discoveri
new
enteroviru
genotyp
rhinoviru
c
speci
present
focus
follow
three
aspect
relat
genu
develop
molecular
tool
detect
quantif
rhinoviru
enteroviru
serotyp
allow
better
appreci
incid
virus
phylogenet
comparison
rhinoviru
enteroviru
refer
serotyp
character
previous
unknown
cisact
replic
element
may
serv
classif
tool
molecular
epidemiolog
circul
strain
led
identif
new
respiratori
enteroviru
recombin
rhinovirus
mrsa
visa
vrsa
b
institut
medic
microbiolog
univers
zurich
zurich
switzerland
worldwid
success
prolifer
mrsa
reflect
incred
adapt
chang
stress
methicillin
resist
staphylococcu
aureu
mrsa
express
acquir
resist
determin
low
affin
penicillinbind
protein
howev
resist
level
vari
greatli
strain
lineag
strongli
depend
strain
genet
background
mrsa
initi
confin
hospit
recent
emerg
commun
acquir
pathogen
associ
lower
methicillin
resist
level
increas
growth
rate
mrsa
also
express
vari
degre
resist
heterogen
differ
abil
segreg
subpopul
higher
resist
vancomycin
resist
took
longer
aris
spread
wide
appear
biolog
costli
although
even
small
increas
vancomycin
mic
level
seen
vancomycinintermedi
resist
aureu
visa
caus
therapi
failur
visa
phenotyp
acquir
intrins
accumul
mutat
multipl
genet
pathway
gener
differ
visa
phenotyp
vari
resist
level
heterogen
hamper
identif
visa
genet
phenotyp
method
trait
common
visa
includ
cell
wall
thicken
decreas
peptidoglycan
crosslink
increas
posit
cell
envelop
charg
sequest
repel
vancomycin
prevent
reach
site
action
high
level
vancomycin
resist
due
acquisit
vana
operon
enterococci
even
costli
requir
bacterium
simultan
synthes
new
resist
cell
wall
degrad
normal
suscept
cell
wall
staphylococci
poss
highli
complex
regulatori
network
consist
two
compon
sensortransduc
transcript
regul
sigma
factor
allow
sens
environ
nutrit
statu
cell
integr
enabl
adjust
metabol
control
virul
factor
product
mani
regulatori
circuit
also
strongli
influenc
express
resist
link
resist
growth
rate
carbon
sourc
avail
environment
factor
zychlinski
abteilung
mikrobiologi
maxplanckinstitut
infektionsbiologi
berlin
germani
essenti
initi
inflamm
proteolyt
matur
cytokin
interleukin
il
sever
adaptor
activ
respons
microbi
endogen
danger
signal
assembl
cytosol
protein
complex
call
inflammasom
superoxid
dismutas
regul
activ
maintain
redox
potenti
cytoplasm
regul
mediat
oxid
two
specif
cystein
result
indic
novel
posttransl
mechan
control
mediat
inflamm
immunomodul
microb
gut
j
buer
institut
medic
microbiolog
univers
hospit
essen
univers
duisburgessen
germani
gut
mucosa
continu
expos
potenti
pathogen
benefici
commens
microorgan
lead
constant
immunolog
stimul
creat
requir
regulatori
network
govern
balanc
toler
immun
mucos
cell
must
remain
immunolog
hyporespons
commens
bacteria
retain
capac
respond
pathogen
challeng
uncontrol
persist
effector
cell
respons
drive
onset
sever
intestin
inflamm
discuss
novel
mous
model
new
platform
studi
biolog
impact
new
emerg
cell
subset
maintain
impair
mucos
homeostasi
gut
